root	feature	value
TARGET-30-PAAPFA	age	1762
TARGET-30-PAAPFA	age group	2-6
TARGET-30-PAAPFA	stage	stage 4
TARGET-30-PAAPFA	ATRX	unknown
TARGET-30-PAAPFA	ALK	
TARGET-30-PAAPFA	MYCN	not amplified
TARGET-30-PAAPFA	Histology	unfavorable
TARGET-30-PAAPFA	Grade	unknown
TARGET-30-PAAPFA	Ploidy	unknown
TARGET-30-PAAPFA	Protocol	B954-I03-E04-321P3-321P2
TARGET-30-PAAPFA	Category	unknown
TARGET-30-PAAPFA	1p-	unknown
TARGET-30-PAAPFA	1q+	unknown
TARGET-30-PAAPFA	11q-	unknown
TARGET-30-PAAPFA	17q+	unknown
TARGET-30-PAAPFA	%tumor	
TARGET-30-PAAPFA	MKI	
TARGET-30-PACLJN	age	1475
TARGET-30-PACLJN	age group	2-6
TARGET-30-PACLJN	stage	stage 4
TARGET-30-PACLJN	ATRX	unknown
TARGET-30-PACLJN	ALK	
TARGET-30-PACLJN	MYCN	not amplified
TARGET-30-PACLJN	Histology	unknown
TARGET-30-PACLJN	Grade	unknown
TARGET-30-PACLJN	Ploidy	unknown
TARGET-30-PACLJN	Protocol	B954-I03-323P-321P3
TARGET-30-PACLJN	Category	unknown
TARGET-30-PACLJN	1p-	unknown
TARGET-30-PACLJN	1q+	unknown
TARGET-30-PACLJN	11q-	unknown
TARGET-30-PACLJN	17q+	unknown
TARGET-30-PACLJN	%tumor	
TARGET-30-PACLJN	MKI	
TARGET-30-PACPJG	age	760
TARGET-30-PACPJG	age group	2-6
TARGET-30-PACPJG	stage	unknown
TARGET-30-PACPJG	ATRX	unknown
TARGET-30-PACPJG	ALK	
TARGET-30-PACPJG	MYCN	unknown
TARGET-30-PACPJG	Histology	unknown
TARGET-30-PACPJG	Grade	unknown
TARGET-30-PACPJG	Ploidy	unknown
TARGET-30-PACPJG	Protocol	B954-323P
TARGET-30-PACPJG	Category	unknown
TARGET-30-PACPJG	1p-	unknown
TARGET-30-PACPJG	1q+	unknown
TARGET-30-PACPJG	11q-	unknown
TARGET-30-PACPJG	17q+	unknown
TARGET-30-PACPJG	%tumor	
TARGET-30-PACPJG	MKI	
TARGET-30-PACRYY	age	1314
TARGET-30-PACRYY	age group	2-6
TARGET-30-PACRYY	stage	stage 4
TARGET-30-PACRYY	ATRX	unknown
TARGET-30-PACRYY	ALK	
TARGET-30-PACRYY	MYCN	not amplified
TARGET-30-PACRYY	Histology	unfavorable
TARGET-30-PACRYY	Grade	unknown
TARGET-30-PACRYY	Ploidy	unknown
TARGET-30-PACRYY	Protocol	I03-S31-321P3
TARGET-30-PACRYY	Category	unknown
TARGET-30-PACRYY	1p-	unknown
TARGET-30-PACRYY	1q+	unknown
TARGET-30-PACRYY	11q-	unknown
TARGET-30-PACRYY	17q+	unknown
TARGET-30-PACRYY	%tumor	
TARGET-30-PACRYY	MKI	
TARGET-30-PACRZM	age	3686
TARGET-30-PACRZM	age group	9-
TARGET-30-PACRZM	stage	stage 4
TARGET-30-PACRZM	ATRX	unknown
TARGET-30-PACRZM	ALK	
TARGET-30-PACRZM	MYCN	not amplified
TARGET-30-PACRZM	Histology	unfavorable
TARGET-30-PACRZM	Grade	unknown
TARGET-30-PACRZM	Ploidy	unknown
TARGET-30-PACRZM	Protocol	321P2
TARGET-30-PACRZM	Category	unknown
TARGET-30-PACRZM	1p-	unknown
TARGET-30-PACRZM	1q+	unknown
TARGET-30-PACRZM	11q-	unknown
TARGET-30-PACRZM	17q+	unknown
TARGET-30-PACRZM	%tumor	
TARGET-30-PACRZM	MKI	
TARGET-30-PACSNL	age	2157
TARGET-30-PACSNL	age group	2-6
TARGET-30-PACSNL	stage	stage 4
TARGET-30-PACSNL	ATRX	unknown
TARGET-30-PACSNL	ALK	
TARGET-30-PACSNL	MYCN	not amplified
TARGET-30-PACSNL	Histology	unfavorable
TARGET-30-PACSNL	Grade	unknown
TARGET-30-PACSNL	Ploidy	unknown
TARGET-30-PACSNL	Protocol	B954-B003-S31-321P2
TARGET-30-PACSNL	Category	unknown
TARGET-30-PACSNL	1p-	unknown
TARGET-30-PACSNL	1q+	unknown
TARGET-30-PACSNL	11q-	unknown
TARGET-30-PACSNL	17q+	unknown
TARGET-30-PACSNL	%tumor	
TARGET-30-PACSNL	MKI	
TARGET-30-PACSSR	age	565
TARGET-30-PACSSR	age group	1-2
TARGET-30-PACSSR	stage	stage 4
TARGET-30-PACSSR	ATRX	unknown
TARGET-30-PACSSR	ALK	
TARGET-30-PACSSR	MYCN	not amplified
TARGET-30-PACSSR	Histology	unfavorable
TARGET-30-PACSSR	Grade	unknown
TARGET-30-PACSSR	Ploidy	unknown
TARGET-30-PACSSR	Protocol	B003-321P3
TARGET-30-PACSSR	Category	unknown
TARGET-30-PACSSR	1p-	unknown
TARGET-30-PACSSR	1q+	unknown
TARGET-30-PACSSR	11q-	unknown
TARGET-30-PACSSR	17q+	unknown
TARGET-30-PACSSR	%tumor	
TARGET-30-PACSSR	MKI	
TARGET-30-PACUGP	age	773
TARGET-30-PACUGP	age group	2-6
TARGET-30-PACUGP	stage	stage 4
TARGET-30-PACUGP	ATRX	unknown
TARGET-30-PACUGP	ALK	
TARGET-30-PACUGP	MYCN	not amplified
TARGET-30-PACUGP	Histology	unfavorable
TARGET-30-PACUGP	Grade	unknown
TARGET-30-PACUGP	Ploidy	unknown
TARGET-30-PACUGP	Protocol	B003-321P3-321P2
TARGET-30-PACUGP	Category	unknown
TARGET-30-PACUGP	1p-	unknown
TARGET-30-PACUGP	1q+	unknown
TARGET-30-PACUGP	11q-	unknown
TARGET-30-PACUGP	17q+	unknown
TARGET-30-PACUGP	%tumor	
TARGET-30-PACUGP	MKI	
TARGET-30-PACVNB	age	1610
TARGET-30-PACVNB	age group	2-6
TARGET-30-PACVNB	stage	stage 4
TARGET-30-PACVNB	ATRX	unknown
TARGET-30-PACVNB	ALK	
TARGET-30-PACVNB	MYCN	not amplified
TARGET-30-PACVNB	Histology	unfavorable
TARGET-30-PACVNB	Grade	unknown
TARGET-30-PACVNB	Ploidy	unknown
TARGET-30-PACVNB	Protocol	B954-B003-321P2
TARGET-30-PACVNB	Category	unknown
TARGET-30-PACVNB	1p-	unknown
TARGET-30-PACVNB	1q+	unknown
TARGET-30-PACVNB	11q-	unknown
TARGET-30-PACVNB	17q+	unknown
TARGET-30-PACVNB	%tumor	
TARGET-30-PACVNB	MKI	
TARGET-30-PACYGY	age	1509
TARGET-30-PACYGY	age group	2-6
TARGET-30-PACYGY	stage	stage 4
TARGET-30-PACYGY	ATRX	unknown
TARGET-30-PACYGY	ALK	
TARGET-30-PACYGY	MYCN	unknown
TARGET-30-PACYGY	Histology	unknown
TARGET-30-PACYGY	Grade	unknown
TARGET-30-PACYGY	Ploidy	unknown
TARGET-30-PACYGY	Protocol	B954-B003-0901-321P2
TARGET-30-PACYGY	Category	unknown
TARGET-30-PACYGY	1p-	unknown
TARGET-30-PACYGY	1q+	unknown
TARGET-30-PACYGY	11q-	unknown
TARGET-30-PACYGY	17q+	unknown
TARGET-30-PACYGY	%tumor	
TARGET-30-PACYGY	MKI	
TARGET-30-PACZPX	age	1046
TARGET-30-PACZPX	age group	2-6
TARGET-30-PACZPX	stage	stage 4
TARGET-30-PACZPX	ATRX	unknown
TARGET-30-PACZPX	ALK	
TARGET-30-PACZPX	MYCN	not amplified
TARGET-30-PACZPX	Histology	unknown
TARGET-30-PACZPX	Grade	unknown
TARGET-30-PACZPX	Ploidy	unknown
TARGET-30-PACZPX	Protocol	B003-321P3-321P2
TARGET-30-PACZPX	Category	unknown
TARGET-30-PACZPX	1p-	unknown
TARGET-30-PACZPX	1q+	unknown
TARGET-30-PACZPX	11q-	unknown
TARGET-30-PACZPX	17q+	unknown
TARGET-30-PACZPX	%tumor	
TARGET-30-PACZPX	MKI	
TARGET-30-PADENF	age	987
TARGET-30-PADENF	age group	2-6
TARGET-30-PADENF	stage	stage 4
TARGET-30-PADENF	ATRX	unknown
TARGET-30-PADENF	ALK	
TARGET-30-PADENF	MYCN	not amplified
TARGET-30-PADENF	Histology	unfavorable
TARGET-30-PADENF	Grade	unknown
TARGET-30-PADENF	Ploidy	unknown
TARGET-30-PADENF	Protocol	B003-3891
TARGET-30-PADENF	Category	unknown
TARGET-30-PADENF	1p-	unknown
TARGET-30-PADENF	1q+	unknown
TARGET-30-PADENF	11q-	unknown
TARGET-30-PADENF	17q+	unknown
TARGET-30-PADENF	%tumor	
TARGET-30-PADENF	MKI	
TARGET-30-PADFLI	age	557
TARGET-30-PADFLI	age group	1-2
TARGET-30-PADFLI	stage	stage 4
TARGET-30-PADFLI	ATRX	unknown
TARGET-30-PADFLI	ALK	
TARGET-30-PADFLI	MYCN	not amplified
TARGET-30-PADFLI	Histology	unfavorable
TARGET-30-PADFLI	Grade	undifferentiated or poorly differentiated
TARGET-30-PADFLI	Ploidy	unknown
TARGET-30-PADFLI	Protocol	B954-B003-3891
TARGET-30-PADFLI	Category	neuroblastoma
TARGET-30-PADFLI	1p-	unknown
TARGET-30-PADFLI	1q+	unknown
TARGET-30-PADFLI	11q-	unknown
TARGET-30-PADFLI	17q+	unknown
TARGET-30-PADFLI	%tumor	
TARGET-30-PADFLI	MKI	high
TARGET-30-PADHWC	age	1152
TARGET-30-PADHWC	age group	2-6
TARGET-30-PADHWC	stage	stage 4
TARGET-30-PADHWC	ATRX	unknown
TARGET-30-PADHWC	ALK	
TARGET-30-PADHWC	MYCN	not amplified
TARGET-30-PADHWC	Histology	unfavorable
TARGET-30-PADHWC	Grade	undifferentiated or poorly differentiated
TARGET-30-PADHWC	Ploidy	unknown
TARGET-30-PADHWC	Protocol	B954-B003-3891-R9702
TARGET-30-PADHWC	Category	ganglioneuroblastoma, nodular
TARGET-30-PADHWC	1p-	unknown
TARGET-30-PADHWC	1q+	unknown
TARGET-30-PADHWC	11q-	unknown
TARGET-30-PADHWC	17q+	unknown
TARGET-30-PADHWC	%tumor	
TARGET-30-PADHWC	MKI	low
TARGET-30-PADIEY	age	1817
TARGET-30-PADIEY	age group	2-6
TARGET-30-PADIEY	stage	stage 4
TARGET-30-PADIEY	ATRX	unknown
TARGET-30-PADIEY	ALK	
TARGET-30-PADIEY	MYCN	not amplified
TARGET-30-PADIEY	Histology	unfavorable
TARGET-30-PADIEY	Grade	undifferentiated or poorly differentiated
TARGET-30-PADIEY	Ploidy	unknown
TARGET-30-PADIEY	Protocol	B003-3891-E18
TARGET-30-PADIEY	Category	ganglioneuroblastoma, nodular
TARGET-30-PADIEY	1p-	unknown
TARGET-30-PADIEY	1q+	unknown
TARGET-30-PADIEY	11q-	unknown
TARGET-30-PADIEY	17q+	unknown
TARGET-30-PADIEY	%tumor	
TARGET-30-PADIEY	MKI	intermediate
TARGET-30-PADIHC	age	1916
TARGET-30-PADIHC	age group	2-6
TARGET-30-PADIHC	stage	stage 4
TARGET-30-PADIHC	ATRX	unknown
TARGET-30-PADIHC	ALK	
TARGET-30-PADIHC	MYCN	not amplified
TARGET-30-PADIHC	Histology	unfavorable
TARGET-30-PADIHC	Grade	undifferentiated or poorly differentiated
TARGET-30-PADIHC	Ploidy	unknown
TARGET-30-PADIHC	Protocol	B003-3891-0914-E18
TARGET-30-PADIHC	Category	neuroblastoma
TARGET-30-PADIHC	1p-	unknown
TARGET-30-PADIHC	1q+	unknown
TARGET-30-PADIHC	11q-	unknown
TARGET-30-PADIHC	17q+	unknown
TARGET-30-PADIHC	%tumor	
TARGET-30-PADIHC	MKI	low
TARGET-30-PADINC	age	1004
TARGET-30-PADINC	age group	2-6
TARGET-30-PADINC	stage	stage 4
TARGET-30-PADINC	ATRX	unknown
TARGET-30-PADINC	ALK	
TARGET-30-PADINC	MYCN	amplified
TARGET-30-PADINC	Histology	unfavorable
TARGET-30-PADINC	Grade	undifferentiated or poorly differentiated
TARGET-30-PADINC	Ploidy	unknown
TARGET-30-PADINC	Protocol	B954-B003-3891-E18
TARGET-30-PADINC	Category	neuroblastoma
TARGET-30-PADINC	1p-	unknown
TARGET-30-PADINC	1q+	unknown
TARGET-30-PADINC	11q-	unknown
TARGET-30-PADINC	17q+	unknown
TARGET-30-PADINC	%tumor	
TARGET-30-PADINC	MKI	low
TARGET-30-PADIRB	age	1191
TARGET-30-PADIRB	age group	2-6
TARGET-30-PADIRB	stage	stage 4
TARGET-30-PADIRB	ATRX	unknown
TARGET-30-PADIRB	ALK	
TARGET-30-PADIRB	MYCN	not amplified
TARGET-30-PADIRB	Histology	unfavorable
TARGET-30-PADIRB	Grade	undifferentiated or poorly differentiated
TARGET-30-PADIRB	Ploidy	unknown
TARGET-30-PADIRB	Protocol	B954-B003-3891-E18
TARGET-30-PADIRB	Category	neuroblastoma
TARGET-30-PADIRB	1p-	unknown
TARGET-30-PADIRB	1q+	unknown
TARGET-30-PADIRB	11q-	unknown
TARGET-30-PADIRB	17q+	unknown
TARGET-30-PADIRB	%tumor	
TARGET-30-PADIRB	MKI	low
TARGET-30-PADKFS	age	1567
TARGET-30-PADKFS	age group	2-6
TARGET-30-PADKFS	stage	stage 4
TARGET-30-PADKFS	ATRX	unknown
TARGET-30-PADKFS	ALK	
TARGET-30-PADKFS	MYCN	not amplified
TARGET-30-PADKFS	Histology	unknown
TARGET-30-PADKFS	Grade	unknown
TARGET-30-PADKFS	Ploidy	unknown
TARGET-30-PADKFS	Protocol	N891-B003-3891-E18
TARGET-30-PADKFS	Category	unknown
TARGET-30-PADKFS	1p-	unknown
TARGET-30-PADKFS	1q+	unknown
TARGET-30-PADKFS	11q-	unknown
TARGET-30-PADKFS	17q+	unknown
TARGET-30-PADKFS	%tumor	
TARGET-30-PADKFS	MKI	
TARGET-30-PADKFU	age	1778
TARGET-30-PADKFU	age group	2-6
TARGET-30-PADKFU	stage	stage 4
TARGET-30-PADKFU	ATRX	unknown
TARGET-30-PADKFU	ALK	
TARGET-30-PADKFU	MYCN	not amplified
TARGET-30-PADKFU	Histology	unfavorable
TARGET-30-PADKFU	Grade	undifferentiated or poorly differentiated
TARGET-30-PADKFU	Ploidy	unknown
TARGET-30-PADKFU	Protocol	B003-3891-E18
TARGET-30-PADKFU	Category	ganglioneuroblastoma, nodular
TARGET-30-PADKFU	1p-	unknown
TARGET-30-PADKFU	1q+	unknown
TARGET-30-PADKFU	11q-	unknown
TARGET-30-PADKFU	17q+	unknown
TARGET-30-PADKFU	%tumor	
TARGET-30-PADKFU	MKI	low
TARGET-30-PADKGF	age	554
TARGET-30-PADKGF	age group	1-2
TARGET-30-PADKGF	stage	stage 4
TARGET-30-PADKGF	ATRX	unknown
TARGET-30-PADKGF	ALK	
TARGET-30-PADKGF	MYCN	not amplified
TARGET-30-PADKGF	Histology	unfavorable
TARGET-30-PADKGF	Grade	undifferentiated or poorly differentiated
TARGET-30-PADKGF	Ploidy	unknown
TARGET-30-PADKGF	Protocol	B954-B003-3891-E18
TARGET-30-PADKGF	Category	neuroblastoma
TARGET-30-PADKGF	1p-	unknown
TARGET-30-PADKGF	1q+	unknown
TARGET-30-PADKGF	11q-	unknown
TARGET-30-PADKGF	17q+	unknown
TARGET-30-PADKGF	%tumor	
TARGET-30-PADKGF	MKI	high
TARGET-30-PADKNE	age	1748
TARGET-30-PADKNE	age group	2-6
TARGET-30-PADKNE	stage	stage 4
TARGET-30-PADKNE	ATRX	unknown
TARGET-30-PADKNE	ALK	
TARGET-30-PADKNE	MYCN	amplified
TARGET-30-PADKNE	Histology	unfavorable
TARGET-30-PADKNE	Grade	undifferentiated or poorly differentiated
TARGET-30-PADKNE	Ploidy	unknown
TARGET-30-PADKNE	Protocol	B003-E18-B954-0925-R9702-3891
TARGET-30-PADKNE	Category	neuroblastoma
TARGET-30-PADKNE	1p-	unknown
TARGET-30-PADKNE	1q+	unknown
TARGET-30-PADKNE	11q-	unknown
TARGET-30-PADKNE	17q+	unknown
TARGET-30-PADKNE	%tumor	
TARGET-30-PADKNE	MKI	high
TARGET-30-PADKRU	age	1426
TARGET-30-PADKRU	age group	2-6
TARGET-30-PADKRU	stage	stage 4
TARGET-30-PADKRU	ATRX	unknown
TARGET-30-PADKRU	ALK	
TARGET-30-PADKRU	MYCN	not amplified
TARGET-30-PADKRU	Histology	unfavorable
TARGET-30-PADKRU	Grade	undifferentiated or poorly differentiated
TARGET-30-PADKRU	Ploidy	unknown
TARGET-30-PADKRU	Protocol	B954-B003-3891-E18
TARGET-30-PADKRU	Category	neuroblastoma
TARGET-30-PADKRU	1p-	unknown
TARGET-30-PADKRU	1q+	unknown
TARGET-30-PADKRU	11q-	unknown
TARGET-30-PADKRU	17q+	unknown
TARGET-30-PADKRU	%tumor	
TARGET-30-PADKRU	MKI	intermediate
TARGET-30-PADKVV	age	807
TARGET-30-PADKVV	age group	2-6
TARGET-30-PADKVV	stage	stage 4
TARGET-30-PADKVV	ATRX	unknown
TARGET-30-PADKVV	ALK	
TARGET-30-PADKVV	MYCN	not amplified
TARGET-30-PADKVV	Histology	unfavorable
TARGET-30-PADKVV	Grade	undifferentiated or poorly differentiated
TARGET-30-PADKVV	Ploidy	unknown
TARGET-30-PADKVV	Protocol	B003-3891-E18
TARGET-30-PADKVV	Category	ganglioneuroblastoma, nodular
TARGET-30-PADKVV	1p-	unknown
TARGET-30-PADKVV	1q+	unknown
TARGET-30-PADKVV	11q-	unknown
TARGET-30-PADKVV	17q+	unknown
TARGET-30-PADKVV	%tumor	
TARGET-30-PADKVV	MKI	low
TARGET-30-PADKXS	age	648
TARGET-30-PADKXS	age group	1-2
TARGET-30-PADKXS	stage	stage 4
TARGET-30-PADKXS	ATRX	unknown
TARGET-30-PADKXS	ALK	
TARGET-30-PADKXS	MYCN	amplified
TARGET-30-PADKXS	Histology	unfavorable
TARGET-30-PADKXS	Grade	undifferentiated or poorly differentiated
TARGET-30-PADKXS	Ploidy	unknown
TARGET-30-PADKXS	Protocol	B003-3891-E18
TARGET-30-PADKXS	Category	neuroblastoma
TARGET-30-PADKXS	1p-	unknown
TARGET-30-PADKXS	1q+	unknown
TARGET-30-PADKXS	11q-	unknown
TARGET-30-PADKXS	17q+	unknown
TARGET-30-PADKXS	%tumor	
TARGET-30-PADKXS	MKI	low
TARGET-30-PADKYP	age	1723
TARGET-30-PADKYP	age group	2-6
TARGET-30-PADKYP	stage	stage 4
TARGET-30-PADKYP	ATRX	unknown
TARGET-30-PADKYP	ALK	
TARGET-30-PADKYP	MYCN	amplified
TARGET-30-PADKYP	Histology	unfavorable
TARGET-30-PADKYP	Grade	undifferentiated or poorly differentiated
TARGET-30-PADKYP	Ploidy	unknown
TARGET-30-PADKYP	Protocol	B954-B003-3891-E18
TARGET-30-PADKYP	Category	neuroblastoma
TARGET-30-PADKYP	1p-	unknown
TARGET-30-PADKYP	1q+	unknown
TARGET-30-PADKYP	11q-	unknown
TARGET-30-PADKYP	17q+	unknown
TARGET-30-PADKYP	%tumor	
TARGET-30-PADKYP	MKI	high
TARGET-30-PADLDA	age	4594
TARGET-30-PADLDA	age group	9-
TARGET-30-PADLDA	stage	stage 4
TARGET-30-PADLDA	ATRX	unknown
TARGET-30-PADLDA	ALK	
TARGET-30-PADLDA	MYCN	not amplified
TARGET-30-PADLDA	Histology	unfavorable
TARGET-30-PADLDA	Grade	undifferentiated or poorly differentiated
TARGET-30-PADLDA	Ploidy	unknown
TARGET-30-PADLDA	Protocol	B003-0925-3891-0911-E18
TARGET-30-PADLDA	Category	neuroblastoma
TARGET-30-PADLDA	1p-	unknown
TARGET-30-PADLDA	1q+	unknown
TARGET-30-PADLDA	11q-	unknown
TARGET-30-PADLDA	17q+	unknown
TARGET-30-PADLDA	%tumor	
TARGET-30-PADLDA	MKI	low
TARGET-30-PADLDT	age	805
TARGET-30-PADLDT	age group	2-6
TARGET-30-PADLDT	stage	stage 4
TARGET-30-PADLDT	ATRX	unknown
TARGET-30-PADLDT	ALK	
TARGET-30-PADLDT	MYCN	amplified
TARGET-30-PADLDT	Histology	unfavorable
TARGET-30-PADLDT	Grade	undifferentiated or poorly differentiated
TARGET-30-PADLDT	Ploidy	unknown
TARGET-30-PADLDT	Protocol	B954-B003-3891-E18
TARGET-30-PADLDT	Category	neuroblastoma
TARGET-30-PADLDT	1p-	unknown
TARGET-30-PADLDT	1q+	unknown
TARGET-30-PADLDT	11q-	unknown
TARGET-30-PADLDT	17q+	unknown
TARGET-30-PADLDT	%tumor	
TARGET-30-PADLDT	MKI	intermediate
TARGET-30-PADLES	age	1787
TARGET-30-PADLES	age group	2-6
TARGET-30-PADLES	stage	stage 4
TARGET-30-PADLES	ATRX	unknown
TARGET-30-PADLES	ALK	
TARGET-30-PADLES	MYCN	not amplified
TARGET-30-PADLES	Histology	unfavorable
TARGET-30-PADLES	Grade	undifferentiated or poorly differentiated
TARGET-30-PADLES	Ploidy	unknown
TARGET-30-PADLES	Protocol	B954-B003-3891-E18
TARGET-30-PADLES	Category	neuroblastoma
TARGET-30-PADLES	1p-	unknown
TARGET-30-PADLES	1q+	unknown
TARGET-30-PADLES	11q-	unknown
TARGET-30-PADLES	17q+	unknown
TARGET-30-PADLES	%tumor	
TARGET-30-PADLES	MKI	intermediate
TARGET-30-PADLIC	age	1837
TARGET-30-PADLIC	age group	2-6
TARGET-30-PADLIC	stage	stage 4
TARGET-30-PADLIC	ATRX	unknown
TARGET-30-PADLIC	ALK	
TARGET-30-PADLIC	MYCN	not amplified
TARGET-30-PADLIC	Histology	unfavorable
TARGET-30-PADLIC	Grade	undifferentiated or poorly differentiated
TARGET-30-PADLIC	Ploidy	unknown
TARGET-30-PADLIC	Protocol	B903-B003-3891-E18-B954
TARGET-30-PADLIC	Category	neuroblastoma
TARGET-30-PADLIC	1p-	unknown
TARGET-30-PADLIC	1q+	unknown
TARGET-30-PADLIC	11q-	unknown
TARGET-30-PADLIC	17q+	unknown
TARGET-30-PADLIC	%tumor	
TARGET-30-PADLIC	MKI	high
TARGET-30-PADLJN	age	1041
TARGET-30-PADLJN	age group	2-6
TARGET-30-PADLJN	stage	stage 4
TARGET-30-PADLJN	ATRX	unknown
TARGET-30-PADLJN	ALK	
TARGET-30-PADLJN	MYCN	not amplified
TARGET-30-PADLJN	Histology	unfavorable
TARGET-30-PADLJN	Grade	undifferentiated or poorly differentiated
TARGET-30-PADLJN	Ploidy	unknown
TARGET-30-PADLJN	Protocol	B954-B003-3891-3881-E18
TARGET-30-PADLJN	Category	ganglioneuroblastoma, nodular
TARGET-30-PADLJN	1p-	unknown
TARGET-30-PADLJN	1q+	unknown
TARGET-30-PADLJN	11q-	unknown
TARGET-30-PADLJN	17q+	unknown
TARGET-30-PADLJN	%tumor	
TARGET-30-PADLJN	MKI	low
TARGET-30-PADLKJ	age	780
TARGET-30-PADLKJ	age group	2-6
TARGET-30-PADLKJ	stage	stage 4
TARGET-30-PADLKJ	ATRX	unknown
TARGET-30-PADLKJ	ALK	
TARGET-30-PADLKJ	MYCN	amplified
TARGET-30-PADLKJ	Histology	unknown
TARGET-30-PADLKJ	Grade	unknown
TARGET-30-PADLKJ	Ploidy	unknown
TARGET-30-PADLKJ	Protocol	B903-B003-3891-R9702-E18
TARGET-30-PADLKJ	Category	neuroblastoma
TARGET-30-PADLKJ	1p-	unknown
TARGET-30-PADLKJ	1q+	unknown
TARGET-30-PADLKJ	11q-	unknown
TARGET-30-PADLKJ	17q+	unknown
TARGET-30-PADLKJ	%tumor	
TARGET-30-PADLKJ	MKI	
TARGET-30-PADLNM	age	948
TARGET-30-PADLNM	age group	2-6
TARGET-30-PADLNM	stage	stage 4
TARGET-30-PADLNM	ATRX	unknown
TARGET-30-PADLNM	ALK	
TARGET-30-PADLNM	MYCN	amplified
TARGET-30-PADLNM	Histology	unfavorable
TARGET-30-PADLNM	Grade	undifferentiated or poorly differentiated
TARGET-30-PADLNM	Ploidy	unknown
TARGET-30-PADLNM	Protocol	B003-3891
TARGET-30-PADLNM	Category	neuroblastoma
TARGET-30-PADLNM	1p-	unknown
TARGET-30-PADLNM	1q+	unknown
TARGET-30-PADLNM	11q-	unknown
TARGET-30-PADLNM	17q+	unknown
TARGET-30-PADLNM	%tumor	
TARGET-30-PADLNM	MKI	high
TARGET-30-PADLPR	age	806
TARGET-30-PADLPR	age group	2-6
TARGET-30-PADLPR	stage	stage 4
TARGET-30-PADLPR	ATRX	unknown
TARGET-30-PADLPR	ALK	
TARGET-30-PADLPR	MYCN	not amplified
TARGET-30-PADLPR	Histology	unfavorable
TARGET-30-PADLPR	Grade	undifferentiated or poorly differentiated
TARGET-30-PADLPR	Ploidy	unknown
TARGET-30-PADLPR	Protocol	B954-B003-3891-E18
TARGET-30-PADLPR	Category	neuroblastoma
TARGET-30-PADLPR	1p-	unknown
TARGET-30-PADLPR	1q+	unknown
TARGET-30-PADLPR	11q-	unknown
TARGET-30-PADLPR	17q+	unknown
TARGET-30-PADLPR	%tumor	
TARGET-30-PADLPR	MKI	low
TARGET-30-PADLPZ	age	2577
TARGET-30-PADLPZ	age group	6-9
TARGET-30-PADLPZ	stage	stage 4
TARGET-30-PADLPZ	ATRX	unknown
TARGET-30-PADLPZ	ALK	
TARGET-30-PADLPZ	MYCN	not amplified
TARGET-30-PADLPZ	Histology	unfavorable
TARGET-30-PADLPZ	Grade	undifferentiated or poorly differentiated
TARGET-30-PADLPZ	Ploidy	unknown
TARGET-30-PADLPZ	Protocol	B903-B003-3891-E18-B954
TARGET-30-PADLPZ	Category	ganglioneuroblastoma, nodular
TARGET-30-PADLPZ	1p-	unknown
TARGET-30-PADLPZ	1q+	unknown
TARGET-30-PADLPZ	11q-	unknown
TARGET-30-PADLPZ	17q+	unknown
TARGET-30-PADLPZ	%tumor	
TARGET-30-PADLPZ	MKI	intermediate
TARGET-30-PADLTD	age	950
TARGET-30-PADLTD	age group	2-6
TARGET-30-PADLTD	stage	stage 4
TARGET-30-PADLTD	ATRX	unknown
TARGET-30-PADLTD	ALK	
TARGET-30-PADLTD	MYCN	amplified
TARGET-30-PADLTD	Histology	unfavorable
TARGET-30-PADLTD	Grade	undifferentiated or poorly differentiated
TARGET-30-PADLTD	Ploidy	unknown
TARGET-30-PADLTD	Protocol	B954-B003-3891
TARGET-30-PADLTD	Category	neuroblastoma
TARGET-30-PADLTD	1p-	unknown
TARGET-30-PADLTD	1q+	unknown
TARGET-30-PADLTD	11q-	unknown
TARGET-30-PADLTD	17q+	unknown
TARGET-30-PADLTD	%tumor	
TARGET-30-PADLTD	MKI	intermediate
TARGET-30-PADMGA	age	1827
TARGET-30-PADMGA	age group	2-6
TARGET-30-PADMGA	stage	stage 4
TARGET-30-PADMGA	ATRX	unknown
TARGET-30-PADMGA	ALK	
TARGET-30-PADMGA	MYCN	not amplified
TARGET-30-PADMGA	Histology	unfavorable
TARGET-30-PADMGA	Grade	undifferentiated or poorly differentiated
TARGET-30-PADMGA	Ploidy	unknown
TARGET-30-PADMGA	Protocol	B003-3891-E18
TARGET-30-PADMGA	Category	ganglioneuroblastoma, nodular
TARGET-30-PADMGA	1p-	unknown
TARGET-30-PADMGA	1q+	unknown
TARGET-30-PADMGA	11q-	unknown
TARGET-30-PADMGA	17q+	unknown
TARGET-30-PADMGA	%tumor	
TARGET-30-PADMGA	MKI	low
TARGET-30-PADMTD	age	1040
TARGET-30-PADMTD	age group	2-6
TARGET-30-PADMTD	stage	stage 4
TARGET-30-PADMTD	ATRX	unknown
TARGET-30-PADMTD	ALK	
TARGET-30-PADMTD	MYCN	amplified
TARGET-30-PADMTD	Histology	unfavorable
TARGET-30-PADMTD	Grade	undifferentiated or poorly differentiated
TARGET-30-PADMTD	Ploidy	unknown
TARGET-30-PADMTD	Protocol	B003-3891-E18
TARGET-30-PADMTD	Category	neuroblastoma
TARGET-30-PADMTD	1p-	unknown
TARGET-30-PADMTD	1q+	unknown
TARGET-30-PADMTD	11q-	unknown
TARGET-30-PADMTD	17q+	unknown
TARGET-30-PADMTD	%tumor	
TARGET-30-PADMTD	MKI	high
TARGET-30-PADMVB	age	936
TARGET-30-PADMVB	age group	2-6
TARGET-30-PADMVB	stage	stage 4
TARGET-30-PADMVB	ATRX	unknown
TARGET-30-PADMVB	ALK	
TARGET-30-PADMVB	MYCN	not amplified
TARGET-30-PADMVB	Histology	unknown
TARGET-30-PADMVB	Grade	unknown
TARGET-30-PADMVB	Ploidy	unknown
TARGET-30-PADMVB	Protocol	B003-3891
TARGET-30-PADMVB	Category	unknown
TARGET-30-PADMVB	1p-	unknown
TARGET-30-PADMVB	1q+	unknown
TARGET-30-PADMVB	11q-	unknown
TARGET-30-PADMVB	17q+	unknown
TARGET-30-PADMVB	%tumor	
TARGET-30-PADMVB	MKI	
TARGET-30-PADMXD	age	1084
TARGET-30-PADMXD	age group	2-6
TARGET-30-PADMXD	stage	stage 4
TARGET-30-PADMXD	ATRX	unknown
TARGET-30-PADMXD	ALK	
TARGET-30-PADMXD	MYCN	amplified
TARGET-30-PADMXD	Histology	unfavorable
TARGET-30-PADMXD	Grade	undifferentiated or poorly differentiated
TARGET-30-PADMXD	Ploidy	unknown
TARGET-30-PADMXD	Protocol	B954-B003-3891-E18
TARGET-30-PADMXD	Category	neuroblastoma
TARGET-30-PADMXD	1p-	unknown
TARGET-30-PADMXD	1q+	unknown
TARGET-30-PADMXD	11q-	unknown
TARGET-30-PADMXD	17q+	unknown
TARGET-30-PADMXD	%tumor	
TARGET-30-PADMXD	MKI	high
TARGET-30-PADMYD	age	1528
TARGET-30-PADMYD	age group	2-6
TARGET-30-PADMYD	stage	stage 4
TARGET-30-PADMYD	ATRX	unknown
TARGET-30-PADMYD	ALK	
TARGET-30-PADMYD	MYCN	not amplified
TARGET-30-PADMYD	Histology	unfavorable
TARGET-30-PADMYD	Grade	undifferentiated or poorly differentiated
TARGET-30-PADMYD	Ploidy	unknown
TARGET-30-PADMYD	Protocol	B003-E18-B954-0925-R9702-3891
TARGET-30-PADMYD	Category	neuroblastoma
TARGET-30-PADMYD	1p-	unknown
TARGET-30-PADMYD	1q+	unknown
TARGET-30-PADMYD	11q-	unknown
TARGET-30-PADMYD	17q+	unknown
TARGET-30-PADMYD	%tumor	95.0
TARGET-30-PADMYD	MKI	intermediate
TARGET-30-PADNFT	age	1494
TARGET-30-PADNFT	age group	2-6
TARGET-30-PADNFT	stage	stage 4
TARGET-30-PADNFT	ATRX	unknown
TARGET-30-PADNFT	ALK	
TARGET-30-PADNFT	MYCN	not amplified
TARGET-30-PADNFT	Histology	unfavorable
TARGET-30-PADNFT	Grade	undifferentiated or poorly differentiated
TARGET-30-PADNFT	Ploidy	unknown
TARGET-30-PADNFT	Protocol	B954-B003-3891
TARGET-30-PADNFT	Category	neuroblastoma
TARGET-30-PADNFT	1p-	unknown
TARGET-30-PADNFT	1q+	unknown
TARGET-30-PADNFT	11q-	unknown
TARGET-30-PADNFT	17q+	unknown
TARGET-30-PADNFT	%tumor	
TARGET-30-PADNFT	MKI	intermediate
TARGET-30-PADNNX	age	1087
TARGET-30-PADNNX	age group	2-6
TARGET-30-PADNNX	stage	stage 4
TARGET-30-PADNNX	ATRX	unknown
TARGET-30-PADNNX	ALK	
TARGET-30-PADNNX	MYCN	not amplified
TARGET-30-PADNNX	Histology	unfavorable
TARGET-30-PADNNX	Grade	undifferentiated or poorly differentiated
TARGET-30-PADNNX	Ploidy	unknown
TARGET-30-PADNNX	Protocol	B903-B003-3891-B954
TARGET-30-PADNNX	Category	ganglioneuroblastoma, nodular
TARGET-30-PADNNX	1p-	unknown
TARGET-30-PADNNX	1q+	unknown
TARGET-30-PADNNX	11q-	unknown
TARGET-30-PADNNX	17q+	unknown
TARGET-30-PADNNX	%tumor	
TARGET-30-PADNNX	MKI	intermediate
TARGET-30-PADNXC	age	561
TARGET-30-PADNXC	age group	1-2
TARGET-30-PADNXC	stage	stage 4
TARGET-30-PADNXC	ATRX	unknown
TARGET-30-PADNXC	ALK	
TARGET-30-PADNXC	MYCN	amplified
TARGET-30-PADNXC	Histology	unfavorable
TARGET-30-PADNXC	Grade	undifferentiated or poorly differentiated
TARGET-30-PADNXC	Ploidy	unknown
TARGET-30-PADNXC	Protocol	B903-B003-3891-E18
TARGET-30-PADNXC	Category	neuroblastoma
TARGET-30-PADNXC	1p-	unknown
TARGET-30-PADNXC	1q+	unknown
TARGET-30-PADNXC	11q-	unknown
TARGET-30-PADNXC	17q+	unknown
TARGET-30-PADNXC	%tumor	
TARGET-30-PADNXC	MKI	high
TARGET-30-PADPCI	age	1996
TARGET-30-PADPCI	age group	2-6
TARGET-30-PADPCI	stage	stage 4
TARGET-30-PADPCI	ATRX	unknown
TARGET-30-PADPCI	ALK	
TARGET-30-PADPCI	MYCN	not amplified
TARGET-30-PADPCI	Histology	unfavorable
TARGET-30-PADPCI	Grade	undifferentiated or poorly differentiated
TARGET-30-PADPCI	Ploidy	unknown
TARGET-30-PADPCI	Protocol	B954-B003-3891
TARGET-30-PADPCI	Category	neuroblastoma
TARGET-30-PADPCI	1p-	unknown
TARGET-30-PADPCI	1q+	unknown
TARGET-30-PADPCI	11q-	unknown
TARGET-30-PADPCI	17q+	unknown
TARGET-30-PADPCI	%tumor	
TARGET-30-PADPCI	MKI	intermediate
TARGET-30-PADPEY	age	1435
TARGET-30-PADPEY	age group	2-6
TARGET-30-PADPEY	stage	stage 4
TARGET-30-PADPEY	ATRX	unknown
TARGET-30-PADPEY	ALK	
TARGET-30-PADPEY	MYCN	amplified
TARGET-30-PADPEY	Histology	unfavorable
TARGET-30-PADPEY	Grade	undifferentiated or poorly differentiated
TARGET-30-PADPEY	Ploidy	unknown
TARGET-30-PADPEY	Protocol	B003-3891
TARGET-30-PADPEY	Category	neuroblastoma
TARGET-30-PADPEY	1p-	unknown
TARGET-30-PADPEY	1q+	unknown
TARGET-30-PADPEY	11q-	unknown
TARGET-30-PADPEY	17q+	unknown
TARGET-30-PADPEY	%tumor	
TARGET-30-PADPEY	MKI	low
TARGET-30-PADPHP	age	1128
TARGET-30-PADPHP	age group	2-6
TARGET-30-PADPHP	stage	stage 4
TARGET-30-PADPHP	ATRX	unknown
TARGET-30-PADPHP	ALK	
TARGET-30-PADPHP	MYCN	not amplified
TARGET-30-PADPHP	Histology	unfavorable
TARGET-30-PADPHP	Grade	undifferentiated or poorly differentiated
TARGET-30-PADPHP	Ploidy	unknown
TARGET-30-PADPHP	Protocol	B003-3891-E18
TARGET-30-PADPHP	Category	neuroblastoma
TARGET-30-PADPHP	1p-	unknown
TARGET-30-PADPHP	1q+	unknown
TARGET-30-PADPHP	11q-	unknown
TARGET-30-PADPHP	17q+	unknown
TARGET-30-PADPHP	%tumor	
TARGET-30-PADPHP	MKI	low
TARGET-30-PADPMU	age	1589
TARGET-30-PADPMU	age group	2-6
TARGET-30-PADPMU	stage	stage 4
TARGET-30-PADPMU	ATRX	unknown
TARGET-30-PADPMU	ALK	
TARGET-30-PADPMU	MYCN	amplified
TARGET-30-PADPMU	Histology	unfavorable
TARGET-30-PADPMU	Grade	undifferentiated or poorly differentiated
TARGET-30-PADPMU	Ploidy	unknown
TARGET-30-PADPMU	Protocol	B003-0937-3891-0901
TARGET-30-PADPMU	Category	neuroblastoma
TARGET-30-PADPMU	1p-	unknown
TARGET-30-PADPMU	1q+	unknown
TARGET-30-PADPMU	11q-	unknown
TARGET-30-PADPMU	17q+	unknown
TARGET-30-PADPMU	%tumor	
TARGET-30-PADPMU	MKI	intermediate
TARGET-30-PADPRJ	age	1423
TARGET-30-PADPRJ	age group	2-6
TARGET-30-PADPRJ	stage	stage 4
TARGET-30-PADPRJ	ATRX	unknown
TARGET-30-PADPRJ	ALK	
TARGET-30-PADPRJ	MYCN	not amplified
TARGET-30-PADPRJ	Histology	unfavorable
TARGET-30-PADPRJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PADPRJ	Ploidy	unknown
TARGET-30-PADPRJ	Protocol	B903-B003-3891-E18-B954
TARGET-30-PADPRJ	Category	ganglioneuroblastoma, nodular
TARGET-30-PADPRJ	1p-	unknown
TARGET-30-PADPRJ	1q+	unknown
TARGET-30-PADPRJ	11q-	unknown
TARGET-30-PADPRJ	17q+	unknown
TARGET-30-PADPRJ	%tumor	
TARGET-30-PADPRJ	MKI	low
TARGET-30-PADRYN	age	670
TARGET-30-PADRYN	age group	1-2
TARGET-30-PADRYN	stage	stage 4
TARGET-30-PADRYN	ATRX	unknown
TARGET-30-PADRYN	ALK	
TARGET-30-PADRYN	MYCN	amplified
TARGET-30-PADRYN	Histology	unfavorable
TARGET-30-PADRYN	Grade	undifferentiated or poorly differentiated
TARGET-30-PADRYN	Ploidy	unknown
TARGET-30-PADRYN	Protocol	B003-3891
TARGET-30-PADRYN	Category	neuroblastoma
TARGET-30-PADRYN	1p-	unknown
TARGET-30-PADRYN	1q+	unknown
TARGET-30-PADRYN	11q-	unknown
TARGET-30-PADRYN	17q+	unknown
TARGET-30-PADRYN	%tumor	
TARGET-30-PADRYN	MKI	high
TARGET-30-PADSEC	age	1476
TARGET-30-PADSEC	age group	2-6
TARGET-30-PADSEC	stage	stage 4
TARGET-30-PADSEC	ATRX	unknown
TARGET-30-PADSEC	ALK	
TARGET-30-PADSEC	MYCN	not amplified
TARGET-30-PADSEC	Histology	unfavorable
TARGET-30-PADSEC	Grade	undifferentiated or poorly differentiated
TARGET-30-PADSEC	Ploidy	unknown
TARGET-30-PADSEC	Protocol	B954-B003-3891
TARGET-30-PADSEC	Category	neuroblastoma
TARGET-30-PADSEC	1p-	unknown
TARGET-30-PADSEC	1q+	unknown
TARGET-30-PADSEC	11q-	unknown
TARGET-30-PADSEC	17q+	unknown
TARGET-30-PADSEC	%tumor	
TARGET-30-PADSEC	MKI	intermediate
TARGET-30-PADSMF	age	1222
TARGET-30-PADSMF	age group	2-6
TARGET-30-PADSMF	stage	stage 4
TARGET-30-PADSMF	ATRX	unknown
TARGET-30-PADSMF	ALK	
TARGET-30-PADSMF	MYCN	not amplified
TARGET-30-PADSMF	Histology	unfavorable
TARGET-30-PADSMF	Grade	undifferentiated or poorly differentiated
TARGET-30-PADSMF	Ploidy	unknown
TARGET-30-PADSMF	Protocol	B954-B003-3891
TARGET-30-PADSMF	Category	neuroblastoma
TARGET-30-PADSMF	1p-	unknown
TARGET-30-PADSMF	1q+	unknown
TARGET-30-PADSMF	11q-	unknown
TARGET-30-PADSMF	17q+	unknown
TARGET-30-PADSMF	%tumor	
TARGET-30-PADSMF	MKI	intermediate
TARGET-30-PADSXE	age	1174
TARGET-30-PADSXE	age group	2-6
TARGET-30-PADSXE	stage	stage 4
TARGET-30-PADSXE	ATRX	unknown
TARGET-30-PADSXE	ALK	
TARGET-30-PADSXE	MYCN	not amplified
TARGET-30-PADSXE	Histology	unfavorable
TARGET-30-PADSXE	Grade	undifferentiated or poorly differentiated
TARGET-30-PADSXE	Ploidy	unknown
TARGET-30-PADSXE	Protocol	B903-B003-3891
TARGET-30-PADSXE	Category	neuroblastoma
TARGET-30-PADSXE	1p-	unknown
TARGET-30-PADSXE	1q+	unknown
TARGET-30-PADSXE	11q-	unknown
TARGET-30-PADSXE	17q+	unknown
TARGET-30-PADSXE	%tumor	
TARGET-30-PADSXE	MKI	intermediate
TARGET-30-PADSXU	age	654
TARGET-30-PADSXU	age group	1-2
TARGET-30-PADSXU	stage	stage 4
TARGET-30-PADSXU	ATRX	unknown
TARGET-30-PADSXU	ALK	
TARGET-30-PADSXU	MYCN	not amplified
TARGET-30-PADSXU	Histology	unfavorable
TARGET-30-PADSXU	Grade	undifferentiated or poorly differentiated
TARGET-30-PADSXU	Ploidy	unknown
TARGET-30-PADSXU	Protocol	B954-B003-3891-0914
TARGET-30-PADSXU	Category	neuroblastoma
TARGET-30-PADSXU	1p-	unknown
TARGET-30-PADSXU	1q+	unknown
TARGET-30-PADSXU	11q-	unknown
TARGET-30-PADSXU	17q+	unknown
TARGET-30-PADSXU	%tumor	
TARGET-30-PADSXU	MKI	low
TARGET-30-PADTCU	age	1294
TARGET-30-PADTCU	age group	2-6
TARGET-30-PADTCU	stage	stage 4
TARGET-30-PADTCU	ATRX	unknown
TARGET-30-PADTCU	ALK	
TARGET-30-PADTCU	MYCN	not amplified
TARGET-30-PADTCU	Histology	unfavorable
TARGET-30-PADTCU	Grade	undifferentiated or poorly differentiated
TARGET-30-PADTCU	Ploidy	unknown
TARGET-30-PADTCU	Protocol	B003-3891
TARGET-30-PADTCU	Category	ganglioneuroblastoma, nodular
TARGET-30-PADTCU	1p-	unknown
TARGET-30-PADTCU	1q+	unknown
TARGET-30-PADTCU	11q-	unknown
TARGET-30-PADTCU	17q+	unknown
TARGET-30-PADTCU	%tumor	
TARGET-30-PADTCU	MKI	low
TARGET-30-PADTJJ	age	529
TARGET-30-PADTJJ	age group	1-2
TARGET-30-PADTJJ	stage	stage 4
TARGET-30-PADTJJ	ATRX	unknown
TARGET-30-PADTJJ	ALK	
TARGET-30-PADTJJ	MYCN	amplified
TARGET-30-PADTJJ	Histology	unfavorable
TARGET-30-PADTJJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PADTJJ	Ploidy	unknown
TARGET-30-PADTJJ	Protocol	B003-3891
TARGET-30-PADTJJ	Category	neuroblastoma
TARGET-30-PADTJJ	1p-	unknown
TARGET-30-PADTJJ	1q+	unknown
TARGET-30-PADTJJ	11q-	unknown
TARGET-30-PADTJJ	17q+	unknown
TARGET-30-PADTJJ	%tumor	
TARGET-30-PADTJJ	MKI	high
TARGET-30-PADTRV	age	562
TARGET-30-PADTRV	age group	1-2
TARGET-30-PADTRV	stage	stage 4
TARGET-30-PADTRV	ATRX	unknown
TARGET-30-PADTRV	ALK	
TARGET-30-PADTRV	MYCN	not amplified
TARGET-30-PADTRV	Histology	unknown
TARGET-30-PADTRV	Grade	unknown
TARGET-30-PADTRV	Ploidy	unknown
TARGET-30-PADTRV	Protocol	B003-3891
TARGET-30-PADTRV	Category	unknown
TARGET-30-PADTRV	1p-	unknown
TARGET-30-PADTRV	1q+	unknown
TARGET-30-PADTRV	11q-	unknown
TARGET-30-PADTRV	17q+	unknown
TARGET-30-PADTRV	%tumor	
TARGET-30-PADTRV	MKI	
TARGET-30-PADUKP	age	1659
TARGET-30-PADUKP	age group	2-6
TARGET-30-PADUKP	stage	stage 4
TARGET-30-PADUKP	ATRX	unknown
TARGET-30-PADUKP	ALK	
TARGET-30-PADUKP	MYCN	not amplified
TARGET-30-PADUKP	Histology	favorable
TARGET-30-PADUKP	Grade	differentiating
TARGET-30-PADUKP	Ploidy	unknown
TARGET-30-PADUKP	Protocol	B003-3891
TARGET-30-PADUKP	Category	neuroblastoma
TARGET-30-PADUKP	1p-	unknown
TARGET-30-PADUKP	1q+	unknown
TARGET-30-PADUKP	11q-	unknown
TARGET-30-PADUKP	17q+	unknown
TARGET-30-PADUKP	%tumor	
TARGET-30-PADUKP	MKI	low
TARGET-30-PADUWR	age	1682
TARGET-30-PADUWR	age group	2-6
TARGET-30-PADUWR	stage	stage 4
TARGET-30-PADUWR	ATRX	unknown
TARGET-30-PADUWR	ALK	
TARGET-30-PADUWR	MYCN	not amplified
TARGET-30-PADUWR	Histology	unfavorable
TARGET-30-PADUWR	Grade	undifferentiated or poorly differentiated
TARGET-30-PADUWR	Ploidy	unknown
TARGET-30-PADUWR	Protocol	B003-ALTE03N1-3891-R9702
TARGET-30-PADUWR	Category	neuroblastoma
TARGET-30-PADUWR	1p-	unknown
TARGET-30-PADUWR	1q+	unknown
TARGET-30-PADUWR	11q-	unknown
TARGET-30-PADUWR	17q+	unknown
TARGET-30-PADUWR	%tumor	
TARGET-30-PADUWR	MKI	low
TARGET-30-PADUYJ	age	3115
TARGET-30-PADUYJ	age group	6-9
TARGET-30-PADUYJ	stage	stage 4
TARGET-30-PADUYJ	ATRX	unknown
TARGET-30-PADUYJ	ALK	
TARGET-30-PADUYJ	MYCN	amplified
TARGET-30-PADUYJ	Histology	unfavorable
TARGET-30-PADUYJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PADUYJ	Ploidy	unknown
TARGET-30-PADUYJ	Protocol	B003-3891
TARGET-30-PADUYJ	Category	neuroblastoma
TARGET-30-PADUYJ	1p-	unknown
TARGET-30-PADUYJ	1q+	unknown
TARGET-30-PADUYJ	11q-	unknown
TARGET-30-PADUYJ	17q+	unknown
TARGET-30-PADUYJ	%tumor	
TARGET-30-PADUYJ	MKI	intermediate
TARGET-30-PADVSN	age	834
TARGET-30-PADVSN	age group	2-6
TARGET-30-PADVSN	stage	stage 4
TARGET-30-PADVSN	ATRX	unknown
TARGET-30-PADVSN	ALK	
TARGET-30-PADVSN	MYCN	not amplified
TARGET-30-PADVSN	Histology	unfavorable
TARGET-30-PADVSN	Grade	unknown
TARGET-30-PADVSN	Ploidy	unknown
TARGET-30-PADVSN	Protocol	B003-3891
TARGET-30-PADVSN	Category	unknown
TARGET-30-PADVSN	1p-	unknown
TARGET-30-PADVSN	1q+	unknown
TARGET-30-PADVSN	11q-	unknown
TARGET-30-PADVSN	17q+	unknown
TARGET-30-PADVSN	%tumor	
TARGET-30-PADVSN	MKI	
TARGET-30-PADVWW	age	1988
TARGET-30-PADVWW	age group	2-6
TARGET-30-PADVWW	stage	stage 4
TARGET-30-PADVWW	ATRX	unknown
TARGET-30-PADVWW	ALK	
TARGET-30-PADVWW	MYCN	not amplified
TARGET-30-PADVWW	Histology	unfavorable
TARGET-30-PADVWW	Grade	unknown
TARGET-30-PADVWW	Ploidy	unknown
TARGET-30-PADVWW	Protocol	B003-3891
TARGET-30-PADVWW	Category	unknown
TARGET-30-PADVWW	1p-	unknown
TARGET-30-PADVWW	1q+	unknown
TARGET-30-PADVWW	11q-	unknown
TARGET-30-PADVWW	17q+	unknown
TARGET-30-PADVWW	%tumor	
TARGET-30-PADVWW	MKI	
TARGET-30-PADWEN	age	2042
TARGET-30-PADWEN	age group	2-6
TARGET-30-PADWEN	stage	stage 4
TARGET-30-PADWEN	ATRX	unknown
TARGET-30-PADWEN	ALK	
TARGET-30-PADWEN	MYCN	not amplified
TARGET-30-PADWEN	Histology	unfavorable
TARGET-30-PADWEN	Grade	unknown
TARGET-30-PADWEN	Ploidy	unknown
TARGET-30-PADWEN	Protocol	B003-3891
TARGET-30-PADWEN	Category	unknown
TARGET-30-PADWEN	1p-	unknown
TARGET-30-PADWEN	1q+	unknown
TARGET-30-PADWEN	11q-	unknown
TARGET-30-PADWEN	17q+	unknown
TARGET-30-PADWEN	%tumor	
TARGET-30-PADWEN	MKI	
TARGET-30-PADWIM	age	2413
TARGET-30-PADWIM	age group	6-9
TARGET-30-PADWIM	stage	stage 4
TARGET-30-PADWIM	ATRX	unknown
TARGET-30-PADWIM	ALK	
TARGET-30-PADWIM	MYCN	not amplified
TARGET-30-PADWIM	Histology	unfavorable
TARGET-30-PADWIM	Grade	unknown
TARGET-30-PADWIM	Ploidy	unknown
TARGET-30-PADWIM	Protocol	B003-3891
TARGET-30-PADWIM	Category	unknown
TARGET-30-PADWIM	1p-	unknown
TARGET-30-PADWIM	1q+	unknown
TARGET-30-PADWIM	11q-	unknown
TARGET-30-PADWIM	17q+	unknown
TARGET-30-PADWIM	%tumor	
TARGET-30-PADWIM	MKI	
TARGET-30-PADWSM	age	2957
TARGET-30-PADWSM	age group	6-9
TARGET-30-PADWSM	stage	stage 4
TARGET-30-PADWSM	ATRX	unknown
TARGET-30-PADWSM	ALK	
TARGET-30-PADWSM	MYCN	not amplified
TARGET-30-PADWSM	Histology	unfavorable
TARGET-30-PADWSM	Grade	unknown
TARGET-30-PADWSM	Ploidy	unknown
TARGET-30-PADWSM	Protocol	B003-3891-0935
TARGET-30-PADWSM	Category	unknown
TARGET-30-PADWSM	1p-	unknown
TARGET-30-PADWSM	1q+	unknown
TARGET-30-PADWSM	11q-	unknown
TARGET-30-PADWSM	17q+	unknown
TARGET-30-PADWSM	%tumor	
TARGET-30-PADWSM	MKI	
TARGET-30-PADWVR	age	2158
TARGET-30-PADWVR	age group	2-6
TARGET-30-PADWVR	stage	stage 4
TARGET-30-PADWVR	ATRX	unknown
TARGET-30-PADWVR	ALK	
TARGET-30-PADWVR	MYCN	not amplified
TARGET-30-PADWVR	Histology	unfavorable
TARGET-30-PADWVR	Grade	unknown
TARGET-30-PADWVR	Ploidy	unknown
TARGET-30-PADWVR	Protocol	B003-3891-0935
TARGET-30-PADWVR	Category	unknown
TARGET-30-PADWVR	1p-	unknown
TARGET-30-PADWVR	1q+	unknown
TARGET-30-PADWVR	11q-	unknown
TARGET-30-PADWVR	17q+	unknown
TARGET-30-PADWVR	%tumor	
TARGET-30-PADWVR	MKI	
TARGET-30-PADXAS	age	2274
TARGET-30-PADXAS	age group	6-9
TARGET-30-PADXAS	stage	stage 4
TARGET-30-PADXAS	ATRX	unknown
TARGET-30-PADXAS	ALK	
TARGET-30-PADXAS	MYCN	not amplified
TARGET-30-PADXAS	Histology	unfavorable
TARGET-30-PADXAS	Grade	unknown
TARGET-30-PADXAS	Ploidy	unknown
TARGET-30-PADXAS	Protocol	B947-B003-3891
TARGET-30-PADXAS	Category	neuroblastoma
TARGET-30-PADXAS	1p-	unknown
TARGET-30-PADXAS	1q+	unknown
TARGET-30-PADXAS	11q-	unknown
TARGET-30-PADXAS	17q+	unknown
TARGET-30-PADXAS	%tumor	
TARGET-30-PADXAS	MKI	
TARGET-30-PADXBB	age	1992
TARGET-30-PADXBB	age group	2-6
TARGET-30-PADXBB	stage	stage 4
TARGET-30-PADXBB	ATRX	unknown
TARGET-30-PADXBB	ALK	
TARGET-30-PADXBB	MYCN	not amplified
TARGET-30-PADXBB	Histology	unfavorable
TARGET-30-PADXBB	Grade	unknown
TARGET-30-PADXBB	Ploidy	unknown
TARGET-30-PADXBB	Protocol	B003-3891
TARGET-30-PADXBB	Category	unknown
TARGET-30-PADXBB	1p-	unknown
TARGET-30-PADXBB	1q+	unknown
TARGET-30-PADXBB	11q-	unknown
TARGET-30-PADXBB	17q+	unknown
TARGET-30-PADXBB	%tumor	
TARGET-30-PADXBB	MKI	
TARGET-30-PAHXZM	age	1079
TARGET-30-PAHXZM	age group	2-6
TARGET-30-PAHXZM	stage	stage 4
TARGET-30-PAHXZM	ATRX	unknown
TARGET-30-PAHXZM	ALK	
TARGET-30-PAHXZM	MYCN	not amplified
TARGET-30-PAHXZM	Histology	unknown
TARGET-30-PAHXZM	Grade	unknown
TARGET-30-PAHXZM	Ploidy	hyperdiploid (di>1)
TARGET-30-PAHXZM	Protocol	9047
TARGET-30-PAHXZM	Category	unknown
TARGET-30-PAHXZM	1p-	unknown
TARGET-30-PAHXZM	1q+	unknown
TARGET-30-PAHXZM	11q-	unknown
TARGET-30-PAHXZM	17q+	unknown
TARGET-30-PAHXZM	%tumor	95.0
TARGET-30-PAHXZM	MKI	
TARGET-30-PAHYWC	age	704
TARGET-30-PAHYWC	age group	1-2
TARGET-30-PAHYWC	stage	stage 4
TARGET-30-PAHYWC	ATRX	unknown
TARGET-30-PAHYWC	ALK	normal
TARGET-30-PAHYWC	MYCN	amplified
TARGET-30-PAHYWC	Histology	unknown
TARGET-30-PAHYWC	Grade	unknown
TARGET-30-PAHYWC	Ploidy	diploid (di=1)
TARGET-30-PAHYWC	Protocol	9340-9047
TARGET-30-PAHYWC	Category	unknown
TARGET-30-PAHYWC	1p-	normal
TARGET-30-PAHYWC	1q+	normal
TARGET-30-PAHYWC	11q-	normal
TARGET-30-PAHYWC	17q+	gain
TARGET-30-PAHYWC	%tumor	85.0
TARGET-30-PAHYWC	MKI	
TARGET-30-PAHYWN	age	825
TARGET-30-PAHYWN	age group	2-6
TARGET-30-PAHYWN	stage	stage 4
TARGET-30-PAHYWN	ATRX	unknown
TARGET-30-PAHYWN	ALK	
TARGET-30-PAHYWN	MYCN	amplified
TARGET-30-PAHYWN	Histology	unknown
TARGET-30-PAHYWN	Grade	unknown
TARGET-30-PAHYWN	Ploidy	hyperdiploid (di>1)
TARGET-30-PAHYWN	Protocol	9340-9341-9342-9047
TARGET-30-PAHYWN	Category	unknown
TARGET-30-PAHYWN	1p-	unknown
TARGET-30-PAHYWN	1q+	unknown
TARGET-30-PAHYWN	11q-	unknown
TARGET-30-PAHYWN	17q+	unknown
TARGET-30-PAHYWN	%tumor	
TARGET-30-PAHYWN	MKI	
TARGET-30-PAIBIW	age	1124
TARGET-30-PAIBIW	age group	2-6
TARGET-30-PAIBIW	stage	stage 4
TARGET-30-PAIBIW	ATRX	unknown
TARGET-30-PAIBIW	ALK	
TARGET-30-PAIBIW	MYCN	amplified
TARGET-30-PAIBIW	Histology	unfavorable
TARGET-30-PAIBIW	Grade	unknown
TARGET-30-PAIBIW	Ploidy	diploid (di=1)
TARGET-30-PAIBIW	Protocol	9340-9341-9342-9047-9082
TARGET-30-PAIBIW	Category	unknown
TARGET-30-PAIBIW	1p-	unknown
TARGET-30-PAIBIW	1q+	unknown
TARGET-30-PAIBIW	11q-	unknown
TARGET-30-PAIBIW	17q+	unknown
TARGET-30-PAIBIW	%tumor	95.0
TARGET-30-PAIBIW	MKI	
TARGET-30-PAICGF	age	1278
TARGET-30-PAICGF	age group	2-6
TARGET-30-PAICGF	stage	stage 4
TARGET-30-PAICGF	ATRX	unknown
TARGET-30-PAICGF	ALK	normal
TARGET-30-PAICGF	MYCN	not amplified
TARGET-30-PAICGF	Histology	unknown
TARGET-30-PAICGF	Grade	unknown
TARGET-30-PAICGF	Ploidy	hyperdiploid (di>1)
TARGET-30-PAICGF	Protocol	9340-9341-9342-9343-9047
TARGET-30-PAICGF	Category	neuroblastoma
TARGET-30-PAICGF	1p-	normal
TARGET-30-PAICGF	1q+	normal
TARGET-30-PAICGF	11q-	normal
TARGET-30-PAICGF	17q+	gain
TARGET-30-PAICGF	%tumor	90.0
TARGET-30-PAICGF	MKI	
TARGET-30-PAIDJS	age	298
TARGET-30-PAIDJS	age group	0-1
TARGET-30-PAIDJS	stage	stage 1
TARGET-30-PAIDJS	ATRX	unknown
TARGET-30-PAIDJS	ALK	
TARGET-30-PAIDJS	MYCN	not amplified
TARGET-30-PAIDJS	Histology	favorable
TARGET-30-PAIDJS	Grade	differentiating
TARGET-30-PAIDJS	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIDJS	Protocol	9047
TARGET-30-PAIDJS	Category	neuroblastoma
TARGET-30-PAIDJS	1p-	unknown
TARGET-30-PAIDJS	1q+	unknown
TARGET-30-PAIDJS	11q-	unknown
TARGET-30-PAIDJS	17q+	unknown
TARGET-30-PAIDJS	%tumor	100.0
TARGET-30-PAIDJS	MKI	low
TARGET-30-PAIDSV	age	1255
TARGET-30-PAIDSV	age group	2-6
TARGET-30-PAIDSV	stage	stage 4
TARGET-30-PAIDSV	ATRX	unknown
TARGET-30-PAIDSV	ALK	
TARGET-30-PAIDSV	MYCN	not amplified
TARGET-30-PAIDSV	Histology	unfavorable
TARGET-30-PAIDSV	Grade	unknown
TARGET-30-PAIDSV	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIDSV	Protocol	9341-9047
TARGET-30-PAIDSV	Category	unknown
TARGET-30-PAIDSV	1p-	unknown
TARGET-30-PAIDSV	1q+	unknown
TARGET-30-PAIDSV	11q-	unknown
TARGET-30-PAIDSV	17q+	unknown
TARGET-30-PAIDSV	%tumor	100.0
TARGET-30-PAIDSV	MKI	
TARGET-30-PAIEFC	age	605
TARGET-30-PAIEFC	age group	1-2
TARGET-30-PAIEFC	stage	stage 4
TARGET-30-PAIEFC	ATRX	unknown
TARGET-30-PAIEFC	ALK	
TARGET-30-PAIEFC	MYCN	amplified
TARGET-30-PAIEFC	Histology	unfavorable
TARGET-30-PAIEFC	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIEFC	Ploidy	diploid (di=1)
TARGET-30-PAIEFC	Protocol	9047
TARGET-30-PAIEFC	Category	neuroblastoma
TARGET-30-PAIEFC	1p-	unknown
TARGET-30-PAIEFC	1q+	unknown
TARGET-30-PAIEFC	11q-	unknown
TARGET-30-PAIEFC	17q+	unknown
TARGET-30-PAIEFC	%tumor	
TARGET-30-PAIEFC	MKI	high
TARGET-30-PAIEIF	age	1710
TARGET-30-PAIEIF	age group	2-6
TARGET-30-PAIEIF	stage	stage 4
TARGET-30-PAIEIF	ATRX	unknown
TARGET-30-PAIEIF	ALK	
TARGET-30-PAIEIF	MYCN	not amplified
TARGET-30-PAIEIF	Histology	unknown
TARGET-30-PAIEIF	Grade	unknown
TARGET-30-PAIEIF	Ploidy	diploid (di=1)
TARGET-30-PAIEIF	Protocol	9047
TARGET-30-PAIEIF	Category	unknown
TARGET-30-PAIEIF	1p-	unknown
TARGET-30-PAIEIF	1q+	unknown
TARGET-30-PAIEIF	11q-	unknown
TARGET-30-PAIEIF	17q+	unknown
TARGET-30-PAIEIF	%tumor	40.0
TARGET-30-PAIEIF	MKI	
TARGET-30-PAIFCS	age	1540
TARGET-30-PAIFCS	age group	2-6
TARGET-30-PAIFCS	stage	stage 4
TARGET-30-PAIFCS	ATRX	unknown
TARGET-30-PAIFCS	ALK	normal
TARGET-30-PAIFCS	MYCN	not amplified
TARGET-30-PAIFCS	Histology	unfavorable
TARGET-30-PAIFCS	Grade	unknown
TARGET-30-PAIFCS	Ploidy	diploid (di=1)
TARGET-30-PAIFCS	Protocol	9340-9341-9047
TARGET-30-PAIFCS	Category	unknown
TARGET-30-PAIFCS	1p-	normal
TARGET-30-PAIFCS	1q+	normal
TARGET-30-PAIFCS	11q-	normal
TARGET-30-PAIFCS	17q+	normal
TARGET-30-PAIFCS	%tumor	95.0
TARGET-30-PAIFCS	MKI	
TARGET-30-PAIFXV	age	2004
TARGET-30-PAIFXV	age group	2-6
TARGET-30-PAIFXV	stage	stage 4
TARGET-30-PAIFXV	ATRX	normal
TARGET-30-PAIFXV	ALK	normal
TARGET-30-PAIFXV	MYCN	not amplified
TARGET-30-PAIFXV	Histology	unfavorable
TARGET-30-PAIFXV	Grade	unknown
TARGET-30-PAIFXV	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIFXV	Protocol	9340-9341-9342-9047-P9462
TARGET-30-PAIFXV	Category	unknown
TARGET-30-PAIFXV	1p-	normal
TARGET-30-PAIFXV	1q+	normal
TARGET-30-PAIFXV	11q-	loss
TARGET-30-PAIFXV	17q+	gain
TARGET-30-PAIFXV	%tumor	
TARGET-30-PAIFXV	MKI	
TARGET-30-PAIGRH	age	744
TARGET-30-PAIGRH	age group	2-6
TARGET-30-PAIGRH	stage	stage 4
TARGET-30-PAIGRH	ATRX	unknown
TARGET-30-PAIGRH	ALK	
TARGET-30-PAIGRH	MYCN	not amplified
TARGET-30-PAIGRH	Histology	unknown
TARGET-30-PAIGRH	Grade	unknown
TARGET-30-PAIGRH	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIGRH	Protocol	9047
TARGET-30-PAIGRH	Category	unknown
TARGET-30-PAIGRH	1p-	unknown
TARGET-30-PAIGRH	1q+	unknown
TARGET-30-PAIGRH	11q-	unknown
TARGET-30-PAIGRH	17q+	unknown
TARGET-30-PAIGRH	%tumor	100.0
TARGET-30-PAIGRH	MKI	
TARGET-30-PAIHAW	age	772
TARGET-30-PAIHAW	age group	2-6
TARGET-30-PAIHAW	stage	stage 4
TARGET-30-PAIHAW	ATRX	unknown
TARGET-30-PAIHAW	ALK	
TARGET-30-PAIHAW	MYCN	not amplified
TARGET-30-PAIHAW	Histology	unknown
TARGET-30-PAIHAW	Grade	unknown
TARGET-30-PAIHAW	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIHAW	Protocol	9047
TARGET-30-PAIHAW	Category	unknown
TARGET-30-PAIHAW	1p-	unknown
TARGET-30-PAIHAW	1q+	unknown
TARGET-30-PAIHAW	11q-	unknown
TARGET-30-PAIHAW	17q+	unknown
TARGET-30-PAIHAW	%tumor	95.0
TARGET-30-PAIHAW	MKI	
TARGET-30-PAIJGC	age	1410
TARGET-30-PAIJGC	age group	2-6
TARGET-30-PAIJGC	stage	stage 4
TARGET-30-PAIJGC	ATRX	unknown
TARGET-30-PAIJGC	ALK	
TARGET-30-PAIJGC	MYCN	not amplified
TARGET-30-PAIJGC	Histology	unknown
TARGET-30-PAIJGC	Grade	differentiating
TARGET-30-PAIJGC	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIJGC	Protocol	9047
TARGET-30-PAIJGC	Category	neuroblastoma
TARGET-30-PAIJGC	1p-	unknown
TARGET-30-PAIJGC	1q+	unknown
TARGET-30-PAIJGC	11q-	unknown
TARGET-30-PAIJGC	17q+	unknown
TARGET-30-PAIJGC	%tumor	30.0
TARGET-30-PAIJGC	MKI	low
TARGET-30-PAILNI	age	1142
TARGET-30-PAILNI	age group	2-6
TARGET-30-PAILNI	stage	stage 4
TARGET-30-PAILNI	ATRX	unknown
TARGET-30-PAILNI	ALK	
TARGET-30-PAILNI	MYCN	not amplified
TARGET-30-PAILNI	Histology	unknown
TARGET-30-PAILNI	Grade	unknown
TARGET-30-PAILNI	Ploidy	hyperdiploid (di>1)
TARGET-30-PAILNI	Protocol	9047
TARGET-30-PAILNI	Category	unknown
TARGET-30-PAILNI	1p-	unknown
TARGET-30-PAILNI	1q+	unknown
TARGET-30-PAILNI	11q-	unknown
TARGET-30-PAILNI	17q+	unknown
TARGET-30-PAILNI	%tumor	80.0
TARGET-30-PAILNI	MKI	
TARGET-30-PAILNU	age	1683
TARGET-30-PAILNU	age group	2-6
TARGET-30-PAILNU	stage	stage 4
TARGET-30-PAILNU	ATRX	deleted
TARGET-30-PAILNU	ALK	normal
TARGET-30-PAILNU	MYCN	not amplified
TARGET-30-PAILNU	Histology	unknown
TARGET-30-PAILNU	Grade	unknown
TARGET-30-PAILNU	Ploidy	hyperdiploid (di>1)
TARGET-30-PAILNU	Protocol	9047
TARGET-30-PAILNU	Category	unknown
TARGET-30-PAILNU	1p-	normal
TARGET-30-PAILNU	1q+	normal
TARGET-30-PAILNU	11q-	loss
TARGET-30-PAILNU	17q+	gain
TARGET-30-PAILNU	%tumor	100.0
TARGET-30-PAILNU	MKI	
TARGET-30-PAILZJ	age	1261
TARGET-30-PAILZJ	age group	2-6
TARGET-30-PAILZJ	stage	stage 4
TARGET-30-PAILZJ	ATRX	unknown
TARGET-30-PAILZJ	ALK	
TARGET-30-PAILZJ	MYCN	not amplified
TARGET-30-PAILZJ	Histology	unknown
TARGET-30-PAILZJ	Grade	unknown
TARGET-30-PAILZJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PAILZJ	Protocol	9464-9047
TARGET-30-PAILZJ	Category	unknown
TARGET-30-PAILZJ	1p-	unknown
TARGET-30-PAILZJ	1q+	unknown
TARGET-30-PAILZJ	11q-	unknown
TARGET-30-PAILZJ	17q+	unknown
TARGET-30-PAILZJ	%tumor	95.0
TARGET-30-PAILZJ	MKI	
TARGET-30-PAIMAN	age	1079
TARGET-30-PAIMAN	age group	2-6
TARGET-30-PAIMAN	stage	stage 4
TARGET-30-PAIMAN	ATRX	unknown
TARGET-30-PAIMAN	ALK	
TARGET-30-PAIMAN	MYCN	not amplified
TARGET-30-PAIMAN	Histology	unknown
TARGET-30-PAIMAN	Grade	unknown
TARGET-30-PAIMAN	Ploidy	diploid (di=1)
TARGET-30-PAIMAN	Protocol	9047
TARGET-30-PAIMAN	Category	unknown
TARGET-30-PAIMAN	1p-	unknown
TARGET-30-PAIMAN	1q+	unknown
TARGET-30-PAIMAN	11q-	unknown
TARGET-30-PAIMAN	17q+	unknown
TARGET-30-PAIMAN	%tumor	30.0
TARGET-30-PAIMAN	MKI	
TARGET-30-PAIMDS	age	1332
TARGET-30-PAIMDS	age group	2-6
TARGET-30-PAIMDS	stage	stage 4
TARGET-30-PAIMDS	ATRX	unknown
TARGET-30-PAIMDS	ALK	
TARGET-30-PAIMDS	MYCN	not amplified
TARGET-30-PAIMDS	Histology	unknown
TARGET-30-PAIMDS	Grade	unknown
TARGET-30-PAIMDS	Ploidy	diploid (di=1)
TARGET-30-PAIMDS	Protocol	9047-P9462
TARGET-30-PAIMDS	Category	unknown
TARGET-30-PAIMDS	1p-	unknown
TARGET-30-PAIMDS	1q+	unknown
TARGET-30-PAIMDS	11q-	unknown
TARGET-30-PAIMDS	17q+	unknown
TARGET-30-PAIMDS	%tumor	95.0
TARGET-30-PAIMDS	MKI	
TARGET-30-PAIMDT	age	1408
TARGET-30-PAIMDT	age group	2-6
TARGET-30-PAIMDT	stage	stage 4
TARGET-30-PAIMDT	ATRX	unknown
TARGET-30-PAIMDT	ALK	normal
TARGET-30-PAIMDT	MYCN	not amplified
TARGET-30-PAIMDT	Histology	unknown
TARGET-30-PAIMDT	Grade	unknown
TARGET-30-PAIMDT	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIMDT	Protocol	9047
TARGET-30-PAIMDT	Category	unknown
TARGET-30-PAIMDT	1p-	normal
TARGET-30-PAIMDT	1q+	normal
TARGET-30-PAIMDT	11q-	loss
TARGET-30-PAIMDT	17q+	gain
TARGET-30-PAIMDT	%tumor	60.0
TARGET-30-PAIMDT	MKI	
TARGET-30-PAINLN	age	1404
TARGET-30-PAINLN	age group	2-6
TARGET-30-PAINLN	stage	stage 4
TARGET-30-PAINLN	ATRX	unknown
TARGET-30-PAINLN	ALK	mutated
TARGET-30-PAINLN	MYCN	not amplified
TARGET-30-PAINLN	Histology	unknown
TARGET-30-PAINLN	Grade	unknown
TARGET-30-PAINLN	Ploidy	hyperdiploid (di>1)
TARGET-30-PAINLN	Protocol	9047
TARGET-30-PAINLN	Category	unknown
TARGET-30-PAINLN	1p-	normal
TARGET-30-PAINLN	1q+	normal
TARGET-30-PAINLN	11q-	normal
TARGET-30-PAINLN	17q+	gain
TARGET-30-PAINLN	%tumor	95.0
TARGET-30-PAINLN	MKI	
TARGET-30-PAINRC	age	1605
TARGET-30-PAINRC	age group	2-6
TARGET-30-PAINRC	stage	stage 4
TARGET-30-PAINRC	ATRX	unknown
TARGET-30-PAINRC	ALK	
TARGET-30-PAINRC	MYCN	amplified
TARGET-30-PAINRC	Histology	unknown
TARGET-30-PAINRC	Grade	unknown
TARGET-30-PAINRC	Ploidy	hyperdiploid (di>1)
TARGET-30-PAINRC	Protocol	9047
TARGET-30-PAINRC	Category	unknown
TARGET-30-PAINRC	1p-	unknown
TARGET-30-PAINRC	1q+	unknown
TARGET-30-PAINRC	11q-	unknown
TARGET-30-PAINRC	17q+	unknown
TARGET-30-PAINRC	%tumor	
TARGET-30-PAINRC	MKI	
TARGET-30-PAIPGU	age	898
TARGET-30-PAIPGU	age group	2-6
TARGET-30-PAIPGU	stage	stage 4
TARGET-30-PAIPGU	ATRX	normal
TARGET-30-PAIPGU	ALK	normal
TARGET-30-PAIPGU	MYCN	not amplified
TARGET-30-PAIPGU	Histology	unknown
TARGET-30-PAIPGU	Grade	unknown
TARGET-30-PAIPGU	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIPGU	Protocol	9047
TARGET-30-PAIPGU	Category	unknown
TARGET-30-PAIPGU	1p-	normal
TARGET-30-PAIPGU	1q+	normal
TARGET-30-PAIPGU	11q-	loss
TARGET-30-PAIPGU	17q+	gain
TARGET-30-PAIPGU	%tumor	90.0
TARGET-30-PAIPGU	MKI	
TARGET-30-PAIPUD	age	659
TARGET-30-PAIPUD	age group	1-2
TARGET-30-PAIPUD	stage	stage 4
TARGET-30-PAIPUD	ATRX	unknown
TARGET-30-PAIPUD	ALK	
TARGET-30-PAIPUD	MYCN	not amplified
TARGET-30-PAIPUD	Histology	favorable
TARGET-30-PAIPUD	Grade	differentiating
TARGET-30-PAIPUD	Ploidy	diploid (di=1)
TARGET-30-PAIPUD	Protocol	9047
TARGET-30-PAIPUD	Category	neuroblastoma
TARGET-30-PAIPUD	1p-	unknown
TARGET-30-PAIPUD	1q+	unknown
TARGET-30-PAIPUD	11q-	unknown
TARGET-30-PAIPUD	17q+	unknown
TARGET-30-PAIPUD	%tumor	85.0
TARGET-30-PAIPUD	MKI	low
TARGET-30-PAIPVH	age	1740
TARGET-30-PAIPVH	age group	2-6
TARGET-30-PAIPVH	stage	stage 4
TARGET-30-PAIPVH	ATRX	unknown
TARGET-30-PAIPVH	ALK	
TARGET-30-PAIPVH	MYCN	not amplified
TARGET-30-PAIPVH	Histology	unfavorable
TARGET-30-PAIPVH	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIPVH	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIPVH	Protocol	9047-P9462
TARGET-30-PAIPVH	Category	neuroblastoma
TARGET-30-PAIPVH	1p-	unknown
TARGET-30-PAIPVH	1q+	unknown
TARGET-30-PAIPVH	11q-	unknown
TARGET-30-PAIPVH	17q+	unknown
TARGET-30-PAIPVH	%tumor	80.0
TARGET-30-PAIPVH	MKI	intermediate
TARGET-30-PAIRCP	age	987
TARGET-30-PAIRCP	age group	2-6
TARGET-30-PAIRCP	stage	stage 4
TARGET-30-PAIRCP	ATRX	unknown
TARGET-30-PAIRCP	ALK	
TARGET-30-PAIRCP	MYCN	not amplified
TARGET-30-PAIRCP	Histology	unfavorable
TARGET-30-PAIRCP	Grade	differentiating
TARGET-30-PAIRCP	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIRCP	Protocol	9047
TARGET-30-PAIRCP	Category	ganglioneuroblastoma, nodular
TARGET-30-PAIRCP	1p-	unknown
TARGET-30-PAIRCP	1q+	unknown
TARGET-30-PAIRCP	11q-	unknown
TARGET-30-PAIRCP	17q+	unknown
TARGET-30-PAIRCP	%tumor	
TARGET-30-PAIRCP	MKI	low
TARGET-30-PAIRDI	age	927
TARGET-30-PAIRDI	age group	2-6
TARGET-30-PAIRDI	stage	stage 4
TARGET-30-PAIRDI	ATRX	unknown
TARGET-30-PAIRDI	ALK	
TARGET-30-PAIRDI	MYCN	not amplified
TARGET-30-PAIRDI	Histology	favorable
TARGET-30-PAIRDI	Grade	differentiating
TARGET-30-PAIRDI	Ploidy	diploid (di=1)
TARGET-30-PAIRDI	Protocol	9047-9640-P9462
TARGET-30-PAIRDI	Category	ganglioneuroblastoma, intermixed
TARGET-30-PAIRDI	1p-	unknown
TARGET-30-PAIRDI	1q+	unknown
TARGET-30-PAIRDI	11q-	unknown
TARGET-30-PAIRDI	17q+	unknown
TARGET-30-PAIRDI	%tumor	30.0
TARGET-30-PAIRDI	MKI	low
TARGET-30-PAIRDP	age	895
TARGET-30-PAIRDP	age group	2-6
TARGET-30-PAIRDP	stage	stage 4
TARGET-30-PAIRDP	ATRX	unknown
TARGET-30-PAIRDP	ALK	
TARGET-30-PAIRDP	MYCN	amplified
TARGET-30-PAIRDP	Histology	unfavorable
TARGET-30-PAIRDP	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIRDP	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIRDP	Protocol	9047-P9462
TARGET-30-PAIRDP	Category	neuroblastoma
TARGET-30-PAIRDP	1p-	unknown
TARGET-30-PAIRDP	1q+	unknown
TARGET-30-PAIRDP	11q-	unknown
TARGET-30-PAIRDP	17q+	unknown
TARGET-30-PAIRDP	%tumor	95.0
TARGET-30-PAIRDP	MKI	high
TARGET-30-PAIRIK	age	594
TARGET-30-PAIRIK	age group	1-2
TARGET-30-PAIRIK	stage	stage 4
TARGET-30-PAIRIK	ATRX	unknown
TARGET-30-PAIRIK	ALK	
TARGET-30-PAIRIK	MYCN	not amplified
TARGET-30-PAIRIK	Histology	unfavorable
TARGET-30-PAIRIK	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIRIK	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIRIK	Protocol	9047-9640
TARGET-30-PAIRIK	Category	neuroblastoma
TARGET-30-PAIRIK	1p-	unknown
TARGET-30-PAIRIK	1q+	unknown
TARGET-30-PAIRIK	11q-	unknown
TARGET-30-PAIRIK	17q+	unknown
TARGET-30-PAIRIK	%tumor	95.0
TARGET-30-PAIRIK	MKI	low
TARGET-30-PAIRLD	age	1715
TARGET-30-PAIRLD	age group	2-6
TARGET-30-PAIRLD	stage	stage 4
TARGET-30-PAIRLD	ATRX	unknown
TARGET-30-PAIRLD	ALK	
TARGET-30-PAIRLD	MYCN	not amplified
TARGET-30-PAIRLD	Histology	unfavorable
TARGET-30-PAIRLD	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIRLD	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIRLD	Protocol	9047
TARGET-30-PAIRLD	Category	neuroblastoma
TARGET-30-PAIRLD	1p-	unknown
TARGET-30-PAIRLD	1q+	unknown
TARGET-30-PAIRLD	11q-	unknown
TARGET-30-PAIRLD	17q+	unknown
TARGET-30-PAIRLD	%tumor	95.0
TARGET-30-PAIRLD	MKI	intermediate
TARGET-30-PAIRLN	age	854
TARGET-30-PAIRLN	age group	2-6
TARGET-30-PAIRLN	stage	stage 4
TARGET-30-PAIRLN	ATRX	unknown
TARGET-30-PAIRLN	ALK	
TARGET-30-PAIRLN	MYCN	amplified
TARGET-30-PAIRLN	Histology	unfavorable
TARGET-30-PAIRLN	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIRLN	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIRLN	Protocol	9047
TARGET-30-PAIRLN	Category	neuroblastoma
TARGET-30-PAIRLN	1p-	unknown
TARGET-30-PAIRLN	1q+	unknown
TARGET-30-PAIRLN	11q-	unknown
TARGET-30-PAIRLN	17q+	unknown
TARGET-30-PAIRLN	%tumor	80.0
TARGET-30-PAIRLN	MKI	intermediate
TARGET-30-PAISNS	age	1070
TARGET-30-PAISNS	age group	2-6
TARGET-30-PAISNS	stage	stage 4
TARGET-30-PAISNS	ATRX	normal
TARGET-30-PAISNS	ALK	
TARGET-30-PAISNS	MYCN	not amplified
TARGET-30-PAISNS	Histology	unknown
TARGET-30-PAISNS	Grade	unknown
TARGET-30-PAISNS	Ploidy	diploid (di=1)
TARGET-30-PAISNS	Protocol	9047-P9462
TARGET-30-PAISNS	Category	unknown
TARGET-30-PAISNS	1p-	unknown
TARGET-30-PAISNS	1q+	unknown
TARGET-30-PAISNS	11q-	unknown
TARGET-30-PAISNS	17q+	unknown
TARGET-30-PAISNS	%tumor	
TARGET-30-PAISNS	MKI	
TARGET-30-PAISSH	age	656
TARGET-30-PAISSH	age group	1-2
TARGET-30-PAISSH	stage	stage 4
TARGET-30-PAISSH	ATRX	unknown
TARGET-30-PAISSH	ALK	normal
TARGET-30-PAISSH	MYCN	amplified
TARGET-30-PAISSH	Histology	unknown
TARGET-30-PAISSH	Grade	unknown
TARGET-30-PAISSH	Ploidy	hyperdiploid (di>1)
TARGET-30-PAISSH	Protocol	9047
TARGET-30-PAISSH	Category	unknown
TARGET-30-PAISSH	1p-	normal
TARGET-30-PAISSH	1q+	normal
TARGET-30-PAISSH	11q-	loss
TARGET-30-PAISSH	17q+	gain
TARGET-30-PAISSH	%tumor	5.0
TARGET-30-PAISSH	MKI	
TARGET-30-PAITCI	age	728
TARGET-30-PAITCI	age group	1-2
TARGET-30-PAITCI	stage	stage 4
TARGET-30-PAITCI	ATRX	unknown
TARGET-30-PAITCI	ALK	normal
TARGET-30-PAITCI	MYCN	not amplified
TARGET-30-PAITCI	Histology	favorable
TARGET-30-PAITCI	Grade	differentiating
TARGET-30-PAITCI	Ploidy	hyperdiploid (di>1)
TARGET-30-PAITCI	Protocol	9047-9082
TARGET-30-PAITCI	Category	neuroblastoma
TARGET-30-PAITCI	1p-	loss
TARGET-30-PAITCI	1q+	normal
TARGET-30-PAITCI	11q-	loss
TARGET-30-PAITCI	17q+	gain
TARGET-30-PAITCI	%tumor	90.0
TARGET-30-PAITCI	MKI	low
TARGET-30-PAITDU	age	1395
TARGET-30-PAITDU	age group	2-6
TARGET-30-PAITDU	stage	stage 4
TARGET-30-PAITDU	ATRX	unknown
TARGET-30-PAITDU	ALK	
TARGET-30-PAITDU	MYCN	not amplified
TARGET-30-PAITDU	Histology	unfavorable
TARGET-30-PAITDU	Grade	unknown
TARGET-30-PAITDU	Ploidy	unknown
TARGET-30-PAITDU	Protocol	9047
TARGET-30-PAITDU	Category	ganglioneuroblastoma, nodular
TARGET-30-PAITDU	1p-	unknown
TARGET-30-PAITDU	1q+	unknown
TARGET-30-PAITDU	11q-	unknown
TARGET-30-PAITDU	17q+	unknown
TARGET-30-PAITDU	%tumor	15.0
TARGET-30-PAITDU	MKI	
TARGET-30-PAITEG	age	1034
TARGET-30-PAITEG	age group	2-6
TARGET-30-PAITEG	stage	stage 4
TARGET-30-PAITEG	ATRX	unknown
TARGET-30-PAITEG	ALK	normal
TARGET-30-PAITEG	MYCN	not amplified
TARGET-30-PAITEG	Histology	unknown
TARGET-30-PAITEG	Grade	unknown
TARGET-30-PAITEG	Ploidy	diploid (di=1)
TARGET-30-PAITEG	Protocol	9047
TARGET-30-PAITEG	Category	neuroblastoma
TARGET-30-PAITEG	1p-	normal
TARGET-30-PAITEG	1q+	normal
TARGET-30-PAITEG	11q-	loss
TARGET-30-PAITEG	17q+	gain
TARGET-30-PAITEG	%tumor	95.0
TARGET-30-PAITEG	MKI	
TARGET-30-PAITRM	age	1499
TARGET-30-PAITRM	age group	2-6
TARGET-30-PAITRM	stage	stage 4
TARGET-30-PAITRM	ATRX	unknown
TARGET-30-PAITRM	ALK	
TARGET-30-PAITRM	MYCN	not amplified
TARGET-30-PAITRM	Histology	unfavorable
TARGET-30-PAITRM	Grade	undifferentiated or poorly differentiated
TARGET-30-PAITRM	Ploidy	diploid (di=1)
TARGET-30-PAITRM	Protocol	9047
TARGET-30-PAITRM	Category	neuroblastoma
TARGET-30-PAITRM	1p-	unknown
TARGET-30-PAITRM	1q+	unknown
TARGET-30-PAITRM	11q-	unknown
TARGET-30-PAITRM	17q+	unknown
TARGET-30-PAITRM	%tumor	80.0
TARGET-30-PAITRM	MKI	intermediate
TARGET-30-PAITZV	age	1689
TARGET-30-PAITZV	age group	2-6
TARGET-30-PAITZV	stage	stage 4
TARGET-30-PAITZV	ATRX	unknown
TARGET-30-PAITZV	ALK	
TARGET-30-PAITZV	MYCN	not amplified
TARGET-30-PAITZV	Histology	unfavorable
TARGET-30-PAITZV	Grade	undifferentiated or poorly differentiated
TARGET-30-PAITZV	Ploidy	hyperdiploid (di>1)
TARGET-30-PAITZV	Protocol	9047
TARGET-30-PAITZV	Category	neuroblastoma
TARGET-30-PAITZV	1p-	unknown
TARGET-30-PAITZV	1q+	unknown
TARGET-30-PAITZV	11q-	unknown
TARGET-30-PAITZV	17q+	unknown
TARGET-30-PAITZV	%tumor	95.0
TARGET-30-PAITZV	MKI	high
TARGET-30-PAIUBC	age	1239
TARGET-30-PAIUBC	age group	2-6
TARGET-30-PAIUBC	stage	stage 4
TARGET-30-PAIUBC	ATRX	unknown
TARGET-30-PAIUBC	ALK	
TARGET-30-PAIUBC	MYCN	not amplified
TARGET-30-PAIUBC	Histology	unknown
TARGET-30-PAIUBC	Grade	unknown
TARGET-30-PAIUBC	Ploidy	diploid (di=1)
TARGET-30-PAIUBC	Protocol	9047
TARGET-30-PAIUBC	Category	neuroblastoma
TARGET-30-PAIUBC	1p-	unknown
TARGET-30-PAIUBC	1q+	unknown
TARGET-30-PAIUBC	11q-	unknown
TARGET-30-PAIUBC	17q+	unknown
TARGET-30-PAIUBC	%tumor	10.0
TARGET-30-PAIUBC	MKI	
TARGET-30-PAIUJB	age	549
TARGET-30-PAIUJB	age group	1-2
TARGET-30-PAIUJB	stage	stage 4
TARGET-30-PAIUJB	ATRX	unknown
TARGET-30-PAIUJB	ALK	
TARGET-30-PAIUJB	MYCN	amplified
TARGET-30-PAIUJB	Histology	unfavorable
TARGET-30-PAIUJB	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIUJB	Ploidy	diploid (di=1)
TARGET-30-PAIUJB	Protocol	9047
TARGET-30-PAIUJB	Category	neuroblastoma
TARGET-30-PAIUJB	1p-	unknown
TARGET-30-PAIUJB	1q+	unknown
TARGET-30-PAIUJB	11q-	unknown
TARGET-30-PAIUJB	17q+	unknown
TARGET-30-PAIUJB	%tumor	95.0
TARGET-30-PAIUJB	MKI	high
TARGET-30-PAIVHE	age	1123
TARGET-30-PAIVHE	age group	2-6
TARGET-30-PAIVHE	stage	stage 4
TARGET-30-PAIVHE	ATRX	normal
TARGET-30-PAIVHE	ALK	normal
TARGET-30-PAIVHE	MYCN	not amplified
TARGET-30-PAIVHE	Histology	unfavorable
TARGET-30-PAIVHE	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIVHE	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIVHE	Protocol	9047-P9462-ANBL0321
TARGET-30-PAIVHE	Category	neuroblastoma
TARGET-30-PAIVHE	1p-	normal
TARGET-30-PAIVHE	1q+	gain
TARGET-30-PAIVHE	11q-	loss
TARGET-30-PAIVHE	17q+	gain
TARGET-30-PAIVHE	%tumor	90.0
TARGET-30-PAIVHE	MKI	low
TARGET-30-PAIVMJ	age	202
TARGET-30-PAIVMJ	age group	0-1
TARGET-30-PAIVMJ	stage	stage 1
TARGET-30-PAIVMJ	ATRX	unknown
TARGET-30-PAIVMJ	ALK	
TARGET-30-PAIVMJ	MYCN	not amplified
TARGET-30-PAIVMJ	Histology	favorable
TARGET-30-PAIVMJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIVMJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIVMJ	Protocol	9047
TARGET-30-PAIVMJ	Category	neuroblastoma
TARGET-30-PAIVMJ	1p-	unknown
TARGET-30-PAIVMJ	1q+	unknown
TARGET-30-PAIVMJ	11q-	unknown
TARGET-30-PAIVMJ	17q+	unknown
TARGET-30-PAIVMJ	%tumor	100.0
TARGET-30-PAIVMJ	MKI	intermediate
TARGET-30-PAIVZR	age	1227
TARGET-30-PAIVZR	age group	2-6
TARGET-30-PAIVZR	stage	stage 4
TARGET-30-PAIVZR	ATRX	unknown
TARGET-30-PAIVZR	ALK	
TARGET-30-PAIVZR	MYCN	amplified
TARGET-30-PAIVZR	Histology	unfavorable
TARGET-30-PAIVZR	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIVZR	Ploidy	diploid (di=1)
TARGET-30-PAIVZR	Protocol	9047
TARGET-30-PAIVZR	Category	neuroblastoma
TARGET-30-PAIVZR	1p-	unknown
TARGET-30-PAIVZR	1q+	unknown
TARGET-30-PAIVZR	11q-	unknown
TARGET-30-PAIVZR	17q+	unknown
TARGET-30-PAIVZR	%tumor	65.0
TARGET-30-PAIVZR	MKI	high
TARGET-30-PAIWEH	age	1078
TARGET-30-PAIWEH	age group	2-6
TARGET-30-PAIWEH	stage	stage 4
TARGET-30-PAIWEH	ATRX	unknown
TARGET-30-PAIWEH	ALK	
TARGET-30-PAIWEH	MYCN	not amplified
TARGET-30-PAIWEH	Histology	unfavorable
TARGET-30-PAIWEH	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIWEH	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIWEH	Protocol	9047
TARGET-30-PAIWEH	Category	neuroblastoma
TARGET-30-PAIWEH	1p-	unknown
TARGET-30-PAIWEH	1q+	unknown
TARGET-30-PAIWEH	11q-	unknown
TARGET-30-PAIWEH	17q+	unknown
TARGET-30-PAIWEH	%tumor	
TARGET-30-PAIWEH	MKI	high
TARGET-30-PAIWHU	age	242
TARGET-30-PAIWHU	age group	0-1
TARGET-30-PAIWHU	stage	stage 1
TARGET-30-PAIWHU	ATRX	unknown
TARGET-30-PAIWHU	ALK	
TARGET-30-PAIWHU	MYCN	not amplified
TARGET-30-PAIWHU	Histology	favorable
TARGET-30-PAIWHU	Grade	differentiating
TARGET-30-PAIWHU	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIWHU	Protocol	9047-P9641
TARGET-30-PAIWHU	Category	neuroblastoma
TARGET-30-PAIWHU	1p-	unknown
TARGET-30-PAIWHU	1q+	unknown
TARGET-30-PAIWHU	11q-	unknown
TARGET-30-PAIWHU	17q+	unknown
TARGET-30-PAIWHU	%tumor	95.0
TARGET-30-PAIWHU	MKI	intermediate
TARGET-30-PAIWRB	age	1065
TARGET-30-PAIWRB	age group	2-6
TARGET-30-PAIWRB	stage	stage 4
TARGET-30-PAIWRB	ATRX	unknown
TARGET-30-PAIWRB	ALK	normal
TARGET-30-PAIWRB	MYCN	amplified
TARGET-30-PAIWRB	Histology	unfavorable
TARGET-30-PAIWRB	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIWRB	Ploidy	diploid (di=1)
TARGET-30-PAIWRB	Protocol	9047
TARGET-30-PAIWRB	Category	neuroblastoma
TARGET-30-PAIWRB	1p-	normal
TARGET-30-PAIWRB	1q+	normal
TARGET-30-PAIWRB	11q-	normal
TARGET-30-PAIWRB	17q+	normal
TARGET-30-PAIWRB	%tumor	98.0
TARGET-30-PAIWRB	MKI	
TARGET-30-PAIWVG	age	645
TARGET-30-PAIWVG	age group	1-2
TARGET-30-PAIWVG	stage	stage 4
TARGET-30-PAIWVG	ATRX	unknown
TARGET-30-PAIWVG	ALK	
TARGET-30-PAIWVG	MYCN	not amplified
TARGET-30-PAIWVG	Histology	unfavorable
TARGET-30-PAIWVG	Grade	unknown
TARGET-30-PAIWVG	Ploidy	diploid (di=1)
TARGET-30-PAIWVG	Protocol	9047-ADVL0212
TARGET-30-PAIWVG	Category	neuroblastoma
TARGET-30-PAIWVG	1p-	unknown
TARGET-30-PAIWVG	1q+	unknown
TARGET-30-PAIWVG	11q-	unknown
TARGET-30-PAIWVG	17q+	unknown
TARGET-30-PAIWVG	%tumor	100.0
TARGET-30-PAIWVG	MKI	
TARGET-30-PAIWZA	age	292
TARGET-30-PAIWZA	age group	0-1
TARGET-30-PAIWZA	stage	stage 1
TARGET-30-PAIWZA	ATRX	unknown
TARGET-30-PAIWZA	ALK	
TARGET-30-PAIWZA	MYCN	not amplified
TARGET-30-PAIWZA	Histology	favorable
TARGET-30-PAIWZA	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIWZA	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIWZA	Protocol	9047-P9641
TARGET-30-PAIWZA	Category	neuroblastoma
TARGET-30-PAIWZA	1p-	unknown
TARGET-30-PAIWZA	1q+	unknown
TARGET-30-PAIWZA	11q-	unknown
TARGET-30-PAIWZA	17q+	unknown
TARGET-30-PAIWZA	%tumor	
TARGET-30-PAIWZA	MKI	intermediate
TARGET-30-PAIXBP	age	832
TARGET-30-PAIXBP	age group	2-6
TARGET-30-PAIXBP	stage	stage 4
TARGET-30-PAIXBP	ATRX	unknown
TARGET-30-PAIXBP	ALK	
TARGET-30-PAIXBP	MYCN	not amplified
TARGET-30-PAIXBP	Histology	unfavorable
TARGET-30-PAIXBP	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIXBP	Ploidy	diploid (di=1)
TARGET-30-PAIXBP	Protocol	9047
TARGET-30-PAIXBP	Category	neuroblastoma
TARGET-30-PAIXBP	1p-	unknown
TARGET-30-PAIXBP	1q+	unknown
TARGET-30-PAIXBP	11q-	unknown
TARGET-30-PAIXBP	17q+	unknown
TARGET-30-PAIXBP	%tumor	
TARGET-30-PAIXBP	MKI	low
TARGET-30-PAIXFZ	age	60
TARGET-30-PAIXFZ	age group	0-1
TARGET-30-PAIXFZ	stage	stage 4s
TARGET-30-PAIXFZ	ATRX	unknown
TARGET-30-PAIXFZ	ALK	
TARGET-30-PAIXFZ	MYCN	not amplified
TARGET-30-PAIXFZ	Histology	favorable
TARGET-30-PAIXFZ	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIXFZ	Ploidy	diploid (di=1)
TARGET-30-PAIXFZ	Protocol	9047
TARGET-30-PAIXFZ	Category	neuroblastoma
TARGET-30-PAIXFZ	1p-	unknown
TARGET-30-PAIXFZ	1q+	unknown
TARGET-30-PAIXFZ	11q-	unknown
TARGET-30-PAIXFZ	17q+	unknown
TARGET-30-PAIXFZ	%tumor	
TARGET-30-PAIXFZ	MKI	low
TARGET-30-PAIXHH	age	38
TARGET-30-PAIXHH	age group	0-1
TARGET-30-PAIXHH	stage	stage 1
TARGET-30-PAIXHH	ATRX	unknown
TARGET-30-PAIXHH	ALK	
TARGET-30-PAIXHH	MYCN	not amplified
TARGET-30-PAIXHH	Histology	favorable
TARGET-30-PAIXHH	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIXHH	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIXHH	Protocol	9047-P9641
TARGET-30-PAIXHH	Category	neuroblastoma
TARGET-30-PAIXHH	1p-	unknown
TARGET-30-PAIXHH	1q+	unknown
TARGET-30-PAIXHH	11q-	unknown
TARGET-30-PAIXHH	17q+	unknown
TARGET-30-PAIXHH	%tumor	
TARGET-30-PAIXHH	MKI	intermediate
TARGET-30-PAIXIF	age	1315
TARGET-30-PAIXIF	age group	2-6
TARGET-30-PAIXIF	stage	stage 4
TARGET-30-PAIXIF	ATRX	unknown
TARGET-30-PAIXIF	ALK	normal
TARGET-30-PAIXIF	MYCN	not amplified
TARGET-30-PAIXIF	Histology	unfavorable
TARGET-30-PAIXIF	Grade	unknown
TARGET-30-PAIXIF	Ploidy	diploid (di=1)
TARGET-30-PAIXIF	Protocol	9047
TARGET-30-PAIXIF	Category	ganglioneuroblastoma, nodular
TARGET-30-PAIXIF	1p-	normal
TARGET-30-PAIXIF	1q+	gain
TARGET-30-PAIXIF	11q-	loss
TARGET-30-PAIXIF	17q+	gain
TARGET-30-PAIXIF	%tumor	
TARGET-30-PAIXIF	MKI	intermediate
TARGET-30-PAIXLC	age	270
TARGET-30-PAIXLC	age group	0-1
TARGET-30-PAIXLC	stage	stage 1
TARGET-30-PAIXLC	ATRX	unknown
TARGET-30-PAIXLC	ALK	
TARGET-30-PAIXLC	MYCN	not amplified
TARGET-30-PAIXLC	Histology	favorable
TARGET-30-PAIXLC	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIXLC	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIXLC	Protocol	9047-P9641
TARGET-30-PAIXLC	Category	neuroblastoma
TARGET-30-PAIXLC	1p-	unknown
TARGET-30-PAIXLC	1q+	unknown
TARGET-30-PAIXLC	11q-	unknown
TARGET-30-PAIXLC	17q+	unknown
TARGET-30-PAIXLC	%tumor	100.0
TARGET-30-PAIXLC	MKI	intermediate
TARGET-30-PAIXLY	age	1241
TARGET-30-PAIXLY	age group	2-6
TARGET-30-PAIXLY	stage	stage 4
TARGET-30-PAIXLY	ATRX	unknown
TARGET-30-PAIXLY	ALK	
TARGET-30-PAIXLY	MYCN	amplified
TARGET-30-PAIXLY	Histology	unknown
TARGET-30-PAIXLY	Grade	unknown
TARGET-30-PAIXLY	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIXLY	Protocol	9047
TARGET-30-PAIXLY	Category	unknown
TARGET-30-PAIXLY	1p-	unknown
TARGET-30-PAIXLY	1q+	unknown
TARGET-30-PAIXLY	11q-	unknown
TARGET-30-PAIXLY	17q+	unknown
TARGET-30-PAIXLY	%tumor	
TARGET-30-PAIXLY	MKI	
TARGET-30-PAIXNC	age	723
TARGET-30-PAIXNC	age group	1-2
TARGET-30-PAIXNC	stage	stage 4
TARGET-30-PAIXNC	ATRX	unknown
TARGET-30-PAIXNC	ALK	normal
TARGET-30-PAIXNC	MYCN	not amplified
TARGET-30-PAIXNC	Histology	unfavorable
TARGET-30-PAIXNC	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIXNC	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIXNC	Protocol	9047
TARGET-30-PAIXNC	Category	neuroblastoma
TARGET-30-PAIXNC	1p-	normal
TARGET-30-PAIXNC	1q+	normal
TARGET-30-PAIXNC	11q-	loss
TARGET-30-PAIXNC	17q+	gain
TARGET-30-PAIXNC	%tumor	
TARGET-30-PAIXNC	MKI	intermediate
TARGET-30-PAIXNG	age	1221
TARGET-30-PAIXNG	age group	2-6
TARGET-30-PAIXNG	stage	stage 4
TARGET-30-PAIXNG	ATRX	unknown
TARGET-30-PAIXNG	ALK	
TARGET-30-PAIXNG	MYCN	not amplified
TARGET-30-PAIXNG	Histology	unknown
TARGET-30-PAIXNG	Grade	unknown
TARGET-30-PAIXNG	Ploidy	diploid (di=1)
TARGET-30-PAIXNG	Protocol	4941-9047
TARGET-30-PAIXNG	Category	unknown
TARGET-30-PAIXNG	1p-	unknown
TARGET-30-PAIXNG	1q+	unknown
TARGET-30-PAIXNG	11q-	unknown
TARGET-30-PAIXNG	17q+	unknown
TARGET-30-PAIXNG	%tumor	100.0
TARGET-30-PAIXNG	MKI	
TARGET-30-PAIXNV	age	644
TARGET-30-PAIXNV	age group	1-2
TARGET-30-PAIXNV	stage	stage 4
TARGET-30-PAIXNV	ATRX	unknown
TARGET-30-PAIXNV	ALK	normal
TARGET-30-PAIXNV	MYCN	not amplified
TARGET-30-PAIXNV	Histology	unfavorable
TARGET-30-PAIXNV	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIXNV	Ploidy	hyperdiploid (di>1)
TARGET-30-PAIXNV	Protocol	9047
TARGET-30-PAIXNV	Category	neuroblastoma
TARGET-30-PAIXNV	1p-	normal
TARGET-30-PAIXNV	1q+	normal
TARGET-30-PAIXNV	11q-	normal
TARGET-30-PAIXNV	17q+	gain
TARGET-30-PAIXNV	%tumor	
TARGET-30-PAIXNV	MKI	intermediate
TARGET-30-PAIXRK	age	564
TARGET-30-PAIXRK	age group	1-2
TARGET-30-PAIXRK	stage	stage 4
TARGET-30-PAIXRK	ATRX	unknown
TARGET-30-PAIXRK	ALK	normal
TARGET-30-PAIXRK	MYCN	amplified
TARGET-30-PAIXRK	Histology	unfavorable
TARGET-30-PAIXRK	Grade	undifferentiated or poorly differentiated
TARGET-30-PAIXRK	Ploidy	diploid (di=1)
TARGET-30-PAIXRK	Protocol	9047-P9963-P9462
TARGET-30-PAIXRK	Category	neuroblastoma
TARGET-30-PAIXRK	1p-	loss
TARGET-30-PAIXRK	1q+	normal
TARGET-30-PAIXRK	11q-	normal
TARGET-30-PAIXRK	17q+	normal
TARGET-30-PAIXRK	%tumor	
TARGET-30-PAIXRK	MKI	high
TARGET-30-PAJXLE	age	720
TARGET-30-PAJXLE	age group	1-2
TARGET-30-PAJXLE	stage	unknown
TARGET-30-PAJXLE	ATRX	unknown
TARGET-30-PAJXLE	ALK	
TARGET-30-PAJXLE	MYCN	unknown
TARGET-30-PAJXLE	Histology	unknown
TARGET-30-PAJXLE	Grade	unknown
TARGET-30-PAJXLE	Ploidy	unknown
TARGET-30-PAJXLE	Protocol	B954-I03-323P-8605
TARGET-30-PAJXLE	Category	unknown
TARGET-30-PAJXLE	1p-	unknown
TARGET-30-PAJXLE	1q+	unknown
TARGET-30-PAJXLE	11q-	unknown
TARGET-30-PAJXLE	17q+	unknown
TARGET-30-PAJXLE	%tumor	
TARGET-30-PAJXLE	MKI	
TARGET-30-PAJYHP	age	1409
TARGET-30-PAJYHP	age group	2-6
TARGET-30-PAJYHP	stage	stage 4
TARGET-30-PAJYHP	ATRX	unknown
TARGET-30-PAJYHP	ALK	
TARGET-30-PAJYHP	MYCN	not amplified
TARGET-30-PAJYHP	Histology	unknown
TARGET-30-PAJYHP	Grade	unknown
TARGET-30-PAJYHP	Ploidy	unknown
TARGET-30-PAJYHP	Protocol	B003-321P2
TARGET-30-PAJYHP	Category	unknown
TARGET-30-PAJYHP	1p-	unknown
TARGET-30-PAJYHP	1q+	unknown
TARGET-30-PAJYHP	11q-	unknown
TARGET-30-PAJYHP	17q+	unknown
TARGET-30-PAJYHP	%tumor	
TARGET-30-PAJYHP	MKI	
TARGET-30-PAJYLA	age	562
TARGET-30-PAJYLA	age group	1-2
TARGET-30-PAJYLA	stage	stage 4
TARGET-30-PAJYLA	ATRX	unknown
TARGET-30-PAJYLA	ALK	
TARGET-30-PAJYLA	MYCN	not amplified
TARGET-30-PAJYLA	Histology	unfavorable
TARGET-30-PAJYLA	Grade	unknown
TARGET-30-PAJYLA	Ploidy	unknown
TARGET-30-PAJYLA	Protocol	B003-321P2
TARGET-30-PAJYLA	Category	unknown
TARGET-30-PAJYLA	1p-	unknown
TARGET-30-PAJYLA	1q+	unknown
TARGET-30-PAJYLA	11q-	unknown
TARGET-30-PAJYLA	17q+	unknown
TARGET-30-PAJYLA	%tumor	
TARGET-30-PAJYLA	MKI	
TARGET-30-PAJYVA	age	708
TARGET-30-PAJYVA	age group	1-2
TARGET-30-PAJYVA	stage	stage 4
TARGET-30-PAJYVA	ATRX	unknown
TARGET-30-PAJYVA	ALK	
TARGET-30-PAJYVA	MYCN	not amplified
TARGET-30-PAJYVA	Histology	unfavorable
TARGET-30-PAJYVA	Grade	unknown
TARGET-30-PAJYVA	Ploidy	unknown
TARGET-30-PAJYVA	Protocol	B003-321P2
TARGET-30-PAJYVA	Category	unknown
TARGET-30-PAJYVA	1p-	unknown
TARGET-30-PAJYVA	1q+	unknown
TARGET-30-PAJYVA	11q-	unknown
TARGET-30-PAJYVA	17q+	unknown
TARGET-30-PAJYVA	%tumor	
TARGET-30-PAJYVA	MKI	
TARGET-30-PAJZUU	age	3231
TARGET-30-PAJZUU	age group	6-9
TARGET-30-PAJZUU	stage	stage 4
TARGET-30-PAJZUU	ATRX	unknown
TARGET-30-PAJZUU	ALK	
TARGET-30-PAJZUU	MYCN	not amplified
TARGET-30-PAJZUU	Histology	unfavorable
TARGET-30-PAJZUU	Grade	undifferentiated or poorly differentiated
TARGET-30-PAJZUU	Ploidy	unknown
TARGET-30-PAJZUU	Protocol	B003-3891-E18
TARGET-30-PAJZUU	Category	neuroblastoma
TARGET-30-PAJZUU	1p-	unknown
TARGET-30-PAJZUU	1q+	unknown
TARGET-30-PAJZUU	11q-	unknown
TARGET-30-PAJZUU	17q+	unknown
TARGET-30-PAJZUU	%tumor	
TARGET-30-PAJZUU	MKI	low
TARGET-30-PAJZWL	age	547
TARGET-30-PAJZWL	age group	1-2
TARGET-30-PAJZWL	stage	stage 4
TARGET-30-PAJZWL	ATRX	unknown
TARGET-30-PAJZWL	ALK	
TARGET-30-PAJZWL	MYCN	amplified
TARGET-30-PAJZWL	Histology	unknown
TARGET-30-PAJZWL	Grade	unknown
TARGET-30-PAJZWL	Ploidy	unknown
TARGET-30-PAJZWL	Protocol	N891-B003-3891-E18
TARGET-30-PAJZWL	Category	unknown
TARGET-30-PAJZWL	1p-	unknown
TARGET-30-PAJZWL	1q+	unknown
TARGET-30-PAJZWL	11q-	unknown
TARGET-30-PAJZWL	17q+	unknown
TARGET-30-PAJZWL	%tumor	
TARGET-30-PAJZWL	MKI	
TARGET-30-PAKACY	age	1114
TARGET-30-PAKACY	age group	2-6
TARGET-30-PAKACY	stage	stage 4
TARGET-30-PAKACY	ATRX	unknown
TARGET-30-PAKACY	ALK	
TARGET-30-PAKACY	MYCN	amplified
TARGET-30-PAKACY	Histology	unfavorable
TARGET-30-PAKACY	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKACY	Ploidy	unknown
TARGET-30-PAKACY	Protocol	B903-B003-3891-E18
TARGET-30-PAKACY	Category	neuroblastoma
TARGET-30-PAKACY	1p-	unknown
TARGET-30-PAKACY	1q+	unknown
TARGET-30-PAKACY	11q-	unknown
TARGET-30-PAKACY	17q+	unknown
TARGET-30-PAKACY	%tumor	
TARGET-30-PAKACY	MKI	high
TARGET-30-PAKADI	age	1456
TARGET-30-PAKADI	age group	2-6
TARGET-30-PAKADI	stage	stage 4
TARGET-30-PAKADI	ATRX	unknown
TARGET-30-PAKADI	ALK	
TARGET-30-PAKADI	MYCN	not amplified
TARGET-30-PAKADI	Histology	unfavorable
TARGET-30-PAKADI	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKADI	Ploidy	unknown
TARGET-30-PAKADI	Protocol	B003-3891-E18
TARGET-30-PAKADI	Category	ganglioneuroblastoma, nodular
TARGET-30-PAKADI	1p-	unknown
TARGET-30-PAKADI	1q+	unknown
TARGET-30-PAKADI	11q-	unknown
TARGET-30-PAKADI	17q+	unknown
TARGET-30-PAKADI	%tumor	
TARGET-30-PAKADI	MKI	low
TARGET-30-PAKAFK	age	1509
TARGET-30-PAKAFK	age group	2-6
TARGET-30-PAKAFK	stage	stage 4
TARGET-30-PAKAFK	ATRX	unknown
TARGET-30-PAKAFK	ALK	
TARGET-30-PAKAFK	MYCN	not amplified
TARGET-30-PAKAFK	Histology	unfavorable
TARGET-30-PAKAFK	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKAFK	Ploidy	unknown
TARGET-30-PAKAFK	Protocol	B003-3891
TARGET-30-PAKAFK	Category	neuroblastoma
TARGET-30-PAKAFK	1p-	unknown
TARGET-30-PAKAFK	1q+	unknown
TARGET-30-PAKAFK	11q-	unknown
TARGET-30-PAKAFK	17q+	unknown
TARGET-30-PAKAFK	%tumor	
TARGET-30-PAKAFK	MKI	low
TARGET-30-PAKANZ	age	1975
TARGET-30-PAKANZ	age group	2-6
TARGET-30-PAKANZ	stage	stage 4
TARGET-30-PAKANZ	ATRX	unknown
TARGET-30-PAKANZ	ALK	
TARGET-30-PAKANZ	MYCN	not amplified
TARGET-30-PAKANZ	Histology	unfavorable
TARGET-30-PAKANZ	Grade	unknown
TARGET-30-PAKANZ	Ploidy	unknown
TARGET-30-PAKANZ	Protocol	B947-B003-3891-S921-P9462
TARGET-30-PAKANZ	Category	unknown
TARGET-30-PAKANZ	1p-	unknown
TARGET-30-PAKANZ	1q+	unknown
TARGET-30-PAKANZ	11q-	unknown
TARGET-30-PAKANZ	17q+	unknown
TARGET-30-PAKANZ	%tumor	
TARGET-30-PAKANZ	MKI	
TARGET-30-PAKDHL	age	1031
TARGET-30-PAKDHL	age group	2-6
TARGET-30-PAKDHL	stage	stage 4
TARGET-30-PAKDHL	ATRX	unknown
TARGET-30-PAKDHL	ALK	
TARGET-30-PAKDHL	MYCN	not amplified
TARGET-30-PAKDHL	Histology	unfavorable
TARGET-30-PAKDHL	Grade	unknown
TARGET-30-PAKDHL	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKDHL	Protocol	B973-ADVL0018
TARGET-30-PAKDHL	Category	neuroblastoma
TARGET-30-PAKDHL	1p-	unknown
TARGET-30-PAKDHL	1q+	unknown
TARGET-30-PAKDHL	11q-	unknown
TARGET-30-PAKDHL	17q+	unknown
TARGET-30-PAKDHL	%tumor	95.0
TARGET-30-PAKDHL	MKI	
TARGET-30-PAKFUY	age	1194
TARGET-30-PAKFUY	age group	2-6
TARGET-30-PAKFUY	stage	stage 4
TARGET-30-PAKFUY	ATRX	unknown
TARGET-30-PAKFUY	ALK	normal
TARGET-30-PAKFUY	MYCN	not amplified
TARGET-30-PAKFUY	Histology	unfavorable
TARGET-30-PAKFUY	Grade	unknown
TARGET-30-PAKFUY	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKFUY	Protocol	9047
TARGET-30-PAKFUY	Category	neuroblastoma
TARGET-30-PAKFUY	1p-	normal
TARGET-30-PAKFUY	1q+	normal
TARGET-30-PAKFUY	11q-	normal
TARGET-30-PAKFUY	17q+	gain
TARGET-30-PAKFUY	%tumor	
TARGET-30-PAKFUY	MKI	
TARGET-30-PAKFVB	age	1098
TARGET-30-PAKFVB	age group	2-6
TARGET-30-PAKFVB	stage	stage 4
TARGET-30-PAKFVB	ATRX	unknown
TARGET-30-PAKFVB	ALK	
TARGET-30-PAKFVB	MYCN	not amplified
TARGET-30-PAKFVB	Histology	unfavorable
TARGET-30-PAKFVB	Grade	unknown
TARGET-30-PAKFVB	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKFVB	Protocol	9047
TARGET-30-PAKFVB	Category	neuroblastoma
TARGET-30-PAKFVB	1p-	unknown
TARGET-30-PAKFVB	1q+	unknown
TARGET-30-PAKFVB	11q-	unknown
TARGET-30-PAKFVB	17q+	unknown
TARGET-30-PAKFVB	%tumor	
TARGET-30-PAKFVB	MKI	
TARGET-30-PAKGAB	age	1108
TARGET-30-PAKGAB	age group	2-6
TARGET-30-PAKGAB	stage	stage 4
TARGET-30-PAKGAB	ATRX	unknown
TARGET-30-PAKGAB	ALK	
TARGET-30-PAKGAB	MYCN	not amplified
TARGET-30-PAKGAB	Histology	unfavorable
TARGET-30-PAKGAB	Grade	unknown
TARGET-30-PAKGAB	Ploidy	diploid (di=1)
TARGET-30-PAKGAB	Protocol	9047
TARGET-30-PAKGAB	Category	neuroblastoma
TARGET-30-PAKGAB	1p-	unknown
TARGET-30-PAKGAB	1q+	unknown
TARGET-30-PAKGAB	11q-	unknown
TARGET-30-PAKGAB	17q+	unknown
TARGET-30-PAKGAB	%tumor	
TARGET-30-PAKGAB	MKI	
TARGET-30-PAKGCI	age	300
TARGET-30-PAKGCI	age group	0-1
TARGET-30-PAKGCI	stage	stage 1
TARGET-30-PAKGCI	ATRX	unknown
TARGET-30-PAKGCI	ALK	
TARGET-30-PAKGCI	MYCN	not amplified
TARGET-30-PAKGCI	Histology	favorable
TARGET-30-PAKGCI	Grade	unknown
TARGET-30-PAKGCI	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKGCI	Protocol	9047-P9641
TARGET-30-PAKGCI	Category	neuroblastoma
TARGET-30-PAKGCI	1p-	unknown
TARGET-30-PAKGCI	1q+	unknown
TARGET-30-PAKGCI	11q-	unknown
TARGET-30-PAKGCI	17q+	unknown
TARGET-30-PAKGCI	%tumor	
TARGET-30-PAKGCI	MKI	
TARGET-30-PAKGGW	age	30
TARGET-30-PAKGGW	age group	0-1
TARGET-30-PAKGGW	stage	stage 1
TARGET-30-PAKGGW	ATRX	unknown
TARGET-30-PAKGGW	ALK	
TARGET-30-PAKGGW	MYCN	not amplified
TARGET-30-PAKGGW	Histology	favorable
TARGET-30-PAKGGW	Grade	unknown
TARGET-30-PAKGGW	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKGGW	Protocol	B947-B973-P9641
TARGET-30-PAKGGW	Category	neuroblastoma
TARGET-30-PAKGGW	1p-	unknown
TARGET-30-PAKGGW	1q+	unknown
TARGET-30-PAKGGW	11q-	unknown
TARGET-30-PAKGGW	17q+	unknown
TARGET-30-PAKGGW	%tumor	
TARGET-30-PAKGGW	MKI	
TARGET-30-PAKGKH	age	882
TARGET-30-PAKGKH	age group	2-6
TARGET-30-PAKGKH	stage	stage 4
TARGET-30-PAKGKH	ATRX	unknown
TARGET-30-PAKGKH	ALK	normal
TARGET-30-PAKGKH	MYCN	not amplified
TARGET-30-PAKGKH	Histology	unfavorable
TARGET-30-PAKGKH	Grade	unknown
TARGET-30-PAKGKH	Ploidy	diploid (di=1)
TARGET-30-PAKGKH	Protocol	9047
TARGET-30-PAKGKH	Category	neuroblastoma
TARGET-30-PAKGKH	1p-	normal
TARGET-30-PAKGKH	1q+	gain
TARGET-30-PAKGKH	11q-	loss
TARGET-30-PAKGKH	17q+	gain
TARGET-30-PAKGKH	%tumor	10.0
TARGET-30-PAKGKH	MKI	
TARGET-30-PAKGMY	age	673
TARGET-30-PAKGMY	age group	1-2
TARGET-30-PAKGMY	stage	stage 4
TARGET-30-PAKGMY	ATRX	unknown
TARGET-30-PAKGMY	ALK	
TARGET-30-PAKGMY	MYCN	amplified
TARGET-30-PAKGMY	Histology	unknown
TARGET-30-PAKGMY	Grade	unknown
TARGET-30-PAKGMY	Ploidy	diploid (di=1)
TARGET-30-PAKGMY	Protocol	B947-B973
TARGET-30-PAKGMY	Category	neuroblastoma
TARGET-30-PAKGMY	1p-	unknown
TARGET-30-PAKGMY	1q+	unknown
TARGET-30-PAKGMY	11q-	unknown
TARGET-30-PAKGMY	17q+	unknown
TARGET-30-PAKGMY	%tumor	60.0
TARGET-30-PAKGMY	MKI	
TARGET-30-PAKGRH	age	711
TARGET-30-PAKGRH	age group	1-2
TARGET-30-PAKGRH	stage	stage 4
TARGET-30-PAKGRH	ATRX	unknown
TARGET-30-PAKGRH	ALK	
TARGET-30-PAKGRH	MYCN	not amplified
TARGET-30-PAKGRH	Histology	unfavorable
TARGET-30-PAKGRH	Grade	unknown
TARGET-30-PAKGRH	Ploidy	diploid (di=1)
TARGET-30-PAKGRH	Protocol	9047
TARGET-30-PAKGRH	Category	neuroblastoma
TARGET-30-PAKGRH	1p-	unknown
TARGET-30-PAKGRH	1q+	unknown
TARGET-30-PAKGRH	11q-	unknown
TARGET-30-PAKGRH	17q+	unknown
TARGET-30-PAKGRH	%tumor	
TARGET-30-PAKGRH	MKI	
TARGET-30-PAKHAE	age	359
TARGET-30-PAKHAE	age group	0-1
TARGET-30-PAKHAE	stage	stage 1
TARGET-30-PAKHAE	ATRX	unknown
TARGET-30-PAKHAE	ALK	
TARGET-30-PAKHAE	MYCN	not amplified
TARGET-30-PAKHAE	Histology	favorable
TARGET-30-PAKHAE	Grade	unknown
TARGET-30-PAKHAE	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKHAE	Protocol	9047-P9641
TARGET-30-PAKHAE	Category	neuroblastoma
TARGET-30-PAKHAE	1p-	unknown
TARGET-30-PAKHAE	1q+	unknown
TARGET-30-PAKHAE	11q-	unknown
TARGET-30-PAKHAE	17q+	unknown
TARGET-30-PAKHAE	%tumor	
TARGET-30-PAKHAE	MKI	
TARGET-30-PAKHAV	age	150
TARGET-30-PAKHAV	age group	0-1
TARGET-30-PAKHAV	stage	stage 1
TARGET-30-PAKHAV	ATRX	unknown
TARGET-30-PAKHAV	ALK	
TARGET-30-PAKHAV	MYCN	not amplified
TARGET-30-PAKHAV	Histology	favorable
TARGET-30-PAKHAV	Grade	unknown
TARGET-30-PAKHAV	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKHAV	Protocol	B973-P9641
TARGET-30-PAKHAV	Category	neuroblastoma
TARGET-30-PAKHAV	1p-	unknown
TARGET-30-PAKHAV	1q+	unknown
TARGET-30-PAKHAV	11q-	unknown
TARGET-30-PAKHAV	17q+	unknown
TARGET-30-PAKHAV	%tumor	
TARGET-30-PAKHAV	MKI	
TARGET-30-PAKHCF	age	839
TARGET-30-PAKHCF	age group	2-6
TARGET-30-PAKHCF	stage	stage 4
TARGET-30-PAKHCF	ATRX	unknown
TARGET-30-PAKHCF	ALK	normal
TARGET-30-PAKHCF	MYCN	not amplified
TARGET-30-PAKHCF	Histology	favorable
TARGET-30-PAKHCF	Grade	unknown
TARGET-30-PAKHCF	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKHCF	Protocol	9047
TARGET-30-PAKHCF	Category	neuroblastoma
TARGET-30-PAKHCF	1p-	normal
TARGET-30-PAKHCF	1q+	normal
TARGET-30-PAKHCF	11q-	loss
TARGET-30-PAKHCF	17q+	gain
TARGET-30-PAKHCF	%tumor	
TARGET-30-PAKHCF	MKI	
TARGET-30-PAKHHB	age	687
TARGET-30-PAKHHB	age group	1-2
TARGET-30-PAKHHB	stage	stage 4
TARGET-30-PAKHHB	ATRX	unknown
TARGET-30-PAKHHB	ALK	normal
TARGET-30-PAKHHB	MYCN	amplified
TARGET-30-PAKHHB	Histology	unfavorable
TARGET-30-PAKHHB	Grade	unknown
TARGET-30-PAKHHB	Ploidy	diploid (di=1)
TARGET-30-PAKHHB	Protocol	9047
TARGET-30-PAKHHB	Category	neuroblastoma
TARGET-30-PAKHHB	1p-	loss
TARGET-30-PAKHHB	1q+	gain
TARGET-30-PAKHHB	11q-	normal
TARGET-30-PAKHHB	17q+	gain
TARGET-30-PAKHHB	%tumor	
TARGET-30-PAKHHB	MKI	
TARGET-30-PAKHPN	age	1488
TARGET-30-PAKHPN	age group	2-6
TARGET-30-PAKHPN	stage	stage 4
TARGET-30-PAKHPN	ATRX	unknown
TARGET-30-PAKHPN	ALK	
TARGET-30-PAKHPN	MYCN	not amplified
TARGET-30-PAKHPN	Histology	unfavorable
TARGET-30-PAKHPN	Grade	unknown
TARGET-30-PAKHPN	Ploidy	diploid (di=1)
TARGET-30-PAKHPN	Protocol	9047
TARGET-30-PAKHPN	Category	ganglioneuroblastoma, intermixed
TARGET-30-PAKHPN	1p-	unknown
TARGET-30-PAKHPN	1q+	unknown
TARGET-30-PAKHPN	11q-	unknown
TARGET-30-PAKHPN	17q+	unknown
TARGET-30-PAKHPN	%tumor	
TARGET-30-PAKHPN	MKI	
TARGET-30-PAKIAP	age	1742
TARGET-30-PAKIAP	age group	2-6
TARGET-30-PAKIAP	stage	stage 4
TARGET-30-PAKIAP	ATRX	unknown
TARGET-30-PAKIAP	ALK	
TARGET-30-PAKIAP	MYCN	not amplified
TARGET-30-PAKIAP	Histology	unfavorable
TARGET-30-PAKIAP	Grade	unknown
TARGET-30-PAKIAP	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKIAP	Protocol	9047
TARGET-30-PAKIAP	Category	neuroblastoma
TARGET-30-PAKIAP	1p-	unknown
TARGET-30-PAKIAP	1q+	unknown
TARGET-30-PAKIAP	11q-	unknown
TARGET-30-PAKIAP	17q+	unknown
TARGET-30-PAKIAP	%tumor	
TARGET-30-PAKIAP	MKI	
TARGET-30-PAKINP	age	813
TARGET-30-PAKINP	age group	2-6
TARGET-30-PAKINP	stage	stage 1
TARGET-30-PAKINP	ATRX	unknown
TARGET-30-PAKINP	ALK	
TARGET-30-PAKINP	MYCN	not amplified
TARGET-30-PAKINP	Histology	favorable
TARGET-30-PAKINP	Grade	unknown
TARGET-30-PAKINP	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKINP	Protocol	9047-P9641
TARGET-30-PAKINP	Category	neuroblastoma
TARGET-30-PAKINP	1p-	unknown
TARGET-30-PAKINP	1q+	unknown
TARGET-30-PAKINP	11q-	unknown
TARGET-30-PAKINP	17q+	unknown
TARGET-30-PAKINP	%tumor	90.0
TARGET-30-PAKINP	MKI	
TARGET-30-PAKIPY	age	1116
TARGET-30-PAKIPY	age group	2-6
TARGET-30-PAKIPY	stage	stage 4
TARGET-30-PAKIPY	ATRX	unknown
TARGET-30-PAKIPY	ALK	normal
TARGET-30-PAKIPY	MYCN	not amplified
TARGET-30-PAKIPY	Histology	unfavorable
TARGET-30-PAKIPY	Grade	unknown
TARGET-30-PAKIPY	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKIPY	Protocol	9047
TARGET-30-PAKIPY	Category	neuroblastoma
TARGET-30-PAKIPY	1p-	normal
TARGET-30-PAKIPY	1q+	normal
TARGET-30-PAKIPY	11q-	normal
TARGET-30-PAKIPY	17q+	normal
TARGET-30-PAKIPY	%tumor	95.0
TARGET-30-PAKIPY	MKI	
TARGET-30-PAKJBA	age	802
TARGET-30-PAKJBA	age group	2-6
TARGET-30-PAKJBA	stage	stage 4
TARGET-30-PAKJBA	ATRX	unknown
TARGET-30-PAKJBA	ALK	
TARGET-30-PAKJBA	MYCN	amplified
TARGET-30-PAKJBA	Histology	unfavorable
TARGET-30-PAKJBA	Grade	unknown
TARGET-30-PAKJBA	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKJBA	Protocol	B947-9047
TARGET-30-PAKJBA	Category	neuroblastoma
TARGET-30-PAKJBA	1p-	unknown
TARGET-30-PAKJBA	1q+	unknown
TARGET-30-PAKJBA	11q-	unknown
TARGET-30-PAKJBA	17q+	unknown
TARGET-30-PAKJBA	%tumor	
TARGET-30-PAKJBA	MKI	
TARGET-30-PAKJRE	age	1100
TARGET-30-PAKJRE	age group	2-6
TARGET-30-PAKJRE	stage	stage 4
TARGET-30-PAKJRE	ATRX	unknown
TARGET-30-PAKJRE	ALK	normal
TARGET-30-PAKJRE	MYCN	not amplified
TARGET-30-PAKJRE	Histology	unfavorable
TARGET-30-PAKJRE	Grade	unknown
TARGET-30-PAKJRE	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKJRE	Protocol	9047
TARGET-30-PAKJRE	Category	neuroblastoma
TARGET-30-PAKJRE	1p-	normal
TARGET-30-PAKJRE	1q+	normal
TARGET-30-PAKJRE	11q-	loss
TARGET-30-PAKJRE	17q+	gain
TARGET-30-PAKJRE	%tumor	
TARGET-30-PAKJRE	MKI	
TARGET-30-PAKMVJ	age	1490
TARGET-30-PAKMVJ	age group	2-6
TARGET-30-PAKMVJ	stage	stage 4
TARGET-30-PAKMVJ	ATRX	unknown
TARGET-30-PAKMVJ	ALK	
TARGET-30-PAKMVJ	MYCN	not amplified
TARGET-30-PAKMVJ	Histology	unfavorable
TARGET-30-PAKMVJ	Grade	unknown
TARGET-30-PAKMVJ	Ploidy	diploid (di=1)
TARGET-30-PAKMVJ	Protocol	B973
TARGET-30-PAKMVJ	Category	neuroblastoma
TARGET-30-PAKMVJ	1p-	unknown
TARGET-30-PAKMVJ	1q+	unknown
TARGET-30-PAKMVJ	11q-	unknown
TARGET-30-PAKMVJ	17q+	unknown
TARGET-30-PAKMVJ	%tumor	
TARGET-30-PAKMVJ	MKI	
TARGET-30-PAKPAL	age	1807
TARGET-30-PAKPAL	age group	2-6
TARGET-30-PAKPAL	stage	stage 4
TARGET-30-PAKPAL	ATRX	unknown
TARGET-30-PAKPAL	ALK	
TARGET-30-PAKPAL	MYCN	not amplified
TARGET-30-PAKPAL	Histology	unfavorable
TARGET-30-PAKPAL	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKPAL	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKPAL	Protocol	ANBL00B1
TARGET-30-PAKPAL	Category	neuroblastoma
TARGET-30-PAKPAL	1p-	unknown
TARGET-30-PAKPAL	1q+	unknown
TARGET-30-PAKPAL	11q-	unknown
TARGET-30-PAKPAL	17q+	unknown
TARGET-30-PAKPAL	%tumor	
TARGET-30-PAKPAL	MKI	
TARGET-30-PAKPJE	age	999
TARGET-30-PAKPJE	age group	2-6
TARGET-30-PAKPJE	stage	stage 4
TARGET-30-PAKPJE	ATRX	unknown
TARGET-30-PAKPJE	ALK	
TARGET-30-PAKPJE	MYCN	not amplified
TARGET-30-PAKPJE	Histology	unfavorable
TARGET-30-PAKPJE	Grade	unknown
TARGET-30-PAKPJE	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKPJE	Protocol	9047
TARGET-30-PAKPJE	Category	neuroblastoma
TARGET-30-PAKPJE	1p-	unknown
TARGET-30-PAKPJE	1q+	unknown
TARGET-30-PAKPJE	11q-	unknown
TARGET-30-PAKPJE	17q+	unknown
TARGET-30-PAKPJE	%tumor	
TARGET-30-PAKPJE	MKI	
TARGET-30-PAKPLH	age	1417
TARGET-30-PAKPLH	age group	2-6
TARGET-30-PAKPLH	stage	stage 4
TARGET-30-PAKPLH	ATRX	unknown
TARGET-30-PAKPLH	ALK	
TARGET-30-PAKPLH	MYCN	not amplified
TARGET-30-PAKPLH	Histology	unfavorable
TARGET-30-PAKPLH	Grade	unknown
TARGET-30-PAKPLH	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKPLH	Protocol	9047
TARGET-30-PAKPLH	Category	neuroblastoma
TARGET-30-PAKPLH	1p-	unknown
TARGET-30-PAKPLH	1q+	unknown
TARGET-30-PAKPLH	11q-	unknown
TARGET-30-PAKPLH	17q+	unknown
TARGET-30-PAKPLH	%tumor	
TARGET-30-PAKPLH	MKI	
TARGET-30-PAKPNF	age	79
TARGET-30-PAKPNF	age group	0-1
TARGET-30-PAKPNF	stage	stage 1
TARGET-30-PAKPNF	ATRX	unknown
TARGET-30-PAKPNF	ALK	
TARGET-30-PAKPNF	MYCN	not amplified
TARGET-30-PAKPNF	Histology	favorable
TARGET-30-PAKPNF	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKPNF	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKPNF	Protocol	ANBL00B1-B947-P9641
TARGET-30-PAKPNF	Category	neuroblastoma
TARGET-30-PAKPNF	1p-	unknown
TARGET-30-PAKPNF	1q+	unknown
TARGET-30-PAKPNF	11q-	unknown
TARGET-30-PAKPNF	17q+	unknown
TARGET-30-PAKPNF	%tumor	
TARGET-30-PAKPNF	MKI	low
TARGET-30-PAKRGC	age	78
TARGET-30-PAKRGC	age group	0-1
TARGET-30-PAKRGC	stage	stage 1
TARGET-30-PAKRGC	ATRX	unknown
TARGET-30-PAKRGC	ALK	
TARGET-30-PAKRGC	MYCN	not amplified
TARGET-30-PAKRGC	Histology	favorable
TARGET-30-PAKRGC	Grade	unknown
TARGET-30-PAKRGC	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKRGC	Protocol	ANBL00B1-P9641
TARGET-30-PAKRGC	Category	unknown
TARGET-30-PAKRGC	1p-	unknown
TARGET-30-PAKRGC	1q+	unknown
TARGET-30-PAKRGC	11q-	unknown
TARGET-30-PAKRGC	17q+	unknown
TARGET-30-PAKRGC	%tumor	
TARGET-30-PAKRGC	MKI	
TARGET-30-PAKRKL	age	515
TARGET-30-PAKRKL	age group	1-2
TARGET-30-PAKRKL	stage	stage 1
TARGET-30-PAKRKL	ATRX	unknown
TARGET-30-PAKRKL	ALK	
TARGET-30-PAKRKL	MYCN	not amplified
TARGET-30-PAKRKL	Histology	favorable
TARGET-30-PAKRKL	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKRKL	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKRKL	Protocol	ANBL00B1
TARGET-30-PAKRKL	Category	neuroblastoma
TARGET-30-PAKRKL	1p-	unknown
TARGET-30-PAKRKL	1q+	unknown
TARGET-30-PAKRKL	11q-	unknown
TARGET-30-PAKRKL	17q+	unknown
TARGET-30-PAKRKL	%tumor	
TARGET-30-PAKRKL	MKI	low
TARGET-30-PAKSFV	age	796
TARGET-30-PAKSFV	age group	2-6
TARGET-30-PAKSFV	stage	stage 4
TARGET-30-PAKSFV	ATRX	unknown
TARGET-30-PAKSFV	ALK	
TARGET-30-PAKSFV	MYCN	not amplified
TARGET-30-PAKSFV	Histology	unfavorable
TARGET-30-PAKSFV	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKSFV	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKSFV	Protocol	ANBL00B1-ALTE05N1-A3973-ANBL0032
TARGET-30-PAKSFV	Category	neuroblastoma
TARGET-30-PAKSFV	1p-	unknown
TARGET-30-PAKSFV	1q+	unknown
TARGET-30-PAKSFV	11q-	unknown
TARGET-30-PAKSFV	17q+	unknown
TARGET-30-PAKSFV	%tumor	50.0
TARGET-30-PAKSFV	MKI	high
TARGET-30-PAKSWB	age	156
TARGET-30-PAKSWB	age group	0-1
TARGET-30-PAKSWB	stage	stage 1
TARGET-30-PAKSWB	ATRX	unknown
TARGET-30-PAKSWB	ALK	
TARGET-30-PAKSWB	MYCN	not amplified
TARGET-30-PAKSWB	Histology	favorable
TARGET-30-PAKSWB	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKSWB	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKSWB	Protocol	ANBL00B1-ALTE03N1-P9641
TARGET-30-PAKSWB	Category	neuroblastoma
TARGET-30-PAKSWB	1p-	unknown
TARGET-30-PAKSWB	1q+	unknown
TARGET-30-PAKSWB	11q-	unknown
TARGET-30-PAKSWB	17q+	unknown
TARGET-30-PAKSWB	%tumor	100.0
TARGET-30-PAKSWB	MKI	low
TARGET-30-PAKUAW	age	416
TARGET-30-PAKUAW	age group	1-2
TARGET-30-PAKUAW	stage	stage 1
TARGET-30-PAKUAW	ATRX	unknown
TARGET-30-PAKUAW	ALK	
TARGET-30-PAKUAW	MYCN	not amplified
TARGET-30-PAKUAW	Histology	favorable
TARGET-30-PAKUAW	Grade	unknown
TARGET-30-PAKUAW	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKUAW	Protocol	ANBL00B1-P9641
TARGET-30-PAKUAW	Category	ganglioneuroblastoma, intermixed
TARGET-30-PAKUAW	1p-	unknown
TARGET-30-PAKUAW	1q+	unknown
TARGET-30-PAKUAW	11q-	unknown
TARGET-30-PAKUAW	17q+	unknown
TARGET-30-PAKUAW	%tumor	
TARGET-30-PAKUAW	MKI	
TARGET-30-PAKUXT	age	971
TARGET-30-PAKUXT	age group	2-6
TARGET-30-PAKUXT	stage	stage 4
TARGET-30-PAKUXT	ATRX	unknown
TARGET-30-PAKUXT	ALK	
TARGET-30-PAKUXT	MYCN	not amplified
TARGET-30-PAKUXT	Histology	favorable
TARGET-30-PAKUXT	Grade	differentiating
TARGET-30-PAKUXT	Ploidy	diploid (di=1)
TARGET-30-PAKUXT	Protocol	ANBL00B1
TARGET-30-PAKUXT	Category	neuroblastoma
TARGET-30-PAKUXT	1p-	unknown
TARGET-30-PAKUXT	1q+	unknown
TARGET-30-PAKUXT	11q-	unknown
TARGET-30-PAKUXT	17q+	unknown
TARGET-30-PAKUXT	%tumor	75.0
TARGET-30-PAKUXT	MKI	low
TARGET-30-PAKVTK	age	1011
TARGET-30-PAKVTK	age group	2-6
TARGET-30-PAKVTK	stage	stage 4
TARGET-30-PAKVTK	ATRX	unknown
TARGET-30-PAKVTK	ALK	
TARGET-30-PAKVTK	MYCN	not amplified
TARGET-30-PAKVTK	Histology	unknown
TARGET-30-PAKVTK	Grade	unknown
TARGET-30-PAKVTK	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKVTK	Protocol	ANBL00B1
TARGET-30-PAKVTK	Category	unknown
TARGET-30-PAKVTK	1p-	unknown
TARGET-30-PAKVTK	1q+	unknown
TARGET-30-PAKVTK	11q-	unknown
TARGET-30-PAKVTK	17q+	unknown
TARGET-30-PAKVTK	%tumor	
TARGET-30-PAKVTK	MKI	
TARGET-30-PAKVUY	age	1482
TARGET-30-PAKVUY	age group	2-6
TARGET-30-PAKVUY	stage	stage 4
TARGET-30-PAKVUY	ATRX	unknown
TARGET-30-PAKVUY	ALK	normal
TARGET-30-PAKVUY	MYCN	amplified
TARGET-30-PAKVUY	Histology	unfavorable
TARGET-30-PAKVUY	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKVUY	Ploidy	diploid (di=1)
TARGET-30-PAKVUY	Protocol	ANBL00B1-A3973
TARGET-30-PAKVUY	Category	neuroblastoma
TARGET-30-PAKVUY	1p-	loss
TARGET-30-PAKVUY	1q+	normal
TARGET-30-PAKVUY	11q-	normal
TARGET-30-PAKVUY	17q+	gain
TARGET-30-PAKVUY	%tumor	
TARGET-30-PAKVUY	MKI	high
TARGET-30-PAKWCJ	age	392
TARGET-30-PAKWCJ	age group	1-2
TARGET-30-PAKWCJ	stage	stage 1
TARGET-30-PAKWCJ	ATRX	unknown
TARGET-30-PAKWCJ	ALK	
TARGET-30-PAKWCJ	MYCN	not amplified
TARGET-30-PAKWCJ	Histology	favorable
TARGET-30-PAKWCJ	Grade	differentiating
TARGET-30-PAKWCJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKWCJ	Protocol	ANBL00B1-P9641
TARGET-30-PAKWCJ	Category	neuroblastoma
TARGET-30-PAKWCJ	1p-	unknown
TARGET-30-PAKWCJ	1q+	unknown
TARGET-30-PAKWCJ	11q-	unknown
TARGET-30-PAKWCJ	17q+	unknown
TARGET-30-PAKWCJ	%tumor	100.0
TARGET-30-PAKWCJ	MKI	low
TARGET-30-PAKWMT	age	1359
TARGET-30-PAKWMT	age group	2-6
TARGET-30-PAKWMT	stage	stage 4
TARGET-30-PAKWMT	ATRX	unknown
TARGET-30-PAKWMT	ALK	
TARGET-30-PAKWMT	MYCN	not amplified
TARGET-30-PAKWMT	Histology	unfavorable
TARGET-30-PAKWMT	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKWMT	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKWMT	Protocol	ANBL00B1
TARGET-30-PAKWMT	Category	neuroblastoma
TARGET-30-PAKWMT	1p-	unknown
TARGET-30-PAKWMT	1q+	unknown
TARGET-30-PAKWMT	11q-	unknown
TARGET-30-PAKWMT	17q+	unknown
TARGET-30-PAKWMT	%tumor	
TARGET-30-PAKWMT	MKI	intermediate
TARGET-30-PAKWWF	age	1312
TARGET-30-PAKWWF	age group	2-6
TARGET-30-PAKWWF	stage	stage 4
TARGET-30-PAKWWF	ATRX	unknown
TARGET-30-PAKWWF	ALK	
TARGET-30-PAKWWF	MYCN	not amplified
TARGET-30-PAKWWF	Histology	unfavorable
TARGET-30-PAKWWF	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKWWF	Ploidy	diploid (di=1)
TARGET-30-PAKWWF	Protocol	ANBL00B1
TARGET-30-PAKWWF	Category	ganglioneuroblastoma, nodular
TARGET-30-PAKWWF	1p-	unknown
TARGET-30-PAKWWF	1q+	unknown
TARGET-30-PAKWWF	11q-	unknown
TARGET-30-PAKWWF	17q+	unknown
TARGET-30-PAKWWF	%tumor	
TARGET-30-PAKWWF	MKI	intermediate
TARGET-30-PAKXDZ	age	828
TARGET-30-PAKXDZ	age group	2-6
TARGET-30-PAKXDZ	stage	stage 4
TARGET-30-PAKXDZ	ATRX	unknown
TARGET-30-PAKXDZ	ALK	mutated
TARGET-30-PAKXDZ	MYCN	amplified
TARGET-30-PAKXDZ	Histology	unfavorable
TARGET-30-PAKXDZ	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKXDZ	Ploidy	diploid (di=1)
TARGET-30-PAKXDZ	Protocol	ANBL00B1
TARGET-30-PAKXDZ	Category	neuroblastoma
TARGET-30-PAKXDZ	1p-	loss
TARGET-30-PAKXDZ	1q+	normal
TARGET-30-PAKXDZ	11q-	normal
TARGET-30-PAKXDZ	17q+	gain
TARGET-30-PAKXDZ	%tumor	
TARGET-30-PAKXDZ	MKI	high
TARGET-30-PAKYMV	age	652
TARGET-30-PAKYMV	age group	1-2
TARGET-30-PAKYMV	stage	stage 4
TARGET-30-PAKYMV	ATRX	unknown
TARGET-30-PAKYMV	ALK	
TARGET-30-PAKYMV	MYCN	not amplified
TARGET-30-PAKYMV	Histology	unfavorable
TARGET-30-PAKYMV	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKYMV	Ploidy	diploid (di=1)
TARGET-30-PAKYMV	Protocol	ANBL00B1
TARGET-30-PAKYMV	Category	neuroblastoma
TARGET-30-PAKYMV	1p-	unknown
TARGET-30-PAKYMV	1q+	unknown
TARGET-30-PAKYMV	11q-	unknown
TARGET-30-PAKYMV	17q+	unknown
TARGET-30-PAKYMV	%tumor	
TARGET-30-PAKYMV	MKI	intermediate
TARGET-30-PAKYRJ	age	102
TARGET-30-PAKYRJ	age group	0-1
TARGET-30-PAKYRJ	stage	stage 1
TARGET-30-PAKYRJ	ATRX	unknown
TARGET-30-PAKYRJ	ALK	
TARGET-30-PAKYRJ	MYCN	not amplified
TARGET-30-PAKYRJ	Histology	favorable
TARGET-30-PAKYRJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKYRJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKYRJ	Protocol	ANBL00B1-P9641
TARGET-30-PAKYRJ	Category	neuroblastoma
TARGET-30-PAKYRJ	1p-	unknown
TARGET-30-PAKYRJ	1q+	unknown
TARGET-30-PAKYRJ	11q-	unknown
TARGET-30-PAKYRJ	17q+	unknown
TARGET-30-PAKYRJ	%tumor	
TARGET-30-PAKYRJ	MKI	intermediate
TARGET-30-PAKYZS	age	659
TARGET-30-PAKYZS	age group	1-2
TARGET-30-PAKYZS	stage	stage 4
TARGET-30-PAKYZS	ATRX	normal
TARGET-30-PAKYZS	ALK	normal
TARGET-30-PAKYZS	MYCN	not amplified
TARGET-30-PAKYZS	Histology	unknown
TARGET-30-PAKYZS	Grade	unknown
TARGET-30-PAKYZS	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKYZS	Protocol	ANBL00B1
TARGET-30-PAKYZS	Category	unknown
TARGET-30-PAKYZS	1p-	normal
TARGET-30-PAKYZS	1q+	normal
TARGET-30-PAKYZS	11q-	normal
TARGET-30-PAKYZS	17q+	normal
TARGET-30-PAKYZS	%tumor	
TARGET-30-PAKYZS	MKI	
TARGET-30-PAKZMI	age	770
TARGET-30-PAKZMI	age group	2-6
TARGET-30-PAKZMI	stage	stage 4
TARGET-30-PAKZMI	ATRX	unknown
TARGET-30-PAKZMI	ALK	
TARGET-30-PAKZMI	MYCN	amplified
TARGET-30-PAKZMI	Histology	unfavorable
TARGET-30-PAKZMI	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKZMI	Ploidy	hyperdiploid (di>1)
TARGET-30-PAKZMI	Protocol	ANBL00B1
TARGET-30-PAKZMI	Category	neuroblastoma
TARGET-30-PAKZMI	1p-	unknown
TARGET-30-PAKZMI	1q+	unknown
TARGET-30-PAKZMI	11q-	unknown
TARGET-30-PAKZMI	17q+	unknown
TARGET-30-PAKZMI	%tumor	
TARGET-30-PAKZMI	MKI	high
TARGET-30-PAKZRE	age	1083
TARGET-30-PAKZRE	age group	2-6
TARGET-30-PAKZRE	stage	stage 4
TARGET-30-PAKZRE	ATRX	unknown
TARGET-30-PAKZRE	ALK	normal
TARGET-30-PAKZRE	MYCN	amplified
TARGET-30-PAKZRE	Histology	unfavorable
TARGET-30-PAKZRE	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKZRE	Ploidy	diploid (di=1)
TARGET-30-PAKZRE	Protocol	ANBL00B1
TARGET-30-PAKZRE	Category	neuroblastoma
TARGET-30-PAKZRE	1p-	loss
TARGET-30-PAKZRE	1q+	normal
TARGET-30-PAKZRE	11q-	normal
TARGET-30-PAKZRE	17q+	gain
TARGET-30-PAKZRE	%tumor	
TARGET-30-PAKZRE	MKI	intermediate
TARGET-30-PAKZRF	age	1285
TARGET-30-PAKZRF	age group	2-6
TARGET-30-PAKZRF	stage	stage 4
TARGET-30-PAKZRF	ATRX	deleted
TARGET-30-PAKZRF	ALK	normal
TARGET-30-PAKZRF	MYCN	unknown
TARGET-30-PAKZRF	Histology	unfavorable
TARGET-30-PAKZRF	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKZRF	Ploidy	diploid (di=1)
TARGET-30-PAKZRF	Protocol	ANBL00B1-A3973
TARGET-30-PAKZRF	Category	neuroblastoma
TARGET-30-PAKZRF	1p-	normal
TARGET-30-PAKZRF	1q+	normal
TARGET-30-PAKZRF	11q-	loss
TARGET-30-PAKZRF	17q+	gain
TARGET-30-PAKZRF	%tumor	
TARGET-30-PAKZRF	MKI	high
TARGET-30-PAKZRH	age	21
TARGET-30-PAKZRH	age group	0-1
TARGET-30-PAKZRH	stage	stage 4s
TARGET-30-PAKZRH	ATRX	normal
TARGET-30-PAKZRH	ALK	
TARGET-30-PAKZRH	MYCN	not amplified
TARGET-30-PAKZRH	Histology	favorable
TARGET-30-PAKZRH	Grade	undifferentiated or poorly differentiated
TARGET-30-PAKZRH	Ploidy	diploid (di=1)
TARGET-30-PAKZRH	Protocol	B947-ANBL00B1-A3961
TARGET-30-PAKZRH	Category	unknown
TARGET-30-PAKZRH	1p-	unknown
TARGET-30-PAKZRH	1q+	unknown
TARGET-30-PAKZRH	11q-	unknown
TARGET-30-PAKZRH	17q+	unknown
TARGET-30-PAKZRH	%tumor	
TARGET-30-PAKZRH	MKI	low
TARGET-30-PALAKE	age	860
TARGET-30-PALAKE	age group	2-6
TARGET-30-PALAKE	stage	stage 4
TARGET-30-PALAKE	ATRX	unknown
TARGET-30-PALAKE	ALK	mutated
TARGET-30-PALAKE	MYCN	amplified
TARGET-30-PALAKE	Histology	unfavorable
TARGET-30-PALAKE	Grade	undifferentiated or poorly differentiated
TARGET-30-PALAKE	Ploidy	diploid (di=1)
TARGET-30-PALAKE	Protocol	ANBL00B1
TARGET-30-PALAKE	Category	neuroblastoma
TARGET-30-PALAKE	1p-	loss
TARGET-30-PALAKE	1q+	normal
TARGET-30-PALAKE	11q-	normal
TARGET-30-PALAKE	17q+	gain
TARGET-30-PALAKE	%tumor	
TARGET-30-PALAKE	MKI	
TARGET-30-PALAKM	age	1758
TARGET-30-PALAKM	age group	2-6
TARGET-30-PALAKM	stage	stage 4
TARGET-30-PALAKM	ATRX	unknown
TARGET-30-PALAKM	ALK	normal
TARGET-30-PALAKM	MYCN	not amplified
TARGET-30-PALAKM	Histology	unfavorable
TARGET-30-PALAKM	Grade	undifferentiated or poorly differentiated
TARGET-30-PALAKM	Ploidy	hyperdiploid (di>1)
TARGET-30-PALAKM	Protocol	ANBL00B1
TARGET-30-PALAKM	Category	neuroblastoma
TARGET-30-PALAKM	1p-	normal
TARGET-30-PALAKM	1q+	gain
TARGET-30-PALAKM	11q-	loss
TARGET-30-PALAKM	17q+	gain
TARGET-30-PALAKM	%tumor	
TARGET-30-PALAKM	MKI	low
TARGET-30-PALAWZ	age	1338
TARGET-30-PALAWZ	age group	2-6
TARGET-30-PALAWZ	stage	stage 4
TARGET-30-PALAWZ	ATRX	unknown
TARGET-30-PALAWZ	ALK	
TARGET-30-PALAWZ	MYCN	not amplified
TARGET-30-PALAWZ	Histology	unfavorable
TARGET-30-PALAWZ	Grade	undifferentiated or poorly differentiated
TARGET-30-PALAWZ	Ploidy	diploid (di=1)
TARGET-30-PALAWZ	Protocol	ANBL00B1
TARGET-30-PALAWZ	Category	neuroblastoma
TARGET-30-PALAWZ	1p-	unknown
TARGET-30-PALAWZ	1q+	unknown
TARGET-30-PALAWZ	11q-	unknown
TARGET-30-PALAWZ	17q+	unknown
TARGET-30-PALAWZ	%tumor	95.0
TARGET-30-PALAWZ	MKI	low
TARGET-30-PALAYH	age	1171
TARGET-30-PALAYH	age group	2-6
TARGET-30-PALAYH	stage	stage 4
TARGET-30-PALAYH	ATRX	unknown
TARGET-30-PALAYH	ALK	
TARGET-30-PALAYH	MYCN	amplified
TARGET-30-PALAYH	Histology	unfavorable
TARGET-30-PALAYH	Grade	undifferentiated or poorly differentiated
TARGET-30-PALAYH	Ploidy	diploid (di=1)
TARGET-30-PALAYH	Protocol	ANBL00B1-A3973
TARGET-30-PALAYH	Category	neuroblastoma
TARGET-30-PALAYH	1p-	unknown
TARGET-30-PALAYH	1q+	unknown
TARGET-30-PALAYH	11q-	unknown
TARGET-30-PALAYH	17q+	unknown
TARGET-30-PALAYH	%tumor	
TARGET-30-PALAYH	MKI	intermediate
TARGET-30-PALBFV	age	1500
TARGET-30-PALBFV	age group	2-6
TARGET-30-PALBFV	stage	stage 4
TARGET-30-PALBFV	ATRX	unknown
TARGET-30-PALBFV	ALK	
TARGET-30-PALBFV	MYCN	amplified
TARGET-30-PALBFV	Histology	unfavorable
TARGET-30-PALBFV	Grade	undifferentiated or poorly differentiated
TARGET-30-PALBFV	Ploidy	diploid (di=1)
TARGET-30-PALBFV	Protocol	ANBL00B1
TARGET-30-PALBFV	Category	neuroblastoma
TARGET-30-PALBFV	1p-	unknown
TARGET-30-PALBFV	1q+	unknown
TARGET-30-PALBFV	11q-	unknown
TARGET-30-PALBFV	17q+	unknown
TARGET-30-PALBFV	%tumor	100.0
TARGET-30-PALBFV	MKI	high
TARGET-30-PALBFW	age	804
TARGET-30-PALBFW	age group	2-6
TARGET-30-PALBFW	stage	stage 4
TARGET-30-PALBFW	ATRX	normal
TARGET-30-PALBFW	ALK	normal
TARGET-30-PALBFW	MYCN	not amplified
TARGET-30-PALBFW	Histology	unfavorable
TARGET-30-PALBFW	Grade	undifferentiated or poorly differentiated
TARGET-30-PALBFW	Ploidy	diploid (di=1)
TARGET-30-PALBFW	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PALBFW	Category	neuroblastoma
TARGET-30-PALBFW	1p-	normal
TARGET-30-PALBFW	1q+	normal
TARGET-30-PALBFW	11q-	loss
TARGET-30-PALBFW	17q+	gain
TARGET-30-PALBFW	%tumor	85.0
TARGET-30-PALBFW	MKI	low
TARGET-30-PALBUY	age	1053
TARGET-30-PALBUY	age group	2-6
TARGET-30-PALBUY	stage	stage 4
TARGET-30-PALBUY	ATRX	unknown
TARGET-30-PALBUY	ALK	
TARGET-30-PALBUY	MYCN	amplified
TARGET-30-PALBUY	Histology	unfavorable
TARGET-30-PALBUY	Grade	undifferentiated or poorly differentiated
TARGET-30-PALBUY	Ploidy	hyperdiploid (di>1)
TARGET-30-PALBUY	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PALBUY	Category	neuroblastoma
TARGET-30-PALBUY	1p-	unknown
TARGET-30-PALBUY	1q+	unknown
TARGET-30-PALBUY	11q-	unknown
TARGET-30-PALBUY	17q+	unknown
TARGET-30-PALBUY	%tumor	
TARGET-30-PALBUY	MKI	high
TARGET-30-PALCBW	age	679
TARGET-30-PALCBW	age group	1-2
TARGET-30-PALCBW	stage	stage 4
TARGET-30-PALCBW	ATRX	normal
TARGET-30-PALCBW	ALK	normal
TARGET-30-PALCBW	MYCN	not amplified
TARGET-30-PALCBW	Histology	favorable
TARGET-30-PALCBW	Grade	differentiating
TARGET-30-PALCBW	Ploidy	diploid (di=1)
TARGET-30-PALCBW	Protocol	ANBL00B1
TARGET-30-PALCBW	Category	neuroblastoma
TARGET-30-PALCBW	1p-	normal
TARGET-30-PALCBW	1q+	normal
TARGET-30-PALCBW	11q-	normal
TARGET-30-PALCBW	17q+	normal
TARGET-30-PALCBW	%tumor	90.0
TARGET-30-PALCBW	MKI	low
TARGET-30-PALCCY	age	821
TARGET-30-PALCCY	age group	2-6
TARGET-30-PALCCY	stage	stage 4
TARGET-30-PALCCY	ATRX	unknown
TARGET-30-PALCCY	ALK	
TARGET-30-PALCCY	MYCN	amplified
TARGET-30-PALCCY	Histology	unfavorable
TARGET-30-PALCCY	Grade	undifferentiated or poorly differentiated
TARGET-30-PALCCY	Ploidy	hyperdiploid (di>1)
TARGET-30-PALCCY	Protocol	ANBL00B1
TARGET-30-PALCCY	Category	neuroblastoma
TARGET-30-PALCCY	1p-	unknown
TARGET-30-PALCCY	1q+	unknown
TARGET-30-PALCCY	11q-	unknown
TARGET-30-PALCCY	17q+	unknown
TARGET-30-PALCCY	%tumor	
TARGET-30-PALCCY	MKI	high
TARGET-30-PALDJW	age	1772
TARGET-30-PALDJW	age group	2-6
TARGET-30-PALDJW	stage	stage 4
TARGET-30-PALDJW	ATRX	unknown
TARGET-30-PALDJW	ALK	
TARGET-30-PALDJW	MYCN	not amplified
TARGET-30-PALDJW	Histology	unfavorable
TARGET-30-PALDJW	Grade	undifferentiated or poorly differentiated
TARGET-30-PALDJW	Ploidy	diploid (di=1)
TARGET-30-PALDJW	Protocol	ANBL00B1-ANBL0321
TARGET-30-PALDJW	Category	neuroblastoma
TARGET-30-PALDJW	1p-	unknown
TARGET-30-PALDJW	1q+	unknown
TARGET-30-PALDJW	11q-	unknown
TARGET-30-PALDJW	17q+	unknown
TARGET-30-PALDJW	%tumor	
TARGET-30-PALDJW	MKI	intermediate
TARGET-30-PALEAC	age	66
TARGET-30-PALEAC	age group	0-1
TARGET-30-PALEAC	stage	stage 1
TARGET-30-PALEAC	ATRX	unknown
TARGET-30-PALEAC	ALK	
TARGET-30-PALEAC	MYCN	not amplified
TARGET-30-PALEAC	Histology	favorable
TARGET-30-PALEAC	Grade	undifferentiated or poorly differentiated
TARGET-30-PALEAC	Ploidy	hyperdiploid (di>1)
TARGET-30-PALEAC	Protocol	ANBL00B1-P9641
TARGET-30-PALEAC	Category	neuroblastoma
TARGET-30-PALEAC	1p-	unknown
TARGET-30-PALEAC	1q+	unknown
TARGET-30-PALEAC	11q-	unknown
TARGET-30-PALEAC	17q+	unknown
TARGET-30-PALEAC	%tumor	100.0
TARGET-30-PALEAC	MKI	low
TARGET-30-PALEBK	age	19
TARGET-30-PALEBK	age group	0-1
TARGET-30-PALEBK	stage	stage 1
TARGET-30-PALEBK	ATRX	unknown
TARGET-30-PALEBK	ALK	
TARGET-30-PALEBK	MYCN	not amplified
TARGET-30-PALEBK	Histology	favorable
TARGET-30-PALEBK	Grade	undifferentiated or poorly differentiated
TARGET-30-PALEBK	Ploidy	hyperdiploid (di>1)
TARGET-30-PALEBK	Protocol	ANBL00B1
TARGET-30-PALEBK	Category	neuroblastoma
TARGET-30-PALEBK	1p-	unknown
TARGET-30-PALEBK	1q+	unknown
TARGET-30-PALEBK	11q-	unknown
TARGET-30-PALEBK	17q+	unknown
TARGET-30-PALEBK	%tumor	100.0
TARGET-30-PALEBK	MKI	low
TARGET-30-PALEEK	age	848
TARGET-30-PALEEK	age group	2-6
TARGET-30-PALEEK	stage	stage 4
TARGET-30-PALEEK	ATRX	unknown
TARGET-30-PALEEK	ALK	
TARGET-30-PALEEK	MYCN	amplified
TARGET-30-PALEEK	Histology	unfavorable
TARGET-30-PALEEK	Grade	undifferentiated or poorly differentiated
TARGET-30-PALEEK	Ploidy	diploid (di=1)
TARGET-30-PALEEK	Protocol	ANBL00B1-A3973-AADM01P1-ANBL0032
TARGET-30-PALEEK	Category	neuroblastoma
TARGET-30-PALEEK	1p-	unknown
TARGET-30-PALEEK	1q+	unknown
TARGET-30-PALEEK	11q-	unknown
TARGET-30-PALEEK	17q+	unknown
TARGET-30-PALEEK	%tumor	
TARGET-30-PALEEK	MKI	high
TARGET-30-PALEND	age	737
TARGET-30-PALEND	age group	2-6
TARGET-30-PALEND	stage	stage 4
TARGET-30-PALEND	ATRX	unknown
TARGET-30-PALEND	ALK	
TARGET-30-PALEND	MYCN	amplified
TARGET-30-PALEND	Histology	unfavorable
TARGET-30-PALEND	Grade	undifferentiated or poorly differentiated
TARGET-30-PALEND	Ploidy	diploid (di=1)
TARGET-30-PALEND	Protocol	ANBL00B1-A3973
TARGET-30-PALEND	Category	neuroblastoma
TARGET-30-PALEND	1p-	unknown
TARGET-30-PALEND	1q+	unknown
TARGET-30-PALEND	11q-	unknown
TARGET-30-PALEND	17q+	unknown
TARGET-30-PALEND	%tumor	65.0
TARGET-30-PALEND	MKI	intermediate
TARGET-30-PALETP	age	1466
TARGET-30-PALETP	age group	2-6
TARGET-30-PALETP	stage	stage 4
TARGET-30-PALETP	ATRX	normal
TARGET-30-PALETP	ALK	normal
TARGET-30-PALETP	MYCN	not amplified
TARGET-30-PALETP	Histology	unfavorable
TARGET-30-PALETP	Grade	undifferentiated or poorly differentiated
TARGET-30-PALETP	Ploidy	diploid (di=1)
TARGET-30-PALETP	Protocol	ANBL00B1-A3973
TARGET-30-PALETP	Category	neuroblastoma
TARGET-30-PALETP	1p-	normal
TARGET-30-PALETP	1q+	normal
TARGET-30-PALETP	11q-	normal
TARGET-30-PALETP	17q+	gain
TARGET-30-PALETP	%tumor	
TARGET-30-PALETP	MKI	intermediate
TARGET-30-PALEVG	age	666
TARGET-30-PALEVG	age group	1-2
TARGET-30-PALEVG	stage	stage 4
TARGET-30-PALEVG	ATRX	normal
TARGET-30-PALEVG	ALK	normal
TARGET-30-PALEVG	MYCN	amplified
TARGET-30-PALEVG	Histology	unfavorable
TARGET-30-PALEVG	Grade	undifferentiated or poorly differentiated
TARGET-30-PALEVG	Ploidy	hyperdiploid (di>1)
TARGET-30-PALEVG	Protocol	ANBL00B1-ALTE05N1-A3973-ANBL0032-ALTE03N1
TARGET-30-PALEVG	Category	neuroblastoma
TARGET-30-PALEVG	1p-	normal
TARGET-30-PALEVG	1q+	normal
TARGET-30-PALEVG	11q-	normal
TARGET-30-PALEVG	17q+	gain
TARGET-30-PALEVG	%tumor	
TARGET-30-PALEVG	MKI	intermediate
TARGET-30-PALEZI	age	1119
TARGET-30-PALEZI	age group	2-6
TARGET-30-PALEZI	stage	stage 4
TARGET-30-PALEZI	ATRX	unknown
TARGET-30-PALEZI	ALK	
TARGET-30-PALEZI	MYCN	amplified
TARGET-30-PALEZI	Histology	unknown
TARGET-30-PALEZI	Grade	unknown
TARGET-30-PALEZI	Ploidy	diploid (di=1)
TARGET-30-PALEZI	Protocol	ANBL00B1-A3973-AADM01P1
TARGET-30-PALEZI	Category	unknown
TARGET-30-PALEZI	1p-	unknown
TARGET-30-PALEZI	1q+	unknown
TARGET-30-PALEZI	11q-	unknown
TARGET-30-PALEZI	17q+	unknown
TARGET-30-PALEZI	%tumor	
TARGET-30-PALEZI	MKI	
TARGET-30-PALFDZ	age	1080
TARGET-30-PALFDZ	age group	2-6
TARGET-30-PALFDZ	stage	stage 4
TARGET-30-PALFDZ	ATRX	unknown
TARGET-30-PALFDZ	ALK	
TARGET-30-PALFDZ	MYCN	not amplified
TARGET-30-PALFDZ	Histology	unfavorable
TARGET-30-PALFDZ	Grade	undifferentiated or poorly differentiated
TARGET-30-PALFDZ	Ploidy	hyperdiploid (di>1)
TARGET-30-PALFDZ	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PALFDZ	Category	ganglioneuroblastoma, nodular
TARGET-30-PALFDZ	1p-	unknown
TARGET-30-PALFDZ	1q+	unknown
TARGET-30-PALFDZ	11q-	unknown
TARGET-30-PALFDZ	17q+	unknown
TARGET-30-PALFDZ	%tumor	95.0
TARGET-30-PALFDZ	MKI	low
TARGET-30-PALFIT	age	1428
TARGET-30-PALFIT	age group	2-6
TARGET-30-PALFIT	stage	stage 4
TARGET-30-PALFIT	ATRX	unknown
TARGET-30-PALFIT	ALK	
TARGET-30-PALFIT	MYCN	not amplified
TARGET-30-PALFIT	Histology	unfavorable
TARGET-30-PALFIT	Grade	undifferentiated or poorly differentiated
TARGET-30-PALFIT	Ploidy	diploid (di=1)
TARGET-30-PALFIT	Protocol	ANBL00B1-ANBL0321
TARGET-30-PALFIT	Category	neuroblastoma
TARGET-30-PALFIT	1p-	unknown
TARGET-30-PALFIT	1q+	unknown
TARGET-30-PALFIT	11q-	unknown
TARGET-30-PALFIT	17q+	unknown
TARGET-30-PALFIT	%tumor	
TARGET-30-PALFIT	MKI	high
TARGET-30-PALFJL	age	829
TARGET-30-PALFJL	age group	2-6
TARGET-30-PALFJL	stage	stage 4
TARGET-30-PALFJL	ATRX	unknown
TARGET-30-PALFJL	ALK	
TARGET-30-PALFJL	MYCN	not amplified
TARGET-30-PALFJL	Histology	unfavorable
TARGET-30-PALFJL	Grade	undifferentiated or poorly differentiated
TARGET-30-PALFJL	Ploidy	unknown
TARGET-30-PALFJL	Protocol	ANBL00B1-ANBL00P1
TARGET-30-PALFJL	Category	ganglioneuroblastoma, nodular
TARGET-30-PALFJL	1p-	unknown
TARGET-30-PALFJL	1q+	unknown
TARGET-30-PALFJL	11q-	unknown
TARGET-30-PALFJL	17q+	unknown
TARGET-30-PALFJL	%tumor	
TARGET-30-PALFJL	MKI	intermediate
TARGET-30-PALFPI	age	1152
TARGET-30-PALFPI	age group	2-6
TARGET-30-PALFPI	stage	stage 4
TARGET-30-PALFPI	ATRX	deleted
TARGET-30-PALFPI	ALK	normal
TARGET-30-PALFPI	MYCN	not amplified
TARGET-30-PALFPI	Histology	unfavorable
TARGET-30-PALFPI	Grade	undifferentiated or poorly differentiated
TARGET-30-PALFPI	Ploidy	diploid (di=1)
TARGET-30-PALFPI	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PALFPI	Category	neuroblastoma
TARGET-30-PALFPI	1p-	normal
TARGET-30-PALFPI	1q+	normal
TARGET-30-PALFPI	11q-	loss
TARGET-30-PALFPI	17q+	gain
TARGET-30-PALFPI	%tumor	
TARGET-30-PALFPI	MKI	
TARGET-30-PALFRE	age	918
TARGET-30-PALFRE	age group	2-6
TARGET-30-PALFRE	stage	stage 4
TARGET-30-PALFRE	ATRX	unknown
TARGET-30-PALFRE	ALK	
TARGET-30-PALFRE	MYCN	not amplified
TARGET-30-PALFRE	Histology	unfavorable
TARGET-30-PALFRE	Grade	undifferentiated or poorly differentiated
TARGET-30-PALFRE	Ploidy	hyperdiploid (di>1)
TARGET-30-PALFRE	Protocol	ANBL00B1-ADVL0421
TARGET-30-PALFRE	Category	ganglioneuroblastoma, nodular
TARGET-30-PALFRE	1p-	unknown
TARGET-30-PALFRE	1q+	unknown
TARGET-30-PALFRE	11q-	unknown
TARGET-30-PALFRE	17q+	unknown
TARGET-30-PALFRE	%tumor	
TARGET-30-PALFRE	MKI	high
TARGET-30-PALFSE	age	200
TARGET-30-PALFSE	age group	0-1
TARGET-30-PALFSE	stage	stage 1
TARGET-30-PALFSE	ATRX	unknown
TARGET-30-PALFSE	ALK	
TARGET-30-PALFSE	MYCN	not amplified
TARGET-30-PALFSE	Histology	favorable
TARGET-30-PALFSE	Grade	undifferentiated or poorly differentiated
TARGET-30-PALFSE	Ploidy	hyperdiploid (di>1)
TARGET-30-PALFSE	Protocol	ANBL00B1-P9641
TARGET-30-PALFSE	Category	neuroblastoma
TARGET-30-PALFSE	1p-	unknown
TARGET-30-PALFSE	1q+	unknown
TARGET-30-PALFSE	11q-	unknown
TARGET-30-PALFSE	17q+	unknown
TARGET-30-PALFSE	%tumor	
TARGET-30-PALFSE	MKI	low
TARGET-30-PALGFF	age	117
TARGET-30-PALGFF	age group	0-1
TARGET-30-PALGFF	stage	stage 1
TARGET-30-PALGFF	ATRX	unknown
TARGET-30-PALGFF	ALK	
TARGET-30-PALGFF	MYCN	not amplified
TARGET-30-PALGFF	Histology	favorable
TARGET-30-PALGFF	Grade	undifferentiated or poorly differentiated
TARGET-30-PALGFF	Ploidy	hyperdiploid (di>1)
TARGET-30-PALGFF	Protocol	ANBL00B1-P9641
TARGET-30-PALGFF	Category	neuroblastoma
TARGET-30-PALGFF	1p-	unknown
TARGET-30-PALGFF	1q+	unknown
TARGET-30-PALGFF	11q-	unknown
TARGET-30-PALGFF	17q+	unknown
TARGET-30-PALGFF	%tumor	95.0
TARGET-30-PALGFF	MKI	low
TARGET-30-PALGGL	age	791
TARGET-30-PALGGL	age group	2-6
TARGET-30-PALGGL	stage	stage 4
TARGET-30-PALGGL	ATRX	unknown
TARGET-30-PALGGL	ALK	
TARGET-30-PALGGL	MYCN	not amplified
TARGET-30-PALGGL	Histology	unfavorable
TARGET-30-PALGGL	Grade	undifferentiated or poorly differentiated
TARGET-30-PALGGL	Ploidy	hyperdiploid (di>1)
TARGET-30-PALGGL	Protocol	ANBL00B1
TARGET-30-PALGGL	Category	neuroblastoma
TARGET-30-PALGGL	1p-	unknown
TARGET-30-PALGGL	1q+	unknown
TARGET-30-PALGGL	11q-	unknown
TARGET-30-PALGGL	17q+	unknown
TARGET-30-PALGGL	%tumor	100.0
TARGET-30-PALGGL	MKI	high
TARGET-30-PALHCB	age	386
TARGET-30-PALHCB	age group	1-2
TARGET-30-PALHCB	stage	stage 1
TARGET-30-PALHCB	ATRX	unknown
TARGET-30-PALHCB	ALK	
TARGET-30-PALHCB	MYCN	not amplified
TARGET-30-PALHCB	Histology	favorable
TARGET-30-PALHCB	Grade	differentiating
TARGET-30-PALHCB	Ploidy	hyperdiploid (di>1)
TARGET-30-PALHCB	Protocol	ANBL00B1-AADM01P1-P9641
TARGET-30-PALHCB	Category	neuroblastoma
TARGET-30-PALHCB	1p-	unknown
TARGET-30-PALHCB	1q+	unknown
TARGET-30-PALHCB	11q-	unknown
TARGET-30-PALHCB	17q+	unknown
TARGET-30-PALHCB	%tumor	
TARGET-30-PALHCB	MKI	low
TARGET-30-PALHHG	age	886
TARGET-30-PALHHG	age group	2-6
TARGET-30-PALHHG	stage	stage 4
TARGET-30-PALHHG	ATRX	unknown
TARGET-30-PALHHG	ALK	
TARGET-30-PALHHG	MYCN	not amplified
TARGET-30-PALHHG	Histology	unfavorable
TARGET-30-PALHHG	Grade	undifferentiated or poorly differentiated
TARGET-30-PALHHG	Ploidy	diploid (di=1)
TARGET-30-PALHHG	Protocol	ANBL00B1-A3973
TARGET-30-PALHHG	Category	neuroblastoma
TARGET-30-PALHHG	1p-	unknown
TARGET-30-PALHHG	1q+	unknown
TARGET-30-PALHHG	11q-	unknown
TARGET-30-PALHHG	17q+	unknown
TARGET-30-PALHHG	%tumor	
TARGET-30-PALHHG	MKI	intermediate
TARGET-30-PALHTR	age	956
TARGET-30-PALHTR	age group	2-6
TARGET-30-PALHTR	stage	stage 4
TARGET-30-PALHTR	ATRX	unknown
TARGET-30-PALHTR	ALK	
TARGET-30-PALHTR	MYCN	amplified
TARGET-30-PALHTR	Histology	unfavorable
TARGET-30-PALHTR	Grade	undifferentiated or poorly differentiated
TARGET-30-PALHTR	Ploidy	hyperdiploid (di>1)
TARGET-30-PALHTR	Protocol	ANBL00B1-ANBL00P1
TARGET-30-PALHTR	Category	neuroblastoma
TARGET-30-PALHTR	1p-	unknown
TARGET-30-PALHTR	1q+	unknown
TARGET-30-PALHTR	11q-	unknown
TARGET-30-PALHTR	17q+	unknown
TARGET-30-PALHTR	%tumor	
TARGET-30-PALHTR	MKI	high
TARGET-30-PALHVD	age	1634
TARGET-30-PALHVD	age group	2-6
TARGET-30-PALHVD	stage	stage 4
TARGET-30-PALHVD	ATRX	unknown
TARGET-30-PALHVD	ALK	normal
TARGET-30-PALHVD	MYCN	not amplified
TARGET-30-PALHVD	Histology	unfavorable
TARGET-30-PALHVD	Grade	undifferentiated or poorly differentiated
TARGET-30-PALHVD	Ploidy	hyperdiploid (di>1)
TARGET-30-PALHVD	Protocol	ANBL00B1-AADM01P1
TARGET-30-PALHVD	Category	neuroblastoma
TARGET-30-PALHVD	1p-	normal
TARGET-30-PALHVD	1q+	gain
TARGET-30-PALHVD	11q-	loss
TARGET-30-PALHVD	17q+	gain
TARGET-30-PALHVD	%tumor	80.0
TARGET-30-PALHVD	MKI	intermediate
TARGET-30-PALIIN	age	1279
TARGET-30-PALIIN	age group	2-6
TARGET-30-PALIIN	stage	stage 4
TARGET-30-PALIIN	ATRX	normal
TARGET-30-PALIIN	ALK	normal
TARGET-30-PALIIN	MYCN	not amplified
TARGET-30-PALIIN	Histology	unfavorable
TARGET-30-PALIIN	Grade	undifferentiated or poorly differentiated
TARGET-30-PALIIN	Ploidy	hyperdiploid (di>1)
TARGET-30-PALIIN	Protocol	ANBL00B1-A3973
TARGET-30-PALIIN	Category	neuroblastoma
TARGET-30-PALIIN	1p-	normal
TARGET-30-PALIIN	1q+	normal
TARGET-30-PALIIN	11q-	loss
TARGET-30-PALIIN	17q+	gain
TARGET-30-PALIIN	%tumor	95.0
TARGET-30-PALIIN	MKI	high
TARGET-30-PALJPF	age	1502
TARGET-30-PALJPF	age group	2-6
TARGET-30-PALJPF	stage	stage 4
TARGET-30-PALJPF	ATRX	unknown
TARGET-30-PALJPF	ALK	
TARGET-30-PALJPF	MYCN	amplified
TARGET-30-PALJPF	Histology	unfavorable
TARGET-30-PALJPF	Grade	undifferentiated or poorly differentiated
TARGET-30-PALJPF	Ploidy	diploid (di=1)
TARGET-30-PALJPF	Protocol	ANBL00B1
TARGET-30-PALJPF	Category	neuroblastoma
TARGET-30-PALJPF	1p-	unknown
TARGET-30-PALJPF	1q+	unknown
TARGET-30-PALJPF	11q-	unknown
TARGET-30-PALJPF	17q+	unknown
TARGET-30-PALJPF	%tumor	
TARGET-30-PALJPF	MKI	high
TARGET-30-PALJPX	age	860
TARGET-30-PALJPX	age group	2-6
TARGET-30-PALJPX	stage	stage 4
TARGET-30-PALJPX	ATRX	unknown
TARGET-30-PALJPX	ALK	normal
TARGET-30-PALJPX	MYCN	amplified
TARGET-30-PALJPX	Histology	unfavorable
TARGET-30-PALJPX	Grade	undifferentiated or poorly differentiated
TARGET-30-PALJPX	Ploidy	hyperdiploid (di>1)
TARGET-30-PALJPX	Protocol	ANBL00B1
TARGET-30-PALJPX	Category	neuroblastoma
TARGET-30-PALJPX	1p-	normal
TARGET-30-PALJPX	1q+	normal
TARGET-30-PALJPX	11q-	loss
TARGET-30-PALJPX	17q+	gain
TARGET-30-PALJPX	%tumor	
TARGET-30-PALJPX	MKI	high
TARGET-30-PALJUV	age	1301
TARGET-30-PALJUV	age group	2-6
TARGET-30-PALJUV	stage	stage 4
TARGET-30-PALJUV	ATRX	unknown
TARGET-30-PALJUV	ALK	normal
TARGET-30-PALJUV	MYCN	not amplified
TARGET-30-PALJUV	Histology	unfavorable
TARGET-30-PALJUV	Grade	undifferentiated or poorly differentiated
TARGET-30-PALJUV	Ploidy	diploid (di=1)
TARGET-30-PALJUV	Protocol	ANBL00B1-AADM01P1
TARGET-30-PALJUV	Category	ganglioneuroblastoma, nodular
TARGET-30-PALJUV	1p-	normal
TARGET-30-PALJUV	1q+	normal
TARGET-30-PALJUV	11q-	normal
TARGET-30-PALJUV	17q+	normal
TARGET-30-PALJUV	%tumor	
TARGET-30-PALJUV	MKI	low
TARGET-30-PALJVX	age	1635
TARGET-30-PALJVX	age group	2-6
TARGET-30-PALJVX	stage	stage 4
TARGET-30-PALJVX	ATRX	unknown
TARGET-30-PALJVX	ALK	
TARGET-30-PALJVX	MYCN	not amplified
TARGET-30-PALJVX	Histology	unfavorable
TARGET-30-PALJVX	Grade	undifferentiated or poorly differentiated
TARGET-30-PALJVX	Ploidy	hyperdiploid (di>1)
TARGET-30-PALJVX	Protocol	ANBL00B1-A3973-ANBL0032-ANBL0621
TARGET-30-PALJVX	Category	neuroblastoma
TARGET-30-PALJVX	1p-	unknown
TARGET-30-PALJVX	1q+	unknown
TARGET-30-PALJVX	11q-	unknown
TARGET-30-PALJVX	17q+	unknown
TARGET-30-PALJVX	%tumor	50.0
TARGET-30-PALJVX	MKI	low
TARGET-30-PALJXU	age	366
TARGET-30-PALJXU	age group	1-2
TARGET-30-PALJXU	stage	stage 1
TARGET-30-PALJXU	ATRX	unknown
TARGET-30-PALJXU	ALK	
TARGET-30-PALJXU	MYCN	not amplified
TARGET-30-PALJXU	Histology	favorable
TARGET-30-PALJXU	Grade	differentiating
TARGET-30-PALJXU	Ploidy	hyperdiploid (di>1)
TARGET-30-PALJXU	Protocol	ANBL00B1-P9641
TARGET-30-PALJXU	Category	neuroblastoma
TARGET-30-PALJXU	1p-	unknown
TARGET-30-PALJXU	1q+	unknown
TARGET-30-PALJXU	11q-	unknown
TARGET-30-PALJXU	17q+	unknown
TARGET-30-PALJXU	%tumor	
TARGET-30-PALJXU	MKI	low
TARGET-30-PALJZV	age	1800
TARGET-30-PALJZV	age group	2-6
TARGET-30-PALJZV	stage	stage 4
TARGET-30-PALJZV	ATRX	unknown
TARGET-30-PALJZV	ALK	
TARGET-30-PALJZV	MYCN	amplified
TARGET-30-PALJZV	Histology	unfavorable
TARGET-30-PALJZV	Grade	undifferentiated or poorly differentiated
TARGET-30-PALJZV	Ploidy	diploid (di=1)
TARGET-30-PALJZV	Protocol	ANBL00B1-A3973
TARGET-30-PALJZV	Category	neuroblastoma
TARGET-30-PALJZV	1p-	unknown
TARGET-30-PALJZV	1q+	unknown
TARGET-30-PALJZV	11q-	unknown
TARGET-30-PALJZV	17q+	unknown
TARGET-30-PALJZV	%tumor	
TARGET-30-PALJZV	MKI	intermediate
TARGET-30-PALKBP	age	5
TARGET-30-PALKBP	age group	0-1
TARGET-30-PALKBP	stage	stage 1
TARGET-30-PALKBP	ATRX	unknown
TARGET-30-PALKBP	ALK	
TARGET-30-PALKBP	MYCN	not amplified
TARGET-30-PALKBP	Histology	favorable
TARGET-30-PALKBP	Grade	undifferentiated or poorly differentiated
TARGET-30-PALKBP	Ploidy	hyperdiploid (di>1)
TARGET-30-PALKBP	Protocol	ANBL00B1-AADM01P1-P9641
TARGET-30-PALKBP	Category	neuroblastoma
TARGET-30-PALKBP	1p-	unknown
TARGET-30-PALKBP	1q+	unknown
TARGET-30-PALKBP	11q-	unknown
TARGET-30-PALKBP	17q+	unknown
TARGET-30-PALKBP	%tumor	
TARGET-30-PALKBP	MKI	low
TARGET-30-PALKER	age	1238
TARGET-30-PALKER	age group	2-6
TARGET-30-PALKER	stage	stage 4
TARGET-30-PALKER	ATRX	unknown
TARGET-30-PALKER	ALK	
TARGET-30-PALKER	MYCN	not amplified
TARGET-30-PALKER	Histology	unfavorable
TARGET-30-PALKER	Grade	undifferentiated or poorly differentiated
TARGET-30-PALKER	Ploidy	hyperdiploid (di>1)
TARGET-30-PALKER	Protocol	ANBL00B1
TARGET-30-PALKER	Category	neuroblastoma
TARGET-30-PALKER	1p-	unknown
TARGET-30-PALKER	1q+	unknown
TARGET-30-PALKER	11q-	unknown
TARGET-30-PALKER	17q+	unknown
TARGET-30-PALKER	%tumor	100.0
TARGET-30-PALKER	MKI	intermediate
TARGET-30-PALKKV	age	283
TARGET-30-PALKKV	age group	0-1
TARGET-30-PALKKV	stage	stage 1
TARGET-30-PALKKV	ATRX	unknown
TARGET-30-PALKKV	ALK	
TARGET-30-PALKKV	MYCN	not amplified
TARGET-30-PALKKV	Histology	favorable
TARGET-30-PALKKV	Grade	undifferentiated or poorly differentiated
TARGET-30-PALKKV	Ploidy	hyperdiploid (di>1)
TARGET-30-PALKKV	Protocol	ANBL00B1-AADM01P1-P9641
TARGET-30-PALKKV	Category	neuroblastoma
TARGET-30-PALKKV	1p-	unknown
TARGET-30-PALKKV	1q+	unknown
TARGET-30-PALKKV	11q-	unknown
TARGET-30-PALKKV	17q+	unknown
TARGET-30-PALKKV	%tumor	
TARGET-30-PALKKV	MKI	low
TARGET-30-PALKUC	age	823
TARGET-30-PALKUC	age group	2-6
TARGET-30-PALKUC	stage	stage 4
TARGET-30-PALKUC	ATRX	unknown
TARGET-30-PALKUC	ALK	
TARGET-30-PALKUC	MYCN	amplified
TARGET-30-PALKUC	Histology	unfavorable
TARGET-30-PALKUC	Grade	undifferentiated or poorly differentiated
TARGET-30-PALKUC	Ploidy	diploid (di=1)
TARGET-30-PALKUC	Protocol	ANBL00B1
TARGET-30-PALKUC	Category	neuroblastoma
TARGET-30-PALKUC	1p-	unknown
TARGET-30-PALKUC	1q+	unknown
TARGET-30-PALKUC	11q-	unknown
TARGET-30-PALKUC	17q+	unknown
TARGET-30-PALKUC	%tumor	100.0
TARGET-30-PALKUC	MKI	high
TARGET-30-PALKXJ	age	10
TARGET-30-PALKXJ	age group	0-1
TARGET-30-PALKXJ	stage	stage 4s
TARGET-30-PALKXJ	ATRX	unknown
TARGET-30-PALKXJ	ALK	
TARGET-30-PALKXJ	MYCN	not amplified
TARGET-30-PALKXJ	Histology	favorable
TARGET-30-PALKXJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PALKXJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PALKXJ	Protocol	ANBL00B1-P9641
TARGET-30-PALKXJ	Category	neuroblastoma
TARGET-30-PALKXJ	1p-	unknown
TARGET-30-PALKXJ	1q+	unknown
TARGET-30-PALKXJ	11q-	unknown
TARGET-30-PALKXJ	17q+	unknown
TARGET-30-PALKXJ	%tumor	
TARGET-30-PALKXJ	MKI	low
TARGET-30-PALLJJ	age	388
TARGET-30-PALLJJ	age group	1-2
TARGET-30-PALLJJ	stage	stage 1
TARGET-30-PALLJJ	ATRX	unknown
TARGET-30-PALLJJ	ALK	
TARGET-30-PALLJJ	MYCN	not amplified
TARGET-30-PALLJJ	Histology	favorable
TARGET-30-PALLJJ	Grade	differentiating
TARGET-30-PALLJJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PALLJJ	Protocol	ANBL00B1-P9641
TARGET-30-PALLJJ	Category	neuroblastoma
TARGET-30-PALLJJ	1p-	unknown
TARGET-30-PALLJJ	1q+	unknown
TARGET-30-PALLJJ	11q-	unknown
TARGET-30-PALLJJ	17q+	unknown
TARGET-30-PALLJJ	%tumor	90.0
TARGET-30-PALLJJ	MKI	low
TARGET-30-PALNFE	age	551
TARGET-30-PALNFE	age group	1-2
TARGET-30-PALNFE	stage	stage 1
TARGET-30-PALNFE	ATRX	unknown
TARGET-30-PALNFE	ALK	
TARGET-30-PALNFE	MYCN	not amplified
TARGET-30-PALNFE	Histology	favorable
TARGET-30-PALNFE	Grade	differentiating
TARGET-30-PALNFE	Ploidy	hyperdiploid (di>1)
TARGET-30-PALNFE	Protocol	ANBL00B1-P9641
TARGET-30-PALNFE	Category	neuroblastoma
TARGET-30-PALNFE	1p-	unknown
TARGET-30-PALNFE	1q+	unknown
TARGET-30-PALNFE	11q-	unknown
TARGET-30-PALNFE	17q+	unknown
TARGET-30-PALNFE	%tumor	95.0
TARGET-30-PALNFE	MKI	low
TARGET-30-PALNHR	age	569
TARGET-30-PALNHR	age group	1-2
TARGET-30-PALNHR	stage	stage 4
TARGET-30-PALNHR	ATRX	unknown
TARGET-30-PALNHR	ALK	
TARGET-30-PALNHR	MYCN	amplified
TARGET-30-PALNHR	Histology	unfavorable
TARGET-30-PALNHR	Grade	undifferentiated or poorly differentiated
TARGET-30-PALNHR	Ploidy	diploid (di=1)
TARGET-30-PALNHR	Protocol	ANBL00B1
TARGET-30-PALNHR	Category	neuroblastoma
TARGET-30-PALNHR	1p-	unknown
TARGET-30-PALNHR	1q+	unknown
TARGET-30-PALNHR	11q-	unknown
TARGET-30-PALNHR	17q+	unknown
TARGET-30-PALNHR	%tumor	20.0
TARGET-30-PALNHR	MKI	
TARGET-30-PALNHZ	age	622
TARGET-30-PALNHZ	age group	1-2
TARGET-30-PALNHZ	stage	stage 4
TARGET-30-PALNHZ	ATRX	unknown
TARGET-30-PALNHZ	ALK	
TARGET-30-PALNHZ	MYCN	amplified
TARGET-30-PALNHZ	Histology	unfavorable
TARGET-30-PALNHZ	Grade	unknown
TARGET-30-PALNHZ	Ploidy	hyperdiploid (di>1)
TARGET-30-PALNHZ	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PALNHZ	Category	neuroblastoma
TARGET-30-PALNHZ	1p-	unknown
TARGET-30-PALNHZ	1q+	unknown
TARGET-30-PALNHZ	11q-	unknown
TARGET-30-PALNHZ	17q+	unknown
TARGET-30-PALNHZ	%tumor	
TARGET-30-PALNHZ	MKI	
TARGET-30-PALNLU	age	1439
TARGET-30-PALNLU	age group	2-6
TARGET-30-PALNLU	stage	stage 4
TARGET-30-PALNLU	ATRX	deleted
TARGET-30-PALNLU	ALK	mutated
TARGET-30-PALNLU	MYCN	not amplified
TARGET-30-PALNLU	Histology	unfavorable
TARGET-30-PALNLU	Grade	undifferentiated or poorly differentiated
TARGET-30-PALNLU	Ploidy	hyperdiploid (di>1)
TARGET-30-PALNLU	Protocol	ANBL00B1-A3973-ANBL0032-ANBL0321
TARGET-30-PALNLU	Category	neuroblastoma
TARGET-30-PALNLU	1p-	normal
TARGET-30-PALNLU	1q+	normal
TARGET-30-PALNLU	11q-	loss
TARGET-30-PALNLU	17q+	gain
TARGET-30-PALNLU	%tumor	
TARGET-30-PALNLU	MKI	low
TARGET-30-PALNMX	age	1607
TARGET-30-PALNMX	age group	2-6
TARGET-30-PALNMX	stage	stage 4
TARGET-30-PALNMX	ATRX	unknown
TARGET-30-PALNMX	ALK	
TARGET-30-PALNMX	MYCN	not amplified
TARGET-30-PALNMX	Histology	unfavorable
TARGET-30-PALNMX	Grade	undifferentiated or poorly differentiated
TARGET-30-PALNMX	Ploidy	hyperdiploid (di>1)
TARGET-30-PALNMX	Protocol	ANBL00B1-A3973
TARGET-30-PALNMX	Category	neuroblastoma
TARGET-30-PALNMX	1p-	unknown
TARGET-30-PALNMX	1q+	unknown
TARGET-30-PALNMX	11q-	unknown
TARGET-30-PALNMX	17q+	unknown
TARGET-30-PALNMX	%tumor	
TARGET-30-PALNMX	MKI	low
TARGET-30-PALNVP	age	1155
TARGET-30-PALNVP	age group	2-6
TARGET-30-PALNVP	stage	stage 4
TARGET-30-PALNVP	ATRX	unknown
TARGET-30-PALNVP	ALK	
TARGET-30-PALNVP	MYCN	not amplified
TARGET-30-PALNVP	Histology	unfavorable
TARGET-30-PALNVP	Grade	undifferentiated or poorly differentiated
TARGET-30-PALNVP	Ploidy	hyperdiploid (di>1)
TARGET-30-PALNVP	Protocol	ANBL00B1-A3973
TARGET-30-PALNVP	Category	neuroblastoma
TARGET-30-PALNVP	1p-	unknown
TARGET-30-PALNVP	1q+	unknown
TARGET-30-PALNVP	11q-	unknown
TARGET-30-PALNVP	17q+	unknown
TARGET-30-PALNVP	%tumor	90.0
TARGET-30-PALNVP	MKI	low
TARGET-30-PALPGG	age	700
TARGET-30-PALPGG	age group	1-2
TARGET-30-PALPGG	stage	stage 4
TARGET-30-PALPGG	ATRX	unknown
TARGET-30-PALPGG	ALK	normal
TARGET-30-PALPGG	MYCN	amplified
TARGET-30-PALPGG	Histology	unknown
TARGET-30-PALPGG	Grade	unknown
TARGET-30-PALPGG	Ploidy	diploid (di=1)
TARGET-30-PALPGG	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PALPGG	Category	unknown
TARGET-30-PALPGG	1p-	normal
TARGET-30-PALPGG	1q+	normal
TARGET-30-PALPGG	11q-	normal
TARGET-30-PALPGG	17q+	gain
TARGET-30-PALPGG	%tumor	
TARGET-30-PALPGG	MKI	
TARGET-30-PALPIN	age	46
TARGET-30-PALPIN	age group	0-1
TARGET-30-PALPIN	stage	stage 1
TARGET-30-PALPIN	ATRX	unknown
TARGET-30-PALPIN	ALK	
TARGET-30-PALPIN	MYCN	not amplified
TARGET-30-PALPIN	Histology	favorable
TARGET-30-PALPIN	Grade	undifferentiated or poorly differentiated
TARGET-30-PALPIN	Ploidy	hyperdiploid (di>1)
TARGET-30-PALPIN	Protocol	ANBL00B1-P9641
TARGET-30-PALPIN	Category	neuroblastoma
TARGET-30-PALPIN	1p-	unknown
TARGET-30-PALPIN	1q+	unknown
TARGET-30-PALPIN	11q-	unknown
TARGET-30-PALPIN	17q+	unknown
TARGET-30-PALPIN	%tumor	95.0
TARGET-30-PALPIN	MKI	low
TARGET-30-PALPKZ	age	1157
TARGET-30-PALPKZ	age group	2-6
TARGET-30-PALPKZ	stage	stage 4
TARGET-30-PALPKZ	ATRX	unknown
TARGET-30-PALPKZ	ALK	
TARGET-30-PALPKZ	MYCN	not amplified
TARGET-30-PALPKZ	Histology	unfavorable
TARGET-30-PALPKZ	Grade	undifferentiated or poorly differentiated
TARGET-30-PALPKZ	Ploidy	diploid (di=1)
TARGET-30-PALPKZ	Protocol	ANBL00B1
TARGET-30-PALPKZ	Category	neuroblastoma
TARGET-30-PALPKZ	1p-	unknown
TARGET-30-PALPKZ	1q+	unknown
TARGET-30-PALPKZ	11q-	unknown
TARGET-30-PALPKZ	17q+	unknown
TARGET-30-PALPKZ	%tumor	
TARGET-30-PALPKZ	MKI	low
TARGET-30-PALPSY	age	307
TARGET-30-PALPSY	age group	0-1
TARGET-30-PALPSY	stage	stage 1
TARGET-30-PALPSY	ATRX	unknown
TARGET-30-PALPSY	ALK	
TARGET-30-PALPSY	MYCN	not amplified
TARGET-30-PALPSY	Histology	favorable
TARGET-30-PALPSY	Grade	undifferentiated or poorly differentiated
TARGET-30-PALPSY	Ploidy	hyperdiploid (di>1)
TARGET-30-PALPSY	Protocol	ANBL00B1
TARGET-30-PALPSY	Category	neuroblastoma
TARGET-30-PALPSY	1p-	unknown
TARGET-30-PALPSY	1q+	unknown
TARGET-30-PALPSY	11q-	unknown
TARGET-30-PALPSY	17q+	unknown
TARGET-30-PALPSY	%tumor	50.0
TARGET-30-PALPSY	MKI	low
TARGET-30-PALRFJ	age	709
TARGET-30-PALRFJ	age group	1-2
TARGET-30-PALRFJ	stage	stage 4
TARGET-30-PALRFJ	ATRX	unknown
TARGET-30-PALRFJ	ALK	
TARGET-30-PALRFJ	MYCN	not amplified
TARGET-30-PALRFJ	Histology	unfavorable
TARGET-30-PALRFJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PALRFJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PALRFJ	Protocol	ANBL00B1
TARGET-30-PALRFJ	Category	neuroblastoma
TARGET-30-PALRFJ	1p-	unknown
TARGET-30-PALRFJ	1q+	unknown
TARGET-30-PALRFJ	11q-	unknown
TARGET-30-PALRFJ	17q+	unknown
TARGET-30-PALRFJ	%tumor	
TARGET-30-PALRFJ	MKI	high
TARGET-30-PALRIA	age	685
TARGET-30-PALRIA	age group	1-2
TARGET-30-PALRIA	stage	stage 1
TARGET-30-PALRIA	ATRX	unknown
TARGET-30-PALRIA	ALK	
TARGET-30-PALRIA	MYCN	not amplified
TARGET-30-PALRIA	Histology	favorable
TARGET-30-PALRIA	Grade	differentiating
TARGET-30-PALRIA	Ploidy	hyperdiploid (di>1)
TARGET-30-PALRIA	Protocol	ANBL00B1
TARGET-30-PALRIA	Category	neuroblastoma
TARGET-30-PALRIA	1p-	unknown
TARGET-30-PALRIA	1q+	unknown
TARGET-30-PALRIA	11q-	unknown
TARGET-30-PALRIA	17q+	unknown
TARGET-30-PALRIA	%tumor	
TARGET-30-PALRIA	MKI	low
TARGET-30-PALRSD	age	2726
TARGET-30-PALRSD	age group	6-9
TARGET-30-PALRSD	stage	stage 4
TARGET-30-PALRSD	ATRX	unknown
TARGET-30-PALRSD	ALK	normal
TARGET-30-PALRSD	MYCN	not amplified
TARGET-30-PALRSD	Histology	unknown
TARGET-30-PALRSD	Grade	unknown
TARGET-30-PALRSD	Ploidy	hyperdiploid (di>1)
TARGET-30-PALRSD	Protocol	B947-ANBL00B1-A3973-ALTE05N1
TARGET-30-PALRSD	Category	unknown
TARGET-30-PALRSD	1p-	normal
TARGET-30-PALRSD	1q+	normal
TARGET-30-PALRSD	11q-	normal
TARGET-30-PALRSD	17q+	normal
TARGET-30-PALRSD	%tumor	
TARGET-30-PALRSD	MKI	
TARGET-30-PALSAE	age	782
TARGET-30-PALSAE	age group	2-6
TARGET-30-PALSAE	stage	stage 4
TARGET-30-PALSAE	ATRX	unknown
TARGET-30-PALSAE	ALK	normal
TARGET-30-PALSAE	MYCN	not amplified
TARGET-30-PALSAE	Histology	unfavorable
TARGET-30-PALSAE	Grade	undifferentiated or poorly differentiated
TARGET-30-PALSAE	Ploidy	hyperdiploid (di>1)
TARGET-30-PALSAE	Protocol	ANBL00B1
TARGET-30-PALSAE	Category	neuroblastoma
TARGET-30-PALSAE	1p-	normal
TARGET-30-PALSAE	1q+	normal
TARGET-30-PALSAE	11q-	loss
TARGET-30-PALSAE	17q+	gain
TARGET-30-PALSAE	%tumor	90.0
TARGET-30-PALSAE	MKI	low
TARGET-30-PALTEG	age	1367
TARGET-30-PALTEG	age group	2-6
TARGET-30-PALTEG	stage	stage 4
TARGET-30-PALTEG	ATRX	unknown
TARGET-30-PALTEG	ALK	normal
TARGET-30-PALTEG	MYCN	not amplified
TARGET-30-PALTEG	Histology	unfavorable
TARGET-30-PALTEG	Grade	undifferentiated or poorly differentiated
TARGET-30-PALTEG	Ploidy	hyperdiploid (di>1)
TARGET-30-PALTEG	Protocol	ANBL00B1
TARGET-30-PALTEG	Category	neuroblastoma
TARGET-30-PALTEG	1p-	normal
TARGET-30-PALTEG	1q+	normal
TARGET-30-PALTEG	11q-	loss
TARGET-30-PALTEG	17q+	gain
TARGET-30-PALTEG	%tumor	
TARGET-30-PALTEG	MKI	intermediate
TARGET-30-PALTYB	age	1536
TARGET-30-PALTYB	age group	2-6
TARGET-30-PALTYB	stage	stage 4
TARGET-30-PALTYB	ATRX	normal
TARGET-30-PALTYB	ALK	normal
TARGET-30-PALTYB	MYCN	not amplified
TARGET-30-PALTYB	Histology	favorable
TARGET-30-PALTYB	Grade	differentiating
TARGET-30-PALTYB	Ploidy	diploid (di=1)
TARGET-30-PALTYB	Protocol	ANBL00B1
TARGET-30-PALTYB	Category	neuroblastoma
TARGET-30-PALTYB	1p-	normal
TARGET-30-PALTYB	1q+	normal
TARGET-30-PALTYB	11q-	normal
TARGET-30-PALTYB	17q+	normal
TARGET-30-PALTYB	%tumor	
TARGET-30-PALTYB	MKI	low
TARGET-30-PALTYS	age	720
TARGET-30-PALTYS	age group	1-2
TARGET-30-PALTYS	stage	stage 4
TARGET-30-PALTYS	ATRX	unknown
TARGET-30-PALTYS	ALK	
TARGET-30-PALTYS	MYCN	amplified
TARGET-30-PALTYS	Histology	unfavorable
TARGET-30-PALTYS	Grade	undifferentiated or poorly differentiated
TARGET-30-PALTYS	Ploidy	diploid (di=1)
TARGET-30-PALTYS	Protocol	ANBL00B1
TARGET-30-PALTYS	Category	neuroblastoma
TARGET-30-PALTYS	1p-	unknown
TARGET-30-PALTYS	1q+	unknown
TARGET-30-PALTYS	11q-	unknown
TARGET-30-PALTYS	17q+	unknown
TARGET-30-PALTYS	%tumor	
TARGET-30-PALTYS	MKI	high
TARGET-30-PALUDH	age	1105
TARGET-30-PALUDH	age group	2-6
TARGET-30-PALUDH	stage	stage 4
TARGET-30-PALUDH	ATRX	unknown
TARGET-30-PALUDH	ALK	normal
TARGET-30-PALUDH	MYCN	not amplified
TARGET-30-PALUDH	Histology	unfavorable
TARGET-30-PALUDH	Grade	undifferentiated or poorly differentiated
TARGET-30-PALUDH	Ploidy	hyperdiploid (di>1)
TARGET-30-PALUDH	Protocol	ANBL00B1
TARGET-30-PALUDH	Category	neuroblastoma
TARGET-30-PALUDH	1p-	normal
TARGET-30-PALUDH	1q+	normal
TARGET-30-PALUDH	11q-	loss
TARGET-30-PALUDH	17q+	gain
TARGET-30-PALUDH	%tumor	
TARGET-30-PALUDH	MKI	intermediate
TARGET-30-PALURF	age	1002
TARGET-30-PALURF	age group	2-6
TARGET-30-PALURF	stage	stage 4
TARGET-30-PALURF	ATRX	unknown
TARGET-30-PALURF	ALK	
TARGET-30-PALURF	MYCN	not amplified
TARGET-30-PALURF	Histology	unfavorable
TARGET-30-PALURF	Grade	undifferentiated or poorly differentiated
TARGET-30-PALURF	Ploidy	hyperdiploid (di>1)
TARGET-30-PALURF	Protocol	ANBL00B1-A3973
TARGET-30-PALURF	Category	neuroblastoma
TARGET-30-PALURF	1p-	unknown
TARGET-30-PALURF	1q+	unknown
TARGET-30-PALURF	11q-	unknown
TARGET-30-PALURF	17q+	unknown
TARGET-30-PALURF	%tumor	
TARGET-30-PALURF	MKI	low
TARGET-30-PALUYS	age	1214
TARGET-30-PALUYS	age group	2-6
TARGET-30-PALUYS	stage	stage 4
TARGET-30-PALUYS	ATRX	unknown
TARGET-30-PALUYS	ALK	
TARGET-30-PALUYS	MYCN	not amplified
TARGET-30-PALUYS	Histology	unfavorable
TARGET-30-PALUYS	Grade	undifferentiated or poorly differentiated
TARGET-30-PALUYS	Ploidy	hyperdiploid (di>1)
TARGET-30-PALUYS	Protocol	ANBL00B1
TARGET-30-PALUYS	Category	neuroblastoma
TARGET-30-PALUYS	1p-	unknown
TARGET-30-PALUYS	1q+	unknown
TARGET-30-PALUYS	11q-	unknown
TARGET-30-PALUYS	17q+	unknown
TARGET-30-PALUYS	%tumor	90.0
TARGET-30-PALUYS	MKI	high
TARGET-30-PALVDR	age	20
TARGET-30-PALVDR	age group	0-1
TARGET-30-PALVDR	stage	stage 1
TARGET-30-PALVDR	ATRX	unknown
TARGET-30-PALVDR	ALK	
TARGET-30-PALVDR	MYCN	not amplified
TARGET-30-PALVDR	Histology	favorable
TARGET-30-PALVDR	Grade	undifferentiated or poorly differentiated
TARGET-30-PALVDR	Ploidy	hyperdiploid (di>1)
TARGET-30-PALVDR	Protocol	ANBL00B1-P9641
TARGET-30-PALVDR	Category	neuroblastoma
TARGET-30-PALVDR	1p-	unknown
TARGET-30-PALVDR	1q+	unknown
TARGET-30-PALVDR	11q-	unknown
TARGET-30-PALVDR	17q+	unknown
TARGET-30-PALVDR	%tumor	
TARGET-30-PALVDR	MKI	low
TARGET-30-PALVFV	age	1133
TARGET-30-PALVFV	age group	2-6
TARGET-30-PALVFV	stage	stage 4
TARGET-30-PALVFV	ATRX	unknown
TARGET-30-PALVFV	ALK	
TARGET-30-PALVFV	MYCN	not amplified
TARGET-30-PALVFV	Histology	unfavorable
TARGET-30-PALVFV	Grade	undifferentiated or poorly differentiated
TARGET-30-PALVFV	Ploidy	hyperdiploid (di>1)
TARGET-30-PALVFV	Protocol	ANBL00B1-A3973
TARGET-30-PALVFV	Category	neuroblastoma
TARGET-30-PALVFV	1p-	unknown
TARGET-30-PALVFV	1q+	unknown
TARGET-30-PALVFV	11q-	unknown
TARGET-30-PALVFV	17q+	unknown
TARGET-30-PALVFV	%tumor	
TARGET-30-PALVFV	MKI	intermediate
TARGET-30-PALVKK	age	1810
TARGET-30-PALVKK	age group	2-6
TARGET-30-PALVKK	stage	stage 4
TARGET-30-PALVKK	ATRX	unknown
TARGET-30-PALVKK	ALK	
TARGET-30-PALVKK	MYCN	not amplified
TARGET-30-PALVKK	Histology	unfavorable
TARGET-30-PALVKK	Grade	undifferentiated or poorly differentiated
TARGET-30-PALVKK	Ploidy	diploid (di=1)
TARGET-30-PALVKK	Protocol	ANBL00B1-A3973-AADM01P1
TARGET-30-PALVKK	Category	ganglioneuroblastoma, nodular
TARGET-30-PALVKK	1p-	unknown
TARGET-30-PALVKK	1q+	unknown
TARGET-30-PALVKK	11q-	unknown
TARGET-30-PALVKK	17q+	unknown
TARGET-30-PALVKK	%tumor	80.0
TARGET-30-PALVKK	MKI	low
TARGET-30-PALVUC	age	194
TARGET-30-PALVUC	age group	0-1
TARGET-30-PALVUC	stage	stage 1
TARGET-30-PALVUC	ATRX	unknown
TARGET-30-PALVUC	ALK	
TARGET-30-PALVUC	MYCN	not amplified
TARGET-30-PALVUC	Histology	favorable
TARGET-30-PALVUC	Grade	undifferentiated or poorly differentiated
TARGET-30-PALVUC	Ploidy	hyperdiploid (di>1)
TARGET-30-PALVUC	Protocol	ANBL00B1-P9641
TARGET-30-PALVUC	Category	neuroblastoma
TARGET-30-PALVUC	1p-	unknown
TARGET-30-PALVUC	1q+	unknown
TARGET-30-PALVUC	11q-	unknown
TARGET-30-PALVUC	17q+	unknown
TARGET-30-PALVUC	%tumor	95.0
TARGET-30-PALVUC	MKI	low
TARGET-30-PALVVH	age	219
TARGET-30-PALVVH	age group	0-1
TARGET-30-PALVVH	stage	stage 1
TARGET-30-PALVVH	ATRX	unknown
TARGET-30-PALVVH	ALK	
TARGET-30-PALVVH	MYCN	not amplified
TARGET-30-PALVVH	Histology	favorable
TARGET-30-PALVVH	Grade	undifferentiated or poorly differentiated
TARGET-30-PALVVH	Ploidy	hyperdiploid (di>1)
TARGET-30-PALVVH	Protocol	ANBL00B1-AADM01P1-P9641
TARGET-30-PALVVH	Category	neuroblastoma
TARGET-30-PALVVH	1p-	unknown
TARGET-30-PALVVH	1q+	unknown
TARGET-30-PALVVH	11q-	unknown
TARGET-30-PALVVH	17q+	unknown
TARGET-30-PALVVH	%tumor	40.0
TARGET-30-PALVVH	MKI	low
TARGET-30-PALVXL	age	1298
TARGET-30-PALVXL	age group	2-6
TARGET-30-PALVXL	stage	stage 4
TARGET-30-PALVXL	ATRX	unknown
TARGET-30-PALVXL	ALK	
TARGET-30-PALVXL	MYCN	amplified
TARGET-30-PALVXL	Histology	unfavorable
TARGET-30-PALVXL	Grade	undifferentiated or poorly differentiated
TARGET-30-PALVXL	Ploidy	diploid (di=1)
TARGET-30-PALVXL	Protocol	ANBL00B1-A3973
TARGET-30-PALVXL	Category	neuroblastoma
TARGET-30-PALVXL	1p-	unknown
TARGET-30-PALVXL	1q+	unknown
TARGET-30-PALVXL	11q-	unknown
TARGET-30-PALVXL	17q+	unknown
TARGET-30-PALVXL	%tumor	
TARGET-30-PALVXL	MKI	
TARGET-30-PALWBT	age	399
TARGET-30-PALWBT	age group	1-2
TARGET-30-PALWBT	stage	stage 1
TARGET-30-PALWBT	ATRX	unknown
TARGET-30-PALWBT	ALK	
TARGET-30-PALWBT	MYCN	not amplified
TARGET-30-PALWBT	Histology	favorable
TARGET-30-PALWBT	Grade	differentiating
TARGET-30-PALWBT	Ploidy	hyperdiploid (di>1)
TARGET-30-PALWBT	Protocol	ANBL00B1-P9641
TARGET-30-PALWBT	Category	neuroblastoma
TARGET-30-PALWBT	1p-	unknown
TARGET-30-PALWBT	1q+	unknown
TARGET-30-PALWBT	11q-	unknown
TARGET-30-PALWBT	17q+	unknown
TARGET-30-PALWBT	%tumor	100.0
TARGET-30-PALWBT	MKI	low
TARGET-30-PALWIP	age	1232
TARGET-30-PALWIP	age group	2-6
TARGET-30-PALWIP	stage	stage 4
TARGET-30-PALWIP	ATRX	unknown
TARGET-30-PALWIP	ALK	normal
TARGET-30-PALWIP	MYCN	not amplified
TARGET-30-PALWIP	Histology	unfavorable
TARGET-30-PALWIP	Grade	undifferentiated or poorly differentiated
TARGET-30-PALWIP	Ploidy	hyperdiploid (di>1)
TARGET-30-PALWIP	Protocol	ANBL00B1-A3973
TARGET-30-PALWIP	Category	neuroblastoma
TARGET-30-PALWIP	1p-	normal
TARGET-30-PALWIP	1q+	normal
TARGET-30-PALWIP	11q-	loss
TARGET-30-PALWIP	17q+	gain
TARGET-30-PALWIP	%tumor	
TARGET-30-PALWIP	MKI	low
TARGET-30-PALWRG	age	138
TARGET-30-PALWRG	age group	0-1
TARGET-30-PALWRG	stage	stage 1
TARGET-30-PALWRG	ATRX	unknown
TARGET-30-PALWRG	ALK	
TARGET-30-PALWRG	MYCN	not amplified
TARGET-30-PALWRG	Histology	favorable
TARGET-30-PALWRG	Grade	undifferentiated or poorly differentiated
TARGET-30-PALWRG	Ploidy	hyperdiploid (di>1)
TARGET-30-PALWRG	Protocol	ANBL00B1-AADM01P1-P9641
TARGET-30-PALWRG	Category	neuroblastoma
TARGET-30-PALWRG	1p-	unknown
TARGET-30-PALWRG	1q+	unknown
TARGET-30-PALWRG	11q-	unknown
TARGET-30-PALWRG	17q+	unknown
TARGET-30-PALWRG	%tumor	
TARGET-30-PALWRG	MKI	intermediate
TARGET-30-PALWSJ	age	12
TARGET-30-PALWSJ	age group	0-1
TARGET-30-PALWSJ	stage	stage 1
TARGET-30-PALWSJ	ATRX	unknown
TARGET-30-PALWSJ	ALK	
TARGET-30-PALWSJ	MYCN	not amplified
TARGET-30-PALWSJ	Histology	favorable
TARGET-30-PALWSJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PALWSJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PALWSJ	Protocol	ANBL00B1-P9641
TARGET-30-PALWSJ	Category	neuroblastoma
TARGET-30-PALWSJ	1p-	unknown
TARGET-30-PALWSJ	1q+	unknown
TARGET-30-PALWSJ	11q-	unknown
TARGET-30-PALWSJ	17q+	unknown
TARGET-30-PALWSJ	%tumor	
TARGET-30-PALWSJ	MKI	low
TARGET-30-PALWVJ	age	1544
TARGET-30-PALWVJ	age group	2-6
TARGET-30-PALWVJ	stage	stage 4
TARGET-30-PALWVJ	ATRX	normal
TARGET-30-PALWVJ	ALK	normal
TARGET-30-PALWVJ	MYCN	not amplified
TARGET-30-PALWVJ	Histology	unfavorable
TARGET-30-PALWVJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PALWVJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PALWVJ	Protocol	ANBL00B1
TARGET-30-PALWVJ	Category	neuroblastoma
TARGET-30-PALWVJ	1p-	normal
TARGET-30-PALWVJ	1q+	normal
TARGET-30-PALWVJ	11q-	loss
TARGET-30-PALWVJ	17q+	gain
TARGET-30-PALWVJ	%tumor	40.0
TARGET-30-PALWVJ	MKI	intermediate
TARGET-30-PALWXP	age	70
TARGET-30-PALWXP	age group	0-1
TARGET-30-PALWXP	stage	stage 1
TARGET-30-PALWXP	ATRX	unknown
TARGET-30-PALWXP	ALK	
TARGET-30-PALWXP	MYCN	not amplified
TARGET-30-PALWXP	Histology	favorable
TARGET-30-PALWXP	Grade	undifferentiated or poorly differentiated
TARGET-30-PALWXP	Ploidy	hyperdiploid (di>1)
TARGET-30-PALWXP	Protocol	ANBL00B1-P9641
TARGET-30-PALWXP	Category	neuroblastoma
TARGET-30-PALWXP	1p-	unknown
TARGET-30-PALWXP	1q+	unknown
TARGET-30-PALWXP	11q-	unknown
TARGET-30-PALWXP	17q+	unknown
TARGET-30-PALWXP	%tumor	100.0
TARGET-30-PALWXP	MKI	low
TARGET-30-PALXHW	age	1131
TARGET-30-PALXHW	age group	2-6
TARGET-30-PALXHW	stage	stage 4
TARGET-30-PALXHW	ATRX	nonsense
TARGET-30-PALXHW	ALK	normal
TARGET-30-PALXHW	MYCN	not amplified
TARGET-30-PALXHW	Histology	unfavorable
TARGET-30-PALXHW	Grade	undifferentiated or poorly differentiated
TARGET-30-PALXHW	Ploidy	diploid (di=1)
TARGET-30-PALXHW	Protocol	ANBL00B1-A3973-ANBL0321
TARGET-30-PALXHW	Category	neuroblastoma
TARGET-30-PALXHW	1p-	normal
TARGET-30-PALXHW	1q+	normal
TARGET-30-PALXHW	11q-	normal
TARGET-30-PALXHW	17q+	gain
TARGET-30-PALXHW	%tumor	
TARGET-30-PALXHW	MKI	intermediate
TARGET-30-PALXMM	age	1475
TARGET-30-PALXMM	age group	2-6
TARGET-30-PALXMM	stage	stage 4
TARGET-30-PALXMM	ATRX	unknown
TARGET-30-PALXMM	ALK	normal
TARGET-30-PALXMM	MYCN	not amplified
TARGET-30-PALXMM	Histology	unfavorable
TARGET-30-PALXMM	Grade	undifferentiated or poorly differentiated
TARGET-30-PALXMM	Ploidy	hyperdiploid (di>1)
TARGET-30-PALXMM	Protocol	ANBL00B1
TARGET-30-PALXMM	Category	neuroblastoma
TARGET-30-PALXMM	1p-	normal
TARGET-30-PALXMM	1q+	normal
TARGET-30-PALXMM	11q-	loss
TARGET-30-PALXMM	17q+	normal
TARGET-30-PALXMM	%tumor	
TARGET-30-PALXMM	MKI	low
TARGET-30-PALXRL	age	1530
TARGET-30-PALXRL	age group	2-6
TARGET-30-PALXRL	stage	stage 4
TARGET-30-PALXRL	ATRX	unknown
TARGET-30-PALXRL	ALK	
TARGET-30-PALXRL	MYCN	not amplified
TARGET-30-PALXRL	Histology	unfavorable
TARGET-30-PALXRL	Grade	undifferentiated or poorly differentiated
TARGET-30-PALXRL	Ploidy	hyperdiploid (di>1)
TARGET-30-PALXRL	Protocol	ANBL00B1-B947-A3973-AADM01P1-AAML00P2
TARGET-30-PALXRL	Category	neuroblastoma
TARGET-30-PALXRL	1p-	unknown
TARGET-30-PALXRL	1q+	unknown
TARGET-30-PALXRL	11q-	unknown
TARGET-30-PALXRL	17q+	unknown
TARGET-30-PALXRL	%tumor	
TARGET-30-PALXRL	MKI	high
TARGET-30-PALXTB	age	635
TARGET-30-PALXTB	age group	1-2
TARGET-30-PALXTB	stage	stage 4
TARGET-30-PALXTB	ATRX	normal
TARGET-30-PALXTB	ALK	
TARGET-30-PALXTB	MYCN	not amplified
TARGET-30-PALXTB	Histology	unfavorable
TARGET-30-PALXTB	Grade	undifferentiated or poorly differentiated
TARGET-30-PALXTB	Ploidy	hyperdiploid (di>1)
TARGET-30-PALXTB	Protocol	ANBL00B1-A3973-ALTE05N1
TARGET-30-PALXTB	Category	neuroblastoma
TARGET-30-PALXTB	1p-	unknown
TARGET-30-PALXTB	1q+	unknown
TARGET-30-PALXTB	11q-	unknown
TARGET-30-PALXTB	17q+	unknown
TARGET-30-PALXTB	%tumor	
TARGET-30-PALXTB	MKI	low
TARGET-30-PALXTE	age	45
TARGET-30-PALXTE	age group	0-1
TARGET-30-PALXTE	stage	stage 1
TARGET-30-PALXTE	ATRX	unknown
TARGET-30-PALXTE	ALK	
TARGET-30-PALXTE	MYCN	not amplified
TARGET-30-PALXTE	Histology	favorable
TARGET-30-PALXTE	Grade	undifferentiated or poorly differentiated
TARGET-30-PALXTE	Ploidy	hyperdiploid (di>1)
TARGET-30-PALXTE	Protocol	ANBL00B1-P9641
TARGET-30-PALXTE	Category	neuroblastoma
TARGET-30-PALXTE	1p-	unknown
TARGET-30-PALXTE	1q+	unknown
TARGET-30-PALXTE	11q-	unknown
TARGET-30-PALXTE	17q+	unknown
TARGET-30-PALXTE	%tumor	100.0
TARGET-30-PALXTE	MKI	low
TARGET-30-PALXUM	age	20
TARGET-30-PALXUM	age group	0-1
TARGET-30-PALXUM	stage	stage 1
TARGET-30-PALXUM	ATRX	unknown
TARGET-30-PALXUM	ALK	
TARGET-30-PALXUM	MYCN	not amplified
TARGET-30-PALXUM	Histology	favorable
TARGET-30-PALXUM	Grade	undifferentiated or poorly differentiated
TARGET-30-PALXUM	Ploidy	hyperdiploid (di>1)
TARGET-30-PALXUM	Protocol	ANBL00B1-P9641
TARGET-30-PALXUM	Category	neuroblastoma
TARGET-30-PALXUM	1p-	unknown
TARGET-30-PALXUM	1q+	unknown
TARGET-30-PALXUM	11q-	unknown
TARGET-30-PALXUM	17q+	unknown
TARGET-30-PALXUM	%tumor	90.0
TARGET-30-PALXUM	MKI	low
TARGET-30-PALYEC	age	1240
TARGET-30-PALYEC	age group	2-6
TARGET-30-PALYEC	stage	stage 4
TARGET-30-PALYEC	ATRX	unknown
TARGET-30-PALYEC	ALK	
TARGET-30-PALYEC	MYCN	amplified
TARGET-30-PALYEC	Histology	unfavorable
TARGET-30-PALYEC	Grade	undifferentiated or poorly differentiated
TARGET-30-PALYEC	Ploidy	hyperdiploid (di>1)
TARGET-30-PALYEC	Protocol	ANBL00B1
TARGET-30-PALYEC	Category	neuroblastoma
TARGET-30-PALYEC	1p-	unknown
TARGET-30-PALYEC	1q+	unknown
TARGET-30-PALYEC	11q-	unknown
TARGET-30-PALYEC	17q+	unknown
TARGET-30-PALYEC	%tumor	70.0
TARGET-30-PALYEC	MKI	high
TARGET-30-PALYLZ	age	488
TARGET-30-PALYLZ	age group	1-2
TARGET-30-PALYLZ	stage	stage 1
TARGET-30-PALYLZ	ATRX	unknown
TARGET-30-PALYLZ	ALK	
TARGET-30-PALYLZ	MYCN	not amplified
TARGET-30-PALYLZ	Histology	favorable
TARGET-30-PALYLZ	Grade	undifferentiated or poorly differentiated
TARGET-30-PALYLZ	Ploidy	hyperdiploid (di>1)
TARGET-30-PALYLZ	Protocol	ANBL00B1-P9641
TARGET-30-PALYLZ	Category	neuroblastoma
TARGET-30-PALYLZ	1p-	unknown
TARGET-30-PALYLZ	1q+	unknown
TARGET-30-PALYLZ	11q-	unknown
TARGET-30-PALYLZ	17q+	unknown
TARGET-30-PALYLZ	%tumor	95.0
TARGET-30-PALYLZ	MKI	intermediate
TARGET-30-PALYPW	age	858
TARGET-30-PALYPW	age group	2-6
TARGET-30-PALYPW	stage	stage 4
TARGET-30-PALYPW	ATRX	unknown
TARGET-30-PALYPW	ALK	
TARGET-30-PALYPW	MYCN	not amplified
TARGET-30-PALYPW	Histology	unfavorable
TARGET-30-PALYPW	Grade	undifferentiated or poorly differentiated
TARGET-30-PALYPW	Ploidy	diploid (di=1)
TARGET-30-PALYPW	Protocol	ANBL00B1
TARGET-30-PALYPW	Category	ganglioneuroblastoma, nodular
TARGET-30-PALYPW	1p-	unknown
TARGET-30-PALYPW	1q+	unknown
TARGET-30-PALYPW	11q-	unknown
TARGET-30-PALYPW	17q+	unknown
TARGET-30-PALYPW	%tumor	
TARGET-30-PALYPW	MKI	
TARGET-30-PALZBH	age	1390
TARGET-30-PALZBH	age group	2-6
TARGET-30-PALZBH	stage	stage 4
TARGET-30-PALZBH	ATRX	unknown
TARGET-30-PALZBH	ALK	
TARGET-30-PALZBH	MYCN	not amplified
TARGET-30-PALZBH	Histology	unfavorable
TARGET-30-PALZBH	Grade	undifferentiated or poorly differentiated
TARGET-30-PALZBH	Ploidy	diploid (di=1)
TARGET-30-PALZBH	Protocol	ANBL00B1
TARGET-30-PALZBH	Category	neuroblastoma
TARGET-30-PALZBH	1p-	unknown
TARGET-30-PALZBH	1q+	unknown
TARGET-30-PALZBH	11q-	unknown
TARGET-30-PALZBH	17q+	unknown
TARGET-30-PALZBH	%tumor	75.0
TARGET-30-PALZBH	MKI	low
TARGET-30-PALZHF	age	16
TARGET-30-PALZHF	age group	0-1
TARGET-30-PALZHF	stage	stage 1
TARGET-30-PALZHF	ATRX	unknown
TARGET-30-PALZHF	ALK	
TARGET-30-PALZHF	MYCN	not amplified
TARGET-30-PALZHF	Histology	favorable
TARGET-30-PALZHF	Grade	undifferentiated or poorly differentiated
TARGET-30-PALZHF	Ploidy	hyperdiploid (di>1)
TARGET-30-PALZHF	Protocol	ANBL00B1-P9641
TARGET-30-PALZHF	Category	neuroblastoma
TARGET-30-PALZHF	1p-	unknown
TARGET-30-PALZHF	1q+	unknown
TARGET-30-PALZHF	11q-	unknown
TARGET-30-PALZHF	17q+	unknown
TARGET-30-PALZHF	%tumor	
TARGET-30-PALZHF	MKI	intermediate
TARGET-30-PALZRB	age	1687
TARGET-30-PALZRB	age group	2-6
TARGET-30-PALZRB	stage	stage 4
TARGET-30-PALZRB	ATRX	unknown
TARGET-30-PALZRB	ALK	
TARGET-30-PALZRB	MYCN	amplified
TARGET-30-PALZRB	Histology	unfavorable
TARGET-30-PALZRB	Grade	undifferentiated or poorly differentiated
TARGET-30-PALZRB	Ploidy	hyperdiploid (di>1)
TARGET-30-PALZRB	Protocol	ANBL00B1
TARGET-30-PALZRB	Category	neuroblastoma
TARGET-30-PALZRB	1p-	unknown
TARGET-30-PALZRB	1q+	unknown
TARGET-30-PALZRB	11q-	unknown
TARGET-30-PALZRB	17q+	unknown
TARGET-30-PALZRB	%tumor	90.0
TARGET-30-PALZRB	MKI	high
TARGET-30-PALZRG	age	577
TARGET-30-PALZRG	age group	1-2
TARGET-30-PALZRG	stage	stage 4
TARGET-30-PALZRG	ATRX	unknown
TARGET-30-PALZRG	ALK	normal
TARGET-30-PALZRG	MYCN	amplified
TARGET-30-PALZRG	Histology	unfavorable
TARGET-30-PALZRG	Grade	undifferentiated or poorly differentiated
TARGET-30-PALZRG	Ploidy	hyperdiploid (di>1)
TARGET-30-PALZRG	Protocol	ANBL00B1-A3973
TARGET-30-PALZRG	Category	neuroblastoma
TARGET-30-PALZRG	1p-	loss
TARGET-30-PALZRG	1q+	normal
TARGET-30-PALZRG	11q-	loss
TARGET-30-PALZRG	17q+	gain
TARGET-30-PALZRG	%tumor	75.0
TARGET-30-PALZRG	MKI	high
TARGET-30-PALZSL	age	1564
TARGET-30-PALZSL	age group	2-6
TARGET-30-PALZSL	stage	stage 4
TARGET-30-PALZSL	ATRX	normal
TARGET-30-PALZSL	ALK	normal
TARGET-30-PALZSL	MYCN	amplified
TARGET-30-PALZSL	Histology	unfavorable
TARGET-30-PALZSL	Grade	undifferentiated or poorly differentiated
TARGET-30-PALZSL	Ploidy	hyperdiploid (di>1)
TARGET-30-PALZSL	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PALZSL	Category	neuroblastoma
TARGET-30-PALZSL	1p-	normal
TARGET-30-PALZSL	1q+	gain
TARGET-30-PALZSL	11q-	normal
TARGET-30-PALZSL	17q+	gain
TARGET-30-PALZSL	%tumor	
TARGET-30-PALZSL	MKI	intermediate
TARGET-30-PALZZV	age	699
TARGET-30-PALZZV	age group	1-2
TARGET-30-PALZZV	stage	stage 4
TARGET-30-PALZZV	ATRX	normal
TARGET-30-PALZZV	ALK	normal
TARGET-30-PALZZV	MYCN	amplified
TARGET-30-PALZZV	Histology	unfavorable
TARGET-30-PALZZV	Grade	undifferentiated or poorly differentiated
TARGET-30-PALZZV	Ploidy	hyperdiploid (di>1)
TARGET-30-PALZZV	Protocol	ANBL00B1
TARGET-30-PALZZV	Category	neuroblastoma
TARGET-30-PALZZV	1p-	loss
TARGET-30-PALZZV	1q+	normal
TARGET-30-PALZZV	11q-	normal
TARGET-30-PALZZV	17q+	gain
TARGET-30-PALZZV	%tumor	95.0
TARGET-30-PALZZV	MKI	intermediate
TARGET-30-PAMACS	age	1352
TARGET-30-PAMACS	age group	2-6
TARGET-30-PAMACS	stage	stage 4
TARGET-30-PAMACS	ATRX	unknown
TARGET-30-PAMACS	ALK	
TARGET-30-PAMACS	MYCN	not amplified
TARGET-30-PAMACS	Histology	unfavorable
TARGET-30-PAMACS	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMACS	Ploidy	diploid (di=1)
TARGET-30-PAMACS	Protocol	ANBL00B1-A3973
TARGET-30-PAMACS	Category	ganglioneuroblastoma, nodular
TARGET-30-PAMACS	1p-	unknown
TARGET-30-PAMACS	1q+	unknown
TARGET-30-PAMACS	11q-	unknown
TARGET-30-PAMACS	17q+	unknown
TARGET-30-PAMACS	%tumor	100.0
TARGET-30-PAMACS	MKI	intermediate
TARGET-30-PAMAFV	age	303
TARGET-30-PAMAFV	age group	0-1
TARGET-30-PAMAFV	stage	stage 1
TARGET-30-PAMAFV	ATRX	unknown
TARGET-30-PAMAFV	ALK	
TARGET-30-PAMAFV	MYCN	not amplified
TARGET-30-PAMAFV	Histology	favorable
TARGET-30-PAMAFV	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMAFV	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMAFV	Protocol	ANBL00B1-P9641
TARGET-30-PAMAFV	Category	neuroblastoma
TARGET-30-PAMAFV	1p-	unknown
TARGET-30-PAMAFV	1q+	unknown
TARGET-30-PAMAFV	11q-	unknown
TARGET-30-PAMAFV	17q+	unknown
TARGET-30-PAMAFV	%tumor	100.0
TARGET-30-PAMAFV	MKI	low
TARGET-30-PAMAJT	age	105
TARGET-30-PAMAJT	age group	0-1
TARGET-30-PAMAJT	stage	stage 1
TARGET-30-PAMAJT	ATRX	unknown
TARGET-30-PAMAJT	ALK	
TARGET-30-PAMAJT	MYCN	not amplified
TARGET-30-PAMAJT	Histology	favorable
TARGET-30-PAMAJT	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMAJT	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMAJT	Protocol	ANBL00B1-P9641
TARGET-30-PAMAJT	Category	neuroblastoma
TARGET-30-PAMAJT	1p-	unknown
TARGET-30-PAMAJT	1q+	unknown
TARGET-30-PAMAJT	11q-	unknown
TARGET-30-PAMAJT	17q+	unknown
TARGET-30-PAMAJT	%tumor	70.0
TARGET-30-PAMAJT	MKI	low
TARGET-30-PAMANU	age	1398
TARGET-30-PAMANU	age group	2-6
TARGET-30-PAMANU	stage	stage 4
TARGET-30-PAMANU	ATRX	unknown
TARGET-30-PAMANU	ALK	
TARGET-30-PAMANU	MYCN	unknown
TARGET-30-PAMANU	Histology	unfavorable
TARGET-30-PAMANU	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMANU	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMANU	Protocol	ANBL00B1
TARGET-30-PAMANU	Category	neuroblastoma
TARGET-30-PAMANU	1p-	unknown
TARGET-30-PAMANU	1q+	unknown
TARGET-30-PAMANU	11q-	unknown
TARGET-30-PAMANU	17q+	unknown
TARGET-30-PAMANU	%tumor	
TARGET-30-PAMANU	MKI	low
TARGET-30-PAMBAC	age	945
TARGET-30-PAMBAC	age group	2-6
TARGET-30-PAMBAC	stage	stage 4
TARGET-30-PAMBAC	ATRX	unknown
TARGET-30-PAMBAC	ALK	normal
TARGET-30-PAMBAC	MYCN	amplified
TARGET-30-PAMBAC	Histology	unfavorable
TARGET-30-PAMBAC	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMBAC	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMBAC	Protocol	ANBL00B1
TARGET-30-PAMBAC	Category	neuroblastoma
TARGET-30-PAMBAC	1p-	normal
TARGET-30-PAMBAC	1q+	gain
TARGET-30-PAMBAC	11q-	normal
TARGET-30-PAMBAC	17q+	gain
TARGET-30-PAMBAC	%tumor	
TARGET-30-PAMBAC	MKI	intermediate
TARGET-30-PAMBDH	age	797
TARGET-30-PAMBDH	age group	2-6
TARGET-30-PAMBDH	stage	stage 4
TARGET-30-PAMBDH	ATRX	unknown
TARGET-30-PAMBDH	ALK	
TARGET-30-PAMBDH	MYCN	amplified
TARGET-30-PAMBDH	Histology	unfavorable
TARGET-30-PAMBDH	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMBDH	Ploidy	diploid (di=1)
TARGET-30-PAMBDH	Protocol	ANBL00B1-A3973
TARGET-30-PAMBDH	Category	neuroblastoma
TARGET-30-PAMBDH	1p-	unknown
TARGET-30-PAMBDH	1q+	unknown
TARGET-30-PAMBDH	11q-	unknown
TARGET-30-PAMBDH	17q+	unknown
TARGET-30-PAMBDH	%tumor	
TARGET-30-PAMBDH	MKI	high
TARGET-30-PAMBMJ	age	954
TARGET-30-PAMBMJ	age group	2-6
TARGET-30-PAMBMJ	stage	stage 4
TARGET-30-PAMBMJ	ATRX	unknown
TARGET-30-PAMBMJ	ALK	
TARGET-30-PAMBMJ	MYCN	amplified
TARGET-30-PAMBMJ	Histology	unfavorable
TARGET-30-PAMBMJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMBMJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMBMJ	Protocol	ANBL00B1-A3973
TARGET-30-PAMBMJ	Category	neuroblastoma
TARGET-30-PAMBMJ	1p-	unknown
TARGET-30-PAMBMJ	1q+	unknown
TARGET-30-PAMBMJ	11q-	unknown
TARGET-30-PAMBMJ	17q+	unknown
TARGET-30-PAMBMJ	%tumor	100.0
TARGET-30-PAMBMJ	MKI	intermediate
TARGET-30-PAMBYG	age	614
TARGET-30-PAMBYG	age group	1-2
TARGET-30-PAMBYG	stage	stage 4
TARGET-30-PAMBYG	ATRX	unknown
TARGET-30-PAMBYG	ALK	
TARGET-30-PAMBYG	MYCN	amplified
TARGET-30-PAMBYG	Histology	unfavorable
TARGET-30-PAMBYG	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMBYG	Ploidy	diploid (di=1)
TARGET-30-PAMBYG	Protocol	ANBL00B1
TARGET-30-PAMBYG	Category	neuroblastoma
TARGET-30-PAMBYG	1p-	unknown
TARGET-30-PAMBYG	1q+	unknown
TARGET-30-PAMBYG	11q-	unknown
TARGET-30-PAMBYG	17q+	unknown
TARGET-30-PAMBYG	%tumor	
TARGET-30-PAMBYG	MKI	high
TARGET-30-PAMCJD	age	733
TARGET-30-PAMCJD	age group	2-6
TARGET-30-PAMCJD	stage	stage 4
TARGET-30-PAMCJD	ATRX	unknown
TARGET-30-PAMCJD	ALK	
TARGET-30-PAMCJD	MYCN	not amplified
TARGET-30-PAMCJD	Histology	unfavorable
TARGET-30-PAMCJD	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMCJD	Ploidy	diploid (di=1)
TARGET-30-PAMCJD	Protocol	ANBL00B1-A3973-ANBL0322
TARGET-30-PAMCJD	Category	neuroblastoma
TARGET-30-PAMCJD	1p-	unknown
TARGET-30-PAMCJD	1q+	unknown
TARGET-30-PAMCJD	11q-	unknown
TARGET-30-PAMCJD	17q+	unknown
TARGET-30-PAMCJD	%tumor	
TARGET-30-PAMCJD	MKI	low
TARGET-30-PAMCXF	age	765
TARGET-30-PAMCXF	age group	2-6
TARGET-30-PAMCXF	stage	stage 4
TARGET-30-PAMCXF	ATRX	unknown
TARGET-30-PAMCXF	ALK	normal
TARGET-30-PAMCXF	MYCN	amplified
TARGET-30-PAMCXF	Histology	unfavorable
TARGET-30-PAMCXF	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMCXF	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMCXF	Protocol	ANBL00B1-A3973
TARGET-30-PAMCXF	Category	neuroblastoma
TARGET-30-PAMCXF	1p-	loss
TARGET-30-PAMCXF	1q+	normal
TARGET-30-PAMCXF	11q-	loss
TARGET-30-PAMCXF	17q+	gain
TARGET-30-PAMCXF	%tumor	
TARGET-30-PAMCXF	MKI	high
TARGET-30-PAMDAL	age	1222
TARGET-30-PAMDAL	age group	2-6
TARGET-30-PAMDAL	stage	stage 4
TARGET-30-PAMDAL	ATRX	unknown
TARGET-30-PAMDAL	ALK	normal
TARGET-30-PAMDAL	MYCN	amplified
TARGET-30-PAMDAL	Histology	unfavorable
TARGET-30-PAMDAL	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMDAL	Ploidy	unknown
TARGET-30-PAMDAL	Protocol	ANBL00B1
TARGET-30-PAMDAL	Category	neuroblastoma
TARGET-30-PAMDAL	1p-	normal
TARGET-30-PAMDAL	1q+	normal
TARGET-30-PAMDAL	11q-	normal
TARGET-30-PAMDAL	17q+	gain
TARGET-30-PAMDAL	%tumor	
TARGET-30-PAMDAL	MKI	high
TARGET-30-PAMEHH	age	915
TARGET-30-PAMEHH	age group	2-6
TARGET-30-PAMEHH	stage	stage 4
TARGET-30-PAMEHH	ATRX	unknown
TARGET-30-PAMEHH	ALK	
TARGET-30-PAMEHH	MYCN	not amplified
TARGET-30-PAMEHH	Histology	unfavorable
TARGET-30-PAMEHH	Grade	unknown
TARGET-30-PAMEHH	Ploidy	diploid (di=1)
TARGET-30-PAMEHH	Protocol	ANBL00B1-A3973
TARGET-30-PAMEHH	Category	neuroblastoma
TARGET-30-PAMEHH	1p-	unknown
TARGET-30-PAMEHH	1q+	unknown
TARGET-30-PAMEHH	11q-	unknown
TARGET-30-PAMEHH	17q+	unknown
TARGET-30-PAMEHH	%tumor	
TARGET-30-PAMEHH	MKI	
TARGET-30-PAMEZH	age	746
TARGET-30-PAMEZH	age group	2-6
TARGET-30-PAMEZH	stage	stage 4
TARGET-30-PAMEZH	ATRX	unknown
TARGET-30-PAMEZH	ALK	
TARGET-30-PAMEZH	MYCN	amplified
TARGET-30-PAMEZH	Histology	unknown
TARGET-30-PAMEZH	Grade	unknown
TARGET-30-PAMEZH	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMEZH	Protocol	ANBL00B1
TARGET-30-PAMEZH	Category	unknown
TARGET-30-PAMEZH	1p-	unknown
TARGET-30-PAMEZH	1q+	unknown
TARGET-30-PAMEZH	11q-	unknown
TARGET-30-PAMEZH	17q+	unknown
TARGET-30-PAMEZH	%tumor	85.0
TARGET-30-PAMEZH	MKI	
TARGET-30-PAMFBR	age	1626
TARGET-30-PAMFBR	age group	2-6
TARGET-30-PAMFBR	stage	stage 4
TARGET-30-PAMFBR	ATRX	unknown
TARGET-30-PAMFBR	ALK	
TARGET-30-PAMFBR	MYCN	amplified
TARGET-30-PAMFBR	Histology	unfavorable
TARGET-30-PAMFBR	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMFBR	Ploidy	diploid (di=1)
TARGET-30-PAMFBR	Protocol	ANBL00B1
TARGET-30-PAMFBR	Category	neuroblastoma
TARGET-30-PAMFBR	1p-	unknown
TARGET-30-PAMFBR	1q+	unknown
TARGET-30-PAMFBR	11q-	unknown
TARGET-30-PAMFBR	17q+	unknown
TARGET-30-PAMFBR	%tumor	
TARGET-30-PAMFBR	MKI	intermediate
TARGET-30-PAMHDM	age	960
TARGET-30-PAMHDM	age group	2-6
TARGET-30-PAMHDM	stage	stage 4
TARGET-30-PAMHDM	ATRX	unknown
TARGET-30-PAMHDM	ALK	
TARGET-30-PAMHDM	MYCN	not amplified
TARGET-30-PAMHDM	Histology	unfavorable
TARGET-30-PAMHDM	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMHDM	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMHDM	Protocol	ANBL00B1
TARGET-30-PAMHDM	Category	neuroblastoma
TARGET-30-PAMHDM	1p-	unknown
TARGET-30-PAMHDM	1q+	unknown
TARGET-30-PAMHDM	11q-	unknown
TARGET-30-PAMHDM	17q+	unknown
TARGET-30-PAMHDM	%tumor	
TARGET-30-PAMHDM	MKI	low
TARGET-30-PAMHPN	age	1075
TARGET-30-PAMHPN	age group	2-6
TARGET-30-PAMHPN	stage	stage 4
TARGET-30-PAMHPN	ATRX	unknown
TARGET-30-PAMHPN	ALK	
TARGET-30-PAMHPN	MYCN	not amplified
TARGET-30-PAMHPN	Histology	unfavorable
TARGET-30-PAMHPN	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMHPN	Ploidy	diploid (di=1)
TARGET-30-PAMHPN	Protocol	ANBL00B1
TARGET-30-PAMHPN	Category	neuroblastoma
TARGET-30-PAMHPN	1p-	unknown
TARGET-30-PAMHPN	1q+	unknown
TARGET-30-PAMHPN	11q-	unknown
TARGET-30-PAMHPN	17q+	unknown
TARGET-30-PAMHPN	%tumor	
TARGET-30-PAMHPN	MKI	low
TARGET-30-PAMIIU	age	1499
TARGET-30-PAMIIU	age group	2-6
TARGET-30-PAMIIU	stage	stage 4
TARGET-30-PAMIIU	ATRX	unknown
TARGET-30-PAMIIU	ALK	
TARGET-30-PAMIIU	MYCN	not amplified
TARGET-30-PAMIIU	Histology	unknown
TARGET-30-PAMIIU	Grade	unknown
TARGET-30-PAMIIU	Ploidy	diploid (di=1)
TARGET-30-PAMIIU	Protocol	ANBL00B1-A3973-ALTE05N1
TARGET-30-PAMIIU	Category	neuroblastoma
TARGET-30-PAMIIU	1p-	unknown
TARGET-30-PAMIIU	1q+	unknown
TARGET-30-PAMIIU	11q-	unknown
TARGET-30-PAMIIU	17q+	unknown
TARGET-30-PAMIIU	%tumor	
TARGET-30-PAMIIU	MKI	
TARGET-30-PAMIZA	age	946
TARGET-30-PAMIZA	age group	2-6
TARGET-30-PAMIZA	stage	stage 4
TARGET-30-PAMIZA	ATRX	unknown
TARGET-30-PAMIZA	ALK	
TARGET-30-PAMIZA	MYCN	not amplified
TARGET-30-PAMIZA	Histology	unfavorable
TARGET-30-PAMIZA	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMIZA	Ploidy	diploid (di=1)
TARGET-30-PAMIZA	Protocol	ANBL00B1-A3973
TARGET-30-PAMIZA	Category	neuroblastoma
TARGET-30-PAMIZA	1p-	unknown
TARGET-30-PAMIZA	1q+	unknown
TARGET-30-PAMIZA	11q-	unknown
TARGET-30-PAMIZA	17q+	unknown
TARGET-30-PAMIZA	%tumor	90.0
TARGET-30-PAMIZA	MKI	high
TARGET-30-PAMJED	age	909
TARGET-30-PAMJED	age group	2-6
TARGET-30-PAMJED	stage	stage 4
TARGET-30-PAMJED	ATRX	unknown
TARGET-30-PAMJED	ALK	
TARGET-30-PAMJED	MYCN	amplified
TARGET-30-PAMJED	Histology	unfavorable
TARGET-30-PAMJED	Grade	unknown
TARGET-30-PAMJED	Ploidy	diploid (di=1)
TARGET-30-PAMJED	Protocol	ANBL00B1
TARGET-30-PAMJED	Category	neuroblastoma
TARGET-30-PAMJED	1p-	unknown
TARGET-30-PAMJED	1q+	unknown
TARGET-30-PAMJED	11q-	unknown
TARGET-30-PAMJED	17q+	unknown
TARGET-30-PAMJED	%tumor	
TARGET-30-PAMJED	MKI	
TARGET-30-PAMKBM	age	41
TARGET-30-PAMKBM	age group	0-1
TARGET-30-PAMKBM	stage	stage 1
TARGET-30-PAMKBM	ATRX	unknown
TARGET-30-PAMKBM	ALK	
TARGET-30-PAMKBM	MYCN	not amplified
TARGET-30-PAMKBM	Histology	favorable
TARGET-30-PAMKBM	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMKBM	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMKBM	Protocol	ANBL00B1-P9641
TARGET-30-PAMKBM	Category	neuroblastoma
TARGET-30-PAMKBM	1p-	unknown
TARGET-30-PAMKBM	1q+	unknown
TARGET-30-PAMKBM	11q-	unknown
TARGET-30-PAMKBM	17q+	unknown
TARGET-30-PAMKBM	%tumor	
TARGET-30-PAMKBM	MKI	low
TARGET-30-PAMKHK	age	314
TARGET-30-PAMKHK	age group	0-1
TARGET-30-PAMKHK	stage	stage 1
TARGET-30-PAMKHK	ATRX	unknown
TARGET-30-PAMKHK	ALK	
TARGET-30-PAMKHK	MYCN	not amplified
TARGET-30-PAMKHK	Histology	favorable
TARGET-30-PAMKHK	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMKHK	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMKHK	Protocol	ANBL00B1-P9641
TARGET-30-PAMKHK	Category	neuroblastoma
TARGET-30-PAMKHK	1p-	unknown
TARGET-30-PAMKHK	1q+	unknown
TARGET-30-PAMKHK	11q-	unknown
TARGET-30-PAMKHK	17q+	unknown
TARGET-30-PAMKHK	%tumor	
TARGET-30-PAMKHK	MKI	low
TARGET-30-PAMLCS	age	1643
TARGET-30-PAMLCS	age group	2-6
TARGET-30-PAMLCS	stage	stage 4
TARGET-30-PAMLCS	ATRX	unknown
TARGET-30-PAMLCS	ALK	
TARGET-30-PAMLCS	MYCN	not amplified
TARGET-30-PAMLCS	Histology	unfavorable
TARGET-30-PAMLCS	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMLCS	Ploidy	diploid (di=1)
TARGET-30-PAMLCS	Protocol	ANBL00B1
TARGET-30-PAMLCS	Category	neuroblastoma
TARGET-30-PAMLCS	1p-	unknown
TARGET-30-PAMLCS	1q+	unknown
TARGET-30-PAMLCS	11q-	unknown
TARGET-30-PAMLCS	17q+	unknown
TARGET-30-PAMLCS	%tumor	
TARGET-30-PAMLCS	MKI	low
TARGET-30-PAMLMY	age	952
TARGET-30-PAMLMY	age group	2-6
TARGET-30-PAMLMY	stage	stage 4
TARGET-30-PAMLMY	ATRX	unknown
TARGET-30-PAMLMY	ALK	
TARGET-30-PAMLMY	MYCN	not amplified
TARGET-30-PAMLMY	Histology	unfavorable
TARGET-30-PAMLMY	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMLMY	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMLMY	Protocol	ANBL00B1
TARGET-30-PAMLMY	Category	neuroblastoma
TARGET-30-PAMLMY	1p-	unknown
TARGET-30-PAMLMY	1q+	unknown
TARGET-30-PAMLMY	11q-	unknown
TARGET-30-PAMLMY	17q+	unknown
TARGET-30-PAMLMY	%tumor	
TARGET-30-PAMLMY	MKI	high
TARGET-30-PAMLNB	age	6
TARGET-30-PAMLNB	age group	0-1
TARGET-30-PAMLNB	stage	stage 1
TARGET-30-PAMLNB	ATRX	unknown
TARGET-30-PAMLNB	ALK	
TARGET-30-PAMLNB	MYCN	not amplified
TARGET-30-PAMLNB	Histology	favorable
TARGET-30-PAMLNB	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMLNB	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMLNB	Protocol	ANBL00B1-P9641
TARGET-30-PAMLNB	Category	neuroblastoma
TARGET-30-PAMLNB	1p-	unknown
TARGET-30-PAMLNB	1q+	unknown
TARGET-30-PAMLNB	11q-	unknown
TARGET-30-PAMLNB	17q+	unknown
TARGET-30-PAMLNB	%tumor	
TARGET-30-PAMLNB	MKI	low
TARGET-30-PAMLWV	age	1820
TARGET-30-PAMLWV	age group	2-6
TARGET-30-PAMLWV	stage	stage 4
TARGET-30-PAMLWV	ATRX	unknown
TARGET-30-PAMLWV	ALK	
TARGET-30-PAMLWV	MYCN	not amplified
TARGET-30-PAMLWV	Histology	unfavorable
TARGET-30-PAMLWV	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMLWV	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMLWV	Protocol	ANBL00B1-ADVL0524
TARGET-30-PAMLWV	Category	neuroblastoma
TARGET-30-PAMLWV	1p-	unknown
TARGET-30-PAMLWV	1q+	unknown
TARGET-30-PAMLWV	11q-	unknown
TARGET-30-PAMLWV	17q+	unknown
TARGET-30-PAMLWV	%tumor	
TARGET-30-PAMLWV	MKI	low
TARGET-30-PAMMFV	age	1129
TARGET-30-PAMMFV	age group	2-6
TARGET-30-PAMMFV	stage	stage 4
TARGET-30-PAMMFV	ATRX	unknown
TARGET-30-PAMMFV	ALK	
TARGET-30-PAMMFV	MYCN	not amplified
TARGET-30-PAMMFV	Histology	unfavorable
TARGET-30-PAMMFV	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMMFV	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMMFV	Protocol	ANBL00B1-ADVL0215-ADVL0421-ADVL0214
TARGET-30-PAMMFV	Category	neuroblastoma
TARGET-30-PAMMFV	1p-	unknown
TARGET-30-PAMMFV	1q+	unknown
TARGET-30-PAMMFV	11q-	unknown
TARGET-30-PAMMFV	17q+	unknown
TARGET-30-PAMMFV	%tumor	
TARGET-30-PAMMFV	MKI	intermediate
TARGET-30-PAMMWD	age	812
TARGET-30-PAMMWD	age group	2-6
TARGET-30-PAMMWD	stage	stage 4
TARGET-30-PAMMWD	ATRX	unknown
TARGET-30-PAMMWD	ALK	normal
TARGET-30-PAMMWD	MYCN	amplified
TARGET-30-PAMMWD	Histology	unfavorable
TARGET-30-PAMMWD	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMMWD	Ploidy	diploid (di=1)
TARGET-30-PAMMWD	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PAMMWD	Category	neuroblastoma
TARGET-30-PAMMWD	1p-	loss
TARGET-30-PAMMWD	1q+	normal
TARGET-30-PAMMWD	11q-	normal
TARGET-30-PAMMWD	17q+	gain
TARGET-30-PAMMWD	%tumor	80.0
TARGET-30-PAMMWD	MKI	intermediate
TARGET-30-PAMMXF	age	1661
TARGET-30-PAMMXF	age group	2-6
TARGET-30-PAMMXF	stage	stage 4
TARGET-30-PAMMXF	ATRX	normal
TARGET-30-PAMMXF	ALK	normal
TARGET-30-PAMMXF	MYCN	amplified
TARGET-30-PAMMXF	Histology	unfavorable
TARGET-30-PAMMXF	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMMXF	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMMXF	Protocol	ANBL00B1
TARGET-30-PAMMXF	Category	neuroblastoma
TARGET-30-PAMMXF	1p-	loss
TARGET-30-PAMMXF	1q+	gain
TARGET-30-PAMMXF	11q-	normal
TARGET-30-PAMMXF	17q+	normal
TARGET-30-PAMMXF	%tumor	75.0
TARGET-30-PAMMXF	MKI	low
TARGET-30-PAMMYR	age	1548
TARGET-30-PAMMYR	age group	2-6
TARGET-30-PAMMYR	stage	stage 4
TARGET-30-PAMMYR	ATRX	unknown
TARGET-30-PAMMYR	ALK	
TARGET-30-PAMMYR	MYCN	not amplified
TARGET-30-PAMMYR	Histology	unfavorable
TARGET-30-PAMMYR	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMMYR	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMMYR	Protocol	ANBL00B1
TARGET-30-PAMMYR	Category	neuroblastoma
TARGET-30-PAMMYR	1p-	unknown
TARGET-30-PAMMYR	1q+	unknown
TARGET-30-PAMMYR	11q-	unknown
TARGET-30-PAMMYR	17q+	unknown
TARGET-30-PAMMYR	%tumor	
TARGET-30-PAMMYR	MKI	intermediate
TARGET-30-PAMNAL	age	1235
TARGET-30-PAMNAL	age group	2-6
TARGET-30-PAMNAL	stage	stage 4
TARGET-30-PAMNAL	ATRX	unknown
TARGET-30-PAMNAL	ALK	
TARGET-30-PAMNAL	MYCN	not amplified
TARGET-30-PAMNAL	Histology	unfavorable
TARGET-30-PAMNAL	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMNAL	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMNAL	Protocol	ANBL00B1-A3973
TARGET-30-PAMNAL	Category	neuroblastoma
TARGET-30-PAMNAL	1p-	unknown
TARGET-30-PAMNAL	1q+	unknown
TARGET-30-PAMNAL	11q-	unknown
TARGET-30-PAMNAL	17q+	unknown
TARGET-30-PAMNAL	%tumor	50.0
TARGET-30-PAMNAL	MKI	intermediate
TARGET-30-PAMNLH	age	1531
TARGET-30-PAMNLH	age group	2-6
TARGET-30-PAMNLH	stage	stage 4
TARGET-30-PAMNLH	ATRX	normal
TARGET-30-PAMNLH	ALK	
TARGET-30-PAMNLH	MYCN	not amplified
TARGET-30-PAMNLH	Histology	unfavorable
TARGET-30-PAMNLH	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMNLH	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMNLH	Protocol	ANBL00B1-A3973
TARGET-30-PAMNLH	Category	ganglioneuroblastoma, nodular
TARGET-30-PAMNLH	1p-	unknown
TARGET-30-PAMNLH	1q+	unknown
TARGET-30-PAMNLH	11q-	unknown
TARGET-30-PAMNLH	17q+	unknown
TARGET-30-PAMNLH	%tumor	85.0
TARGET-30-PAMNLH	MKI	intermediate
TARGET-30-PAMNVX	age	742
TARGET-30-PAMNVX	age group	2-6
TARGET-30-PAMNVX	stage	stage 4
TARGET-30-PAMNVX	ATRX	unknown
TARGET-30-PAMNVX	ALK	
TARGET-30-PAMNVX	MYCN	not amplified
TARGET-30-PAMNVX	Histology	unfavorable
TARGET-30-PAMNVX	Grade	differentiating
TARGET-30-PAMNVX	Ploidy	diploid (di=1)
TARGET-30-PAMNVX	Protocol	ANBL00B1-A3973-ALTE05N1
TARGET-30-PAMNVX	Category	neuroblastoma
TARGET-30-PAMNVX	1p-	unknown
TARGET-30-PAMNVX	1q+	unknown
TARGET-30-PAMNVX	11q-	unknown
TARGET-30-PAMNVX	17q+	unknown
TARGET-30-PAMNVX	%tumor	
TARGET-30-PAMNVX	MKI	high
TARGET-30-PAMNYX	age	1923
TARGET-30-PAMNYX	age group	2-6
TARGET-30-PAMNYX	stage	stage 4
TARGET-30-PAMNYX	ATRX	unknown
TARGET-30-PAMNYX	ALK	normal
TARGET-30-PAMNYX	MYCN	not amplified
TARGET-30-PAMNYX	Histology	unfavorable
TARGET-30-PAMNYX	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMNYX	Ploidy	diploid (di=1)
TARGET-30-PAMNYX	Protocol	ANBL00B1
TARGET-30-PAMNYX	Category	ganglioneuroblastoma, nodular
TARGET-30-PAMNYX	1p-	normal
TARGET-30-PAMNYX	1q+	normal
TARGET-30-PAMNYX	11q-	normal
TARGET-30-PAMNYX	17q+	normal
TARGET-30-PAMNYX	%tumor	
TARGET-30-PAMNYX	MKI	low
TARGET-30-PAMPCU	age	872
TARGET-30-PAMPCU	age group	2-6
TARGET-30-PAMPCU	stage	stage 4
TARGET-30-PAMPCU	ATRX	unknown
TARGET-30-PAMPCU	ALK	
TARGET-30-PAMPCU	MYCN	not amplified
TARGET-30-PAMPCU	Histology	unfavorable
TARGET-30-PAMPCU	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMPCU	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMPCU	Protocol	ANBL00B1-A3973-ALTE05N1
TARGET-30-PAMPCU	Category	neuroblastoma
TARGET-30-PAMPCU	1p-	unknown
TARGET-30-PAMPCU	1q+	unknown
TARGET-30-PAMPCU	11q-	unknown
TARGET-30-PAMPCU	17q+	unknown
TARGET-30-PAMPCU	%tumor	
TARGET-30-PAMPCU	MKI	high
TARGET-30-PAMPFJ	age	596
TARGET-30-PAMPFJ	age group	1-2
TARGET-30-PAMPFJ	stage	stage 4
TARGET-30-PAMPFJ	ATRX	unknown
TARGET-30-PAMPFJ	ALK	
TARGET-30-PAMPFJ	MYCN	amplified
TARGET-30-PAMPFJ	Histology	unfavorable
TARGET-30-PAMPFJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMPFJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMPFJ	Protocol	ANBL00B1-A3973
TARGET-30-PAMPFJ	Category	neuroblastoma
TARGET-30-PAMPFJ	1p-	unknown
TARGET-30-PAMPFJ	1q+	unknown
TARGET-30-PAMPFJ	11q-	unknown
TARGET-30-PAMPFJ	17q+	unknown
TARGET-30-PAMPFJ	%tumor	35.0
TARGET-30-PAMPFJ	MKI	intermediate
TARGET-30-PAMRKH	age	1202
TARGET-30-PAMRKH	age group	2-6
TARGET-30-PAMRKH	stage	stage 4
TARGET-30-PAMRKH	ATRX	unknown
TARGET-30-PAMRKH	ALK	
TARGET-30-PAMRKH	MYCN	not amplified
TARGET-30-PAMRKH	Histology	unfavorable
TARGET-30-PAMRKH	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMRKH	Ploidy	diploid (di=1)
TARGET-30-PAMRKH	Protocol	ANBL00B1-A3973-ANBL0032-ANBL0621
TARGET-30-PAMRKH	Category	neuroblastoma
TARGET-30-PAMRKH	1p-	unknown
TARGET-30-PAMRKH	1q+	unknown
TARGET-30-PAMRKH	11q-	unknown
TARGET-30-PAMRKH	17q+	unknown
TARGET-30-PAMRKH	%tumor	
TARGET-30-PAMRKH	MKI	low
TARGET-30-PAMRZD	age	1009
TARGET-30-PAMRZD	age group	2-6
TARGET-30-PAMRZD	stage	stage 4
TARGET-30-PAMRZD	ATRX	unknown
TARGET-30-PAMRZD	ALK	
TARGET-30-PAMRZD	MYCN	amplified
TARGET-30-PAMRZD	Histology	unfavorable
TARGET-30-PAMRZD	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMRZD	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMRZD	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PAMRZD	Category	neuroblastoma
TARGET-30-PAMRZD	1p-	unknown
TARGET-30-PAMRZD	1q+	unknown
TARGET-30-PAMRZD	11q-	unknown
TARGET-30-PAMRZD	17q+	unknown
TARGET-30-PAMRZD	%tumor	
TARGET-30-PAMRZD	MKI	high
TARGET-30-PAMSXU	age	1663
TARGET-30-PAMSXU	age group	2-6
TARGET-30-PAMSXU	stage	stage 4
TARGET-30-PAMSXU	ATRX	unknown
TARGET-30-PAMSXU	ALK	
TARGET-30-PAMSXU	MYCN	not amplified
TARGET-30-PAMSXU	Histology	unfavorable
TARGET-30-PAMSXU	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMSXU	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMSXU	Protocol	ANBL00B1-ANBL00P1
TARGET-30-PAMSXU	Category	ganglioneuroblastoma, nodular
TARGET-30-PAMSXU	1p-	unknown
TARGET-30-PAMSXU	1q+	unknown
TARGET-30-PAMSXU	11q-	unknown
TARGET-30-PAMSXU	17q+	unknown
TARGET-30-PAMSXU	%tumor	
TARGET-30-PAMSXU	MKI	low
TARGET-30-PAMTBI	age	1526
TARGET-30-PAMTBI	age group	2-6
TARGET-30-PAMTBI	stage	stage 4
TARGET-30-PAMTBI	ATRX	unknown
TARGET-30-PAMTBI	ALK	
TARGET-30-PAMTBI	MYCN	not amplified
TARGET-30-PAMTBI	Histology	unfavorable
TARGET-30-PAMTBI	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMTBI	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMTBI	Protocol	ANBL00B1
TARGET-30-PAMTBI	Category	neuroblastoma
TARGET-30-PAMTBI	1p-	unknown
TARGET-30-PAMTBI	1q+	unknown
TARGET-30-PAMTBI	11q-	unknown
TARGET-30-PAMTBI	17q+	unknown
TARGET-30-PAMTBI	%tumor	
TARGET-30-PAMTBI	MKI	high
TARGET-30-PAMTTA	age	1652
TARGET-30-PAMTTA	age group	2-6
TARGET-30-PAMTTA	stage	stage 4
TARGET-30-PAMTTA	ATRX	unknown
TARGET-30-PAMTTA	ALK	
TARGET-30-PAMTTA	MYCN	not amplified
TARGET-30-PAMTTA	Histology	unfavorable
TARGET-30-PAMTTA	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMTTA	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMTTA	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PAMTTA	Category	ganglioneuroblastoma, nodular
TARGET-30-PAMTTA	1p-	unknown
TARGET-30-PAMTTA	1q+	unknown
TARGET-30-PAMTTA	11q-	unknown
TARGET-30-PAMTTA	17q+	unknown
TARGET-30-PAMTTA	%tumor	
TARGET-30-PAMTTA	MKI	intermediate
TARGET-30-PAMTUV	age	4795
TARGET-30-PAMTUV	age group	9-
TARGET-30-PAMTUV	stage	stage 4
TARGET-30-PAMTUV	ATRX	unknown
TARGET-30-PAMTUV	ALK	
TARGET-30-PAMTUV	MYCN	not amplified
TARGET-30-PAMTUV	Histology	unfavorable
TARGET-30-PAMTUV	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMTUV	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMTUV	Protocol	ANBL00B1
TARGET-30-PAMTUV	Category	neuroblastoma
TARGET-30-PAMTUV	1p-	unknown
TARGET-30-PAMTUV	1q+	unknown
TARGET-30-PAMTUV	11q-	unknown
TARGET-30-PAMTUV	17q+	unknown
TARGET-30-PAMTUV	%tumor	
TARGET-30-PAMTUV	MKI	high
TARGET-30-PAMTZV	age	902
TARGET-30-PAMTZV	age group	2-6
TARGET-30-PAMTZV	stage	stage 4
TARGET-30-PAMTZV	ATRX	unknown
TARGET-30-PAMTZV	ALK	
TARGET-30-PAMTZV	MYCN	amplified
TARGET-30-PAMTZV	Histology	unfavorable
TARGET-30-PAMTZV	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMTZV	Ploidy	diploid (di=1)
TARGET-30-PAMTZV	Protocol	ANBL00B1
TARGET-30-PAMTZV	Category	neuroblastoma
TARGET-30-PAMTZV	1p-	unknown
TARGET-30-PAMTZV	1q+	unknown
TARGET-30-PAMTZV	11q-	unknown
TARGET-30-PAMTZV	17q+	unknown
TARGET-30-PAMTZV	%tumor	
TARGET-30-PAMTZV	MKI	low
TARGET-30-PAMUFZ	age	1489
TARGET-30-PAMUFZ	age group	2-6
TARGET-30-PAMUFZ	stage	stage 4
TARGET-30-PAMUFZ	ATRX	unknown
TARGET-30-PAMUFZ	ALK	
TARGET-30-PAMUFZ	MYCN	amplified
TARGET-30-PAMUFZ	Histology	unfavorable
TARGET-30-PAMUFZ	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMUFZ	Ploidy	diploid (di=1)
TARGET-30-PAMUFZ	Protocol	ANBL00B1-A3973
TARGET-30-PAMUFZ	Category	neuroblastoma
TARGET-30-PAMUFZ	1p-	unknown
TARGET-30-PAMUFZ	1q+	unknown
TARGET-30-PAMUFZ	11q-	unknown
TARGET-30-PAMUFZ	17q+	unknown
TARGET-30-PAMUFZ	%tumor	
TARGET-30-PAMUFZ	MKI	high
TARGET-30-PAMUIJ	age	1018
TARGET-30-PAMUIJ	age group	2-6
TARGET-30-PAMUIJ	stage	stage 4
TARGET-30-PAMUIJ	ATRX	unknown
TARGET-30-PAMUIJ	ALK	
TARGET-30-PAMUIJ	MYCN	amplified
TARGET-30-PAMUIJ	Histology	unfavorable
TARGET-30-PAMUIJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMUIJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMUIJ	Protocol	ANBL00B1
TARGET-30-PAMUIJ	Category	neuroblastoma
TARGET-30-PAMUIJ	1p-	unknown
TARGET-30-PAMUIJ	1q+	unknown
TARGET-30-PAMUIJ	11q-	unknown
TARGET-30-PAMUIJ	17q+	unknown
TARGET-30-PAMUIJ	%tumor	
TARGET-30-PAMUIJ	MKI	high
TARGET-30-PAMUTD	age	825
TARGET-30-PAMUTD	age group	2-6
TARGET-30-PAMUTD	stage	stage 4
TARGET-30-PAMUTD	ATRX	unknown
TARGET-30-PAMUTD	ALK	normal
TARGET-30-PAMUTD	MYCN	amplified
TARGET-30-PAMUTD	Histology	unfavorable
TARGET-30-PAMUTD	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMUTD	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMUTD	Protocol	ANBL00B1-A3973
TARGET-30-PAMUTD	Category	neuroblastoma
TARGET-30-PAMUTD	1p-	normal
TARGET-30-PAMUTD	1q+	normal
TARGET-30-PAMUTD	11q-	normal
TARGET-30-PAMUTD	17q+	gain
TARGET-30-PAMUTD	%tumor	
TARGET-30-PAMUTD	MKI	low
TARGET-30-PAMVAG	age	663
TARGET-30-PAMVAG	age group	1-2
TARGET-30-PAMVAG	stage	stage 4
TARGET-30-PAMVAG	ATRX	unknown
TARGET-30-PAMVAG	ALK	
TARGET-30-PAMVAG	MYCN	not amplified
TARGET-30-PAMVAG	Histology	unfavorable
TARGET-30-PAMVAG	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMVAG	Ploidy	diploid (di=1)
TARGET-30-PAMVAG	Protocol	ANBL00B1-A3973
TARGET-30-PAMVAG	Category	neuroblastoma
TARGET-30-PAMVAG	1p-	unknown
TARGET-30-PAMVAG	1q+	unknown
TARGET-30-PAMVAG	11q-	unknown
TARGET-30-PAMVAG	17q+	unknown
TARGET-30-PAMVAG	%tumor	
TARGET-30-PAMVAG	MKI	intermediate
TARGET-30-PAMVCL	age	87
TARGET-30-PAMVCL	age group	0-1
TARGET-30-PAMVCL	stage	stage 1
TARGET-30-PAMVCL	ATRX	unknown
TARGET-30-PAMVCL	ALK	
TARGET-30-PAMVCL	MYCN	not amplified
TARGET-30-PAMVCL	Histology	favorable
TARGET-30-PAMVCL	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMVCL	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMVCL	Protocol	ANBL00B1-P9641
TARGET-30-PAMVCL	Category	neuroblastoma
TARGET-30-PAMVCL	1p-	unknown
TARGET-30-PAMVCL	1q+	unknown
TARGET-30-PAMVCL	11q-	unknown
TARGET-30-PAMVCL	17q+	unknown
TARGET-30-PAMVCL	%tumor	
TARGET-30-PAMVCL	MKI	low
TARGET-30-PAMVLG	age	1978
TARGET-30-PAMVLG	age group	2-6
TARGET-30-PAMVLG	stage	stage 4
TARGET-30-PAMVLG	ATRX	deleted
TARGET-30-PAMVLG	ALK	normal
TARGET-30-PAMVLG	MYCN	not amplified
TARGET-30-PAMVLG	Histology	unfavorable
TARGET-30-PAMVLG	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMVLG	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMVLG	Protocol	ANBL00B1-A3973-AADM01P1-ANBL0032-ANBL0621
TARGET-30-PAMVLG	Category	neuroblastoma
TARGET-30-PAMVLG	1p-	normal
TARGET-30-PAMVLG	1q+	normal
TARGET-30-PAMVLG	11q-	loss
TARGET-30-PAMVLG	17q+	gain
TARGET-30-PAMVLG	%tumor	
TARGET-30-PAMVLG	MKI	low
TARGET-30-PAMVRA	age	1554
TARGET-30-PAMVRA	age group	2-6
TARGET-30-PAMVRA	stage	stage 4
TARGET-30-PAMVRA	ATRX	unknown
TARGET-30-PAMVRA	ALK	normal
TARGET-30-PAMVRA	MYCN	not amplified
TARGET-30-PAMVRA	Histology	unfavorable
TARGET-30-PAMVRA	Grade	differentiating
TARGET-30-PAMVRA	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMVRA	Protocol	ANBL00B1-A3973-AADM01P1
TARGET-30-PAMVRA	Category	ganglioneuroblastoma, nodular
TARGET-30-PAMVRA	1p-	normal
TARGET-30-PAMVRA	1q+	normal
TARGET-30-PAMVRA	11q-	normal
TARGET-30-PAMVRA	17q+	normal
TARGET-30-PAMVRA	%tumor	
TARGET-30-PAMVRA	MKI	low
TARGET-30-PAMWSV	age	1190
TARGET-30-PAMWSV	age group	2-6
TARGET-30-PAMWSV	stage	stage 4
TARGET-30-PAMWSV	ATRX	unknown
TARGET-30-PAMWSV	ALK	
TARGET-30-PAMWSV	MYCN	not amplified
TARGET-30-PAMWSV	Histology	unfavorable
TARGET-30-PAMWSV	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMWSV	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMWSV	Protocol	ANBL00B1-A3973
TARGET-30-PAMWSV	Category	ganglioneuroblastoma, nodular
TARGET-30-PAMWSV	1p-	unknown
TARGET-30-PAMWSV	1q+	unknown
TARGET-30-PAMWSV	11q-	unknown
TARGET-30-PAMWSV	17q+	unknown
TARGET-30-PAMWSV	%tumor	
TARGET-30-PAMWSV	MKI	intermediate
TARGET-30-PAMXFP	age	1053
TARGET-30-PAMXFP	age group	2-6
TARGET-30-PAMXFP	stage	stage 4
TARGET-30-PAMXFP	ATRX	unknown
TARGET-30-PAMXFP	ALK	
TARGET-30-PAMXFP	MYCN	amplified
TARGET-30-PAMXFP	Histology	unknown
TARGET-30-PAMXFP	Grade	unknown
TARGET-30-PAMXFP	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMXFP	Protocol	ANBL00B1
TARGET-30-PAMXFP	Category	neuroblastoma
TARGET-30-PAMXFP	1p-	unknown
TARGET-30-PAMXFP	1q+	unknown
TARGET-30-PAMXFP	11q-	unknown
TARGET-30-PAMXFP	17q+	unknown
TARGET-30-PAMXFP	%tumor	80.0
TARGET-30-PAMXFP	MKI	
TARGET-30-PAMXGF	age	1327
TARGET-30-PAMXGF	age group	2-6
TARGET-30-PAMXGF	stage	stage 4
TARGET-30-PAMXGF	ATRX	unknown
TARGET-30-PAMXGF	ALK	
TARGET-30-PAMXGF	MYCN	amplified
TARGET-30-PAMXGF	Histology	unfavorable
TARGET-30-PAMXGF	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMXGF	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMXGF	Protocol	ANBL00B1
TARGET-30-PAMXGF	Category	ganglioneuroblastoma, nodular
TARGET-30-PAMXGF	1p-	unknown
TARGET-30-PAMXGF	1q+	unknown
TARGET-30-PAMXGF	11q-	unknown
TARGET-30-PAMXGF	17q+	unknown
TARGET-30-PAMXGF	%tumor	
TARGET-30-PAMXGF	MKI	intermediate
TARGET-30-PAMXWF	age	932
TARGET-30-PAMXWF	age group	2-6
TARGET-30-PAMXWF	stage	stage 4
TARGET-30-PAMXWF	ATRX	unknown
TARGET-30-PAMXWF	ALK	
TARGET-30-PAMXWF	MYCN	not amplified
TARGET-30-PAMXWF	Histology	unknown
TARGET-30-PAMXWF	Grade	unknown
TARGET-30-PAMXWF	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMXWF	Protocol	ANBL00B1-A3973
TARGET-30-PAMXWF	Category	unknown
TARGET-30-PAMXWF	1p-	unknown
TARGET-30-PAMXWF	1q+	unknown
TARGET-30-PAMXWF	11q-	unknown
TARGET-30-PAMXWF	17q+	unknown
TARGET-30-PAMXWF	%tumor	
TARGET-30-PAMXWF	MKI	
TARGET-30-PAMXYK	age	1157
TARGET-30-PAMXYK	age group	2-6
TARGET-30-PAMXYK	stage	stage 4
TARGET-30-PAMXYK	ATRX	unknown
TARGET-30-PAMXYK	ALK	
TARGET-30-PAMXYK	MYCN	amplified
TARGET-30-PAMXYK	Histology	unfavorable
TARGET-30-PAMXYK	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMXYK	Ploidy	diploid (di=1)
TARGET-30-PAMXYK	Protocol	ANBL00B1-A3973-ADVL0524
TARGET-30-PAMXYK	Category	neuroblastoma
TARGET-30-PAMXYK	1p-	unknown
TARGET-30-PAMXYK	1q+	unknown
TARGET-30-PAMXYK	11q-	unknown
TARGET-30-PAMXYK	17q+	unknown
TARGET-30-PAMXYK	%tumor	
TARGET-30-PAMXYK	MKI	intermediate
TARGET-30-PAMXYU	age	185
TARGET-30-PAMXYU	age group	0-1
TARGET-30-PAMXYU	stage	stage 1
TARGET-30-PAMXYU	ATRX	unknown
TARGET-30-PAMXYU	ALK	
TARGET-30-PAMXYU	MYCN	not amplified
TARGET-30-PAMXYU	Histology	favorable
TARGET-30-PAMXYU	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMXYU	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMXYU	Protocol	ANBL00B1-P9641
TARGET-30-PAMXYU	Category	neuroblastoma
TARGET-30-PAMXYU	1p-	unknown
TARGET-30-PAMXYU	1q+	unknown
TARGET-30-PAMXYU	11q-	unknown
TARGET-30-PAMXYU	17q+	unknown
TARGET-30-PAMXYU	%tumor	
TARGET-30-PAMXYU	MKI	low
TARGET-30-PAMYCE	age	1059
TARGET-30-PAMYCE	age group	2-6
TARGET-30-PAMYCE	stage	stage 4
TARGET-30-PAMYCE	ATRX	normal
TARGET-30-PAMYCE	ALK	normal
TARGET-30-PAMYCE	MYCN	not amplified
TARGET-30-PAMYCE	Histology	unfavorable
TARGET-30-PAMYCE	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMYCE	Ploidy	diploid (di=1)
TARGET-30-PAMYCE	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PAMYCE	Category	neuroblastoma
TARGET-30-PAMYCE	1p-	normal
TARGET-30-PAMYCE	1q+	normal
TARGET-30-PAMYCE	11q-	loss
TARGET-30-PAMYCE	17q+	gain
TARGET-30-PAMYCE	%tumor	
TARGET-30-PAMYCE	MKI	intermediate
TARGET-30-PAMYCK	age	958
TARGET-30-PAMYCK	age group	2-6
TARGET-30-PAMYCK	stage	stage 4
TARGET-30-PAMYCK	ATRX	unknown
TARGET-30-PAMYCK	ALK	
TARGET-30-PAMYCK	MYCN	amplified
TARGET-30-PAMYCK	Histology	unfavorable
TARGET-30-PAMYCK	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMYCK	Ploidy	diploid (di=1)
TARGET-30-PAMYCK	Protocol	ANBL00B1-A3973-ALTE05N1
TARGET-30-PAMYCK	Category	neuroblastoma
TARGET-30-PAMYCK	1p-	unknown
TARGET-30-PAMYCK	1q+	unknown
TARGET-30-PAMYCK	11q-	unknown
TARGET-30-PAMYCK	17q+	unknown
TARGET-30-PAMYCK	%tumor	
TARGET-30-PAMYCK	MKI	low
TARGET-30-PAMYPK	age	1374
TARGET-30-PAMYPK	age group	2-6
TARGET-30-PAMYPK	stage	stage 4
TARGET-30-PAMYPK	ATRX	unknown
TARGET-30-PAMYPK	ALK	
TARGET-30-PAMYPK	MYCN	not amplified
TARGET-30-PAMYPK	Histology	unfavorable
TARGET-30-PAMYPK	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMYPK	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMYPK	Protocol	ANBL00B1-A3973
TARGET-30-PAMYPK	Category	neuroblastoma
TARGET-30-PAMYPK	1p-	unknown
TARGET-30-PAMYPK	1q+	unknown
TARGET-30-PAMYPK	11q-	unknown
TARGET-30-PAMYPK	17q+	unknown
TARGET-30-PAMYPK	%tumor	
TARGET-30-PAMYPK	MKI	low
TARGET-30-PAMYVA	age	988
TARGET-30-PAMYVA	age group	2-6
TARGET-30-PAMYVA	stage	stage 4
TARGET-30-PAMYVA	ATRX	unknown
TARGET-30-PAMYVA	ALK	
TARGET-30-PAMYVA	MYCN	not amplified
TARGET-30-PAMYVA	Histology	unfavorable
TARGET-30-PAMYVA	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMYVA	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMYVA	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PAMYVA	Category	neuroblastoma
TARGET-30-PAMYVA	1p-	unknown
TARGET-30-PAMYVA	1q+	unknown
TARGET-30-PAMYVA	11q-	unknown
TARGET-30-PAMYVA	17q+	unknown
TARGET-30-PAMYVA	%tumor	
TARGET-30-PAMYVA	MKI	low
TARGET-30-PAMYXR	age	713
TARGET-30-PAMYXR	age group	1-2
TARGET-30-PAMYXR	stage	stage 4
TARGET-30-PAMYXR	ATRX	unknown
TARGET-30-PAMYXR	ALK	
TARGET-30-PAMYXR	MYCN	amplified
TARGET-30-PAMYXR	Histology	unknown
TARGET-30-PAMYXR	Grade	unknown
TARGET-30-PAMYXR	Ploidy	diploid (di=1)
TARGET-30-PAMYXR	Protocol	ANBL00B1
TARGET-30-PAMYXR	Category	unknown
TARGET-30-PAMYXR	1p-	unknown
TARGET-30-PAMYXR	1q+	unknown
TARGET-30-PAMYXR	11q-	unknown
TARGET-30-PAMYXR	17q+	unknown
TARGET-30-PAMYXR	%tumor	
TARGET-30-PAMYXR	MKI	
TARGET-30-PAMZCE	age	847
TARGET-30-PAMZCE	age group	2-6
TARGET-30-PAMZCE	stage	stage 4
TARGET-30-PAMZCE	ATRX	unknown
TARGET-30-PAMZCE	ALK	
TARGET-30-PAMZCE	MYCN	amplified
TARGET-30-PAMZCE	Histology	unfavorable
TARGET-30-PAMZCE	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMZCE	Ploidy	diploid (di=1)
TARGET-30-PAMZCE	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PAMZCE	Category	neuroblastoma
TARGET-30-PAMZCE	1p-	unknown
TARGET-30-PAMZCE	1q+	unknown
TARGET-30-PAMZCE	11q-	unknown
TARGET-30-PAMZCE	17q+	unknown
TARGET-30-PAMZCE	%tumor	
TARGET-30-PAMZCE	MKI	high
TARGET-30-PAMZGT	age	602
TARGET-30-PAMZGT	age group	1-2
TARGET-30-PAMZGT	stage	stage 4
TARGET-30-PAMZGT	ATRX	normal
TARGET-30-PAMZGT	ALK	normal
TARGET-30-PAMZGT	MYCN	amplified
TARGET-30-PAMZGT	Histology	unknown
TARGET-30-PAMZGT	Grade	unknown
TARGET-30-PAMZGT	Ploidy	diploid (di=1)
TARGET-30-PAMZGT	Protocol	ANBL00B1-A3973
TARGET-30-PAMZGT	Category	neuroblastoma
TARGET-30-PAMZGT	1p-	loss
TARGET-30-PAMZGT	1q+	normal
TARGET-30-PAMZGT	11q-	loss
TARGET-30-PAMZGT	17q+	gain
TARGET-30-PAMZGT	%tumor	
TARGET-30-PAMZGT	MKI	
TARGET-30-PAMZMG	age	614
TARGET-30-PAMZMG	age group	1-2
TARGET-30-PAMZMG	stage	stage 4
TARGET-30-PAMZMG	ATRX	normal
TARGET-30-PAMZMG	ALK	normal
TARGET-30-PAMZMG	MYCN	amplified
TARGET-30-PAMZMG	Histology	unfavorable
TARGET-30-PAMZMG	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMZMG	Ploidy	diploid (di=1)
TARGET-30-PAMZMG	Protocol	ANBL00B1-A3973
TARGET-30-PAMZMG	Category	neuroblastoma
TARGET-30-PAMZMG	1p-	normal
TARGET-30-PAMZMG	1q+	normal
TARGET-30-PAMZMG	11q-	normal
TARGET-30-PAMZMG	17q+	gain
TARGET-30-PAMZMG	%tumor	
TARGET-30-PAMZMG	MKI	intermediate
TARGET-30-PAMZMJ	age	195
TARGET-30-PAMZMJ	age group	0-1
TARGET-30-PAMZMJ	stage	stage 1
TARGET-30-PAMZMJ	ATRX	unknown
TARGET-30-PAMZMJ	ALK	
TARGET-30-PAMZMJ	MYCN	not amplified
TARGET-30-PAMZMJ	Histology	favorable
TARGET-30-PAMZMJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMZMJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMZMJ	Protocol	ANBL00B1-P9641
TARGET-30-PAMZMJ	Category	neuroblastoma
TARGET-30-PAMZMJ	1p-	unknown
TARGET-30-PAMZMJ	1q+	unknown
TARGET-30-PAMZMJ	11q-	unknown
TARGET-30-PAMZMJ	17q+	unknown
TARGET-30-PAMZMJ	%tumor	
TARGET-30-PAMZMJ	MKI	low
TARGET-30-PAMZRP	age	120
TARGET-30-PAMZRP	age group	0-1
TARGET-30-PAMZRP	stage	stage 1
TARGET-30-PAMZRP	ATRX	unknown
TARGET-30-PAMZRP	ALK	
TARGET-30-PAMZRP	MYCN	not amplified
TARGET-30-PAMZRP	Histology	favorable
TARGET-30-PAMZRP	Grade	differentiating
TARGET-30-PAMZRP	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMZRP	Protocol	B947-ANBL00B1-P9641
TARGET-30-PAMZRP	Category	neuroblastoma
TARGET-30-PAMZRP	1p-	unknown
TARGET-30-PAMZRP	1q+	unknown
TARGET-30-PAMZRP	11q-	unknown
TARGET-30-PAMZRP	17q+	unknown
TARGET-30-PAMZRP	%tumor	
TARGET-30-PAMZRP	MKI	low
TARGET-30-PAMZSH	age	315
TARGET-30-PAMZSH	age group	0-1
TARGET-30-PAMZSH	stage	stage 1
TARGET-30-PAMZSH	ATRX	unknown
TARGET-30-PAMZSH	ALK	
TARGET-30-PAMZSH	MYCN	not amplified
TARGET-30-PAMZSH	Histology	favorable
TARGET-30-PAMZSH	Grade	differentiating
TARGET-30-PAMZSH	Ploidy	hyperdiploid (di>1)
TARGET-30-PAMZSH	Protocol	ANBL00B1-P9641
TARGET-30-PAMZSH	Category	neuroblastoma
TARGET-30-PAMZSH	1p-	unknown
TARGET-30-PAMZSH	1q+	unknown
TARGET-30-PAMZSH	11q-	unknown
TARGET-30-PAMZSH	17q+	unknown
TARGET-30-PAMZSH	%tumor	
TARGET-30-PAMZSH	MKI	low
TARGET-30-PAMZYM	age	1191
TARGET-30-PAMZYM	age group	2-6
TARGET-30-PAMZYM	stage	stage 4
TARGET-30-PAMZYM	ATRX	unknown
TARGET-30-PAMZYM	ALK	
TARGET-30-PAMZYM	MYCN	not amplified
TARGET-30-PAMZYM	Histology	unfavorable
TARGET-30-PAMZYM	Grade	undifferentiated or poorly differentiated
TARGET-30-PAMZYM	Ploidy	diploid (di=1)
TARGET-30-PAMZYM	Protocol	ANBL00B1
TARGET-30-PAMZYM	Category	neuroblastoma
TARGET-30-PAMZYM	1p-	unknown
TARGET-30-PAMZYM	1q+	unknown
TARGET-30-PAMZYM	11q-	unknown
TARGET-30-PAMZYM	17q+	unknown
TARGET-30-PAMZYM	%tumor	
TARGET-30-PAMZYM	MKI	intermediate
TARGET-30-PANAKY	age	924
TARGET-30-PANAKY	age group	2-6
TARGET-30-PANAKY	stage	stage 4
TARGET-30-PANAKY	ATRX	unknown
TARGET-30-PANAKY	ALK	
TARGET-30-PANAKY	MYCN	amplified
TARGET-30-PANAKY	Histology	unfavorable
TARGET-30-PANAKY	Grade	undifferentiated or poorly differentiated
TARGET-30-PANAKY	Ploidy	diploid (di=1)
TARGET-30-PANAKY	Protocol	ANBL00B1
TARGET-30-PANAKY	Category	neuroblastoma
TARGET-30-PANAKY	1p-	unknown
TARGET-30-PANAKY	1q+	unknown
TARGET-30-PANAKY	11q-	unknown
TARGET-30-PANAKY	17q+	unknown
TARGET-30-PANAKY	%tumor	
TARGET-30-PANAKY	MKI	intermediate
TARGET-30-PANATP	age	1631
TARGET-30-PANATP	age group	2-6
TARGET-30-PANATP	stage	stage 4
TARGET-30-PANATP	ATRX	unknown
TARGET-30-PANATP	ALK	
TARGET-30-PANATP	MYCN	not amplified
TARGET-30-PANATP	Histology	unfavorable
TARGET-30-PANATP	Grade	undifferentiated or poorly differentiated
TARGET-30-PANATP	Ploidy	diploid (di=1)
TARGET-30-PANATP	Protocol	ANBL00B1
TARGET-30-PANATP	Category	neuroblastoma
TARGET-30-PANATP	1p-	unknown
TARGET-30-PANATP	1q+	unknown
TARGET-30-PANATP	11q-	unknown
TARGET-30-PANATP	17q+	unknown
TARGET-30-PANATP	%tumor	
TARGET-30-PANATP	MKI	low
TARGET-30-PANBCI	age	753
TARGET-30-PANBCI	age group	2-6
TARGET-30-PANBCI	stage	stage 4
TARGET-30-PANBCI	ATRX	unknown
TARGET-30-PANBCI	ALK	mutated
TARGET-30-PANBCI	MYCN	amplified
TARGET-30-PANBCI	Histology	unfavorable
TARGET-30-PANBCI	Grade	undifferentiated or poorly differentiated
TARGET-30-PANBCI	Ploidy	diploid (di=1)
TARGET-30-PANBCI	Protocol	ANBL00B1-ADVL0524
TARGET-30-PANBCI	Category	neuroblastoma
TARGET-30-PANBCI	1p-	loss
TARGET-30-PANBCI	1q+	normal
TARGET-30-PANBCI	11q-	normal
TARGET-30-PANBCI	17q+	gain
TARGET-30-PANBCI	%tumor	
TARGET-30-PANBCI	MKI	high
TARGET-30-PANBJH	age	1030
TARGET-30-PANBJH	age group	2-6
TARGET-30-PANBJH	stage	stage 4
TARGET-30-PANBJH	ATRX	unknown
TARGET-30-PANBJH	ALK	
TARGET-30-PANBJH	MYCN	not amplified
TARGET-30-PANBJH	Histology	unfavorable
TARGET-30-PANBJH	Grade	undifferentiated or poorly differentiated
TARGET-30-PANBJH	Ploidy	diploid (di=1)
TARGET-30-PANBJH	Protocol	ANBL00B1-A3973-ANBL0322-ADVL0524
TARGET-30-PANBJH	Category	neuroblastoma
TARGET-30-PANBJH	1p-	unknown
TARGET-30-PANBJH	1q+	unknown
TARGET-30-PANBJH	11q-	unknown
TARGET-30-PANBJH	17q+	unknown
TARGET-30-PANBJH	%tumor	
TARGET-30-PANBJH	MKI	intermediate
TARGET-30-PANBMJ	age	993
TARGET-30-PANBMJ	age group	2-6
TARGET-30-PANBMJ	stage	stage 4
TARGET-30-PANBMJ	ATRX	normal
TARGET-30-PANBMJ	ALK	normal
TARGET-30-PANBMJ	MYCN	not amplified
TARGET-30-PANBMJ	Histology	unfavorable
TARGET-30-PANBMJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PANBMJ	Ploidy	diploid (di=1)
TARGET-30-PANBMJ	Protocol	ANBL00B1-ADVL0813-ADVL0921-ALTE05N1-P9641-A3973-ANBL0032
TARGET-30-PANBMJ	Category	ganglioneuroblastoma, nodular
TARGET-30-PANBMJ	1p-	normal
TARGET-30-PANBMJ	1q+	normal
TARGET-30-PANBMJ	11q-	normal
TARGET-30-PANBMJ	17q+	normal
TARGET-30-PANBMJ	%tumor	
TARGET-30-PANBMJ	MKI	low
TARGET-30-PANBSP	age	1064
TARGET-30-PANBSP	age group	2-6
TARGET-30-PANBSP	stage	stage 4
TARGET-30-PANBSP	ATRX	unknown
TARGET-30-PANBSP	ALK	normal
TARGET-30-PANBSP	MYCN	not amplified
TARGET-30-PANBSP	Histology	unfavorable
TARGET-30-PANBSP	Grade	undifferentiated or poorly differentiated
TARGET-30-PANBSP	Ploidy	diploid (di=1)
TARGET-30-PANBSP	Protocol	ANBL00B1-A3973
TARGET-30-PANBSP	Category	neuroblastoma
TARGET-30-PANBSP	1p-	normal
TARGET-30-PANBSP	1q+	normal
TARGET-30-PANBSP	11q-	normal
TARGET-30-PANBSP	17q+	normal
TARGET-30-PANBSP	%tumor	
TARGET-30-PANBSP	MKI	low
TARGET-30-PANCEU	age	814
TARGET-30-PANCEU	age group	2-6
TARGET-30-PANCEU	stage	stage 4
TARGET-30-PANCEU	ATRX	unknown
TARGET-30-PANCEU	ALK	
TARGET-30-PANCEU	MYCN	not amplified
TARGET-30-PANCEU	Histology	unfavorable
TARGET-30-PANCEU	Grade	undifferentiated or poorly differentiated
TARGET-30-PANCEU	Ploidy	diploid (di=1)
TARGET-30-PANCEU	Protocol	ANBL00B1-ALTE05N1-A3973-AADM01P1-ANBL0032
TARGET-30-PANCEU	Category	neuroblastoma
TARGET-30-PANCEU	1p-	unknown
TARGET-30-PANCEU	1q+	unknown
TARGET-30-PANCEU	11q-	unknown
TARGET-30-PANCEU	17q+	unknown
TARGET-30-PANCEU	%tumor	
TARGET-30-PANCEU	MKI	low
TARGET-30-PANCYF	age	1646
TARGET-30-PANCYF	age group	2-6
TARGET-30-PANCYF	stage	stage 4
TARGET-30-PANCYF	ATRX	unknown
TARGET-30-PANCYF	ALK	
TARGET-30-PANCYF	MYCN	amplified
TARGET-30-PANCYF	Histology	unfavorable
TARGET-30-PANCYF	Grade	undifferentiated or poorly differentiated
TARGET-30-PANCYF	Ploidy	diploid (di=1)
TARGET-30-PANCYF	Protocol	ANBL00B1-A3973
TARGET-30-PANCYF	Category	neuroblastoma
TARGET-30-PANCYF	1p-	unknown
TARGET-30-PANCYF	1q+	unknown
TARGET-30-PANCYF	11q-	unknown
TARGET-30-PANCYF	17q+	unknown
TARGET-30-PANCYF	%tumor	
TARGET-30-PANCYF	MKI	high
TARGET-30-PANDGA	age	666
TARGET-30-PANDGA	age group	1-2
TARGET-30-PANDGA	stage	stage 4
TARGET-30-PANDGA	ATRX	unknown
TARGET-30-PANDGA	ALK	
TARGET-30-PANDGA	MYCN	amplified
TARGET-30-PANDGA	Histology	unfavorable
TARGET-30-PANDGA	Grade	undifferentiated or poorly differentiated
TARGET-30-PANDGA	Ploidy	hyperdiploid (di>1)
TARGET-30-PANDGA	Protocol	ANBL02P1-ANBL00B1
TARGET-30-PANDGA	Category	neuroblastoma
TARGET-30-PANDGA	1p-	unknown
TARGET-30-PANDGA	1q+	unknown
TARGET-30-PANDGA	11q-	unknown
TARGET-30-PANDGA	17q+	unknown
TARGET-30-PANDGA	%tumor	
TARGET-30-PANDGA	MKI	high
TARGET-30-PANDHZ	age	1129
TARGET-30-PANDHZ	age group	2-6
TARGET-30-PANDHZ	stage	stage 4
TARGET-30-PANDHZ	ATRX	unknown
TARGET-30-PANDHZ	ALK	
TARGET-30-PANDHZ	MYCN	not amplified
TARGET-30-PANDHZ	Histology	unfavorable
TARGET-30-PANDHZ	Grade	undifferentiated or poorly differentiated
TARGET-30-PANDHZ	Ploidy	hyperdiploid (di>1)
TARGET-30-PANDHZ	Protocol	ANBL00B1-ANBL02P1
TARGET-30-PANDHZ	Category	neuroblastoma
TARGET-30-PANDHZ	1p-	unknown
TARGET-30-PANDHZ	1q+	unknown
TARGET-30-PANDHZ	11q-	unknown
TARGET-30-PANDHZ	17q+	unknown
TARGET-30-PANDHZ	%tumor	
TARGET-30-PANDHZ	MKI	low
TARGET-30-PANDVF	age	687
TARGET-30-PANDVF	age group	1-2
TARGET-30-PANDVF	stage	stage 4
TARGET-30-PANDVF	ATRX	unknown
TARGET-30-PANDVF	ALK	
TARGET-30-PANDVF	MYCN	not amplified
TARGET-30-PANDVF	Histology	unfavorable
TARGET-30-PANDVF	Grade	undifferentiated or poorly differentiated
TARGET-30-PANDVF	Ploidy	diploid (di=1)
TARGET-30-PANDVF	Protocol	ANBL00B1
TARGET-30-PANDVF	Category	neuroblastoma
TARGET-30-PANDVF	1p-	unknown
TARGET-30-PANDVF	1q+	unknown
TARGET-30-PANDVF	11q-	unknown
TARGET-30-PANDVF	17q+	unknown
TARGET-30-PANDVF	%tumor	
TARGET-30-PANDVF	MKI	high
TARGET-30-PANEYN	age	551
TARGET-30-PANEYN	age group	1-2
TARGET-30-PANEYN	stage	stage 4
TARGET-30-PANEYN	ATRX	unknown
TARGET-30-PANEYN	ALK	
TARGET-30-PANEYN	MYCN	not amplified
TARGET-30-PANEYN	Histology	unfavorable
TARGET-30-PANEYN	Grade	undifferentiated or poorly differentiated
TARGET-30-PANEYN	Ploidy	hyperdiploid (di>1)
TARGET-30-PANEYN	Protocol	ANBL00B1
TARGET-30-PANEYN	Category	neuroblastoma
TARGET-30-PANEYN	1p-	unknown
TARGET-30-PANEYN	1q+	unknown
TARGET-30-PANEYN	11q-	unknown
TARGET-30-PANEYN	17q+	unknown
TARGET-30-PANEYN	%tumor	
TARGET-30-PANEYN	MKI	low
TARGET-30-PANGTS	age	1639
TARGET-30-PANGTS	age group	2-6
TARGET-30-PANGTS	stage	stage 4
TARGET-30-PANGTS	ATRX	unknown
TARGET-30-PANGTS	ALK	
TARGET-30-PANGTS	MYCN	not amplified
TARGET-30-PANGTS	Histology	unfavorable
TARGET-30-PANGTS	Grade	undifferentiated or poorly differentiated
TARGET-30-PANGTS	Ploidy	hyperdiploid (di>1)
TARGET-30-PANGTS	Protocol	ANBL00B1-A3973
TARGET-30-PANGTS	Category	ganglioneuroblastoma, nodular
TARGET-30-PANGTS	1p-	unknown
TARGET-30-PANGTS	1q+	unknown
TARGET-30-PANGTS	11q-	unknown
TARGET-30-PANGTS	17q+	unknown
TARGET-30-PANGTS	%tumor	
TARGET-30-PANGTS	MKI	intermediate
TARGET-30-PANGXK	age	1266
TARGET-30-PANGXK	age group	2-6
TARGET-30-PANGXK	stage	stage 4
TARGET-30-PANGXK	ATRX	unknown
TARGET-30-PANGXK	ALK	
TARGET-30-PANGXK	MYCN	not amplified
TARGET-30-PANGXK	Histology	unfavorable
TARGET-30-PANGXK	Grade	undifferentiated or poorly differentiated
TARGET-30-PANGXK	Ploidy	diploid (di=1)
TARGET-30-PANGXK	Protocol	ANBL02P1-ANBL00B1-ALTE03N1
TARGET-30-PANGXK	Category	ganglioneuroblastoma, nodular
TARGET-30-PANGXK	1p-	unknown
TARGET-30-PANGXK	1q+	unknown
TARGET-30-PANGXK	11q-	unknown
TARGET-30-PANGXK	17q+	unknown
TARGET-30-PANGXK	%tumor	95.0
TARGET-30-PANGXK	MKI	low
TARGET-30-PANHUA	age	1430
TARGET-30-PANHUA	age group	2-6
TARGET-30-PANHUA	stage	stage 4
TARGET-30-PANHUA	ATRX	unknown
TARGET-30-PANHUA	ALK	
TARGET-30-PANHUA	MYCN	not amplified
TARGET-30-PANHUA	Histology	unfavorable
TARGET-30-PANHUA	Grade	undifferentiated or poorly differentiated
TARGET-30-PANHUA	Ploidy	diploid (di=1)
TARGET-30-PANHUA	Protocol	ANBL00B1
TARGET-30-PANHUA	Category	neuroblastoma
TARGET-30-PANHUA	1p-	unknown
TARGET-30-PANHUA	1q+	unknown
TARGET-30-PANHUA	11q-	unknown
TARGET-30-PANHUA	17q+	unknown
TARGET-30-PANHUA	%tumor	
TARGET-30-PANHUA	MKI	intermediate
TARGET-30-PANIPC	age	921
TARGET-30-PANIPC	age group	2-6
TARGET-30-PANIPC	stage	stage 4
TARGET-30-PANIPC	ATRX	unknown
TARGET-30-PANIPC	ALK	normal
TARGET-30-PANIPC	MYCN	amplified
TARGET-30-PANIPC	Histology	unknown
TARGET-30-PANIPC	Grade	unknown
TARGET-30-PANIPC	Ploidy	hyperdiploid (di>1)
TARGET-30-PANIPC	Protocol	ANBL00B1
TARGET-30-PANIPC	Category	neuroblastoma
TARGET-30-PANIPC	1p-	loss
TARGET-30-PANIPC	1q+	gain
TARGET-30-PANIPC	11q-	normal
TARGET-30-PANIPC	17q+	gain
TARGET-30-PANIPC	%tumor	
TARGET-30-PANIPC	MKI	
TARGET-30-PANJLH	age	1010
TARGET-30-PANJLH	age group	2-6
TARGET-30-PANJLH	stage	stage 4
TARGET-30-PANJLH	ATRX	unknown
TARGET-30-PANJLH	ALK	
TARGET-30-PANJLH	MYCN	amplified
TARGET-30-PANJLH	Histology	unfavorable
TARGET-30-PANJLH	Grade	undifferentiated or poorly differentiated
TARGET-30-PANJLH	Ploidy	diploid (di=1)
TARGET-30-PANJLH	Protocol	ANBL00B1-A3973
TARGET-30-PANJLH	Category	neuroblastoma
TARGET-30-PANJLH	1p-	unknown
TARGET-30-PANJLH	1q+	unknown
TARGET-30-PANJLH	11q-	unknown
TARGET-30-PANJLH	17q+	unknown
TARGET-30-PANJLH	%tumor	
TARGET-30-PANJLH	MKI	intermediate
TARGET-30-PANJMD	age	1536
TARGET-30-PANJMD	age group	2-6
TARGET-30-PANJMD	stage	stage 4
TARGET-30-PANJMD	ATRX	unknown
TARGET-30-PANJMD	ALK	
TARGET-30-PANJMD	MYCN	not amplified
TARGET-30-PANJMD	Histology	unfavorable
TARGET-30-PANJMD	Grade	undifferentiated or poorly differentiated
TARGET-30-PANJMD	Ploidy	hyperdiploid (di>1)
TARGET-30-PANJMD	Protocol	ANBL00B1-A3973-ANBL0321
TARGET-30-PANJMD	Category	neuroblastoma
TARGET-30-PANJMD	1p-	unknown
TARGET-30-PANJMD	1q+	unknown
TARGET-30-PANJMD	11q-	unknown
TARGET-30-PANJMD	17q+	unknown
TARGET-30-PANJMD	%tumor	
TARGET-30-PANJMD	MKI	intermediate
TARGET-30-PANKFE	age	1280
TARGET-30-PANKFE	age group	2-6
TARGET-30-PANKFE	stage	stage 4
TARGET-30-PANKFE	ATRX	normal
TARGET-30-PANKFE	ALK	normal
TARGET-30-PANKFE	MYCN	not amplified
TARGET-30-PANKFE	Histology	unfavorable
TARGET-30-PANKFE	Grade	undifferentiated or poorly differentiated
TARGET-30-PANKFE	Ploidy	diploid (di=1)
TARGET-30-PANKFE	Protocol	ANBL00B1-ACCL0331
TARGET-30-PANKFE	Category	neuroblastoma
TARGET-30-PANKFE	1p-	normal
TARGET-30-PANKFE	1q+	normal
TARGET-30-PANKFE	11q-	normal
TARGET-30-PANKFE	17q+	normal
TARGET-30-PANKFE	%tumor	90.0
TARGET-30-PANKFE	MKI	low
TARGET-30-PANLET	age	1973
TARGET-30-PANLET	age group	2-6
TARGET-30-PANLET	stage	stage 4
TARGET-30-PANLET	ATRX	deleted
TARGET-30-PANLET	ALK	normal
TARGET-30-PANLET	MYCN	not amplified
TARGET-30-PANLET	Histology	unfavorable
TARGET-30-PANLET	Grade	unknown
TARGET-30-PANLET	Ploidy	diploid (di=1)
TARGET-30-PANLET	Protocol	ANBL00B1-ANBL0421
TARGET-30-PANLET	Category	ganglioneuroblastoma, nodular
TARGET-30-PANLET	1p-	normal
TARGET-30-PANLET	1q+	normal
TARGET-30-PANLET	11q-	loss
TARGET-30-PANLET	17q+	gain
TARGET-30-PANLET	%tumor	
TARGET-30-PANLET	MKI	
TARGET-30-PANLSG	age	1073
TARGET-30-PANLSG	age group	2-6
TARGET-30-PANLSG	stage	stage 4
TARGET-30-PANLSG	ATRX	unknown
TARGET-30-PANLSG	ALK	
TARGET-30-PANLSG	MYCN	amplified
TARGET-30-PANLSG	Histology	unfavorable
TARGET-30-PANLSG	Grade	undifferentiated or poorly differentiated
TARGET-30-PANLSG	Ploidy	hyperdiploid (di>1)
TARGET-30-PANLSG	Protocol	ANBL00B1-A3973-ANBL0322
TARGET-30-PANLSG	Category	neuroblastoma
TARGET-30-PANLSG	1p-	unknown
TARGET-30-PANLSG	1q+	unknown
TARGET-30-PANLSG	11q-	unknown
TARGET-30-PANLSG	17q+	unknown
TARGET-30-PANLSG	%tumor	
TARGET-30-PANLSG	MKI	high
TARGET-30-PANLWP	age	1461
TARGET-30-PANLWP	age group	2-6
TARGET-30-PANLWP	stage	stage 4
TARGET-30-PANLWP	ATRX	unknown
TARGET-30-PANLWP	ALK	
TARGET-30-PANLWP	MYCN	not amplified
TARGET-30-PANLWP	Histology	unfavorable
TARGET-30-PANLWP	Grade	unknown
TARGET-30-PANLWP	Ploidy	hyperdiploid (di>1)
TARGET-30-PANLWP	Protocol	ANBL00B1
TARGET-30-PANLWP	Category	ganglioneuroblastoma, nodular
TARGET-30-PANLWP	1p-	unknown
TARGET-30-PANLWP	1q+	unknown
TARGET-30-PANLWP	11q-	unknown
TARGET-30-PANLWP	17q+	unknown
TARGET-30-PANLWP	%tumor	
TARGET-30-PANLWP	MKI	
TARGET-30-PANNIJ	age	1084
TARGET-30-PANNIJ	age group	2-6
TARGET-30-PANNIJ	stage	stage 4
TARGET-30-PANNIJ	ATRX	unknown
TARGET-30-PANNIJ	ALK	
TARGET-30-PANNIJ	MYCN	amplified
TARGET-30-PANNIJ	Histology	unknown
TARGET-30-PANNIJ	Grade	unknown
TARGET-30-PANNIJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PANNIJ	Protocol	ANBL00B1
TARGET-30-PANNIJ	Category	neuroblastoma
TARGET-30-PANNIJ	1p-	unknown
TARGET-30-PANNIJ	1q+	unknown
TARGET-30-PANNIJ	11q-	unknown
TARGET-30-PANNIJ	17q+	unknown
TARGET-30-PANNIJ	%tumor	
TARGET-30-PANNIJ	MKI	
TARGET-30-PANNMS	age	1080
TARGET-30-PANNMS	age group	2-6
TARGET-30-PANNMS	stage	stage 4
TARGET-30-PANNMS	ATRX	normal
TARGET-30-PANNMS	ALK	normal
TARGET-30-PANNMS	MYCN	not amplified
TARGET-30-PANNMS	Histology	unfavorable
TARGET-30-PANNMS	Grade	unknown
TARGET-30-PANNMS	Ploidy	hyperdiploid (di>1)
TARGET-30-PANNMS	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PANNMS	Category	neuroblastoma
TARGET-30-PANNMS	1p-	normal
TARGET-30-PANNMS	1q+	normal
TARGET-30-PANNMS	11q-	loss
TARGET-30-PANNMS	17q+	gain
TARGET-30-PANNMS	%tumor	
TARGET-30-PANNMS	MKI	
TARGET-30-PANPUW	age	765
TARGET-30-PANPUW	age group	2-6
TARGET-30-PANPUW	stage	stage 4
TARGET-30-PANPUW	ATRX	unknown
TARGET-30-PANPUW	ALK	
TARGET-30-PANPUW	MYCN	amplified
TARGET-30-PANPUW	Histology	unfavorable
TARGET-30-PANPUW	Grade	undifferentiated or poorly differentiated
TARGET-30-PANPUW	Ploidy	diploid (di=1)
TARGET-30-PANPUW	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PANPUW	Category	neuroblastoma
TARGET-30-PANPUW	1p-	unknown
TARGET-30-PANPUW	1q+	unknown
TARGET-30-PANPUW	11q-	unknown
TARGET-30-PANPUW	17q+	unknown
TARGET-30-PANPUW	%tumor	
TARGET-30-PANPUW	MKI	intermediate
TARGET-30-PANPVI	age	1289
TARGET-30-PANPVI	age group	2-6
TARGET-30-PANPVI	stage	stage 4
TARGET-30-PANPVI	ATRX	unknown
TARGET-30-PANPVI	ALK	normal
TARGET-30-PANPVI	MYCN	not amplified
TARGET-30-PANPVI	Histology	unfavorable
TARGET-30-PANPVI	Grade	differentiating
TARGET-30-PANPVI	Ploidy	hyperdiploid (di>1)
TARGET-30-PANPVI	Protocol	ANBL00B1-ADVL0714-A3973-ADVL0525-ANBL0621
TARGET-30-PANPVI	Category	neuroblastoma
TARGET-30-PANPVI	1p-	normal
TARGET-30-PANPVI	1q+	gain
TARGET-30-PANPVI	11q-	loss
TARGET-30-PANPVI	17q+	gain
TARGET-30-PANPVI	%tumor	
TARGET-30-PANPVI	MKI	intermediate
TARGET-30-PANRHJ	age	1117
TARGET-30-PANRHJ	age group	2-6
TARGET-30-PANRHJ	stage	stage 4
TARGET-30-PANRHJ	ATRX	normal
TARGET-30-PANRHJ	ALK	normal
TARGET-30-PANRHJ	MYCN	not amplified
TARGET-30-PANRHJ	Histology	unfavorable
TARGET-30-PANRHJ	Grade	unknown
TARGET-30-PANRHJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PANRHJ	Protocol	ANBL00B1
TARGET-30-PANRHJ	Category	neuroblastoma
TARGET-30-PANRHJ	1p-	normal
TARGET-30-PANRHJ	1q+	normal
TARGET-30-PANRHJ	11q-	normal
TARGET-30-PANRHJ	17q+	gain
TARGET-30-PANRHJ	%tumor	
TARGET-30-PANRHJ	MKI	
TARGET-30-PANRRN	age	848
TARGET-30-PANRRN	age group	2-6
TARGET-30-PANRRN	stage	stage 4
TARGET-30-PANRRN	ATRX	unknown
TARGET-30-PANRRN	ALK	
TARGET-30-PANRRN	MYCN	not amplified
TARGET-30-PANRRN	Histology	unfavorable
TARGET-30-PANRRN	Grade	undifferentiated or poorly differentiated
TARGET-30-PANRRN	Ploidy	hyperdiploid (di>1)
TARGET-30-PANRRN	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PANRRN	Category	neuroblastoma
TARGET-30-PANRRN	1p-	unknown
TARGET-30-PANRRN	1q+	unknown
TARGET-30-PANRRN	11q-	unknown
TARGET-30-PANRRN	17q+	unknown
TARGET-30-PANRRN	%tumor	
TARGET-30-PANRRN	MKI	intermediate
TARGET-30-PANRRW	age	1730
TARGET-30-PANRRW	age group	2-6
TARGET-30-PANRRW	stage	stage 4
TARGET-30-PANRRW	ATRX	unknown
TARGET-30-PANRRW	ALK	normal
TARGET-30-PANRRW	MYCN	not amplified
TARGET-30-PANRRW	Histology	unfavorable
TARGET-30-PANRRW	Grade	unknown
TARGET-30-PANRRW	Ploidy	diploid (di=1)
TARGET-30-PANRRW	Protocol	ANBL00B1-ANBL0322-A3973-ANBL0032
TARGET-30-PANRRW	Category	neuroblastoma
TARGET-30-PANRRW	1p-	normal
TARGET-30-PANRRW	1q+	normal
TARGET-30-PANRRW	11q-	loss
TARGET-30-PANRRW	17q+	gain
TARGET-30-PANRRW	%tumor	
TARGET-30-PANRRW	MKI	
TARGET-30-PANRVJ	age	4781
TARGET-30-PANRVJ	age group	9-
TARGET-30-PANRVJ	stage	stage 4
TARGET-30-PANRVJ	ATRX	nonsense
TARGET-30-PANRVJ	ALK	mutated
TARGET-30-PANRVJ	MYCN	not amplified
TARGET-30-PANRVJ	Histology	unfavorable
TARGET-30-PANRVJ	Grade	differentiating
TARGET-30-PANRVJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PANRVJ	Protocol	ANBL00B1-ALTE03N1-ANBL0032
TARGET-30-PANRVJ	Category	neuroblastoma
TARGET-30-PANRVJ	1p-	loss
TARGET-30-PANRVJ	1q+	normal
TARGET-30-PANRVJ	11q-	loss
TARGET-30-PANRVJ	17q+	gain
TARGET-30-PANRVJ	%tumor	
TARGET-30-PANRVJ	MKI	intermediate
TARGET-30-PANSBN	age	2329
TARGET-30-PANSBN	age group	6-9
TARGET-30-PANSBN	stage	stage 4
TARGET-30-PANSBN	ATRX	normal
TARGET-30-PANSBN	ALK	normal
TARGET-30-PANSBN	MYCN	not amplified
TARGET-30-PANSBN	Histology	unfavorable
TARGET-30-PANSBN	Grade	differentiating
TARGET-30-PANSBN	Ploidy	diploid (di=1)
TARGET-30-PANSBN	Protocol	ANBL00B1
TARGET-30-PANSBN	Category	ganglioneuroblastoma, nodular
TARGET-30-PANSBN	1p-	normal
TARGET-30-PANSBN	1q+	normal
TARGET-30-PANSBN	11q-	normal
TARGET-30-PANSBN	17q+	normal
TARGET-30-PANSBN	%tumor	
TARGET-30-PANSBN	MKI	high
TARGET-30-PANUIF	age	2234
TARGET-30-PANUIF	age group	6-9
TARGET-30-PANUIF	stage	stage 4
TARGET-30-PANUIF	ATRX	unknown
TARGET-30-PANUIF	ALK	normal
TARGET-30-PANUIF	MYCN	not amplified
TARGET-30-PANUIF	Histology	unfavorable
TARGET-30-PANUIF	Grade	undifferentiated or poorly differentiated
TARGET-30-PANUIF	Ploidy	diploid (di=1)
TARGET-30-PANUIF	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PANUIF	Category	neuroblastoma
TARGET-30-PANUIF	1p-	normal
TARGET-30-PANUIF	1q+	normal
TARGET-30-PANUIF	11q-	loss
TARGET-30-PANUIF	17q+	gain
TARGET-30-PANUIF	%tumor	
TARGET-30-PANUIF	MKI	low
TARGET-30-PANUKV	age	1486
TARGET-30-PANUKV	age group	2-6
TARGET-30-PANUKV	stage	stage 4
TARGET-30-PANUKV	ATRX	normal
TARGET-30-PANUKV	ALK	normal
TARGET-30-PANUKV	MYCN	amplified
TARGET-30-PANUKV	Histology	unfavorable
TARGET-30-PANUKV	Grade	undifferentiated or poorly differentiated
TARGET-30-PANUKV	Ploidy	diploid (di=1)
TARGET-30-PANUKV	Protocol	ANBL00B1-A3973
TARGET-30-PANUKV	Category	neuroblastoma
TARGET-30-PANUKV	1p-	loss
TARGET-30-PANUKV	1q+	gain
TARGET-30-PANUKV	11q-	normal
TARGET-30-PANUKV	17q+	gain
TARGET-30-PANUKV	%tumor	
TARGET-30-PANUKV	MKI	intermediate
TARGET-30-PANUVK	age	1031
TARGET-30-PANUVK	age group	2-6
TARGET-30-PANUVK	stage	stage 4
TARGET-30-PANUVK	ATRX	unknown
TARGET-30-PANUVK	ALK	
TARGET-30-PANUVK	MYCN	not amplified
TARGET-30-PANUVK	Histology	unfavorable
TARGET-30-PANUVK	Grade	unknown
TARGET-30-PANUVK	Ploidy	hyperdiploid (di>1)
TARGET-30-PANUVK	Protocol	ANBL00B1
TARGET-30-PANUVK	Category	neuroblastoma
TARGET-30-PANUVK	1p-	unknown
TARGET-30-PANUVK	1q+	unknown
TARGET-30-PANUVK	11q-	unknown
TARGET-30-PANUVK	17q+	unknown
TARGET-30-PANUVK	%tumor	
TARGET-30-PANUVK	MKI	
TARGET-30-PANVAN	age	1518
TARGET-30-PANVAN	age group	2-6
TARGET-30-PANVAN	stage	stage 4
TARGET-30-PANVAN	ATRX	unknown
TARGET-30-PANVAN	ALK	
TARGET-30-PANVAN	MYCN	amplified
TARGET-30-PANVAN	Histology	unfavorable
TARGET-30-PANVAN	Grade	undifferentiated or poorly differentiated
TARGET-30-PANVAN	Ploidy	hyperdiploid (di>1)
TARGET-30-PANVAN	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PANVAN	Category	neuroblastoma
TARGET-30-PANVAN	1p-	unknown
TARGET-30-PANVAN	1q+	unknown
TARGET-30-PANVAN	11q-	unknown
TARGET-30-PANVAN	17q+	unknown
TARGET-30-PANVAN	%tumor	
TARGET-30-PANVAN	MKI	high
TARGET-30-PANVWD	age	749
TARGET-30-PANVWD	age group	2-6
TARGET-30-PANVWD	stage	stage 4
TARGET-30-PANVWD	ATRX	unknown
TARGET-30-PANVWD	ALK	
TARGET-30-PANVWD	MYCN	not amplified
TARGET-30-PANVWD	Histology	unfavorable
TARGET-30-PANVWD	Grade	differentiating
TARGET-30-PANVWD	Ploidy	hyperdiploid (di>1)
TARGET-30-PANVWD	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PANVWD	Category	ganglioneuroblastoma, nodular
TARGET-30-PANVWD	1p-	unknown
TARGET-30-PANVWD	1q+	unknown
TARGET-30-PANVWD	11q-	unknown
TARGET-30-PANVWD	17q+	unknown
TARGET-30-PANVWD	%tumor	
TARGET-30-PANVWD	MKI	low
TARGET-30-PANWAT	age	1128
TARGET-30-PANWAT	age group	2-6
TARGET-30-PANWAT	stage	stage 4
TARGET-30-PANWAT	ATRX	unknown
TARGET-30-PANWAT	ALK	
TARGET-30-PANWAT	MYCN	not amplified
TARGET-30-PANWAT	Histology	unfavorable
TARGET-30-PANWAT	Grade	unknown
TARGET-30-PANWAT	Ploidy	hyperdiploid (di>1)
TARGET-30-PANWAT	Protocol	ANBL00B1-A3973
TARGET-30-PANWAT	Category	neuroblastoma
TARGET-30-PANWAT	1p-	unknown
TARGET-30-PANWAT	1q+	unknown
TARGET-30-PANWAT	11q-	unknown
TARGET-30-PANWAT	17q+	unknown
TARGET-30-PANWAT	%tumor	
TARGET-30-PANWAT	MKI	
TARGET-30-PANWBG	age	948
TARGET-30-PANWBG	age group	2-6
TARGET-30-PANWBG	stage	stage 4
TARGET-30-PANWBG	ATRX	unknown
TARGET-30-PANWBG	ALK	
TARGET-30-PANWBG	MYCN	amplified
TARGET-30-PANWBG	Histology	unfavorable
TARGET-30-PANWBG	Grade	unknown
TARGET-30-PANWBG	Ploidy	hyperdiploid (di>1)
TARGET-30-PANWBG	Protocol	ANBL00B1
TARGET-30-PANWBG	Category	neuroblastoma
TARGET-30-PANWBG	1p-	unknown
TARGET-30-PANWBG	1q+	unknown
TARGET-30-PANWBG	11q-	unknown
TARGET-30-PANWBG	17q+	unknown
TARGET-30-PANWBG	%tumor	
TARGET-30-PANWBG	MKI	
TARGET-30-PANWRR	age	2937
TARGET-30-PANWRR	age group	6-9
TARGET-30-PANWRR	stage	stage 4
TARGET-30-PANWRR	ATRX	normal
TARGET-30-PANWRR	ALK	mutated
TARGET-30-PANWRR	MYCN	not amplified
TARGET-30-PANWRR	Histology	unfavorable
TARGET-30-PANWRR	Grade	differentiating
TARGET-30-PANWRR	Ploidy	diploid (di=1)
TARGET-30-PANWRR	Protocol	ANBL00B1-A3973
TARGET-30-PANWRR	Category	neuroblastoma
TARGET-30-PANWRR	1p-	normal
TARGET-30-PANWRR	1q+	normal
TARGET-30-PANWRR	11q-	normal
TARGET-30-PANWRR	17q+	normal
TARGET-30-PANWRR	%tumor	
TARGET-30-PANWRR	MKI	low
TARGET-30-PANXFT	age	1706
TARGET-30-PANXFT	age group	2-6
TARGET-30-PANXFT	stage	stage 4
TARGET-30-PANXFT	ATRX	unknown
TARGET-30-PANXFT	ALK	
TARGET-30-PANXFT	MYCN	not amplified
TARGET-30-PANXFT	Histology	unfavorable
TARGET-30-PANXFT	Grade	differentiating
TARGET-30-PANXFT	Ploidy	hyperdiploid (di>1)
TARGET-30-PANXFT	Protocol	ANBL00B1-A3973
TARGET-30-PANXFT	Category	ganglioneuroblastoma, nodular
TARGET-30-PANXFT	1p-	unknown
TARGET-30-PANXFT	1q+	unknown
TARGET-30-PANXFT	11q-	unknown
TARGET-30-PANXFT	17q+	unknown
TARGET-30-PANXFT	%tumor	
TARGET-30-PANXFT	MKI	intermediate
TARGET-30-PANXJL	age	5734
TARGET-30-PANXJL	age group	9-
TARGET-30-PANXJL	stage	stage 4
TARGET-30-PANXJL	ATRX	deleted
TARGET-30-PANXJL	ALK	mutated
TARGET-30-PANXJL	MYCN	not amplified
TARGET-30-PANXJL	Histology	unfavorable
TARGET-30-PANXJL	Grade	undifferentiated or poorly differentiated
TARGET-30-PANXJL	Ploidy	hyperdiploid (di>1)
TARGET-30-PANXJL	Protocol	ANBL00B1
TARGET-30-PANXJL	Category	ganglioneuroblastoma, nodular
TARGET-30-PANXJL	1p-	normal
TARGET-30-PANXJL	1q+	normal
TARGET-30-PANXJL	11q-	loss
TARGET-30-PANXJL	17q+	gain
TARGET-30-PANXJL	%tumor	
TARGET-30-PANXJL	MKI	low
TARGET-30-PANYBL	age	1216
TARGET-30-PANYBL	age group	2-6
TARGET-30-PANYBL	stage	stage 4
TARGET-30-PANYBL	ATRX	unknown
TARGET-30-PANYBL	ALK	normal
TARGET-30-PANYBL	MYCN	not amplified
TARGET-30-PANYBL	Histology	unknown
TARGET-30-PANYBL	Grade	unknown
TARGET-30-PANYBL	Ploidy	hyperdiploid (di>1)
TARGET-30-PANYBL	Protocol	ANBL00B1-AADM01P1
TARGET-30-PANYBL	Category	unknown
TARGET-30-PANYBL	1p-	loss
TARGET-30-PANYBL	1q+	normal
TARGET-30-PANYBL	11q-	normal
TARGET-30-PANYBL	17q+	gain
TARGET-30-PANYBL	%tumor	
TARGET-30-PANYBL	MKI	
TARGET-30-PANYGR	age	993
TARGET-30-PANYGR	age group	2-6
TARGET-30-PANYGR	stage	stage 4
TARGET-30-PANYGR	ATRX	normal
TARGET-30-PANYGR	ALK	mutated
TARGET-30-PANYGR	MYCN	not amplified
TARGET-30-PANYGR	Histology	unfavorable
TARGET-30-PANYGR	Grade	undifferentiated or poorly differentiated
TARGET-30-PANYGR	Ploidy	diploid (di=1)
TARGET-30-PANYGR	Protocol	ANBL00B1
TARGET-30-PANYGR	Category	neuroblastoma
TARGET-30-PANYGR	1p-	normal
TARGET-30-PANYGR	1q+	normal
TARGET-30-PANYGR	11q-	loss
TARGET-30-PANYGR	17q+	gain
TARGET-30-PANYGR	%tumor	
TARGET-30-PANYGR	MKI	
TARGET-30-PANYUG	age	614
TARGET-30-PANYUG	age group	1-2
TARGET-30-PANYUG	stage	stage 4
TARGET-30-PANYUG	ATRX	unknown
TARGET-30-PANYUG	ALK	
TARGET-30-PANYUG	MYCN	not amplified
TARGET-30-PANYUG	Histology	unfavorable
TARGET-30-PANYUG	Grade	undifferentiated or poorly differentiated
TARGET-30-PANYUG	Ploidy	hyperdiploid (di>1)
TARGET-30-PANYUG	Protocol	ANBL00B1-A3973-AADM01P1
TARGET-30-PANYUG	Category	neuroblastoma
TARGET-30-PANYUG	1p-	unknown
TARGET-30-PANYUG	1q+	unknown
TARGET-30-PANYUG	11q-	unknown
TARGET-30-PANYUG	17q+	unknown
TARGET-30-PANYUG	%tumor	
TARGET-30-PANYUG	MKI	intermediate
TARGET-30-PANZHT	age	1454
TARGET-30-PANZHT	age group	2-6
TARGET-30-PANZHT	stage	stage 4
TARGET-30-PANZHT	ATRX	unknown
TARGET-30-PANZHT	ALK	
TARGET-30-PANZHT	MYCN	not amplified
TARGET-30-PANZHT	Histology	unfavorable
TARGET-30-PANZHT	Grade	undifferentiated or poorly differentiated
TARGET-30-PANZHT	Ploidy	hyperdiploid (di>1)
TARGET-30-PANZHT	Protocol	ANBL00B1-A3973-ADVL0921
TARGET-30-PANZHT	Category	neuroblastoma
TARGET-30-PANZHT	1p-	unknown
TARGET-30-PANZHT	1q+	unknown
TARGET-30-PANZHT	11q-	unknown
TARGET-30-PANZHT	17q+	unknown
TARGET-30-PANZHT	%tumor	
TARGET-30-PANZHT	MKI	intermediate
TARGET-30-PANZPV	age	1757
TARGET-30-PANZPV	age group	2-6
TARGET-30-PANZPV	stage	stage 4
TARGET-30-PANZPV	ATRX	unknown
TARGET-30-PANZPV	ALK	normal
TARGET-30-PANZPV	MYCN	not amplified
TARGET-30-PANZPV	Histology	unfavorable
TARGET-30-PANZPV	Grade	unknown
TARGET-30-PANZPV	Ploidy	diploid (di=1)
TARGET-30-PANZPV	Protocol	ANBL00B1
TARGET-30-PANZPV	Category	neuroblastoma
TARGET-30-PANZPV	1p-	normal
TARGET-30-PANZPV	1q+	normal
TARGET-30-PANZPV	11q-	normal
TARGET-30-PANZPV	17q+	normal
TARGET-30-PANZPV	%tumor	
TARGET-30-PANZPV	MKI	
TARGET-30-PANZRV	age	72
TARGET-30-PANZRV	age group	0-1
TARGET-30-PANZRV	stage	stage 4s
TARGET-30-PANZRV	ATRX	unknown
TARGET-30-PANZRV	ALK	
TARGET-30-PANZRV	MYCN	not amplified
TARGET-30-PANZRV	Histology	favorable
TARGET-30-PANZRV	Grade	undifferentiated or poorly differentiated
TARGET-30-PANZRV	Ploidy	hyperdiploid (di>1)
TARGET-30-PANZRV	Protocol	ANBL00B1
TARGET-30-PANZRV	Category	neuroblastoma
TARGET-30-PANZRV	1p-	unknown
TARGET-30-PANZRV	1q+	unknown
TARGET-30-PANZRV	11q-	unknown
TARGET-30-PANZRV	17q+	unknown
TARGET-30-PANZRV	%tumor	
TARGET-30-PANZRV	MKI	intermediate
TARGET-30-PANZVU	age	1713
TARGET-30-PANZVU	age group	2-6
TARGET-30-PANZVU	stage	stage 4
TARGET-30-PANZVU	ATRX	deleted
TARGET-30-PANZVU	ALK	mutated
TARGET-30-PANZVU	MYCN	not amplified
TARGET-30-PANZVU	Histology	unfavorable
TARGET-30-PANZVU	Grade	unknown
TARGET-30-PANZVU	Ploidy	hyperdiploid (di>1)
TARGET-30-PANZVU	Protocol	ANBL00B1-A3973
TARGET-30-PANZVU	Category	neuroblastoma
TARGET-30-PANZVU	1p-	normal
TARGET-30-PANZVU	1q+	normal
TARGET-30-PANZVU	11q-	loss
TARGET-30-PANZVU	17q+	gain
TARGET-30-PANZVU	%tumor	
TARGET-30-PANZVU	MKI	
TARGET-30-PAPAKS	age	677
TARGET-30-PAPAKS	age group	1-2
TARGET-30-PAPAKS	stage	stage 4
TARGET-30-PAPAKS	ATRX	unknown
TARGET-30-PAPAKS	ALK	
TARGET-30-PAPAKS	MYCN	amplified
TARGET-30-PAPAKS	Histology	unfavorable
TARGET-30-PAPAKS	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPAKS	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPAKS	Protocol	ANBL00B1
TARGET-30-PAPAKS	Category	neuroblastoma
TARGET-30-PAPAKS	1p-	unknown
TARGET-30-PAPAKS	1q+	unknown
TARGET-30-PAPAKS	11q-	unknown
TARGET-30-PAPAKS	17q+	unknown
TARGET-30-PAPAKS	%tumor	
TARGET-30-PAPAKS	MKI	low
TARGET-30-PAPBFP	age	1800
TARGET-30-PAPBFP	age group	2-6
TARGET-30-PAPBFP	stage	stage 4
TARGET-30-PAPBFP	ATRX	unknown
TARGET-30-PAPBFP	ALK	
TARGET-30-PAPBFP	MYCN	not amplified
TARGET-30-PAPBFP	Histology	unfavorable
TARGET-30-PAPBFP	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPBFP	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPBFP	Protocol	ANBL00B1-AADM01P1-ANBL0621
TARGET-30-PAPBFP	Category	neuroblastoma
TARGET-30-PAPBFP	1p-	unknown
TARGET-30-PAPBFP	1q+	unknown
TARGET-30-PAPBFP	11q-	unknown
TARGET-30-PAPBFP	17q+	unknown
TARGET-30-PAPBFP	%tumor	
TARGET-30-PAPBFP	MKI	low
TARGET-30-PAPBGH	age	1074
TARGET-30-PAPBGH	age group	2-6
TARGET-30-PAPBGH	stage	stage 4
TARGET-30-PAPBGH	ATRX	normal
TARGET-30-PAPBGH	ALK	normal
TARGET-30-PAPBGH	MYCN	not amplified
TARGET-30-PAPBGH	Histology	unfavorable
TARGET-30-PAPBGH	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPBGH	Ploidy	diploid (di=1)
TARGET-30-PAPBGH	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PAPBGH	Category	neuroblastoma
TARGET-30-PAPBGH	1p-	loss
TARGET-30-PAPBGH	1q+	gain
TARGET-30-PAPBGH	11q-	normal
TARGET-30-PAPBGH	17q+	normal
TARGET-30-PAPBGH	%tumor	
TARGET-30-PAPBGH	MKI	
TARGET-30-PAPBJE	age	1860
TARGET-30-PAPBJE	age group	2-6
TARGET-30-PAPBJE	stage	stage 4
TARGET-30-PAPBJE	ATRX	normal
TARGET-30-PAPBJE	ALK	normal
TARGET-30-PAPBJE	MYCN	amplified
TARGET-30-PAPBJE	Histology	unfavorable
TARGET-30-PAPBJE	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPBJE	Ploidy	diploid (di=1)
TARGET-30-PAPBJE	Protocol	ANBL00B1-A3973-AADM01P1-ALTE05N1
TARGET-30-PAPBJE	Category	neuroblastoma
TARGET-30-PAPBJE	1p-	loss
TARGET-30-PAPBJE	1q+	normal
TARGET-30-PAPBJE	11q-	normal
TARGET-30-PAPBJE	17q+	gain
TARGET-30-PAPBJE	%tumor	
TARGET-30-PAPBJE	MKI	high
TARGET-30-PAPBJT	age	570
TARGET-30-PAPBJT	age group	1-2
TARGET-30-PAPBJT	stage	stage 4
TARGET-30-PAPBJT	ATRX	unknown
TARGET-30-PAPBJT	ALK	normal
TARGET-30-PAPBJT	MYCN	not amplified
TARGET-30-PAPBJT	Histology	unknown
TARGET-30-PAPBJT	Grade	unknown
TARGET-30-PAPBJT	Ploidy	diploid (di=1)
TARGET-30-PAPBJT	Protocol	ANBL00B1
TARGET-30-PAPBJT	Category	neuroblastoma
TARGET-30-PAPBJT	1p-	normal
TARGET-30-PAPBJT	1q+	normal
TARGET-30-PAPBJT	11q-	normal
TARGET-30-PAPBJT	17q+	normal
TARGET-30-PAPBJT	%tumor	
TARGET-30-PAPBJT	MKI	
TARGET-30-PAPBWW	age	888
TARGET-30-PAPBWW	age group	2-6
TARGET-30-PAPBWW	stage	stage 4
TARGET-30-PAPBWW	ATRX	unknown
TARGET-30-PAPBWW	ALK	
TARGET-30-PAPBWW	MYCN	not amplified
TARGET-30-PAPBWW	Histology	unfavorable
TARGET-30-PAPBWW	Grade	unknown
TARGET-30-PAPBWW	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPBWW	Protocol	ANBL00B1
TARGET-30-PAPBWW	Category	neuroblastoma
TARGET-30-PAPBWW	1p-	unknown
TARGET-30-PAPBWW	1q+	unknown
TARGET-30-PAPBWW	11q-	unknown
TARGET-30-PAPBWW	17q+	unknown
TARGET-30-PAPBWW	%tumor	
TARGET-30-PAPBWW	MKI	
TARGET-30-PAPBZI	age	1710
TARGET-30-PAPBZI	age group	2-6
TARGET-30-PAPBZI	stage	stage 4
TARGET-30-PAPBZI	ATRX	normal
TARGET-30-PAPBZI	ALK	normal
TARGET-30-PAPBZI	MYCN	not amplified
TARGET-30-PAPBZI	Histology	unfavorable
TARGET-30-PAPBZI	Grade	unknown
TARGET-30-PAPBZI	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPBZI	Protocol	ANBL00B1-A3973
TARGET-30-PAPBZI	Category	neuroblastoma
TARGET-30-PAPBZI	1p-	normal
TARGET-30-PAPBZI	1q+	gain
TARGET-30-PAPBZI	11q-	loss
TARGET-30-PAPBZI	17q+	gain
TARGET-30-PAPBZI	%tumor	
TARGET-30-PAPBZI	MKI	
TARGET-30-PAPCSJ	age	1430
TARGET-30-PAPCSJ	age group	2-6
TARGET-30-PAPCSJ	stage	stage 4
TARGET-30-PAPCSJ	ATRX	unknown
TARGET-30-PAPCSJ	ALK	
TARGET-30-PAPCSJ	MYCN	not amplified
TARGET-30-PAPCSJ	Histology	unfavorable
TARGET-30-PAPCSJ	Grade	unknown
TARGET-30-PAPCSJ	Ploidy	diploid (di=1)
TARGET-30-PAPCSJ	Protocol	ANBL00B1-A3973
TARGET-30-PAPCSJ	Category	ganglioneuroblastoma, nodular
TARGET-30-PAPCSJ	1p-	unknown
TARGET-30-PAPCSJ	1q+	unknown
TARGET-30-PAPCSJ	11q-	unknown
TARGET-30-PAPCSJ	17q+	unknown
TARGET-30-PAPCSJ	%tumor	
TARGET-30-PAPCSJ	MKI	
TARGET-30-PAPCTS	age	2008
TARGET-30-PAPCTS	age group	2-6
TARGET-30-PAPCTS	stage	stage 4
TARGET-30-PAPCTS	ATRX	normal
TARGET-30-PAPCTS	ALK	normal
TARGET-30-PAPCTS	MYCN	amplified
TARGET-30-PAPCTS	Histology	unfavorable
TARGET-30-PAPCTS	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPCTS	Ploidy	diploid (di=1)
TARGET-30-PAPCTS	Protocol	ANBL00B1
TARGET-30-PAPCTS	Category	neuroblastoma
TARGET-30-PAPCTS	1p-	loss
TARGET-30-PAPCTS	1q+	normal
TARGET-30-PAPCTS	11q-	normal
TARGET-30-PAPCTS	17q+	gain
TARGET-30-PAPCTS	%tumor	
TARGET-30-PAPCTS	MKI	
TARGET-30-PAPDIM	age	1455
TARGET-30-PAPDIM	age group	2-6
TARGET-30-PAPDIM	stage	stage 4
TARGET-30-PAPDIM	ATRX	unknown
TARGET-30-PAPDIM	ALK	
TARGET-30-PAPDIM	MYCN	not amplified
TARGET-30-PAPDIM	Histology	unfavorable
TARGET-30-PAPDIM	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPDIM	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPDIM	Protocol	ANBL00B1-ANBL0322-ANBL0621
TARGET-30-PAPDIM	Category	neuroblastoma
TARGET-30-PAPDIM	1p-	unknown
TARGET-30-PAPDIM	1q+	unknown
TARGET-30-PAPDIM	11q-	unknown
TARGET-30-PAPDIM	17q+	unknown
TARGET-30-PAPDIM	%tumor	
TARGET-30-PAPDIM	MKI	low
TARGET-30-PAPDNP	age	1466
TARGET-30-PAPDNP	age group	2-6
TARGET-30-PAPDNP	stage	stage 4
TARGET-30-PAPDNP	ATRX	unknown
TARGET-30-PAPDNP	ALK	
TARGET-30-PAPDNP	MYCN	not amplified
TARGET-30-PAPDNP	Histology	unfavorable
TARGET-30-PAPDNP	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPDNP	Ploidy	diploid (di=1)
TARGET-30-PAPDNP	Protocol	ANBL00B1-A3973
TARGET-30-PAPDNP	Category	ganglioneuroblastoma, nodular
TARGET-30-PAPDNP	1p-	unknown
TARGET-30-PAPDNP	1q+	unknown
TARGET-30-PAPDNP	11q-	unknown
TARGET-30-PAPDNP	17q+	unknown
TARGET-30-PAPDNP	%tumor	
TARGET-30-PAPDNP	MKI	low
TARGET-30-PAPEAV	age	696
TARGET-30-PAPEAV	age group	1-2
TARGET-30-PAPEAV	stage	stage 4
TARGET-30-PAPEAV	ATRX	nonsense
TARGET-30-PAPEAV	ALK	
TARGET-30-PAPEAV	MYCN	not amplified
TARGET-30-PAPEAV	Histology	unfavorable
TARGET-30-PAPEAV	Grade	differentiating
TARGET-30-PAPEAV	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPEAV	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PAPEAV	Category	neuroblastoma
TARGET-30-PAPEAV	1p-	unknown
TARGET-30-PAPEAV	1q+	unknown
TARGET-30-PAPEAV	11q-	unknown
TARGET-30-PAPEAV	17q+	unknown
TARGET-30-PAPEAV	%tumor	
TARGET-30-PAPEAV	MKI	low
TARGET-30-PAPEFE	age	990
TARGET-30-PAPEFE	age group	2-6
TARGET-30-PAPEFE	stage	stage 4
TARGET-30-PAPEFE	ATRX	normal
TARGET-30-PAPEFE	ALK	normal
TARGET-30-PAPEFE	MYCN	amplified
TARGET-30-PAPEFE	Histology	unfavorable
TARGET-30-PAPEFE	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPEFE	Ploidy	diploid (di=1)
TARGET-30-PAPEFE	Protocol	ANBL00B1-A3973
TARGET-30-PAPEFE	Category	neuroblastoma
TARGET-30-PAPEFE	1p-	normal
TARGET-30-PAPEFE	1q+	normal
TARGET-30-PAPEFE	11q-	normal
TARGET-30-PAPEFE	17q+	gain
TARGET-30-PAPEFE	%tumor	
TARGET-30-PAPEFE	MKI	intermediate
TARGET-30-PAPEJW	age	757
TARGET-30-PAPEJW	age group	2-6
TARGET-30-PAPEJW	stage	stage 4
TARGET-30-PAPEJW	ATRX	unknown
TARGET-30-PAPEJW	ALK	
TARGET-30-PAPEJW	MYCN	amplified
TARGET-30-PAPEJW	Histology	unfavorable
TARGET-30-PAPEJW	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPEJW	Ploidy	diploid (di=1)
TARGET-30-PAPEJW	Protocol	ANBL00B1-A3973
TARGET-30-PAPEJW	Category	neuroblastoma
TARGET-30-PAPEJW	1p-	unknown
TARGET-30-PAPEJW	1q+	unknown
TARGET-30-PAPEJW	11q-	unknown
TARGET-30-PAPEJW	17q+	unknown
TARGET-30-PAPEJW	%tumor	
TARGET-30-PAPEJW	MKI	intermediate
TARGET-30-PAPEVV	age	1050
TARGET-30-PAPEVV	age group	2-6
TARGET-30-PAPEVV	stage	stage 4
TARGET-30-PAPEVV	ATRX	unknown
TARGET-30-PAPEVV	ALK	
TARGET-30-PAPEVV	MYCN	amplified
TARGET-30-PAPEVV	Histology	unfavorable
TARGET-30-PAPEVV	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPEVV	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPEVV	Protocol	ANBL00B1-A3973-ANBL0032
TARGET-30-PAPEVV	Category	neuroblastoma
TARGET-30-PAPEVV	1p-	unknown
TARGET-30-PAPEVV	1q+	unknown
TARGET-30-PAPEVV	11q-	unknown
TARGET-30-PAPEVV	17q+	unknown
TARGET-30-PAPEVV	%tumor	
TARGET-30-PAPEVV	MKI	high
TARGET-30-PAPGJR	age	611
TARGET-30-PAPGJR	age group	1-2
TARGET-30-PAPGJR	stage	stage 4
TARGET-30-PAPGJR	ATRX	unknown
TARGET-30-PAPGJR	ALK	
TARGET-30-PAPGJR	MYCN	amplified
TARGET-30-PAPGJR	Histology	unfavorable
TARGET-30-PAPGJR	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPGJR	Ploidy	diploid (di=1)
TARGET-30-PAPGJR	Protocol	ANBL00B1-A3973
TARGET-30-PAPGJR	Category	neuroblastoma
TARGET-30-PAPGJR	1p-	unknown
TARGET-30-PAPGJR	1q+	unknown
TARGET-30-PAPGJR	11q-	unknown
TARGET-30-PAPGJR	17q+	unknown
TARGET-30-PAPGJR	%tumor	
TARGET-30-PAPGJR	MKI	intermediate
TARGET-30-PAPHGF	age	890
TARGET-30-PAPHGF	age group	2-6
TARGET-30-PAPHGF	stage	stage 4
TARGET-30-PAPHGF	ATRX	unknown
TARGET-30-PAPHGF	ALK	
TARGET-30-PAPHGF	MYCN	amplified
TARGET-30-PAPHGF	Histology	unfavorable
TARGET-30-PAPHGF	Grade	unknown
TARGET-30-PAPHGF	Ploidy	diploid (di=1)
TARGET-30-PAPHGF	Protocol	ANBL00B1
TARGET-30-PAPHGF	Category	neuroblastoma
TARGET-30-PAPHGF	1p-	unknown
TARGET-30-PAPHGF	1q+	unknown
TARGET-30-PAPHGF	11q-	unknown
TARGET-30-PAPHGF	17q+	unknown
TARGET-30-PAPHGF	%tumor	
TARGET-30-PAPHGF	MKI	
TARGET-30-PAPHPE	age	806
TARGET-30-PAPHPE	age group	2-6
TARGET-30-PAPHPE	stage	stage 4
TARGET-30-PAPHPE	ATRX	unknown
TARGET-30-PAPHPE	ALK	normal
TARGET-30-PAPHPE	MYCN	not amplified
TARGET-30-PAPHPE	Histology	unfavorable
TARGET-30-PAPHPE	Grade	unknown
TARGET-30-PAPHPE	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPHPE	Protocol	ANBL00B1
TARGET-30-PAPHPE	Category	neuroblastoma
TARGET-30-PAPHPE	1p-	normal
TARGET-30-PAPHPE	1q+	gain
TARGET-30-PAPHPE	11q-	normal
TARGET-30-PAPHPE	17q+	gain
TARGET-30-PAPHPE	%tumor	90.0
TARGET-30-PAPHPE	MKI	
TARGET-30-PAPICY	age	58
TARGET-30-PAPICY	age group	0-1
TARGET-30-PAPICY	stage	stage 4s
TARGET-30-PAPICY	ATRX	normal
TARGET-30-PAPICY	ALK	
TARGET-30-PAPICY	MYCN	not amplified
TARGET-30-PAPICY	Histology	favorable
TARGET-30-PAPICY	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPICY	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPICY	Protocol	ANBL00B1
TARGET-30-PAPICY	Category	neuroblastoma
TARGET-30-PAPICY	1p-	unknown
TARGET-30-PAPICY	1q+	unknown
TARGET-30-PAPICY	11q-	unknown
TARGET-30-PAPICY	17q+	unknown
TARGET-30-PAPICY	%tumor	
TARGET-30-PAPICY	MKI	intermediate
TARGET-30-PAPJLD	age	1309
TARGET-30-PAPJLD	age group	2-6
TARGET-30-PAPJLD	stage	stage 4
TARGET-30-PAPJLD	ATRX	unknown
TARGET-30-PAPJLD	ALK	
TARGET-30-PAPJLD	MYCN	not amplified
TARGET-30-PAPJLD	Histology	unfavorable
TARGET-30-PAPJLD	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPJLD	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPJLD	Protocol	ANBL00B1
TARGET-30-PAPJLD	Category	ganglioneuroblastoma, nodular
TARGET-30-PAPJLD	1p-	unknown
TARGET-30-PAPJLD	1q+	unknown
TARGET-30-PAPJLD	11q-	unknown
TARGET-30-PAPJLD	17q+	unknown
TARGET-30-PAPJLD	%tumor	
TARGET-30-PAPJLD	MKI	high
TARGET-30-PAPKWN	age	710
TARGET-30-PAPKWN	age group	1-2
TARGET-30-PAPKWN	stage	stage 4
TARGET-30-PAPKWN	ATRX	normal
TARGET-30-PAPKWN	ALK	normal
TARGET-30-PAPKWN	MYCN	amplified
TARGET-30-PAPKWN	Histology	unfavorable
TARGET-30-PAPKWN	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPKWN	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPKWN	Protocol	ANBL00B1
TARGET-30-PAPKWN	Category	neuroblastoma
TARGET-30-PAPKWN	1p-	normal
TARGET-30-PAPKWN	1q+	normal
TARGET-30-PAPKWN	11q-	loss
TARGET-30-PAPKWN	17q+	gain
TARGET-30-PAPKWN	%tumor	
TARGET-30-PAPKWN	MKI	high
TARGET-30-PAPKXS	age	2547
TARGET-30-PAPKXS	age group	6-9
TARGET-30-PAPKXS	stage	stage 4
TARGET-30-PAPKXS	ATRX	deleted
TARGET-30-PAPKXS	ALK	normal
TARGET-30-PAPKXS	MYCN	not amplified
TARGET-30-PAPKXS	Histology	unfavorable
TARGET-30-PAPKXS	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPKXS	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPKXS	Protocol	ANBL00B1-ADVL0821
TARGET-30-PAPKXS	Category	neuroblastoma
TARGET-30-PAPKXS	1p-	normal
TARGET-30-PAPKXS	1q+	normal
TARGET-30-PAPKXS	11q-	normal
TARGET-30-PAPKXS	17q+	gain
TARGET-30-PAPKXS	%tumor	
TARGET-30-PAPKXS	MKI	intermediate
TARGET-30-PAPLSD	age	710
TARGET-30-PAPLSD	age group	1-2
TARGET-30-PAPLSD	stage	stage 4
TARGET-30-PAPLSD	ATRX	normal
TARGET-30-PAPLSD	ALK	normal
TARGET-30-PAPLSD	MYCN	not amplified
TARGET-30-PAPLSD	Histology	unknown
TARGET-30-PAPLSD	Grade	unknown
TARGET-30-PAPLSD	Ploidy	diploid (di=1)
TARGET-30-PAPLSD	Protocol	ANBL00B1-ANBL0421
TARGET-30-PAPLSD	Category	neuroblastoma
TARGET-30-PAPLSD	1p-	normal
TARGET-30-PAPLSD	1q+	normal
TARGET-30-PAPLSD	11q-	loss
TARGET-30-PAPLSD	17q+	gain
TARGET-30-PAPLSD	%tumor	20.0
TARGET-30-PAPLSD	MKI	
TARGET-30-PAPNEP	age	720
TARGET-30-PAPNEP	age group	1-2
TARGET-30-PAPNEP	stage	stage 4
TARGET-30-PAPNEP	ATRX	normal
TARGET-30-PAPNEP	ALK	normal
TARGET-30-PAPNEP	MYCN	amplified
TARGET-30-PAPNEP	Histology	unfavorable
TARGET-30-PAPNEP	Grade	unknown
TARGET-30-PAPNEP	Ploidy	diploid (di=1)
TARGET-30-PAPNEP	Protocol	ANBL00B1
TARGET-30-PAPNEP	Category	neuroblastoma
TARGET-30-PAPNEP	1p-	normal
TARGET-30-PAPNEP	1q+	normal
TARGET-30-PAPNEP	11q-	normal
TARGET-30-PAPNEP	17q+	gain
TARGET-30-PAPNEP	%tumor	70.0
TARGET-30-PAPNEP	MKI	
TARGET-30-PAPPKJ	age	1731
TARGET-30-PAPPKJ	age group	2-6
TARGET-30-PAPPKJ	stage	stage 4
TARGET-30-PAPPKJ	ATRX	unknown
TARGET-30-PAPPKJ	ALK	normal
TARGET-30-PAPPKJ	MYCN	not amplified
TARGET-30-PAPPKJ	Histology	unfavorable
TARGET-30-PAPPKJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPPKJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPPKJ	Protocol	ANBL00B1
TARGET-30-PAPPKJ	Category	ganglioneuroblastoma, nodular
TARGET-30-PAPPKJ	1p-	normal
TARGET-30-PAPPKJ	1q+	gain
TARGET-30-PAPPKJ	11q-	loss
TARGET-30-PAPPKJ	17q+	gain
TARGET-30-PAPPKJ	%tumor	
TARGET-30-PAPPKJ	MKI	high
TARGET-30-PAPREJ	age	3806
TARGET-30-PAPREJ	age group	9-
TARGET-30-PAPREJ	stage	stage 4
TARGET-30-PAPREJ	ATRX	unknown
TARGET-30-PAPREJ	ALK	normal
TARGET-30-PAPREJ	MYCN	amplified
TARGET-30-PAPREJ	Histology	unfavorable
TARGET-30-PAPREJ	Grade	unknown
TARGET-30-PAPREJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPREJ	Protocol	ANBL00B1
TARGET-30-PAPREJ	Category	neuroblastoma
TARGET-30-PAPREJ	1p-	loss
TARGET-30-PAPREJ	1q+	gain
TARGET-30-PAPREJ	11q-	normal
TARGET-30-PAPREJ	17q+	gain
TARGET-30-PAPREJ	%tumor	80.0
TARGET-30-PAPREJ	MKI	
TARGET-30-PAPRMJ	age	1339
TARGET-30-PAPRMJ	age group	2-6
TARGET-30-PAPRMJ	stage	stage 4
TARGET-30-PAPRMJ	ATRX	unknown
TARGET-30-PAPRMJ	ALK	normal
TARGET-30-PAPRMJ	MYCN	not amplified
TARGET-30-PAPRMJ	Histology	unknown
TARGET-30-PAPRMJ	Grade	unknown
TARGET-30-PAPRMJ	Ploidy	diploid (di=1)
TARGET-30-PAPRMJ	Protocol	unknown
TARGET-30-PAPRMJ	Category	unknown
TARGET-30-PAPRMJ	1p-	normal
TARGET-30-PAPRMJ	1q+	gain
TARGET-30-PAPRMJ	11q-	loss
TARGET-30-PAPRMJ	17q+	gain
TARGET-30-PAPRMJ	%tumor	10.0
TARGET-30-PAPRMJ	MKI	
TARGET-30-PAPRPR	age	614
TARGET-30-PAPRPR	age group	1-2
TARGET-30-PAPRPR	stage	stage 4
TARGET-30-PAPRPR	ATRX	unknown
TARGET-30-PAPRPR	ALK	mutated
TARGET-30-PAPRPR	MYCN	amplified
TARGET-30-PAPRPR	Histology	unfavorable
TARGET-30-PAPRPR	Grade	unknown
TARGET-30-PAPRPR	Ploidy	diploid (di=1)
TARGET-30-PAPRPR	Protocol	ANBL00B1
TARGET-30-PAPRPR	Category	neuroblastoma
TARGET-30-PAPRPR	1p-	loss
TARGET-30-PAPRPR	1q+	normal
TARGET-30-PAPRPR	11q-	normal
TARGET-30-PAPRPR	17q+	normal
TARGET-30-PAPRPR	%tumor	
TARGET-30-PAPRPR	MKI	
TARGET-30-PAPRTD	age	1568
TARGET-30-PAPRTD	age group	2-6
TARGET-30-PAPRTD	stage	stage 4
TARGET-30-PAPRTD	ATRX	unknown
TARGET-30-PAPRTD	ALK	
TARGET-30-PAPRTD	MYCN	not amplified
TARGET-30-PAPRTD	Histology	unfavorable
TARGET-30-PAPRTD	Grade	unknown
TARGET-30-PAPRTD	Ploidy	diploid (di=1)
TARGET-30-PAPRTD	Protocol	ANBL00B1-ANBL0032
TARGET-30-PAPRTD	Category	ganglioneuroblastoma, nodular
TARGET-30-PAPRTD	1p-	unknown
TARGET-30-PAPRTD	1q+	unknown
TARGET-30-PAPRTD	11q-	unknown
TARGET-30-PAPRTD	17q+	unknown
TARGET-30-PAPRTD	%tumor	100.0
TARGET-30-PAPRTD	MKI	
TARGET-30-PAPRXW	age	888
TARGET-30-PAPRXW	age group	2-6
TARGET-30-PAPRXW	stage	stage 4
TARGET-30-PAPRXW	ATRX	unknown
TARGET-30-PAPRXW	ALK	normal
TARGET-30-PAPRXW	MYCN	amplified
TARGET-30-PAPRXW	Histology	unfavorable
TARGET-30-PAPRXW	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPRXW	Ploidy	diploid (di=1)
TARGET-30-PAPRXW	Protocol	ANBL00B1
TARGET-30-PAPRXW	Category	neuroblastoma
TARGET-30-PAPRXW	1p-	loss
TARGET-30-PAPRXW	1q+	normal
TARGET-30-PAPRXW	11q-	normal
TARGET-30-PAPRXW	17q+	gain
TARGET-30-PAPRXW	%tumor	60.0
TARGET-30-PAPRXW	MKI	intermediate
TARGET-30-PAPSEI	age	573
TARGET-30-PAPSEI	age group	1-2
TARGET-30-PAPSEI	stage	stage 4
TARGET-30-PAPSEI	ATRX	unknown
TARGET-30-PAPSEI	ALK	
TARGET-30-PAPSEI	MYCN	amplified
TARGET-30-PAPSEI	Histology	unfavorable
TARGET-30-PAPSEI	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPSEI	Ploidy	diploid (di=1)
TARGET-30-PAPSEI	Protocol	ANBL00B1-ADVL0912
TARGET-30-PAPSEI	Category	neuroblastoma
TARGET-30-PAPSEI	1p-	unknown
TARGET-30-PAPSEI	1q+	unknown
TARGET-30-PAPSEI	11q-	unknown
TARGET-30-PAPSEI	17q+	unknown
TARGET-30-PAPSEI	%tumor	40.0
TARGET-30-PAPSEI	MKI	intermediate
TARGET-30-PAPSKM	age	1330
TARGET-30-PAPSKM	age group	2-6
TARGET-30-PAPSKM	stage	stage 4
TARGET-30-PAPSKM	ATRX	unknown
TARGET-30-PAPSKM	ALK	normal
TARGET-30-PAPSKM	MYCN	not amplified
TARGET-30-PAPSKM	Histology	unfavorable
TARGET-30-PAPSKM	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPSKM	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPSKM	Protocol	ANBL00B1-ANBL0421
TARGET-30-PAPSKM	Category	neuroblastoma
TARGET-30-PAPSKM	1p-	normal
TARGET-30-PAPSKM	1q+	normal
TARGET-30-PAPSKM	11q-	loss
TARGET-30-PAPSKM	17q+	gain
TARGET-30-PAPSKM	%tumor	100.0
TARGET-30-PAPSKM	MKI	high
TARGET-30-PAPSMC	age	1337
TARGET-30-PAPSMC	age group	2-6
TARGET-30-PAPSMC	stage	stage 4
TARGET-30-PAPSMC	ATRX	unknown
TARGET-30-PAPSMC	ALK	normal
TARGET-30-PAPSMC	MYCN	amplified
TARGET-30-PAPSMC	Histology	unfavorable
TARGET-30-PAPSMC	Grade	unknown
TARGET-30-PAPSMC	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPSMC	Protocol	ANBL00B1-ANBL0032
TARGET-30-PAPSMC	Category	neuroblastoma
TARGET-30-PAPSMC	1p-	normal
TARGET-30-PAPSMC	1q+	normal
TARGET-30-PAPSMC	11q-	normal
TARGET-30-PAPSMC	17q+	normal
TARGET-30-PAPSMC	%tumor	100.0
TARGET-30-PAPSMC	MKI	
TARGET-30-PAPSSE	age	1267
TARGET-30-PAPSSE	age group	2-6
TARGET-30-PAPSSE	stage	stage 4
TARGET-30-PAPSSE	ATRX	unknown
TARGET-30-PAPSSE	ALK	
TARGET-30-PAPSSE	MYCN	not amplified
TARGET-30-PAPSSE	Histology	unfavorable
TARGET-30-PAPSSE	Grade	unknown
TARGET-30-PAPSSE	Ploidy	diploid (di=1)
TARGET-30-PAPSSE	Protocol	ANBL00B1
TARGET-30-PAPSSE	Category	ganglioneuroblastoma, nodular
TARGET-30-PAPSSE	1p-	unknown
TARGET-30-PAPSSE	1q+	unknown
TARGET-30-PAPSSE	11q-	unknown
TARGET-30-PAPSSE	17q+	unknown
TARGET-30-PAPSSE	%tumor	100.0
TARGET-30-PAPSSE	MKI	
TARGET-30-PAPTAN	age	1462
TARGET-30-PAPTAN	age group	2-6
TARGET-30-PAPTAN	stage	stage 4
TARGET-30-PAPTAN	ATRX	normal
TARGET-30-PAPTAN	ALK	normal
TARGET-30-PAPTAN	MYCN	not amplified
TARGET-30-PAPTAN	Histology	unfavorable
TARGET-30-PAPTAN	Grade	unknown
TARGET-30-PAPTAN	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPTAN	Protocol	ANBL00B1
TARGET-30-PAPTAN	Category	ganglioneuroblastoma, nodular
TARGET-30-PAPTAN	1p-	normal
TARGET-30-PAPTAN	1q+	normal
TARGET-30-PAPTAN	11q-	loss
TARGET-30-PAPTAN	17q+	gain
TARGET-30-PAPTAN	%tumor	40.0
TARGET-30-PAPTAN	MKI	
TARGET-30-PAPTCR	age	754
TARGET-30-PAPTCR	age group	2-6
TARGET-30-PAPTCR	stage	stage 4
TARGET-30-PAPTCR	ATRX	normal
TARGET-30-PAPTCR	ALK	normal
TARGET-30-PAPTCR	MYCN	unknown
TARGET-30-PAPTCR	Histology	unknown
TARGET-30-PAPTCR	Grade	unknown
TARGET-30-PAPTCR	Ploidy	unknown
TARGET-30-PAPTCR	Protocol	ANBL00B1-ANBL0621
TARGET-30-PAPTCR	Category	neuroblastoma
TARGET-30-PAPTCR	1p-	normal
TARGET-30-PAPTCR	1q+	normal
TARGET-30-PAPTCR	11q-	normal
TARGET-30-PAPTCR	17q+	normal
TARGET-30-PAPTCR	%tumor	20.0
TARGET-30-PAPTCR	MKI	
TARGET-30-PAPTDH	age	11
TARGET-30-PAPTDH	age group	0-1
TARGET-30-PAPTDH	stage	stage 4s
TARGET-30-PAPTDH	ATRX	normal
TARGET-30-PAPTDH	ALK	
TARGET-30-PAPTDH	MYCN	not amplified
TARGET-30-PAPTDH	Histology	favorable
TARGET-30-PAPTDH	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPTDH	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPTDH	Protocol	ANBL00B1
TARGET-30-PAPTDH	Category	neuroblastoma
TARGET-30-PAPTDH	1p-	unknown
TARGET-30-PAPTDH	1q+	unknown
TARGET-30-PAPTDH	11q-	unknown
TARGET-30-PAPTDH	17q+	unknown
TARGET-30-PAPTDH	%tumor	40.0
TARGET-30-PAPTDH	MKI	low
TARGET-30-PAPTFZ	age	564
TARGET-30-PAPTFZ	age group	1-2
TARGET-30-PAPTFZ	stage	stage 4
TARGET-30-PAPTFZ	ATRX	normal
TARGET-30-PAPTFZ	ALK	mutated
TARGET-30-PAPTFZ	MYCN	amplified
TARGET-30-PAPTFZ	Histology	unfavorable
TARGET-30-PAPTFZ	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPTFZ	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPTFZ	Protocol	ANBL00B1-ANBL0421-ANBL0621
TARGET-30-PAPTFZ	Category	neuroblastoma
TARGET-30-PAPTFZ	1p-	normal
TARGET-30-PAPTFZ	1q+	normal
TARGET-30-PAPTFZ	11q-	normal
TARGET-30-PAPTFZ	17q+	gain
TARGET-30-PAPTFZ	%tumor	5.0
TARGET-30-PAPTFZ	MKI	high
TARGET-30-PAPTIP	age	1208
TARGET-30-PAPTIP	age group	2-6
TARGET-30-PAPTIP	stage	stage 4
TARGET-30-PAPTIP	ATRX	unknown
TARGET-30-PAPTIP	ALK	
TARGET-30-PAPTIP	MYCN	amplified
TARGET-30-PAPTIP	Histology	unfavorable
TARGET-30-PAPTIP	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPTIP	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPTIP	Protocol	ANBL00B1-ADVL0912
TARGET-30-PAPTIP	Category	neuroblastoma
TARGET-30-PAPTIP	1p-	unknown
TARGET-30-PAPTIP	1q+	unknown
TARGET-30-PAPTIP	11q-	unknown
TARGET-30-PAPTIP	17q+	unknown
TARGET-30-PAPTIP	%tumor	80.0
TARGET-30-PAPTIP	MKI	high
TARGET-30-PAPTJB	age	1991
TARGET-30-PAPTJB	age group	2-6
TARGET-30-PAPTJB	stage	stage 4
TARGET-30-PAPTJB	ATRX	normal
TARGET-30-PAPTJB	ALK	normal
TARGET-30-PAPTJB	MYCN	not amplified
TARGET-30-PAPTJB	Histology	unfavorable
TARGET-30-PAPTJB	Grade	unknown
TARGET-30-PAPTJB	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPTJB	Protocol	ANBL00B1
TARGET-30-PAPTJB	Category	neuroblastoma
TARGET-30-PAPTJB	1p-	loss
TARGET-30-PAPTJB	1q+	gain
TARGET-30-PAPTJB	11q-	normal
TARGET-30-PAPTJB	17q+	gain
TARGET-30-PAPTJB	%tumor	50.0
TARGET-30-PAPTJB	MKI	
TARGET-30-PAPTLA	age	1089
TARGET-30-PAPTLA	age group	2-6
TARGET-30-PAPTLA	stage	stage 4
TARGET-30-PAPTLA	ATRX	unknown
TARGET-30-PAPTLA	ALK	normal
TARGET-30-PAPTLA	MYCN	not amplified
TARGET-30-PAPTLA	Histology	unfavorable
TARGET-30-PAPTLA	Grade	unknown
TARGET-30-PAPTLA	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPTLA	Protocol	ANBL0421-ADVL1011-ANBL0032-ADVL0911-ADVL1111
TARGET-30-PAPTLA	Category	unknown
TARGET-30-PAPTLA	1p-	normal
TARGET-30-PAPTLA	1q+	gain
TARGET-30-PAPTLA	11q-	loss
TARGET-30-PAPTLA	17q+	gain
TARGET-30-PAPTLA	%tumor	10.0
TARGET-30-PAPTLA	MKI	
TARGET-30-PAPTLD	age	1244
TARGET-30-PAPTLD	age group	2-6
TARGET-30-PAPTLD	stage	stage 4
TARGET-30-PAPTLD	ATRX	unknown
TARGET-30-PAPTLD	ALK	normal
TARGET-30-PAPTLD	MYCN	not amplified
TARGET-30-PAPTLD	Histology	unfavorable
TARGET-30-PAPTLD	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPTLD	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPTLD	Protocol	ANBL00B1-ANBL0032
TARGET-30-PAPTLD	Category	neuroblastoma
TARGET-30-PAPTLD	1p-	normal
TARGET-30-PAPTLD	1q+	normal
TARGET-30-PAPTLD	11q-	loss
TARGET-30-PAPTLD	17q+	gain
TARGET-30-PAPTLD	%tumor	90.0
TARGET-30-PAPTLD	MKI	high
TARGET-30-PAPTLV	age	641
TARGET-30-PAPTLV	age group	1-2
TARGET-30-PAPTLV	stage	stage 4
TARGET-30-PAPTLV	ATRX	normal
TARGET-30-PAPTLV	ALK	mutated
TARGET-30-PAPTLV	MYCN	amplified
TARGET-30-PAPTLV	Histology	unfavorable
TARGET-30-PAPTLV	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPTLV	Ploidy	diploid (di=1)
TARGET-30-PAPTLV	Protocol	ANBL00B1
TARGET-30-PAPTLV	Category	neuroblastoma
TARGET-30-PAPTLV	1p-	normal
TARGET-30-PAPTLV	1q+	gain
TARGET-30-PAPTLV	11q-	normal
TARGET-30-PAPTLV	17q+	gain
TARGET-30-PAPTLV	%tumor	
TARGET-30-PAPTLV	MKI	low
TARGET-30-PAPTLY	age	1514
TARGET-30-PAPTLY	age group	2-6
TARGET-30-PAPTLY	stage	stage 4
TARGET-30-PAPTLY	ATRX	unknown
TARGET-30-PAPTLY	ALK	
TARGET-30-PAPTLY	MYCN	amplified
TARGET-30-PAPTLY	Histology	unfavorable
TARGET-30-PAPTLY	Grade	unknown
TARGET-30-PAPTLY	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPTLY	Protocol	ANBL00B1
TARGET-30-PAPTLY	Category	neuroblastoma
TARGET-30-PAPTLY	1p-	unknown
TARGET-30-PAPTLY	1q+	unknown
TARGET-30-PAPTLY	11q-	unknown
TARGET-30-PAPTLY	17q+	unknown
TARGET-30-PAPTLY	%tumor	60.0
TARGET-30-PAPTLY	MKI	
TARGET-30-PAPTMM	age	559
TARGET-30-PAPTMM	age group	1-2
TARGET-30-PAPTMM	stage	stage 4
TARGET-30-PAPTMM	ATRX	unknown
TARGET-30-PAPTMM	ALK	normal
TARGET-30-PAPTMM	MYCN	amplified
TARGET-30-PAPTMM	Histology	unfavorable
TARGET-30-PAPTMM	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPTMM	Ploidy	diploid (di=1)
TARGET-30-PAPTMM	Protocol	ANBL00B1
TARGET-30-PAPTMM	Category	neuroblastoma
TARGET-30-PAPTMM	1p-	loss
TARGET-30-PAPTMM	1q+	normal
TARGET-30-PAPTMM	11q-	normal
TARGET-30-PAPTMM	17q+	gain
TARGET-30-PAPTMM	%tumor	80.0
TARGET-30-PAPTMM	MKI	
TARGET-30-PAPUAR	age	515
TARGET-30-PAPUAR	age group	1-2
TARGET-30-PAPUAR	stage	stage 4
TARGET-30-PAPUAR	ATRX	normal
TARGET-30-PAPUAR	ALK	
TARGET-30-PAPUAR	MYCN	not amplified
TARGET-30-PAPUAR	Histology	favorable
TARGET-30-PAPUAR	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPUAR	Ploidy	diploid (di=1)
TARGET-30-PAPUAR	Protocol	ANBL00B1
TARGET-30-PAPUAR	Category	neuroblastoma
TARGET-30-PAPUAR	1p-	unknown
TARGET-30-PAPUAR	1q+	unknown
TARGET-30-PAPUAR	11q-	unknown
TARGET-30-PAPUAR	17q+	unknown
TARGET-30-PAPUAR	%tumor	70.0
TARGET-30-PAPUAR	MKI	intermediate
TARGET-30-PAPUEB	age	1595
TARGET-30-PAPUEB	age group	2-6
TARGET-30-PAPUEB	stage	stage 4
TARGET-30-PAPUEB	ATRX	unknown
TARGET-30-PAPUEB	ALK	
TARGET-30-PAPUEB	MYCN	not amplified
TARGET-30-PAPUEB	Histology	unfavorable
TARGET-30-PAPUEB	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPUEB	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPUEB	Protocol	ANBL00B1
TARGET-30-PAPUEB	Category	neuroblastoma
TARGET-30-PAPUEB	1p-	unknown
TARGET-30-PAPUEB	1q+	unknown
TARGET-30-PAPUEB	11q-	unknown
TARGET-30-PAPUEB	17q+	unknown
TARGET-30-PAPUEB	%tumor	40.0
TARGET-30-PAPUEB	MKI	
TARGET-30-PAPUJU	age	954
TARGET-30-PAPUJU	age group	2-6
TARGET-30-PAPUJU	stage	stage 4
TARGET-30-PAPUJU	ATRX	unknown
TARGET-30-PAPUJU	ALK	normal
TARGET-30-PAPUJU	MYCN	not amplified
TARGET-30-PAPUJU	Histology	unknown
TARGET-30-PAPUJU	Grade	unknown
TARGET-30-PAPUJU	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPUJU	Protocol	ANBL00B1
TARGET-30-PAPUJU	Category	unknown
TARGET-30-PAPUJU	1p-	normal
TARGET-30-PAPUJU	1q+	normal
TARGET-30-PAPUJU	11q-	loss
TARGET-30-PAPUJU	17q+	gain
TARGET-30-PAPUJU	%tumor	60.0
TARGET-30-PAPUJU	MKI	
TARGET-30-PAPUNH	age	3425
TARGET-30-PAPUNH	age group	9-
TARGET-30-PAPUNH	stage	stage 3
TARGET-30-PAPUNH	ATRX	unknown
TARGET-30-PAPUNH	ALK	
TARGET-30-PAPUNH	MYCN	amplified
TARGET-30-PAPUNH	Histology	unfavorable
TARGET-30-PAPUNH	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPUNH	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPUNH	Protocol	ANBL00B1
TARGET-30-PAPUNH	Category	neuroblastoma
TARGET-30-PAPUNH	1p-	unknown
TARGET-30-PAPUNH	1q+	unknown
TARGET-30-PAPUNH	11q-	unknown
TARGET-30-PAPUNH	17q+	unknown
TARGET-30-PAPUNH	%tumor	30.0
TARGET-30-PAPUNH	MKI	high
TARGET-30-PAPUTN	age	1223
TARGET-30-PAPUTN	age group	2-6
TARGET-30-PAPUTN	stage	stage 4
TARGET-30-PAPUTN	ATRX	unknown
TARGET-30-PAPUTN	ALK	
TARGET-30-PAPUTN	MYCN	amplified
TARGET-30-PAPUTN	Histology	unknown
TARGET-30-PAPUTN	Grade	unknown
TARGET-30-PAPUTN	Ploidy	diploid (di=1)
TARGET-30-PAPUTN	Protocol	ANBL00B1
TARGET-30-PAPUTN	Category	unknown
TARGET-30-PAPUTN	1p-	unknown
TARGET-30-PAPUTN	1q+	unknown
TARGET-30-PAPUTN	11q-	unknown
TARGET-30-PAPUTN	17q+	unknown
TARGET-30-PAPUTN	%tumor	0.0
TARGET-30-PAPUTN	MKI	
TARGET-30-PAPUWY	age	1955
TARGET-30-PAPUWY	age group	2-6
TARGET-30-PAPUWY	stage	stage 4
TARGET-30-PAPUWY	ATRX	normal
TARGET-30-PAPUWY	ALK	normal
TARGET-30-PAPUWY	MYCN	not amplified
TARGET-30-PAPUWY	Histology	unfavorable
TARGET-30-PAPUWY	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPUWY	Ploidy	diploid (di=1)
TARGET-30-PAPUWY	Protocol	ANBL00B1-ANBL0621
TARGET-30-PAPUWY	Category	neuroblastoma
TARGET-30-PAPUWY	1p-	normal
TARGET-30-PAPUWY	1q+	normal
TARGET-30-PAPUWY	11q-	loss
TARGET-30-PAPUWY	17q+	gain
TARGET-30-PAPUWY	%tumor	40.0
TARGET-30-PAPUWY	MKI	high
TARGET-30-PAPVEB	age	1720
TARGET-30-PAPVEB	age group	2-6
TARGET-30-PAPVEB	stage	stage 2b
TARGET-30-PAPVEB	ATRX	unknown
TARGET-30-PAPVEB	ALK	
TARGET-30-PAPVEB	MYCN	not amplified
TARGET-30-PAPVEB	Histology	unfavorable
TARGET-30-PAPVEB	Grade	differentiating
TARGET-30-PAPVEB	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPVEB	Protocol	ANBL00B1-ANBL0621
TARGET-30-PAPVEB	Category	neuroblastoma
TARGET-30-PAPVEB	1p-	unknown
TARGET-30-PAPVEB	1q+	unknown
TARGET-30-PAPVEB	11q-	unknown
TARGET-30-PAPVEB	17q+	unknown
TARGET-30-PAPVEB	%tumor	60.0
TARGET-30-PAPVEB	MKI	intermediate
TARGET-30-PAPVFD	age	1961
TARGET-30-PAPVFD	age group	2-6
TARGET-30-PAPVFD	stage	stage 4
TARGET-30-PAPVFD	ATRX	normal
TARGET-30-PAPVFD	ALK	normal
TARGET-30-PAPVFD	MYCN	not amplified
TARGET-30-PAPVFD	Histology	unfavorable
TARGET-30-PAPVFD	Grade	unknown
TARGET-30-PAPVFD	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPVFD	Protocol	ANBL00B1
TARGET-30-PAPVFD	Category	neuroblastoma
TARGET-30-PAPVFD	1p-	normal
TARGET-30-PAPVFD	1q+	normal
TARGET-30-PAPVFD	11q-	loss
TARGET-30-PAPVFD	17q+	gain
TARGET-30-PAPVFD	%tumor	90.0
TARGET-30-PAPVFD	MKI	
TARGET-30-PAPVRN	age	2300
TARGET-30-PAPVRN	age group	6-9
TARGET-30-PAPVRN	stage	stage 4
TARGET-30-PAPVRN	ATRX	normal
TARGET-30-PAPVRN	ALK	normal
TARGET-30-PAPVRN	MYCN	not amplified
TARGET-30-PAPVRN	Histology	unfavorable
TARGET-30-PAPVRN	Grade	differentiating
TARGET-30-PAPVRN	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPVRN	Protocol	ANBL00B1
TARGET-30-PAPVRN	Category	ganglioneuroblastoma, nodular
TARGET-30-PAPVRN	1p-	normal
TARGET-30-PAPVRN	1q+	normal
TARGET-30-PAPVRN	11q-	normal
TARGET-30-PAPVRN	17q+	gain
TARGET-30-PAPVRN	%tumor	30.0
TARGET-30-PAPVRN	MKI	low
TARGET-30-PAPVXS	age	1366
TARGET-30-PAPVXS	age group	2-6
TARGET-30-PAPVXS	stage	stage 4
TARGET-30-PAPVXS	ATRX	normal
TARGET-30-PAPVXS	ALK	normal
TARGET-30-PAPVXS	MYCN	not amplified
TARGET-30-PAPVXS	Histology	unfavorable
TARGET-30-PAPVXS	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPVXS	Ploidy	diploid (di=1)
TARGET-30-PAPVXS	Protocol	ANBL00B1
TARGET-30-PAPVXS	Category	neuroblastoma
TARGET-30-PAPVXS	1p-	normal
TARGET-30-PAPVXS	1q+	normal
TARGET-30-PAPVXS	11q-	loss
TARGET-30-PAPVXS	17q+	gain
TARGET-30-PAPVXS	%tumor	80.0
TARGET-30-PAPVXS	MKI	high
TARGET-30-PAPWFY	age	757
TARGET-30-PAPWFY	age group	2-6
TARGET-30-PAPWFY	stage	stage 4
TARGET-30-PAPWFY	ATRX	unknown
TARGET-30-PAPWFY	ALK	normal
TARGET-30-PAPWFY	MYCN	amplified
TARGET-30-PAPWFY	Histology	unknown
TARGET-30-PAPWFY	Grade	unknown
TARGET-30-PAPWFY	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPWFY	Protocol	ANBL00B1
TARGET-30-PAPWFY	Category	unknown
TARGET-30-PAPWFY	1p-	normal
TARGET-30-PAPWFY	1q+	normal
TARGET-30-PAPWFY	11q-	normal
TARGET-30-PAPWFY	17q+	normal
TARGET-30-PAPWFY	%tumor	70.0
TARGET-30-PAPWFY	MKI	
TARGET-30-PAPWUC	age	983
TARGET-30-PAPWUC	age group	2-6
TARGET-30-PAPWUC	stage	stage 4
TARGET-30-PAPWUC	ATRX	unknown
TARGET-30-PAPWUC	ALK	
TARGET-30-PAPWUC	MYCN	not amplified
TARGET-30-PAPWUC	Histology	unfavorable
TARGET-30-PAPWUC	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPWUC	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPWUC	Protocol	ANBL00B1
TARGET-30-PAPWUC	Category	neuroblastoma
TARGET-30-PAPWUC	1p-	unknown
TARGET-30-PAPWUC	1q+	unknown
TARGET-30-PAPWUC	11q-	unknown
TARGET-30-PAPWUC	17q+	unknown
TARGET-30-PAPWUC	%tumor	80.0
TARGET-30-PAPWUC	MKI	intermediate
TARGET-30-PAPYNZ	age	1024
TARGET-30-PAPYNZ	age group	2-6
TARGET-30-PAPYNZ	stage	stage 4
TARGET-30-PAPYNZ	ATRX	unknown
TARGET-30-PAPYNZ	ALK	normal
TARGET-30-PAPYNZ	MYCN	amplified
TARGET-30-PAPYNZ	Histology	unfavorable
TARGET-30-PAPYNZ	Grade	unknown
TARGET-30-PAPYNZ	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPYNZ	Protocol	ANBL00B1
TARGET-30-PAPYNZ	Category	neuroblastoma
TARGET-30-PAPYNZ	1p-	loss
TARGET-30-PAPYNZ	1q+	normal
TARGET-30-PAPYNZ	11q-	normal
TARGET-30-PAPYNZ	17q+	gain
TARGET-30-PAPYNZ	%tumor	0.0
TARGET-30-PAPYNZ	MKI	
TARGET-30-PAPZFW	age	1342
TARGET-30-PAPZFW	age group	2-6
TARGET-30-PAPZFW	stage	stage 4
TARGET-30-PAPZFW	ATRX	unknown
TARGET-30-PAPZFW	ALK	normal
TARGET-30-PAPZFW	MYCN	not amplified
TARGET-30-PAPZFW	Histology	unfavorable
TARGET-30-PAPZFW	Grade	unknown
TARGET-30-PAPZFW	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPZFW	Protocol	ANBL00B1
TARGET-30-PAPZFW	Category	ganglioneuroblastoma, nodular
TARGET-30-PAPZFW	1p-	normal
TARGET-30-PAPZFW	1q+	normal
TARGET-30-PAPZFW	11q-	loss
TARGET-30-PAPZFW	17q+	gain
TARGET-30-PAPZFW	%tumor	30.0
TARGET-30-PAPZFW	MKI	
TARGET-30-PAPZWS	age	557
TARGET-30-PAPZWS	age group	1-2
TARGET-30-PAPZWS	stage	stage 4
TARGET-30-PAPZWS	ATRX	unknown
TARGET-30-PAPZWS	ALK	
TARGET-30-PAPZWS	MYCN	amplified
TARGET-30-PAPZWS	Histology	unfavorable
TARGET-30-PAPZWS	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPZWS	Ploidy	diploid (di=1)
TARGET-30-PAPZWS	Protocol	ANBL00B1
TARGET-30-PAPZWS	Category	neuroblastoma
TARGET-30-PAPZWS	1p-	unknown
TARGET-30-PAPZWS	1q+	unknown
TARGET-30-PAPZWS	11q-	unknown
TARGET-30-PAPZWS	17q+	unknown
TARGET-30-PAPZWS	%tumor	40.0
TARGET-30-PAPZWS	MKI	high
TARGET-30-PAPZYP	age	1010
TARGET-30-PAPZYP	age group	2-6
TARGET-30-PAPZYP	stage	stage 4
TARGET-30-PAPZYP	ATRX	normal
TARGET-30-PAPZYP	ALK	
TARGET-30-PAPZYP	MYCN	amplified
TARGET-30-PAPZYP	Histology	unfavorable
TARGET-30-PAPZYP	Grade	undifferentiated or poorly differentiated
TARGET-30-PAPZYP	Ploidy	diploid (di=1)
TARGET-30-PAPZYP	Protocol	ANBL00B1
TARGET-30-PAPZYP	Category	neuroblastoma
TARGET-30-PAPZYP	1p-	unknown
TARGET-30-PAPZYP	1q+	unknown
TARGET-30-PAPZYP	11q-	unknown
TARGET-30-PAPZYP	17q+	unknown
TARGET-30-PAPZYP	%tumor	90.0
TARGET-30-PAPZYP	MKI	
TARGET-30-PAPZYZ	age	550
TARGET-30-PAPZYZ	age group	1-2
TARGET-30-PAPZYZ	stage	stage 4
TARGET-30-PAPZYZ	ATRX	normal
TARGET-30-PAPZYZ	ALK	normal
TARGET-30-PAPZYZ	MYCN	amplified
TARGET-30-PAPZYZ	Histology	unknown
TARGET-30-PAPZYZ	Grade	unknown
TARGET-30-PAPZYZ	Ploidy	hyperdiploid (di>1)
TARGET-30-PAPZYZ	Protocol	ANBL00B1-ANBL0032
TARGET-30-PAPZYZ	Category	neuroblastoma
TARGET-30-PAPZYZ	1p-	loss
TARGET-30-PAPZYZ	1q+	gain
TARGET-30-PAPZYZ	11q-	normal
TARGET-30-PAPZYZ	17q+	gain
TARGET-30-PAPZYZ	%tumor	60.0
TARGET-30-PAPZYZ	MKI	
TARGET-30-PARABJ	age	661
TARGET-30-PARABJ	age group	1-2
TARGET-30-PARABJ	stage	stage 4
TARGET-30-PARABJ	ATRX	unknown
TARGET-30-PARABJ	ALK	normal
TARGET-30-PARABJ	MYCN	not amplified
TARGET-30-PARABJ	Histology	unfavorable
TARGET-30-PARABJ	Grade	unknown
TARGET-30-PARABJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PARABJ	Protocol	ANBL00B1
TARGET-30-PARABJ	Category	ganglioneuroblastoma, nodular
TARGET-30-PARABJ	1p-	normal
TARGET-30-PARABJ	1q+	normal
TARGET-30-PARABJ	11q-	normal
TARGET-30-PARABJ	17q+	gain
TARGET-30-PARABJ	%tumor	25.0
TARGET-30-PARABJ	MKI	
TARGET-30-PARABN	age	974
TARGET-30-PARABN	age group	2-6
TARGET-30-PARABN	stage	stage 4
TARGET-30-PARABN	ATRX	unknown
TARGET-30-PARABN	ALK	
TARGET-30-PARABN	MYCN	amplified
TARGET-30-PARABN	Histology	unknown
TARGET-30-PARABN	Grade	unknown
TARGET-30-PARABN	Ploidy	hyperdiploid (di>1)
TARGET-30-PARABN	Protocol	ANBL00B1-ANBL0032
TARGET-30-PARABN	Category	neuroblastoma
TARGET-30-PARABN	1p-	unknown
TARGET-30-PARABN	1q+	unknown
TARGET-30-PARABN	11q-	unknown
TARGET-30-PARABN	17q+	unknown
TARGET-30-PARABN	%tumor	10.0
TARGET-30-PARABN	MKI	
TARGET-30-PARACM	age	1442
TARGET-30-PARACM	age group	2-6
TARGET-30-PARACM	stage	stage 4
TARGET-30-PARACM	ATRX	normal
TARGET-30-PARACM	ALK	
TARGET-30-PARACM	MYCN	not amplified
TARGET-30-PARACM	Histology	unfavorable
TARGET-30-PARACM	Grade	undifferentiated or poorly differentiated
TARGET-30-PARACM	Ploidy	hyperdiploid (di>1)
TARGET-30-PARACM	Protocol	ANBL00B1
TARGET-30-PARACM	Category	ganglioneuroblastoma, nodular
TARGET-30-PARACM	1p-	unknown
TARGET-30-PARACM	1q+	unknown
TARGET-30-PARACM	11q-	unknown
TARGET-30-PARACM	17q+	unknown
TARGET-30-PARACM	%tumor	
TARGET-30-PARACM	MKI	high
TARGET-30-PARACR	age	1191
TARGET-30-PARACR	age group	2-6
TARGET-30-PARACR	stage	stage 4
TARGET-30-PARACR	ATRX	normal
TARGET-30-PARACR	ALK	normal
TARGET-30-PARACR	MYCN	unknown
TARGET-30-PARACR	Histology	unfavorable
TARGET-30-PARACR	Grade	undifferentiated or poorly differentiated
TARGET-30-PARACR	Ploidy	unknown
TARGET-30-PARACR	Protocol	ANBL00B1
TARGET-30-PARACR	Category	neuroblastoma
TARGET-30-PARACR	1p-	normal
TARGET-30-PARACR	1q+	gain
TARGET-30-PARACR	11q-	normal
TARGET-30-PARACR	17q+	gain
TARGET-30-PARACR	%tumor	0.0
TARGET-30-PARACR	MKI	
TARGET-30-PARACS	age	1180
TARGET-30-PARACS	age group	2-6
TARGET-30-PARACS	stage	stage 4
TARGET-30-PARACS	ATRX	deleted
TARGET-30-PARACS	ALK	normal
TARGET-30-PARACS	MYCN	not amplified
TARGET-30-PARACS	Histology	unfavorable
TARGET-30-PARACS	Grade	undifferentiated or poorly differentiated
TARGET-30-PARACS	Ploidy	hyperdiploid (di>1)
TARGET-30-PARACS	Protocol	ANBL00B1
TARGET-30-PARACS	Category	neuroblastoma
TARGET-30-PARACS	1p-	normal
TARGET-30-PARACS	1q+	normal
TARGET-30-PARACS	11q-	loss
TARGET-30-PARACS	17q+	gain
TARGET-30-PARACS	%tumor	80.0
TARGET-30-PARACS	MKI	high
TARGET-30-PARAHE	age	1326
TARGET-30-PARAHE	age group	2-6
TARGET-30-PARAHE	stage	stage 4
TARGET-30-PARAHE	ATRX	unknown
TARGET-30-PARAHE	ALK	
TARGET-30-PARAHE	MYCN	not amplified
TARGET-30-PARAHE	Histology	unfavorable
TARGET-30-PARAHE	Grade	undifferentiated or poorly differentiated
TARGET-30-PARAHE	Ploidy	diploid (di=1)
TARGET-30-PARAHE	Protocol	ANBL00B1
TARGET-30-PARAHE	Category	neuroblastoma
TARGET-30-PARAHE	1p-	unknown
TARGET-30-PARAHE	1q+	unknown
TARGET-30-PARAHE	11q-	unknown
TARGET-30-PARAHE	17q+	unknown
TARGET-30-PARAHE	%tumor	10.0
TARGET-30-PARAHE	MKI	intermediate
TARGET-30-PARAMT	age	885
TARGET-30-PARAMT	age group	2-6
TARGET-30-PARAMT	stage	stage 4
TARGET-30-PARAMT	ATRX	normal
TARGET-30-PARAMT	ALK	normal
TARGET-30-PARAMT	MYCN	not amplified
TARGET-30-PARAMT	Histology	unfavorable
TARGET-30-PARAMT	Grade	undifferentiated or poorly differentiated
TARGET-30-PARAMT	Ploidy	hyperdiploid (di>1)
TARGET-30-PARAMT	Protocol	ANBL00B1
TARGET-30-PARAMT	Category	ganglioneuroblastoma, nodular
TARGET-30-PARAMT	1p-	normal
TARGET-30-PARAMT	1q+	normal
TARGET-30-PARAMT	11q-	normal
TARGET-30-PARAMT	17q+	gain
TARGET-30-PARAMT	%tumor	80.0
TARGET-30-PARAMT	MKI	intermediate
TARGET-30-PARASL	age	1606
TARGET-30-PARASL	age group	2-6
TARGET-30-PARASL	stage	stage 4
TARGET-30-PARASL	ATRX	unknown
TARGET-30-PARASL	ALK	normal
TARGET-30-PARASL	MYCN	not amplified
TARGET-30-PARASL	Histology	unknown
TARGET-30-PARASL	Grade	unknown
TARGET-30-PARASL	Ploidy	hyperdiploid (di>1)
TARGET-30-PARASL	Protocol	ANBL00B1
TARGET-30-PARASL	Category	unknown
TARGET-30-PARASL	1p-	normal
TARGET-30-PARASL	1q+	normal
TARGET-30-PARASL	11q-	loss
TARGET-30-PARASL	17q+	gain
TARGET-30-PARASL	%tumor	
TARGET-30-PARASL	MKI	
TARGET-30-PARBAJ	age	35
TARGET-30-PARBAJ	age group	0-1
TARGET-30-PARBAJ	stage	stage 3
TARGET-30-PARBAJ	ATRX	unknown
TARGET-30-PARBAJ	ALK	
TARGET-30-PARBAJ	MYCN	not amplified
TARGET-30-PARBAJ	Histology	favorable
TARGET-30-PARBAJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PARBAJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PARBAJ	Protocol	ANBL00B1
TARGET-30-PARBAJ	Category	neuroblastoma
TARGET-30-PARBAJ	1p-	unknown
TARGET-30-PARBAJ	1q+	unknown
TARGET-30-PARBAJ	11q-	unknown
TARGET-30-PARBAJ	17q+	unknown
TARGET-30-PARBAJ	%tumor	
TARGET-30-PARBAJ	MKI	intermediate
TARGET-30-PARBGP	age	3625
TARGET-30-PARBGP	age group	9-
TARGET-30-PARBGP	stage	stage 4
TARGET-30-PARBGP	ATRX	normal
TARGET-30-PARBGP	ALK	normal
TARGET-30-PARBGP	MYCN	not amplified
TARGET-30-PARBGP	Histology	unfavorable
TARGET-30-PARBGP	Grade	undifferentiated or poorly differentiated
TARGET-30-PARBGP	Ploidy	diploid (di=1)
TARGET-30-PARBGP	Protocol	ANBL00B1-ADVL0912
TARGET-30-PARBGP	Category	neuroblastoma
TARGET-30-PARBGP	1p-	normal
TARGET-30-PARBGP	1q+	normal
TARGET-30-PARBGP	11q-	loss
TARGET-30-PARBGP	17q+	gain
TARGET-30-PARBGP	%tumor	
TARGET-30-PARBGP	MKI	high
TARGET-30-PARBLH	age	1360
TARGET-30-PARBLH	age group	2-6
TARGET-30-PARBLH	stage	stage 4
TARGET-30-PARBLH	ATRX	unknown
TARGET-30-PARBLH	ALK	normal
TARGET-30-PARBLH	MYCN	not amplified
TARGET-30-PARBLH	Histology	unknown
TARGET-30-PARBLH	Grade	unknown
TARGET-30-PARBLH	Ploidy	diploid (di=1)
TARGET-30-PARBLH	Protocol	ANBL00B1-ANBL0032
TARGET-30-PARBLH	Category	unknown
TARGET-30-PARBLH	1p-	normal
TARGET-30-PARBLH	1q+	gain
TARGET-30-PARBLH	11q-	loss
TARGET-30-PARBLH	17q+	gain
TARGET-30-PARBLH	%tumor	40.0
TARGET-30-PARBLH	MKI	
TARGET-30-PARCET	age	43
TARGET-30-PARCET	age group	0-1
TARGET-30-PARCET	stage	stage 4s
TARGET-30-PARCET	ATRX	unknown
TARGET-30-PARCET	ALK	
TARGET-30-PARCET	MYCN	not amplified
TARGET-30-PARCET	Histology	favorable
TARGET-30-PARCET	Grade	unknown
TARGET-30-PARCET	Ploidy	hyperdiploid (di>1)
TARGET-30-PARCET	Protocol	ANBL00B1
TARGET-30-PARCET	Category	neuroblastoma
TARGET-30-PARCET	1p-	unknown
TARGET-30-PARCET	1q+	unknown
TARGET-30-PARCET	11q-	unknown
TARGET-30-PARCET	17q+	unknown
TARGET-30-PARCET	%tumor	10.0
TARGET-30-PARCET	MKI	
TARGET-30-PARCRR	age	1742
TARGET-30-PARCRR	age group	2-6
TARGET-30-PARCRR	stage	stage 4
TARGET-30-PARCRR	ATRX	unknown
TARGET-30-PARCRR	ALK	normal
TARGET-30-PARCRR	MYCN	not amplified
TARGET-30-PARCRR	Histology	unfavorable
TARGET-30-PARCRR	Grade	unknown
TARGET-30-PARCRR	Ploidy	hyperdiploid (di>1)
TARGET-30-PARCRR	Protocol	unknown
TARGET-30-PARCRR	Category	unknown
TARGET-30-PARCRR	1p-	normal
TARGET-30-PARCRR	1q+	gain
TARGET-30-PARCRR	11q-	normal
TARGET-30-PARCRR	17q+	gain
TARGET-30-PARCRR	%tumor	70.0
TARGET-30-PARCRR	MKI	
TARGET-30-PARCWT	age	1026
TARGET-30-PARCWT	age group	2-6
TARGET-30-PARCWT	stage	stage 4
TARGET-30-PARCWT	ATRX	unknown
TARGET-30-PARCWT	ALK	
TARGET-30-PARCWT	MYCN	not amplified
TARGET-30-PARCWT	Histology	unfavorable
TARGET-30-PARCWT	Grade	differentiating
TARGET-30-PARCWT	Ploidy	diploid (di=1)
TARGET-30-PARCWT	Protocol	ANBL00B1-ADVL0921-ANBL1021
TARGET-30-PARCWT	Category	ganglioneuroblastoma, nodular
TARGET-30-PARCWT	1p-	unknown
TARGET-30-PARCWT	1q+	unknown
TARGET-30-PARCWT	11q-	unknown
TARGET-30-PARCWT	17q+	unknown
TARGET-30-PARCWT	%tumor	20.0
TARGET-30-PARCWT	MKI	
TARGET-30-PARDCK	age	2060
TARGET-30-PARDCK	age group	2-6
TARGET-30-PARDCK	stage	stage 4
TARGET-30-PARDCK	ATRX	nonsense
TARGET-30-PARDCK	ALK	normal
TARGET-30-PARDCK	MYCN	not amplified
TARGET-30-PARDCK	Histology	unfavorable
TARGET-30-PARDCK	Grade	unknown
TARGET-30-PARDCK	Ploidy	hyperdiploid (di>1)
TARGET-30-PARDCK	Protocol	ANBL00B1-ANBL0032
TARGET-30-PARDCK	Category	ganglioneuroblastoma, nodular
TARGET-30-PARDCK	1p-	normal
TARGET-30-PARDCK	1q+	normal
TARGET-30-PARDCK	11q-	loss
TARGET-30-PARDCK	17q+	gain
TARGET-30-PARDCK	%tumor	90.0
TARGET-30-PARDCK	MKI	
TARGET-30-PARDIW	age	2048
TARGET-30-PARDIW	age group	2-6
TARGET-30-PARDIW	stage	stage 4
TARGET-30-PARDIW	ATRX	normal
TARGET-30-PARDIW	ALK	normal
TARGET-30-PARDIW	MYCN	not amplified
TARGET-30-PARDIW	Histology	unfavorable
TARGET-30-PARDIW	Grade	undifferentiated or poorly differentiated
TARGET-30-PARDIW	Ploidy	hyperdiploid (di>1)
TARGET-30-PARDIW	Protocol	ANBL00B1
TARGET-30-PARDIW	Category	neuroblastoma
TARGET-30-PARDIW	1p-	normal
TARGET-30-PARDIW	1q+	normal
TARGET-30-PARDIW	11q-	loss
TARGET-30-PARDIW	17q+	gain
TARGET-30-PARDIW	%tumor	10.0
TARGET-30-PARDIW	MKI	intermediate
TARGET-30-PARDUJ	age	1052
TARGET-30-PARDUJ	age group	2-6
TARGET-30-PARDUJ	stage	stage 4
TARGET-30-PARDUJ	ATRX	unknown
TARGET-30-PARDUJ	ALK	normal
TARGET-30-PARDUJ	MYCN	not amplified
TARGET-30-PARDUJ	Histology	unfavorable
TARGET-30-PARDUJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PARDUJ	Ploidy	unknown
TARGET-30-PARDUJ	Protocol	ANBL00B1-ANBL0032
TARGET-30-PARDUJ	Category	neuroblastoma
TARGET-30-PARDUJ	1p-	normal
TARGET-30-PARDUJ	1q+	normal
TARGET-30-PARDUJ	11q-	loss
TARGET-30-PARDUJ	17q+	gain
TARGET-30-PARDUJ	%tumor	
TARGET-30-PARDUJ	MKI	low
TARGET-30-PARDVT	age	1338
TARGET-30-PARDVT	age group	2-6
TARGET-30-PARDVT	stage	stage 4
TARGET-30-PARDVT	ATRX	unknown
TARGET-30-PARDVT	ALK	normal
TARGET-30-PARDVT	MYCN	not amplified
TARGET-30-PARDVT	Histology	unfavorable
TARGET-30-PARDVT	Grade	unknown
TARGET-30-PARDVT	Ploidy	diploid (di=1)
TARGET-30-PARDVT	Protocol	ANBL00B1
TARGET-30-PARDVT	Category	neuroblastoma
TARGET-30-PARDVT	1p-	normal
TARGET-30-PARDVT	1q+	normal
TARGET-30-PARDVT	11q-	loss
TARGET-30-PARDVT	17q+	gain
TARGET-30-PARDVT	%tumor	90.0
TARGET-30-PARDVT	MKI	
TARGET-30-PARDYU	age	1942
TARGET-30-PARDYU	age group	2-6
TARGET-30-PARDYU	stage	stage 4
TARGET-30-PARDYU	ATRX	unknown
TARGET-30-PARDYU	ALK	normal
TARGET-30-PARDYU	MYCN	amplified
TARGET-30-PARDYU	Histology	unfavorable
TARGET-30-PARDYU	Grade	undifferentiated or poorly differentiated
TARGET-30-PARDYU	Ploidy	diploid (di=1)
TARGET-30-PARDYU	Protocol	ANBL00B1
TARGET-30-PARDYU	Category	neuroblastoma
TARGET-30-PARDYU	1p-	loss
TARGET-30-PARDYU	1q+	normal
TARGET-30-PARDYU	11q-	normal
TARGET-30-PARDYU	17q+	gain
TARGET-30-PARDYU	%tumor	90.0
TARGET-30-PARDYU	MKI	high
TARGET-30-PAREAG	age	2091
TARGET-30-PAREAG	age group	2-6
TARGET-30-PAREAG	stage	stage 4
TARGET-30-PAREAG	ATRX	normal
TARGET-30-PAREAG	ALK	normal
TARGET-30-PAREAG	MYCN	not amplified
TARGET-30-PAREAG	Histology	unfavorable
TARGET-30-PAREAG	Grade	undifferentiated or poorly differentiated
TARGET-30-PAREAG	Ploidy	hyperdiploid (di>1)
TARGET-30-PAREAG	Protocol	ANBL00B1-ALTE03N1
TARGET-30-PAREAG	Category	unknown
TARGET-30-PAREAG	1p-	normal
TARGET-30-PAREAG	1q+	gain
TARGET-30-PAREAG	11q-	loss
TARGET-30-PAREAG	17q+	gain
TARGET-30-PAREAG	%tumor	90.0
TARGET-30-PAREAG	MKI	
TARGET-30-PAREGK	age	568
TARGET-30-PAREGK	age group	1-2
TARGET-30-PAREGK	stage	stage 4
TARGET-30-PAREGK	ATRX	unknown
TARGET-30-PAREGK	ALK	mutated
TARGET-30-PAREGK	MYCN	not amplified
TARGET-30-PAREGK	Histology	unfavorable
TARGET-30-PAREGK	Grade	undifferentiated or poorly differentiated
TARGET-30-PAREGK	Ploidy	hyperdiploid (di>1)
TARGET-30-PAREGK	Protocol	ANBL00B1
TARGET-30-PAREGK	Category	neuroblastoma
TARGET-30-PAREGK	1p-	normal
TARGET-30-PAREGK	1q+	normal
TARGET-30-PAREGK	11q-	loss
TARGET-30-PAREGK	17q+	gain
TARGET-30-PAREGK	%tumor	50.0
TARGET-30-PAREGK	MKI	high
TARGET-30-PARETE	age	686
TARGET-30-PARETE	age group	1-2
TARGET-30-PARETE	stage	stage 4
TARGET-30-PARETE	ATRX	unknown
TARGET-30-PARETE	ALK	normal
TARGET-30-PARETE	MYCN	amplified
TARGET-30-PARETE	Histology	unfavorable
TARGET-30-PARETE	Grade	undifferentiated or poorly differentiated
TARGET-30-PARETE	Ploidy	hyperdiploid (di>1)
TARGET-30-PARETE	Protocol	ANBL00B1
TARGET-30-PARETE	Category	neuroblastoma
TARGET-30-PARETE	1p-	normal
TARGET-30-PARETE	1q+	normal
TARGET-30-PARETE	11q-	loss
TARGET-30-PARETE	17q+	gain
TARGET-30-PARETE	%tumor	40.0
TARGET-30-PARETE	MKI	intermediate
TARGET-30-PARFBW	age	759
TARGET-30-PARFBW	age group	2-6
TARGET-30-PARFBW	stage	stage 4
TARGET-30-PARFBW	ATRX	unknown
TARGET-30-PARFBW	ALK	
TARGET-30-PARFBW	MYCN	unknown
TARGET-30-PARFBW	Histology	unknown
TARGET-30-PARFBW	Grade	unknown
TARGET-30-PARFBW	Ploidy	unknown
TARGET-30-PARFBW	Protocol	ANBL00B1
TARGET-30-PARFBW	Category	neuroblastoma
TARGET-30-PARFBW	1p-	unknown
TARGET-30-PARFBW	1q+	unknown
TARGET-30-PARFBW	11q-	unknown
TARGET-30-PARFBW	17q+	unknown
TARGET-30-PARFBW	%tumor	80.0
TARGET-30-PARFBW	MKI	
TARGET-30-PARFRE	age	60
TARGET-30-PARFRE	age group	0-1
TARGET-30-PARFRE	stage	stage 4s
TARGET-30-PARFRE	ATRX	unknown
TARGET-30-PARFRE	ALK	
TARGET-30-PARFRE	MYCN	not amplified
TARGET-30-PARFRE	Histology	favorable
TARGET-30-PARFRE	Grade	unknown
TARGET-30-PARFRE	Ploidy	hyperdiploid (di>1)
TARGET-30-PARFRE	Protocol	ANBL00B1
TARGET-30-PARFRE	Category	neuroblastoma
TARGET-30-PARFRE	1p-	unknown
TARGET-30-PARFRE	1q+	unknown
TARGET-30-PARFRE	11q-	unknown
TARGET-30-PARFRE	17q+	unknown
TARGET-30-PARFRE	%tumor	90.0
TARGET-30-PARFRE	MKI	
TARGET-30-PARFWB	age	1555
TARGET-30-PARFWB	age group	2-6
TARGET-30-PARFWB	stage	stage 4
TARGET-30-PARFWB	ATRX	nonsense
TARGET-30-PARFWB	ALK	normal
TARGET-30-PARFWB	MYCN	not amplified
TARGET-30-PARFWB	Histology	unfavorable
TARGET-30-PARFWB	Grade	undifferentiated or poorly differentiated
TARGET-30-PARFWB	Ploidy	diploid (di=1)
TARGET-30-PARFWB	Protocol	ANBL00B1-ADVL0921-ANBL1021
TARGET-30-PARFWB	Category	neuroblastoma
TARGET-30-PARFWB	1p-	normal
TARGET-30-PARFWB	1q+	normal
TARGET-30-PARFWB	11q-	loss
TARGET-30-PARFWB	17q+	gain
TARGET-30-PARFWB	%tumor	90.0
TARGET-30-PARFWB	MKI	low
TARGET-30-PARGDJ	age	1112
TARGET-30-PARGDJ	age group	2-6
TARGET-30-PARGDJ	stage	stage 4
TARGET-30-PARGDJ	ATRX	unknown
TARGET-30-PARGDJ	ALK	
TARGET-30-PARGDJ	MYCN	not amplified
TARGET-30-PARGDJ	Histology	favorable
TARGET-30-PARGDJ	Grade	differentiating
TARGET-30-PARGDJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PARGDJ	Protocol	ANBL00B1-ANBL0421-ADVL0525-ANBL0032
TARGET-30-PARGDJ	Category	neuroblastoma
TARGET-30-PARGDJ	1p-	unknown
TARGET-30-PARGDJ	1q+	unknown
TARGET-30-PARGDJ	11q-	unknown
TARGET-30-PARGDJ	17q+	unknown
TARGET-30-PARGDJ	%tumor	60.0
TARGET-30-PARGDJ	MKI	low
TARGET-30-PARGHY	age	1229
TARGET-30-PARGHY	age group	2-6
TARGET-30-PARGHY	stage	stage 4
TARGET-30-PARGHY	ATRX	unknown
TARGET-30-PARGHY	ALK	normal
TARGET-30-PARGHY	MYCN	not amplified
TARGET-30-PARGHY	Histology	unknown
TARGET-30-PARGHY	Grade	unknown
TARGET-30-PARGHY	Ploidy	hyperdiploid (di>1)
TARGET-30-PARGHY	Protocol	ANBL00B1
TARGET-30-PARGHY	Category	unknown
TARGET-30-PARGHY	1p-	normal
TARGET-30-PARGHY	1q+	normal
TARGET-30-PARGHY	11q-	normal
TARGET-30-PARGHY	17q+	normal
TARGET-30-PARGHY	%tumor	20.0
TARGET-30-PARGHY	MKI	
TARGET-30-PARGKK	age	2241
TARGET-30-PARGKK	age group	6-9
TARGET-30-PARGKK	stage	stage 4
TARGET-30-PARGKK	ATRX	normal
TARGET-30-PARGKK	ALK	normal
TARGET-30-PARGKK	MYCN	not amplified
TARGET-30-PARGKK	Histology	unfavorable
TARGET-30-PARGKK	Grade	differentiating
TARGET-30-PARGKK	Ploidy	diploid (di=1)
TARGET-30-PARGKK	Protocol	ANBL00B1-ADVL0812
TARGET-30-PARGKK	Category	neuroblastoma
TARGET-30-PARGKK	1p-	normal
TARGET-30-PARGKK	1q+	gain
TARGET-30-PARGKK	11q-	loss
TARGET-30-PARGKK	17q+	gain
TARGET-30-PARGKK	%tumor	40.0
TARGET-30-PARGKK	MKI	low
TARGET-30-PARGUX	age	1704
TARGET-30-PARGUX	age group	2-6
TARGET-30-PARGUX	stage	stage 4
TARGET-30-PARGUX	ATRX	unknown
TARGET-30-PARGUX	ALK	normal
TARGET-30-PARGUX	MYCN	not amplified
TARGET-30-PARGUX	Histology	unfavorable
TARGET-30-PARGUX	Grade	undifferentiated or poorly differentiated
TARGET-30-PARGUX	Ploidy	diploid (di=1)
TARGET-30-PARGUX	Protocol	ANBL00B1
TARGET-30-PARGUX	Category	neuroblastoma
TARGET-30-PARGUX	1p-	normal
TARGET-30-PARGUX	1q+	normal
TARGET-30-PARGUX	11q-	loss
TARGET-30-PARGUX	17q+	gain
TARGET-30-PARGUX	%tumor	70.0
TARGET-30-PARGUX	MKI	low
TARGET-30-PARGZK	age	1583
TARGET-30-PARGZK	age group	2-6
TARGET-30-PARGZK	stage	stage 4
TARGET-30-PARGZK	ATRX	unknown
TARGET-30-PARGZK	ALK	normal
TARGET-30-PARGZK	MYCN	amplified
TARGET-30-PARGZK	Histology	unfavorable
TARGET-30-PARGZK	Grade	unknown
TARGET-30-PARGZK	Ploidy	diploid (di=1)
TARGET-30-PARGZK	Protocol	ANBL00B1
TARGET-30-PARGZK	Category	neuroblastoma
TARGET-30-PARGZK	1p-	normal
TARGET-30-PARGZK	1q+	normal
TARGET-30-PARGZK	11q-	normal
TARGET-30-PARGZK	17q+	gain
TARGET-30-PARGZK	%tumor	70.0
TARGET-30-PARGZK	MKI	
TARGET-30-PARHAM	age	341
TARGET-30-PARHAM	age group	0-1
TARGET-30-PARHAM	stage	stage 4
TARGET-30-PARHAM	ATRX	normal
TARGET-30-PARHAM	ALK	
TARGET-30-PARHAM	MYCN	not amplified
TARGET-30-PARHAM	Histology	favorable
TARGET-30-PARHAM	Grade	unknown
TARGET-30-PARHAM	Ploidy	hyperdiploid (di>1)
TARGET-30-PARHAM	Protocol	ANBL00B1
TARGET-30-PARHAM	Category	neuroblastoma
TARGET-30-PARHAM	1p-	unknown
TARGET-30-PARHAM	1q+	unknown
TARGET-30-PARHAM	11q-	unknown
TARGET-30-PARHAM	17q+	unknown
TARGET-30-PARHAM	%tumor	90.0
TARGET-30-PARHAM	MKI	
TARGET-30-PARHDE	age	842
TARGET-30-PARHDE	age group	2-6
TARGET-30-PARHDE	stage	stage 4
TARGET-30-PARHDE	ATRX	unknown
TARGET-30-PARHDE	ALK	normal
TARGET-30-PARHDE	MYCN	amplified
TARGET-30-PARHDE	Histology	unfavorable
TARGET-30-PARHDE	Grade	undifferentiated or poorly differentiated
TARGET-30-PARHDE	Ploidy	hyperdiploid (di>1)
TARGET-30-PARHDE	Protocol	ANBL00B1-ANBL0032
TARGET-30-PARHDE	Category	neuroblastoma
TARGET-30-PARHDE	1p-	normal
TARGET-30-PARHDE	1q+	normal
TARGET-30-PARHDE	11q-	normal
TARGET-30-PARHDE	17q+	normal
TARGET-30-PARHDE	%tumor	40.0
TARGET-30-PARHDE	MKI	high
TARGET-30-PARHUX	age	698
TARGET-30-PARHUX	age group	1-2
TARGET-30-PARHUX	stage	stage 4
TARGET-30-PARHUX	ATRX	unknown
TARGET-30-PARHUX	ALK	normal
TARGET-30-PARHUX	MYCN	amplified
TARGET-30-PARHUX	Histology	unfavorable
TARGET-30-PARHUX	Grade	undifferentiated or poorly differentiated
TARGET-30-PARHUX	Ploidy	hyperdiploid (di>1)
TARGET-30-PARHUX	Protocol	ANBL00B1
TARGET-30-PARHUX	Category	neuroblastoma
TARGET-30-PARHUX	1p-	normal
TARGET-30-PARHUX	1q+	normal
TARGET-30-PARHUX	11q-	normal
TARGET-30-PARHUX	17q+	gain
TARGET-30-PARHUX	%tumor	80.0
TARGET-30-PARHUX	MKI	high
TARGET-30-PARHYL	age	1394
TARGET-30-PARHYL	age group	2-6
TARGET-30-PARHYL	stage	stage 4
TARGET-30-PARHYL	ATRX	unknown
TARGET-30-PARHYL	ALK	
TARGET-30-PARHYL	MYCN	not amplified
TARGET-30-PARHYL	Histology	unfavorable
TARGET-30-PARHYL	Grade	undifferentiated or poorly differentiated
TARGET-30-PARHYL	Ploidy	hyperdiploid (di>1)
TARGET-30-PARHYL	Protocol	ANBL00B1
TARGET-30-PARHYL	Category	neuroblastoma
TARGET-30-PARHYL	1p-	unknown
TARGET-30-PARHYL	1q+	unknown
TARGET-30-PARHYL	11q-	unknown
TARGET-30-PARHYL	17q+	unknown
TARGET-30-PARHYL	%tumor	20.0
TARGET-30-PARHYL	MKI	intermediate
TARGET-30-PARIKF	age	832
TARGET-30-PARIKF	age group	2-6
TARGET-30-PARIKF	stage	stage 4
TARGET-30-PARIKF	ATRX	unknown
TARGET-30-PARIKF	ALK	
TARGET-30-PARIKF	MYCN	amplified
TARGET-30-PARIKF	Histology	unfavorable
TARGET-30-PARIKF	Grade	undifferentiated or poorly differentiated
TARGET-30-PARIKF	Ploidy	diploid (di=1)
TARGET-30-PARIKF	Protocol	ANBL00B1
TARGET-30-PARIKF	Category	neuroblastoma
TARGET-30-PARIKF	1p-	unknown
TARGET-30-PARIKF	1q+	unknown
TARGET-30-PARIKF	11q-	unknown
TARGET-30-PARIKF	17q+	unknown
TARGET-30-PARIKF	%tumor	80.0
TARGET-30-PARIKF	MKI	high
TARGET-30-PARIKT	age	1031
TARGET-30-PARIKT	age group	2-6
TARGET-30-PARIKT	stage	stage 4
TARGET-30-PARIKT	ATRX	unknown
TARGET-30-PARIKT	ALK	
TARGET-30-PARIKT	MYCN	unknown
TARGET-30-PARIKT	Histology	unknown
TARGET-30-PARIKT	Grade	unknown
TARGET-30-PARIKT	Ploidy	unknown
TARGET-30-PARIKT	Protocol	ANBL00B1
TARGET-30-PARIKT	Category	unknown
TARGET-30-PARIKT	1p-	unknown
TARGET-30-PARIKT	1q+	unknown
TARGET-30-PARIKT	11q-	unknown
TARGET-30-PARIKT	17q+	unknown
TARGET-30-PARIKT	%tumor	10.0
TARGET-30-PARIKT	MKI	
TARGET-30-PARIRD	age	733
TARGET-30-PARIRD	age group	2-6
TARGET-30-PARIRD	stage	stage 4
TARGET-30-PARIRD	ATRX	unknown
TARGET-30-PARIRD	ALK	normal
TARGET-30-PARIRD	MYCN	amplified
TARGET-30-PARIRD	Histology	unfavorable
TARGET-30-PARIRD	Grade	unknown
TARGET-30-PARIRD	Ploidy	hyperdiploid (di>1)
TARGET-30-PARIRD	Protocol	ANBL00B1
TARGET-30-PARIRD	Category	neuroblastoma
TARGET-30-PARIRD	1p-	normal
TARGET-30-PARIRD	1q+	normal
TARGET-30-PARIRD	11q-	normal
TARGET-30-PARIRD	17q+	gain
TARGET-30-PARIRD	%tumor	90.0
TARGET-30-PARIRD	MKI	
TARGET-30-PARJAR	age	1459
TARGET-30-PARJAR	age group	2-6
TARGET-30-PARJAR	stage	stage 4
TARGET-30-PARJAR	ATRX	unknown
TARGET-30-PARJAR	ALK	
TARGET-30-PARJAR	MYCN	not amplified
TARGET-30-PARJAR	Histology	unfavorable
TARGET-30-PARJAR	Grade	undifferentiated or poorly differentiated
TARGET-30-PARJAR	Ploidy	hyperdiploid (di>1)
TARGET-30-PARJAR	Protocol	ANBL00B1
TARGET-30-PARJAR	Category	ganglioneuroblastoma, nodular
TARGET-30-PARJAR	1p-	unknown
TARGET-30-PARJAR	1q+	unknown
TARGET-30-PARJAR	11q-	unknown
TARGET-30-PARJAR	17q+	unknown
TARGET-30-PARJAR	%tumor	40.0
TARGET-30-PARJAR	MKI	low
TARGET-30-PARJEN	age	727
TARGET-30-PARJEN	age group	1-2
TARGET-30-PARJEN	stage	stage 4
TARGET-30-PARJEN	ATRX	unknown
TARGET-30-PARJEN	ALK	normal
TARGET-30-PARJEN	MYCN	amplified
TARGET-30-PARJEN	Histology	unfavorable
TARGET-30-PARJEN	Grade	undifferentiated or poorly differentiated
TARGET-30-PARJEN	Ploidy	diploid (di=1)
TARGET-30-PARJEN	Protocol	ANBL00B1
TARGET-30-PARJEN	Category	neuroblastoma
TARGET-30-PARJEN	1p-	normal
TARGET-30-PARJEN	1q+	normal
TARGET-30-PARJEN	11q-	normal
TARGET-30-PARJEN	17q+	normal
TARGET-30-PARJEN	%tumor	80.0
TARGET-30-PARJEN	MKI	intermediate
TARGET-30-PARJMX	age	903
TARGET-30-PARJMX	age group	2-6
TARGET-30-PARJMX	stage	stage 4
TARGET-30-PARJMX	ATRX	unknown
TARGET-30-PARJMX	ALK	normal
TARGET-30-PARJMX	MYCN	not amplified
TARGET-30-PARJMX	Histology	unfavorable
TARGET-30-PARJMX	Grade	undifferentiated or poorly differentiated
TARGET-30-PARJMX	Ploidy	hyperdiploid (di>1)
TARGET-30-PARJMX	Protocol	ANBL00B1-ANBL0032
TARGET-30-PARJMX	Category	neuroblastoma
TARGET-30-PARJMX	1p-	normal
TARGET-30-PARJMX	1q+	normal
TARGET-30-PARJMX	11q-	normal
TARGET-30-PARJMX	17q+	gain
TARGET-30-PARJMX	%tumor	10.0
TARGET-30-PARJMX	MKI	low
TARGET-30-PARJTB	age	656
TARGET-30-PARJTB	age group	1-2
TARGET-30-PARJTB	stage	stage 4
TARGET-30-PARJTB	ATRX	unknown
TARGET-30-PARJTB	ALK	
TARGET-30-PARJTB	MYCN	amplified
TARGET-30-PARJTB	Histology	unfavorable
TARGET-30-PARJTB	Grade	undifferentiated or poorly differentiated
TARGET-30-PARJTB	Ploidy	diploid (di=1)
TARGET-30-PARJTB	Protocol	ANBL00B1-ANBL0032
TARGET-30-PARJTB	Category	neuroblastoma
TARGET-30-PARJTB	1p-	unknown
TARGET-30-PARJTB	1q+	unknown
TARGET-30-PARJTB	11q-	unknown
TARGET-30-PARJTB	17q+	unknown
TARGET-30-PARJTB	%tumor	90.0
TARGET-30-PARJTB	MKI	high
TARGET-30-PARJVP	age	56
TARGET-30-PARJVP	age group	0-1
TARGET-30-PARJVP	stage	stage 4s
TARGET-30-PARJVP	ATRX	normal
TARGET-30-PARJVP	ALK	
TARGET-30-PARJVP	MYCN	not amplified
TARGET-30-PARJVP	Histology	favorable
TARGET-30-PARJVP	Grade	undifferentiated or poorly differentiated
TARGET-30-PARJVP	Ploidy	hyperdiploid (di>1)
TARGET-30-PARJVP	Protocol	ANBL00B1
TARGET-30-PARJVP	Category	neuroblastoma
TARGET-30-PARJVP	1p-	unknown
TARGET-30-PARJVP	1q+	unknown
TARGET-30-PARJVP	11q-	unknown
TARGET-30-PARJVP	17q+	unknown
TARGET-30-PARJVP	%tumor	90.0
TARGET-30-PARJVP	MKI	
TARGET-30-PARKAG	age	1363
TARGET-30-PARKAG	age group	2-6
TARGET-30-PARKAG	stage	stage 4
TARGET-30-PARKAG	ATRX	unknown
TARGET-30-PARKAG	ALK	normal
TARGET-30-PARKAG	MYCN	amplified
TARGET-30-PARKAG	Histology	unknown
TARGET-30-PARKAG	Grade	unknown
TARGET-30-PARKAG	Ploidy	diploid (di=1)
TARGET-30-PARKAG	Protocol	ANBL00B1-ANBL0421-ADVL0821
TARGET-30-PARKAG	Category	neuroblastoma
TARGET-30-PARKAG	1p-	loss
TARGET-30-PARKAG	1q+	normal
TARGET-30-PARKAG	11q-	normal
TARGET-30-PARKAG	17q+	normal
TARGET-30-PARKAG	%tumor	70.0
TARGET-30-PARKAG	MKI	
TARGET-30-PARKGJ	age	1616
TARGET-30-PARKGJ	age group	2-6
TARGET-30-PARKGJ	stage	stage 4
TARGET-30-PARKGJ	ATRX	normal
TARGET-30-PARKGJ	ALK	normal
TARGET-30-PARKGJ	MYCN	not amplified
TARGET-30-PARKGJ	Histology	unfavorable
TARGET-30-PARKGJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PARKGJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PARKGJ	Protocol	ANBL00B1
TARGET-30-PARKGJ	Category	neuroblastoma
TARGET-30-PARKGJ	1p-	normal
TARGET-30-PARKGJ	1q+	normal
TARGET-30-PARKGJ	11q-	loss
TARGET-30-PARKGJ	17q+	gain
TARGET-30-PARKGJ	%tumor	80.0
TARGET-30-PARKGJ	MKI	high
TARGET-30-PARKNP	age	3214
TARGET-30-PARKNP	age group	6-9
TARGET-30-PARKNP	stage	stage 4
TARGET-30-PARKNP	ATRX	deleted
TARGET-30-PARKNP	ALK	mutated
TARGET-30-PARKNP	MYCN	not amplified
TARGET-30-PARKNP	Histology	unfavorable
TARGET-30-PARKNP	Grade	undifferentiated or poorly differentiated
TARGET-30-PARKNP	Ploidy	diploid (di=1)
TARGET-30-PARKNP	Protocol	ANBL00B1
TARGET-30-PARKNP	Category	neuroblastoma
TARGET-30-PARKNP	1p-	normal
TARGET-30-PARKNP	1q+	normal
TARGET-30-PARKNP	11q-	normal
TARGET-30-PARKNP	17q+	gain
TARGET-30-PARKNP	%tumor	80.0
TARGET-30-PARKNP	MKI	low
TARGET-30-PARKZF	age	730
TARGET-30-PARKZF	age group	1-2
TARGET-30-PARKZF	stage	stage 4
TARGET-30-PARKZF	ATRX	unknown
TARGET-30-PARKZF	ALK	normal
TARGET-30-PARKZF	MYCN	amplified
TARGET-30-PARKZF	Histology	unfavorable
TARGET-30-PARKZF	Grade	undifferentiated or poorly differentiated
TARGET-30-PARKZF	Ploidy	diploid (di=1)
TARGET-30-PARKZF	Protocol	ANBL00B1
TARGET-30-PARKZF	Category	neuroblastoma
TARGET-30-PARKZF	1p-	loss
TARGET-30-PARKZF	1q+	normal
TARGET-30-PARKZF	11q-	normal
TARGET-30-PARKZF	17q+	gain
TARGET-30-PARKZF	%tumor	90.0
TARGET-30-PARKZF	MKI	high
TARGET-30-PARLMK	age	1597
TARGET-30-PARLMK	age group	2-6
TARGET-30-PARLMK	stage	stage 4
TARGET-30-PARLMK	ATRX	unknown
TARGET-30-PARLMK	ALK	normal
TARGET-30-PARLMK	MYCN	not amplified
TARGET-30-PARLMK	Histology	unfavorable
TARGET-30-PARLMK	Grade	undifferentiated or poorly differentiated
TARGET-30-PARLMK	Ploidy	hyperdiploid (di>1)
TARGET-30-PARLMK	Protocol	ANBL00B1-ACCL05C1-ANBL0421-ANBL0032
TARGET-30-PARLMK	Category	ganglioneuroblastoma, nodular
TARGET-30-PARLMK	1p-	normal
TARGET-30-PARLMK	1q+	normal
TARGET-30-PARLMK	11q-	normal
TARGET-30-PARLMK	17q+	normal
TARGET-30-PARLMK	%tumor	85.0
TARGET-30-PARLMK	MKI	low
TARGET-30-PARLTG	age	2436
TARGET-30-PARLTG	age group	6-9
TARGET-30-PARLTG	stage	stage 4
TARGET-30-PARLTG	ATRX	unknown
TARGET-30-PARLTG	ALK	mutated
TARGET-30-PARLTG	MYCN	not amplified
TARGET-30-PARLTG	Histology	unfavorable
TARGET-30-PARLTG	Grade	undifferentiated or poorly differentiated
TARGET-30-PARLTG	Ploidy	diploid (di=1)
TARGET-30-PARLTG	Protocol	ANBL00B1
TARGET-30-PARLTG	Category	ganglioneuroblastoma, nodular
TARGET-30-PARLTG	1p-	normal
TARGET-30-PARLTG	1q+	normal
TARGET-30-PARLTG	11q-	normal
TARGET-30-PARLTG	17q+	gain
TARGET-30-PARLTG	%tumor	90.0
TARGET-30-PARLTG	MKI	low
TARGET-30-PARMDD	age	1180
TARGET-30-PARMDD	age group	2-6
TARGET-30-PARMDD	stage	stage 4
TARGET-30-PARMDD	ATRX	normal
TARGET-30-PARMDD	ALK	normal
TARGET-30-PARMDD	MYCN	not amplified
TARGET-30-PARMDD	Histology	unfavorable
TARGET-30-PARMDD	Grade	undifferentiated or poorly differentiated
TARGET-30-PARMDD	Ploidy	diploid (di=1)
TARGET-30-PARMDD	Protocol	ANBL00B1-ACCL05C1-ANBL0032
TARGET-30-PARMDD	Category	neuroblastoma
TARGET-30-PARMDD	1p-	normal
TARGET-30-PARMDD	1q+	normal
TARGET-30-PARMDD	11q-	normal
TARGET-30-PARMDD	17q+	normal
TARGET-30-PARMDD	%tumor	0.0
TARGET-30-PARMDD	MKI	intermediate
TARGET-30-PARMFA	age	1205
TARGET-30-PARMFA	age group	2-6
TARGET-30-PARMFA	stage	stage 4
TARGET-30-PARMFA	ATRX	unknown
TARGET-30-PARMFA	ALK	
TARGET-30-PARMFA	MYCN	not amplified
TARGET-30-PARMFA	Histology	unfavorable
TARGET-30-PARMFA	Grade	unknown
TARGET-30-PARMFA	Ploidy	diploid (di=1)
TARGET-30-PARMFA	Protocol	ANBL00B1-ACCL05C1
TARGET-30-PARMFA	Category	ganglioneuroblastoma, nodular
TARGET-30-PARMFA	1p-	unknown
TARGET-30-PARMFA	1q+	unknown
TARGET-30-PARMFA	11q-	unknown
TARGET-30-PARMFA	17q+	unknown
TARGET-30-PARMFA	%tumor	40.0
TARGET-30-PARMFA	MKI	
TARGET-30-PARMLF	age	2512
TARGET-30-PARMLF	age group	6-9
TARGET-30-PARMLF	stage	stage 4
TARGET-30-PARMLF	ATRX	deleted
TARGET-30-PARMLF	ALK	normal
TARGET-30-PARMLF	MYCN	not amplified
TARGET-30-PARMLF	Histology	unfavorable
TARGET-30-PARMLF	Grade	undifferentiated or poorly differentiated
TARGET-30-PARMLF	Ploidy	diploid (di=1)
TARGET-30-PARMLF	Protocol	ANBL00B1-ANBL0032
TARGET-30-PARMLF	Category	neuroblastoma
TARGET-30-PARMLF	1p-	normal
TARGET-30-PARMLF	1q+	normal
TARGET-30-PARMLF	11q-	loss
TARGET-30-PARMLF	17q+	gain
TARGET-30-PARMLF	%tumor	10.0
TARGET-30-PARMLF	MKI	low
TARGET-30-PARMPP	age	1370
TARGET-30-PARMPP	age group	2-6
TARGET-30-PARMPP	stage	stage 4
TARGET-30-PARMPP	ATRX	unknown
TARGET-30-PARMPP	ALK	normal
TARGET-30-PARMPP	MYCN	not amplified
TARGET-30-PARMPP	Histology	unfavorable
TARGET-30-PARMPP	Grade	undifferentiated or poorly differentiated
TARGET-30-PARMPP	Ploidy	hyperdiploid (di>1)
TARGET-30-PARMPP	Protocol	ANBL00B1
TARGET-30-PARMPP	Category	ganglioneuroblastoma, nodular
TARGET-30-PARMPP	1p-	normal
TARGET-30-PARMPP	1q+	normal
TARGET-30-PARMPP	11q-	loss
TARGET-30-PARMPP	17q+	gain
TARGET-30-PARMPP	%tumor	70.0
TARGET-30-PARMPP	MKI	high
TARGET-30-PARMTT	age	945
TARGET-30-PARMTT	age group	2-6
TARGET-30-PARMTT	stage	stage 4
TARGET-30-PARMTT	ATRX	unknown
TARGET-30-PARMTT	ALK	
TARGET-30-PARMTT	MYCN	not amplified
TARGET-30-PARMTT	Histology	unfavorable
TARGET-30-PARMTT	Grade	undifferentiated or poorly differentiated
TARGET-30-PARMTT	Ploidy	hyperdiploid (di>1)
TARGET-30-PARMTT	Protocol	ANBL00B1
TARGET-30-PARMTT	Category	ganglioneuroblastoma, nodular
TARGET-30-PARMTT	1p-	unknown
TARGET-30-PARMTT	1q+	unknown
TARGET-30-PARMTT	11q-	unknown
TARGET-30-PARMTT	17q+	unknown
TARGET-30-PARMTT	%tumor	
TARGET-30-PARMTT	MKI	high
TARGET-30-PARNCW	age	1639
TARGET-30-PARNCW	age group	2-6
TARGET-30-PARNCW	stage	stage 4
TARGET-30-PARNCW	ATRX	unknown
TARGET-30-PARNCW	ALK	
TARGET-30-PARNCW	MYCN	not amplified
TARGET-30-PARNCW	Histology	unfavorable
TARGET-30-PARNCW	Grade	undifferentiated or poorly differentiated
TARGET-30-PARNCW	Ploidy	diploid (di=1)
TARGET-30-PARNCW	Protocol	ANBL00B1
TARGET-30-PARNCW	Category	neuroblastoma
TARGET-30-PARNCW	1p-	unknown
TARGET-30-PARNCW	1q+	unknown
TARGET-30-PARNCW	11q-	unknown
TARGET-30-PARNCW	17q+	unknown
TARGET-30-PARNCW	%tumor	90.0
TARGET-30-PARNCW	MKI	low
TARGET-30-PARNEE	age	1071
TARGET-30-PARNEE	age group	2-6
TARGET-30-PARNEE	stage	stage 4
TARGET-30-PARNEE	ATRX	unknown
TARGET-30-PARNEE	ALK	
TARGET-30-PARNEE	MYCN	amplified
TARGET-30-PARNEE	Histology	unfavorable
TARGET-30-PARNEE	Grade	undifferentiated or poorly differentiated
TARGET-30-PARNEE	Ploidy	diploid (di=1)
TARGET-30-PARNEE	Protocol	ANBL00B1
TARGET-30-PARNEE	Category	neuroblastoma
TARGET-30-PARNEE	1p-	unknown
TARGET-30-PARNEE	1q+	unknown
TARGET-30-PARNEE	11q-	unknown
TARGET-30-PARNEE	17q+	unknown
TARGET-30-PARNEE	%tumor	40.0
TARGET-30-PARNEE	MKI	intermediate
TARGET-30-PARNLJ	age	662
TARGET-30-PARNLJ	age group	1-2
TARGET-30-PARNLJ	stage	stage 4
TARGET-30-PARNLJ	ATRX	unknown
TARGET-30-PARNLJ	ALK	normal
TARGET-30-PARNLJ	MYCN	amplified
TARGET-30-PARNLJ	Histology	unfavorable
TARGET-30-PARNLJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PARNLJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PARNLJ	Protocol	ANBL00B1-ANBL0032
TARGET-30-PARNLJ	Category	neuroblastoma
TARGET-30-PARNLJ	1p-	normal
TARGET-30-PARNLJ	1q+	normal
TARGET-30-PARNLJ	11q-	normal
TARGET-30-PARNLJ	17q+	normal
TARGET-30-PARNLJ	%tumor	25.0
TARGET-30-PARNLJ	MKI	high
TARGET-30-PARNNC	age	41
TARGET-30-PARNNC	age group	0-1
TARGET-30-PARNNC	stage	stage 4s
TARGET-30-PARNNC	ATRX	normal
TARGET-30-PARNNC	ALK	
TARGET-30-PARNNC	MYCN	not amplified
TARGET-30-PARNNC	Histology	favorable
TARGET-30-PARNNC	Grade	undifferentiated or poorly differentiated
TARGET-30-PARNNC	Ploidy	hyperdiploid (di>1)
TARGET-30-PARNNC	Protocol	ANBL00B1
TARGET-30-PARNNC	Category	neuroblastoma
TARGET-30-PARNNC	1p-	unknown
TARGET-30-PARNNC	1q+	unknown
TARGET-30-PARNNC	11q-	unknown
TARGET-30-PARNNC	17q+	unknown
TARGET-30-PARNNC	%tumor	
TARGET-30-PARNNC	MKI	low
TARGET-30-PARNNG	age	1336
TARGET-30-PARNNG	age group	2-6
TARGET-30-PARNNG	stage	stage 4
TARGET-30-PARNNG	ATRX	unknown
TARGET-30-PARNNG	ALK	normal
TARGET-30-PARNNG	MYCN	not amplified
TARGET-30-PARNNG	Histology	unfavorable
TARGET-30-PARNNG	Grade	undifferentiated or poorly differentiated
TARGET-30-PARNNG	Ploidy	hyperdiploid (di>1)
TARGET-30-PARNNG	Protocol	ANBL00B1-ANBL0532-ANBL0531
TARGET-30-PARNNG	Category	neuroblastoma
TARGET-30-PARNNG	1p-	normal
TARGET-30-PARNNG	1q+	gain
TARGET-30-PARNNG	11q-	normal
TARGET-30-PARNNG	17q+	gain
TARGET-30-PARNNG	%tumor	70.0
TARGET-30-PARNNG	MKI	low
TARGET-30-PARNTS	age	1035
TARGET-30-PARNTS	age group	2-6
TARGET-30-PARNTS	stage	stage 4
TARGET-30-PARNTS	ATRX	unknown
TARGET-30-PARNTS	ALK	normal
TARGET-30-PARNTS	MYCN	amplified
TARGET-30-PARNTS	Histology	unfavorable
TARGET-30-PARNTS	Grade	undifferentiated or poorly differentiated
TARGET-30-PARNTS	Ploidy	hyperdiploid (di>1)
TARGET-30-PARNTS	Protocol	ANBL00B1
TARGET-30-PARNTS	Category	neuroblastoma
TARGET-30-PARNTS	1p-	normal
TARGET-30-PARNTS	1q+	gain
TARGET-30-PARNTS	11q-	loss
TARGET-30-PARNTS	17q+	normal
TARGET-30-PARNTS	%tumor	80.0
TARGET-30-PARNTS	MKI	high
TARGET-30-PARPGU	age	1145
TARGET-30-PARPGU	age group	2-6
TARGET-30-PARPGU	stage	stage 4
TARGET-30-PARPGU	ATRX	normal
TARGET-30-PARPGU	ALK	normal
TARGET-30-PARPGU	MYCN	unknown
TARGET-30-PARPGU	Histology	unfavorable
TARGET-30-PARPGU	Grade	undifferentiated or poorly differentiated
TARGET-30-PARPGU	Ploidy	unknown
TARGET-30-PARPGU	Protocol	ANBL00B1
TARGET-30-PARPGU	Category	neuroblastoma
TARGET-30-PARPGU	1p-	normal
TARGET-30-PARPGU	1q+	normal
TARGET-30-PARPGU	11q-	normal
TARGET-30-PARPGU	17q+	normal
TARGET-30-PARPGU	%tumor	
TARGET-30-PARPGU	MKI	
TARGET-30-PARRBU	age	1448
TARGET-30-PARRBU	age group	2-6
TARGET-30-PARRBU	stage	stage 4
TARGET-30-PARRBU	ATRX	unknown
TARGET-30-PARRBU	ALK	normal
TARGET-30-PARRBU	MYCN	amplified
TARGET-30-PARRBU	Histology	unfavorable
TARGET-30-PARRBU	Grade	undifferentiated or poorly differentiated
TARGET-30-PARRBU	Ploidy	hyperdiploid (di>1)
TARGET-30-PARRBU	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PARRBU	Category	neuroblastoma
TARGET-30-PARRBU	1p-	loss
TARGET-30-PARRBU	1q+	normal
TARGET-30-PARRBU	11q-	normal
TARGET-30-PARRBU	17q+	gain
TARGET-30-PARRBU	%tumor	80.0
TARGET-30-PARRBU	MKI	high
TARGET-30-PARRLH	age	1299
TARGET-30-PARRLH	age group	2-6
TARGET-30-PARRLH	stage	stage 4
TARGET-30-PARRLH	ATRX	unknown
TARGET-30-PARRLH	ALK	normal
TARGET-30-PARRLH	MYCN	not amplified
TARGET-30-PARRLH	Histology	unfavorable
TARGET-30-PARRLH	Grade	undifferentiated or poorly differentiated
TARGET-30-PARRLH	Ploidy	diploid (di=1)
TARGET-30-PARRLH	Protocol	ANBL00B1
TARGET-30-PARRLH	Category	neuroblastoma
TARGET-30-PARRLH	1p-	loss
TARGET-30-PARRLH	1q+	normal
TARGET-30-PARRLH	11q-	loss
TARGET-30-PARRLH	17q+	gain
TARGET-30-PARRLH	%tumor	90.0
TARGET-30-PARRLH	MKI	high
TARGET-30-PARSBI	age	2390
TARGET-30-PARSBI	age group	6-9
TARGET-30-PARSBI	stage	stage 4
TARGET-30-PARSBI	ATRX	normal
TARGET-30-PARSBI	ALK	normal
TARGET-30-PARSBI	MYCN	not amplified
TARGET-30-PARSBI	Histology	unfavorable
TARGET-30-PARSBI	Grade	undifferentiated or poorly differentiated
TARGET-30-PARSBI	Ploidy	hyperdiploid (di>1)
TARGET-30-PARSBI	Protocol	ANBL00B1-ADVL0921-ANBL1021
TARGET-30-PARSBI	Category	neuroblastoma
TARGET-30-PARSBI	1p-	loss
TARGET-30-PARSBI	1q+	normal
TARGET-30-PARSBI	11q-	loss
TARGET-30-PARSBI	17q+	gain
TARGET-30-PARSBI	%tumor	90.0
TARGET-30-PARSBI	MKI	low
TARGET-30-PARSEA	age	1779
TARGET-30-PARSEA	age group	2-6
TARGET-30-PARSEA	stage	stage 4
TARGET-30-PARSEA	ATRX	unknown
TARGET-30-PARSEA	ALK	
TARGET-30-PARSEA	MYCN	not amplified
TARGET-30-PARSEA	Histology	unfavorable
TARGET-30-PARSEA	Grade	undifferentiated or poorly differentiated
TARGET-30-PARSEA	Ploidy	diploid (di=1)
TARGET-30-PARSEA	Protocol	ANBL00B1
TARGET-30-PARSEA	Category	ganglioneuroblastoma, nodular
TARGET-30-PARSEA	1p-	unknown
TARGET-30-PARSEA	1q+	unknown
TARGET-30-PARSEA	11q-	unknown
TARGET-30-PARSEA	17q+	unknown
TARGET-30-PARSEA	%tumor	40.0
TARGET-30-PARSEA	MKI	intermediate
TARGET-30-PARSHT	age	752
TARGET-30-PARSHT	age group	2-6
TARGET-30-PARSHT	stage	stage 4
TARGET-30-PARSHT	ATRX	unknown
TARGET-30-PARSHT	ALK	normal
TARGET-30-PARSHT	MYCN	amplified
TARGET-30-PARSHT	Histology	unfavorable
TARGET-30-PARSHT	Grade	undifferentiated or poorly differentiated
TARGET-30-PARSHT	Ploidy	hyperdiploid (di>1)
TARGET-30-PARSHT	Protocol	ANBL00B1-ANBL0032
TARGET-30-PARSHT	Category	neuroblastoma
TARGET-30-PARSHT	1p-	loss
TARGET-30-PARSHT	1q+	normal
TARGET-30-PARSHT	11q-	normal
TARGET-30-PARSHT	17q+	gain
TARGET-30-PARSHT	%tumor	90.0
TARGET-30-PARSHT	MKI	intermediate
TARGET-30-PARSRJ	age	1905
TARGET-30-PARSRJ	age group	2-6
TARGET-30-PARSRJ	stage	stage 4
TARGET-30-PARSRJ	ATRX	normal
TARGET-30-PARSRJ	ALK	normal
TARGET-30-PARSRJ	MYCN	amplified
TARGET-30-PARSRJ	Histology	unfavorable
TARGET-30-PARSRJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PARSRJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PARSRJ	Protocol	ANBL00B1
TARGET-30-PARSRJ	Category	neuroblastoma
TARGET-30-PARSRJ	1p-	normal
TARGET-30-PARSRJ	1q+	gain
TARGET-30-PARSRJ	11q-	loss
TARGET-30-PARSRJ	17q+	gain
TARGET-30-PARSRJ	%tumor	5.0
TARGET-30-PARSRJ	MKI	intermediate
TARGET-30-PARUPN	age	3636
TARGET-30-PARUPN	age group	9-
TARGET-30-PARUPN	stage	stage 4
TARGET-30-PARUPN	ATRX	normal
TARGET-30-PARUPN	ALK	normal
TARGET-30-PARUPN	MYCN	unknown
TARGET-30-PARUPN	Histology	unfavorable
TARGET-30-PARUPN	Grade	undifferentiated or poorly differentiated
TARGET-30-PARUPN	Ploidy	diploid (di=1)
TARGET-30-PARUPN	Protocol	ANBL00B1
TARGET-30-PARUPN	Category	neuroblastoma
TARGET-30-PARUPN	1p-	normal
TARGET-30-PARUPN	1q+	normal
TARGET-30-PARUPN	11q-	normal
TARGET-30-PARUPN	17q+	normal
TARGET-30-PARUPN	%tumor	20.0
TARGET-30-PARUPN	MKI	intermediate
TARGET-30-PARURB	age	2178
TARGET-30-PARURB	age group	2-6
TARGET-30-PARURB	stage	stage 4
TARGET-30-PARURB	ATRX	normal
TARGET-30-PARURB	ALK	mutated
TARGET-30-PARURB	MYCN	not amplified
TARGET-30-PARURB	Histology	unfavorable
TARGET-30-PARURB	Grade	undifferentiated or poorly differentiated
TARGET-30-PARURB	Ploidy	hyperdiploid (di>1)
TARGET-30-PARURB	Protocol	ANBL00B1-ACCL05C1-ANBL0032
TARGET-30-PARURB	Category	neuroblastoma
TARGET-30-PARURB	1p-	normal
TARGET-30-PARURB	1q+	gain
TARGET-30-PARURB	11q-	normal
TARGET-30-PARURB	17q+	normal
TARGET-30-PARURB	%tumor	0.0
TARGET-30-PARURB	MKI	low
TARGET-30-PARUXY	age	1767
TARGET-30-PARUXY	age group	2-6
TARGET-30-PARUXY	stage	stage 4
TARGET-30-PARUXY	ATRX	unknown
TARGET-30-PARUXY	ALK	
TARGET-30-PARUXY	MYCN	unknown
TARGET-30-PARUXY	Histology	unknown
TARGET-30-PARUXY	Grade	unknown
TARGET-30-PARUXY	Ploidy	unknown
TARGET-30-PARUXY	Protocol	ANBL00B1-ANBL0421
TARGET-30-PARUXY	Category	unknown
TARGET-30-PARUXY	1p-	unknown
TARGET-30-PARUXY	1q+	unknown
TARGET-30-PARUXY	11q-	unknown
TARGET-30-PARUXY	17q+	unknown
TARGET-30-PARUXY	%tumor	30.0
TARGET-30-PARUXY	MKI	
TARGET-30-PARVFJ	age	1364
TARGET-30-PARVFJ	age group	2-6
TARGET-30-PARVFJ	stage	stage 4
TARGET-30-PARVFJ	ATRX	unknown
TARGET-30-PARVFJ	ALK	normal
TARGET-30-PARVFJ	MYCN	not amplified
TARGET-30-PARVFJ	Histology	unfavorable
TARGET-30-PARVFJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PARVFJ	Ploidy	diploid (di=1)
TARGET-30-PARVFJ	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PARVFJ	Category	neuroblastoma
TARGET-30-PARVFJ	1p-	normal
TARGET-30-PARVFJ	1q+	normal
TARGET-30-PARVFJ	11q-	normal
TARGET-30-PARVFJ	17q+	normal
TARGET-30-PARVFJ	%tumor	70.0
TARGET-30-PARVFJ	MKI	low
TARGET-30-PARVLK	age	6021
TARGET-30-PARVLK	age group	9-
TARGET-30-PARVLK	stage	stage 4
TARGET-30-PARVLK	ATRX	unknown
TARGET-30-PARVLK	ALK	mutated
TARGET-30-PARVLK	MYCN	not amplified
TARGET-30-PARVLK	Histology	unknown
TARGET-30-PARVLK	Grade	unknown
TARGET-30-PARVLK	Ploidy	hyperdiploid (di>1)
TARGET-30-PARVLK	Protocol	ANBL00B1
TARGET-30-PARVLK	Category	ganglioneuroblastoma, intermixed
TARGET-30-PARVLK	1p-	normal
TARGET-30-PARVLK	1q+	gain
TARGET-30-PARVLK	11q-	normal
TARGET-30-PARVLK	17q+	gain
TARGET-30-PARVLK	%tumor	70.0
TARGET-30-PARVLK	MKI	
TARGET-30-PARVME	age	1495
TARGET-30-PARVME	age group	2-6
TARGET-30-PARVME	stage	stage 4
TARGET-30-PARVME	ATRX	unknown
TARGET-30-PARVME	ALK	
TARGET-30-PARVME	MYCN	not amplified
TARGET-30-PARVME	Histology	unfavorable
TARGET-30-PARVME	Grade	undifferentiated or poorly differentiated
TARGET-30-PARVME	Ploidy	hyperdiploid (di>1)
TARGET-30-PARVME	Protocol	ANBL00B1
TARGET-30-PARVME	Category	neuroblastoma
TARGET-30-PARVME	1p-	unknown
TARGET-30-PARVME	1q+	unknown
TARGET-30-PARVME	11q-	unknown
TARGET-30-PARVME	17q+	unknown
TARGET-30-PARVME	%tumor	70.0
TARGET-30-PARVME	MKI	high
TARGET-30-PARVNT	age	2487
TARGET-30-PARVNT	age group	6-9
TARGET-30-PARVNT	stage	stage 4
TARGET-30-PARVNT	ATRX	unknown
TARGET-30-PARVNT	ALK	normal
TARGET-30-PARVNT	MYCN	not amplified
TARGET-30-PARVNT	Histology	unfavorable
TARGET-30-PARVNT	Grade	undifferentiated or poorly differentiated
TARGET-30-PARVNT	Ploidy	hyperdiploid (di>1)
TARGET-30-PARVNT	Protocol	ANBL00B1
TARGET-30-PARVNT	Category	ganglioneuroblastoma, nodular
TARGET-30-PARVNT	1p-	normal
TARGET-30-PARVNT	1q+	gain
TARGET-30-PARVNT	11q-	normal
TARGET-30-PARVNT	17q+	gain
TARGET-30-PARVNT	%tumor	10.0
TARGET-30-PARVNT	MKI	high
TARGET-30-PARVRR	age	705
TARGET-30-PARVRR	age group	1-2
TARGET-30-PARVRR	stage	stage 4
TARGET-30-PARVRR	ATRX	unknown
TARGET-30-PARVRR	ALK	
TARGET-30-PARVRR	MYCN	amplified
TARGET-30-PARVRR	Histology	unfavorable
TARGET-30-PARVRR	Grade	undifferentiated or poorly differentiated
TARGET-30-PARVRR	Ploidy	hyperdiploid (di>1)
TARGET-30-PARVRR	Protocol	ANBL00B1
TARGET-30-PARVRR	Category	neuroblastoma
TARGET-30-PARVRR	1p-	unknown
TARGET-30-PARVRR	1q+	unknown
TARGET-30-PARVRR	11q-	unknown
TARGET-30-PARVRR	17q+	unknown
TARGET-30-PARVRR	%tumor	60.0
TARGET-30-PARVRR	MKI	intermediate
TARGET-30-PARXLM	age	658
TARGET-30-PARXLM	age group	1-2
TARGET-30-PARXLM	stage	stage 4
TARGET-30-PARXLM	ATRX	unknown
TARGET-30-PARXLM	ALK	
TARGET-30-PARXLM	MYCN	not amplified
TARGET-30-PARXLM	Histology	unfavorable
TARGET-30-PARXLM	Grade	undifferentiated or poorly differentiated
TARGET-30-PARXLM	Ploidy	hyperdiploid (di>1)
TARGET-30-PARXLM	Protocol	ANBL00B1-ANBL0532
TARGET-30-PARXLM	Category	neuroblastoma
TARGET-30-PARXLM	1p-	unknown
TARGET-30-PARXLM	1q+	unknown
TARGET-30-PARXLM	11q-	unknown
TARGET-30-PARXLM	17q+	unknown
TARGET-30-PARXLM	%tumor	30.0
TARGET-30-PARXLM	MKI	intermediate
TARGET-30-PARXZR	age	1126
TARGET-30-PARXZR	age group	2-6
TARGET-30-PARXZR	stage	stage 4
TARGET-30-PARXZR	ATRX	unknown
TARGET-30-PARXZR	ALK	
TARGET-30-PARXZR	MYCN	not amplified
TARGET-30-PARXZR	Histology	unfavorable
TARGET-30-PARXZR	Grade	undifferentiated or poorly differentiated
TARGET-30-PARXZR	Ploidy	hyperdiploid (di>1)
TARGET-30-PARXZR	Protocol	ANBL00B1-ANBL0532-ACCL05C1
TARGET-30-PARXZR	Category	neuroblastoma
TARGET-30-PARXZR	1p-	unknown
TARGET-30-PARXZR	1q+	unknown
TARGET-30-PARXZR	11q-	unknown
TARGET-30-PARXZR	17q+	unknown
TARGET-30-PARXZR	%tumor	5.0
TARGET-30-PARXZR	MKI	low
TARGET-30-PARYMN	age	1599
TARGET-30-PARYMN	age group	2-6
TARGET-30-PARYMN	stage	stage 4
TARGET-30-PARYMN	ATRX	unknown
TARGET-30-PARYMN	ALK	
TARGET-30-PARYMN	MYCN	not amplified
TARGET-30-PARYMN	Histology	unfavorable
TARGET-30-PARYMN	Grade	undifferentiated or poorly differentiated
TARGET-30-PARYMN	Ploidy	hyperdiploid (di>1)
TARGET-30-PARYMN	Protocol	ANBL00B1-ANBL0532-AEPI07N1-ADVL0921
TARGET-30-PARYMN	Category	neuroblastoma
TARGET-30-PARYMN	1p-	unknown
TARGET-30-PARYMN	1q+	unknown
TARGET-30-PARYMN	11q-	unknown
TARGET-30-PARYMN	17q+	unknown
TARGET-30-PARYMN	%tumor	90.0
TARGET-30-PARYMN	MKI	intermediate
TARGET-30-PARYNK	age	2279
TARGET-30-PARYNK	age group	6-9
TARGET-30-PARYNK	stage	stage 4
TARGET-30-PARYNK	ATRX	deleted
TARGET-30-PARYNK	ALK	normal
TARGET-30-PARYNK	MYCN	not amplified
TARGET-30-PARYNK	Histology	unfavorable
TARGET-30-PARYNK	Grade	undifferentiated or poorly differentiated
TARGET-30-PARYNK	Ploidy	diploid (di=1)
TARGET-30-PARYNK	Protocol	ANBL00B1-ANBL0532
TARGET-30-PARYNK	Category	neuroblastoma
TARGET-30-PARYNK	1p-	normal
TARGET-30-PARYNK	1q+	normal
TARGET-30-PARYNK	11q-	loss
TARGET-30-PARYNK	17q+	gain
TARGET-30-PARYNK	%tumor	90.0
TARGET-30-PARYNK	MKI	intermediate
TARGET-30-PARYXW	age	2208
TARGET-30-PARYXW	age group	6-9
TARGET-30-PARYXW	stage	stage 4
TARGET-30-PARYXW	ATRX	normal
TARGET-30-PARYXW	ALK	normal
TARGET-30-PARYXW	MYCN	amplified
TARGET-30-PARYXW	Histology	unfavorable
TARGET-30-PARYXW	Grade	undifferentiated or poorly differentiated
TARGET-30-PARYXW	Ploidy	hyperdiploid (di>1)
TARGET-30-PARYXW	Protocol	ANBL00B1
TARGET-30-PARYXW	Category	ganglioneuroblastoma, nodular
TARGET-30-PARYXW	1p-	normal
TARGET-30-PARYXW	1q+	gain
TARGET-30-PARYXW	11q-	loss
TARGET-30-PARYXW	17q+	gain
TARGET-30-PARYXW	%tumor	90.0
TARGET-30-PARYXW	MKI	low
TARGET-30-PARZCJ	age	242
TARGET-30-PARZCJ	age group	0-1
TARGET-30-PARZCJ	stage	stage 3
TARGET-30-PARZCJ	ATRX	unknown
TARGET-30-PARZCJ	ALK	
TARGET-30-PARZCJ	MYCN	not amplified
TARGET-30-PARZCJ	Histology	favorable
TARGET-30-PARZCJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PARZCJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PARZCJ	Protocol	ANBL00B1-ANBL0531-AEPI07N1
TARGET-30-PARZCJ	Category	neuroblastoma
TARGET-30-PARZCJ	1p-	unknown
TARGET-30-PARZCJ	1q+	unknown
TARGET-30-PARZCJ	11q-	unknown
TARGET-30-PARZCJ	17q+	unknown
TARGET-30-PARZCJ	%tumor	70.0
TARGET-30-PARZCJ	MKI	low
TARGET-30-PARZHA	age	3
TARGET-30-PARZHA	age group	0-1
TARGET-30-PARZHA	stage	stage 4s
TARGET-30-PARZHA	ATRX	normal
TARGET-30-PARZHA	ALK	
TARGET-30-PARZHA	MYCN	not amplified
TARGET-30-PARZHA	Histology	favorable
TARGET-30-PARZHA	Grade	undifferentiated or poorly differentiated
TARGET-30-PARZHA	Ploidy	hyperdiploid (di>1)
TARGET-30-PARZHA	Protocol	ANBL00B1
TARGET-30-PARZHA	Category	neuroblastoma
TARGET-30-PARZHA	1p-	unknown
TARGET-30-PARZHA	1q+	unknown
TARGET-30-PARZHA	11q-	unknown
TARGET-30-PARZHA	17q+	unknown
TARGET-30-PARZHA	%tumor	90.0
TARGET-30-PARZHA	MKI	low
TARGET-30-PARZIP	age	2273
TARGET-30-PARZIP	age group	6-9
TARGET-30-PARZIP	stage	stage 4
TARGET-30-PARZIP	ATRX	normal
TARGET-30-PARZIP	ALK	mutated
TARGET-30-PARZIP	MYCN	not amplified
TARGET-30-PARZIP	Histology	unfavorable
TARGET-30-PARZIP	Grade	undifferentiated or poorly differentiated
TARGET-30-PARZIP	Ploidy	hyperdiploid (di>1)
TARGET-30-PARZIP	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PARZIP	Category	neuroblastoma
TARGET-30-PARZIP	1p-	normal
TARGET-30-PARZIP	1q+	normal
TARGET-30-PARZIP	11q-	normal
TARGET-30-PARZIP	17q+	gain
TARGET-30-PARZIP	%tumor	80.0
TARGET-30-PARZIP	MKI	low
TARGET-30-PARZMY	age	1691
TARGET-30-PARZMY	age group	2-6
TARGET-30-PARZMY	stage	stage 4
TARGET-30-PARZMY	ATRX	unknown
TARGET-30-PARZMY	ALK	normal
TARGET-30-PARZMY	MYCN	amplified
TARGET-30-PARZMY	Histology	unfavorable
TARGET-30-PARZMY	Grade	undifferentiated or poorly differentiated
TARGET-30-PARZMY	Ploidy	diploid (di=1)
TARGET-30-PARZMY	Protocol	ANBL00B1-ANBL0532
TARGET-30-PARZMY	Category	neuroblastoma
TARGET-30-PARZMY	1p-	loss
TARGET-30-PARZMY	1q+	normal
TARGET-30-PARZMY	11q-	normal
TARGET-30-PARZMY	17q+	gain
TARGET-30-PARZMY	%tumor	70.0
TARGET-30-PARZMY	MKI	low
TARGET-30-PASAAN	age	1525
TARGET-30-PASAAN	age group	2-6
TARGET-30-PASAAN	stage	stage 4
TARGET-30-PASAAN	ATRX	deleted
TARGET-30-PASAAN	ALK	normal
TARGET-30-PASAAN	MYCN	not amplified
TARGET-30-PASAAN	Histology	unfavorable
TARGET-30-PASAAN	Grade	undifferentiated or poorly differentiated
TARGET-30-PASAAN	Ploidy	hyperdiploid (di>1)
TARGET-30-PASAAN	Protocol	ANBL00B1-ANBL0532-AEPI07N1
TARGET-30-PASAAN	Category	neuroblastoma
TARGET-30-PASAAN	1p-	normal
TARGET-30-PASAAN	1q+	normal
TARGET-30-PASAAN	11q-	loss
TARGET-30-PASAAN	17q+	gain
TARGET-30-PASAAN	%tumor	10.0
TARGET-30-PASAAN	MKI	low
TARGET-30-PASAJU	age	2140
TARGET-30-PASAJU	age group	2-6
TARGET-30-PASAJU	stage	stage 4
TARGET-30-PASAJU	ATRX	gain
TARGET-30-PASAJU	ALK	normal
TARGET-30-PASAJU	MYCN	not amplified
TARGET-30-PASAJU	Histology	unfavorable
TARGET-30-PASAJU	Grade	undifferentiated or poorly differentiated
TARGET-30-PASAJU	Ploidy	hyperdiploid (di>1)
TARGET-30-PASAJU	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PASAJU	Category	ganglioneuroblastoma, nodular
TARGET-30-PASAJU	1p-	normal
TARGET-30-PASAJU	1q+	normal
TARGET-30-PASAJU	11q-	normal
TARGET-30-PASAJU	17q+	gain
TARGET-30-PASAJU	%tumor	50.0
TARGET-30-PASAJU	MKI	intermediate
TARGET-30-PASATK	age	893
TARGET-30-PASATK	age group	2-6
TARGET-30-PASATK	stage	stage 4
TARGET-30-PASATK	ATRX	unknown
TARGET-30-PASATK	ALK	
TARGET-30-PASATK	MYCN	not amplified
TARGET-30-PASATK	Histology	unfavorable
TARGET-30-PASATK	Grade	undifferentiated or poorly differentiated
TARGET-30-PASATK	Ploidy	hyperdiploid (di>1)
TARGET-30-PASATK	Protocol	ANBL00B1
TARGET-30-PASATK	Category	neuroblastoma
TARGET-30-PASATK	1p-	unknown
TARGET-30-PASATK	1q+	unknown
TARGET-30-PASATK	11q-	unknown
TARGET-30-PASATK	17q+	unknown
TARGET-30-PASATK	%tumor	90.0
TARGET-30-PASATK	MKI	high
TARGET-30-PASAZJ	age	1764
TARGET-30-PASAZJ	age group	2-6
TARGET-30-PASAZJ	stage	stage 4
TARGET-30-PASAZJ	ATRX	unknown
TARGET-30-PASAZJ	ALK	mutated
TARGET-30-PASAZJ	MYCN	not amplified
TARGET-30-PASAZJ	Histology	unfavorable
TARGET-30-PASAZJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PASAZJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PASAZJ	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PASAZJ	Category	neuroblastoma
TARGET-30-PASAZJ	1p-	normal
TARGET-30-PASAZJ	1q+	normal
TARGET-30-PASAZJ	11q-	normal
TARGET-30-PASAZJ	17q+	gain
TARGET-30-PASAZJ	%tumor	80.0
TARGET-30-PASAZJ	MKI	high
TARGET-30-PASBEN	age	1543
TARGET-30-PASBEN	age group	2-6
TARGET-30-PASBEN	stage	stage 4
TARGET-30-PASBEN	ATRX	unknown
TARGET-30-PASBEN	ALK	
TARGET-30-PASBEN	MYCN	not amplified
TARGET-30-PASBEN	Histology	unfavorable
TARGET-30-PASBEN	Grade	undifferentiated or poorly differentiated
TARGET-30-PASBEN	Ploidy	hyperdiploid (di>1)
TARGET-30-PASBEN	Protocol	ANBL00B1
TARGET-30-PASBEN	Category	ganglioneuroblastoma, nodular
TARGET-30-PASBEN	1p-	unknown
TARGET-30-PASBEN	1q+	unknown
TARGET-30-PASBEN	11q-	unknown
TARGET-30-PASBEN	17q+	unknown
TARGET-30-PASBEN	%tumor	60.0
TARGET-30-PASBEN	MKI	low
TARGET-30-PASBGV	age	1304
TARGET-30-PASBGV	age group	2-6
TARGET-30-PASBGV	stage	stage 4
TARGET-30-PASBGV	ATRX	unknown
TARGET-30-PASBGV	ALK	normal
TARGET-30-PASBGV	MYCN	not amplified
TARGET-30-PASBGV	Histology	unknown
TARGET-30-PASBGV	Grade	unknown
TARGET-30-PASBGV	Ploidy	hyperdiploid (di>1)
TARGET-30-PASBGV	Protocol	ANBL00B1-ANBL0532-ADVL0921
TARGET-30-PASBGV	Category	unknown
TARGET-30-PASBGV	1p-	normal
TARGET-30-PASBGV	1q+	normal
TARGET-30-PASBGV	11q-	loss
TARGET-30-PASBGV	17q+	gain
TARGET-30-PASBGV	%tumor	75.0
TARGET-30-PASBGV	MKI	
TARGET-30-PASCDX	age	652
TARGET-30-PASCDX	age group	1-2
TARGET-30-PASCDX	stage	stage 4
TARGET-30-PASCDX	ATRX	unknown
TARGET-30-PASCDX	ALK	normal
TARGET-30-PASCDX	MYCN	amplified
TARGET-30-PASCDX	Histology	unfavorable
TARGET-30-PASCDX	Grade	undifferentiated or poorly differentiated
TARGET-30-PASCDX	Ploidy	hyperdiploid (di>1)
TARGET-30-PASCDX	Protocol	ANBL00B1-ANBL0532-AEPI07N1
TARGET-30-PASCDX	Category	neuroblastoma
TARGET-30-PASCDX	1p-	loss
TARGET-30-PASCDX	1q+	gain
TARGET-30-PASCDX	11q-	normal
TARGET-30-PASCDX	17q+	gain
TARGET-30-PASCDX	%tumor	60.0
TARGET-30-PASCDX	MKI	high
TARGET-30-PASCFC	age	18
TARGET-30-PASCFC	age group	0-1
TARGET-30-PASCFC	stage	stage 4s
TARGET-30-PASCFC	ATRX	normal
TARGET-30-PASCFC	ALK	
TARGET-30-PASCFC	MYCN	not amplified
TARGET-30-PASCFC	Histology	favorable
TARGET-30-PASCFC	Grade	undifferentiated or poorly differentiated
TARGET-30-PASCFC	Ploidy	hyperdiploid (di>1)
TARGET-30-PASCFC	Protocol	ANBL00B1
TARGET-30-PASCFC	Category	neuroblastoma
TARGET-30-PASCFC	1p-	unknown
TARGET-30-PASCFC	1q+	unknown
TARGET-30-PASCFC	11q-	unknown
TARGET-30-PASCFC	17q+	unknown
TARGET-30-PASCFC	%tumor	75.0
TARGET-30-PASCFC	MKI	low
TARGET-30-PASCJJ	age	1319
TARGET-30-PASCJJ	age group	2-6
TARGET-30-PASCJJ	stage	stage 4
TARGET-30-PASCJJ	ATRX	unknown
TARGET-30-PASCJJ	ALK	normal
TARGET-30-PASCJJ	MYCN	not amplified
TARGET-30-PASCJJ	Histology	unfavorable
TARGET-30-PASCJJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PASCJJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PASCJJ	Protocol	ANBL00B1-ANBL0032
TARGET-30-PASCJJ	Category	neuroblastoma
TARGET-30-PASCJJ	1p-	loss
TARGET-30-PASCJJ	1q+	gain
TARGET-30-PASCJJ	11q-	loss
TARGET-30-PASCJJ	17q+	gain
TARGET-30-PASCJJ	%tumor	40.0
TARGET-30-PASCJJ	MKI	high
TARGET-30-PASCKI	age	911
TARGET-30-PASCKI	age group	2-6
TARGET-30-PASCKI	stage	stage 4
TARGET-30-PASCKI	ATRX	unknown
TARGET-30-PASCKI	ALK	normal
TARGET-30-PASCKI	MYCN	not amplified
TARGET-30-PASCKI	Histology	unfavorable
TARGET-30-PASCKI	Grade	undifferentiated or poorly differentiated
TARGET-30-PASCKI	Ploidy	diploid (di=1)
TARGET-30-PASCKI	Protocol	ANBL00B1
TARGET-30-PASCKI	Category	ganglioneuroblastoma, nodular
TARGET-30-PASCKI	1p-	normal
TARGET-30-PASCKI	1q+	normal
TARGET-30-PASCKI	11q-	loss
TARGET-30-PASCKI	17q+	gain
TARGET-30-PASCKI	%tumor	80.0
TARGET-30-PASCKI	MKI	intermediate
TARGET-30-PASCLP	age	644
TARGET-30-PASCLP	age group	1-2
TARGET-30-PASCLP	stage	stage 4
TARGET-30-PASCLP	ATRX	unknown
TARGET-30-PASCLP	ALK	normal
TARGET-30-PASCLP	MYCN	amplified
TARGET-30-PASCLP	Histology	unfavorable
TARGET-30-PASCLP	Grade	undifferentiated or poorly differentiated
TARGET-30-PASCLP	Ploidy	hyperdiploid (di>1)
TARGET-30-PASCLP	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PASCLP	Category	neuroblastoma
TARGET-30-PASCLP	1p-	loss
TARGET-30-PASCLP	1q+	normal
TARGET-30-PASCLP	11q-	normal
TARGET-30-PASCLP	17q+	gain
TARGET-30-PASCLP	%tumor	90.0
TARGET-30-PASCLP	MKI	high
TARGET-30-PASCTR	age	60
TARGET-30-PASCTR	age group	0-1
TARGET-30-PASCTR	stage	stage 4s
TARGET-30-PASCTR	ATRX	normal
TARGET-30-PASCTR	ALK	
TARGET-30-PASCTR	MYCN	not amplified
TARGET-30-PASCTR	Histology	favorable
TARGET-30-PASCTR	Grade	undifferentiated or poorly differentiated
TARGET-30-PASCTR	Ploidy	hyperdiploid (di>1)
TARGET-30-PASCTR	Protocol	ANBL00B1-ANBL0531
TARGET-30-PASCTR	Category	neuroblastoma
TARGET-30-PASCTR	1p-	unknown
TARGET-30-PASCTR	1q+	unknown
TARGET-30-PASCTR	11q-	unknown
TARGET-30-PASCTR	17q+	unknown
TARGET-30-PASCTR	%tumor	40.0
TARGET-30-PASCTR	MKI	low
TARGET-30-PASCUF	age	1622
TARGET-30-PASCUF	age group	2-6
TARGET-30-PASCUF	stage	stage 4
TARGET-30-PASCUF	ATRX	unknown
TARGET-30-PASCUF	ALK	
TARGET-30-PASCUF	MYCN	not amplified
TARGET-30-PASCUF	Histology	unknown
TARGET-30-PASCUF	Grade	undifferentiated or poorly differentiated
TARGET-30-PASCUF	Ploidy	hyperdiploid (di>1)
TARGET-30-PASCUF	Protocol	ANBL00B1-ANBL0532-ANBL0032-ACCL05C1
TARGET-30-PASCUF	Category	neuroblastoma
TARGET-30-PASCUF	1p-	unknown
TARGET-30-PASCUF	1q+	unknown
TARGET-30-PASCUF	11q-	unknown
TARGET-30-PASCUF	17q+	unknown
TARGET-30-PASCUF	%tumor	60.0
TARGET-30-PASCUF	MKI	high
TARGET-30-PASDZJ	age	902
TARGET-30-PASDZJ	age group	2-6
TARGET-30-PASDZJ	stage	stage 4
TARGET-30-PASDZJ	ATRX	unknown
TARGET-30-PASDZJ	ALK	normal
TARGET-30-PASDZJ	MYCN	amplified
TARGET-30-PASDZJ	Histology	unfavorable
TARGET-30-PASDZJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PASDZJ	Ploidy	diploid (di=1)
TARGET-30-PASDZJ	Protocol	ANBL00B1-ANBL0532
TARGET-30-PASDZJ	Category	neuroblastoma
TARGET-30-PASDZJ	1p-	normal
TARGET-30-PASDZJ	1q+	normal
TARGET-30-PASDZJ	11q-	normal
TARGET-30-PASDZJ	17q+	normal
TARGET-30-PASDZJ	%tumor	75.0
TARGET-30-PASDZJ	MKI	intermediate
TARGET-30-PASEGA	age	1091
TARGET-30-PASEGA	age group	2-6
TARGET-30-PASEGA	stage	stage 4
TARGET-30-PASEGA	ATRX	normal
TARGET-30-PASEGA	ALK	normal
TARGET-30-PASEGA	MYCN	not amplified
TARGET-30-PASEGA	Histology	unfavorable
TARGET-30-PASEGA	Grade	undifferentiated or poorly differentiated
TARGET-30-PASEGA	Ploidy	diploid (di=1)
TARGET-30-PASEGA	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PASEGA	Category	ganglioneuroblastoma, nodular
TARGET-30-PASEGA	1p-	normal
TARGET-30-PASEGA	1q+	gain
TARGET-30-PASEGA	11q-	loss
TARGET-30-PASEGA	17q+	normal
TARGET-30-PASEGA	%tumor	70.0
TARGET-30-PASEGA	MKI	high
TARGET-30-PASFGG	age	1037
TARGET-30-PASFGG	age group	2-6
TARGET-30-PASFGG	stage	stage 4
TARGET-30-PASFGG	ATRX	normal
TARGET-30-PASFGG	ALK	normal
TARGET-30-PASFGG	MYCN	not amplified
TARGET-30-PASFGG	Histology	unfavorable
TARGET-30-PASFGG	Grade	undifferentiated or poorly differentiated
TARGET-30-PASFGG	Ploidy	hyperdiploid (di>1)
TARGET-30-PASFGG	Protocol	ANBL00B1
TARGET-30-PASFGG	Category	neuroblastoma
TARGET-30-PASFGG	1p-	normal
TARGET-30-PASFGG	1q+	gain
TARGET-30-PASFGG	11q-	loss
TARGET-30-PASFGG	17q+	gain
TARGET-30-PASFGG	%tumor	60.0
TARGET-30-PASFGG	MKI	high
TARGET-30-PASFIC	age	51
TARGET-30-PASFIC	age group	0-1
TARGET-30-PASFIC	stage	stage 4s
TARGET-30-PASFIC	ATRX	normal
TARGET-30-PASFIC	ALK	
TARGET-30-PASFIC	MYCN	not amplified
TARGET-30-PASFIC	Histology	favorable
TARGET-30-PASFIC	Grade	undifferentiated or poorly differentiated
TARGET-30-PASFIC	Ploidy	hyperdiploid (di>1)
TARGET-30-PASFIC	Protocol	ANBL00B1-AEPI07N1
TARGET-30-PASFIC	Category	neuroblastoma
TARGET-30-PASFIC	1p-	unknown
TARGET-30-PASFIC	1q+	unknown
TARGET-30-PASFIC	11q-	unknown
TARGET-30-PASFIC	17q+	unknown
TARGET-30-PASFIC	%tumor	80.0
TARGET-30-PASFIC	MKI	low
TARGET-30-PASFNY	age	945
TARGET-30-PASFNY	age group	2-6
TARGET-30-PASFNY	stage	stage 4
TARGET-30-PASFNY	ATRX	unknown
TARGET-30-PASFNY	ALK	normal
TARGET-30-PASFNY	MYCN	amplified
TARGET-30-PASFNY	Histology	unfavorable
TARGET-30-PASFNY	Grade	undifferentiated or poorly differentiated
TARGET-30-PASFNY	Ploidy	hyperdiploid (di>1)
TARGET-30-PASFNY	Protocol	ANBL00B1-ANBL0532-AEPI07N1-ANBL0032
TARGET-30-PASFNY	Category	neuroblastoma
TARGET-30-PASFNY	1p-	normal
TARGET-30-PASFNY	1q+	gain
TARGET-30-PASFNY	11q-	normal
TARGET-30-PASFNY	17q+	gain
TARGET-30-PASFNY	%tumor	75.0
TARGET-30-PASFNY	MKI	intermediate
TARGET-30-PASFRV	age	1057
TARGET-30-PASFRV	age group	2-6
TARGET-30-PASFRV	stage	stage 4
TARGET-30-PASFRV	ATRX	unknown
TARGET-30-PASFRV	ALK	normal
TARGET-30-PASFRV	MYCN	not amplified
TARGET-30-PASFRV	Histology	unfavorable
TARGET-30-PASFRV	Grade	undifferentiated or poorly differentiated
TARGET-30-PASFRV	Ploidy	hyperdiploid (di>1)
TARGET-30-PASFRV	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PASFRV	Category	ganglioneuroblastoma, nodular
TARGET-30-PASFRV	1p-	normal
TARGET-30-PASFRV	1q+	normal
TARGET-30-PASFRV	11q-	loss
TARGET-30-PASFRV	17q+	gain
TARGET-30-PASFRV	%tumor	90.0
TARGET-30-PASFRV	MKI	high
TARGET-30-PASGAP	age	1330
TARGET-30-PASGAP	age group	2-6
TARGET-30-PASGAP	stage	stage 4
TARGET-30-PASGAP	ATRX	normal
TARGET-30-PASGAP	ALK	normal
TARGET-30-PASGAP	MYCN	not amplified
TARGET-30-PASGAP	Histology	unfavorable
TARGET-30-PASGAP	Grade	undifferentiated or poorly differentiated
TARGET-30-PASGAP	Ploidy	diploid (di=1)
TARGET-30-PASGAP	Protocol	ANBL00B1-ANBL0032
TARGET-30-PASGAP	Category	ganglioneuroblastoma, nodular
TARGET-30-PASGAP	1p-	normal
TARGET-30-PASGAP	1q+	normal
TARGET-30-PASGAP	11q-	loss
TARGET-30-PASGAP	17q+	gain
TARGET-30-PASGAP	%tumor	90.0
TARGET-30-PASGAP	MKI	low
TARGET-30-PASGPY	age	1972
TARGET-30-PASGPY	age group	2-6
TARGET-30-PASGPY	stage	stage 4
TARGET-30-PASGPY	ATRX	unknown
TARGET-30-PASGPY	ALK	normal
TARGET-30-PASGPY	MYCN	not amplified
TARGET-30-PASGPY	Histology	unfavorable
TARGET-30-PASGPY	Grade	undifferentiated or poorly differentiated
TARGET-30-PASGPY	Ploidy	hyperdiploid (di>1)
TARGET-30-PASGPY	Protocol	ANBL00B1-ANBL0532
TARGET-30-PASGPY	Category	neuroblastoma
TARGET-30-PASGPY	1p-	normal
TARGET-30-PASGPY	1q+	normal
TARGET-30-PASGPY	11q-	normal
TARGET-30-PASGPY	17q+	gain
TARGET-30-PASGPY	%tumor	80.0
TARGET-30-PASGPY	MKI	low
TARGET-30-PASGUT	age	1259
TARGET-30-PASGUT	age group	2-6
TARGET-30-PASGUT	stage	stage 4
TARGET-30-PASGUT	ATRX	normal
TARGET-30-PASGUT	ALK	normal
TARGET-30-PASGUT	MYCN	not amplified
TARGET-30-PASGUT	Histology	unfavorable
TARGET-30-PASGUT	Grade	undifferentiated or poorly differentiated
TARGET-30-PASGUT	Ploidy	diploid (di=1)
TARGET-30-PASGUT	Protocol	ANBL00B1
TARGET-30-PASGUT	Category	ganglioneuroblastoma, nodular
TARGET-30-PASGUT	1p-	normal
TARGET-30-PASGUT	1q+	normal
TARGET-30-PASGUT	11q-	loss
TARGET-30-PASGUT	17q+	gain
TARGET-30-PASGUT	%tumor	90.0
TARGET-30-PASGUT	MKI	low
TARGET-30-PASHFA	age	406
TARGET-30-PASHFA	age group	1-2
TARGET-30-PASHFA	stage	stage 3
TARGET-30-PASHFA	ATRX	unknown
TARGET-30-PASHFA	ALK	
TARGET-30-PASHFA	MYCN	amplified
TARGET-30-PASHFA	Histology	unfavorable
TARGET-30-PASHFA	Grade	undifferentiated or poorly differentiated
TARGET-30-PASHFA	Ploidy	diploid (di=1)
TARGET-30-PASHFA	Protocol	ANBL00B1-ANBL0532-ANBL0531
TARGET-30-PASHFA	Category	neuroblastoma
TARGET-30-PASHFA	1p-	unknown
TARGET-30-PASHFA	1q+	unknown
TARGET-30-PASHFA	11q-	unknown
TARGET-30-PASHFA	17q+	unknown
TARGET-30-PASHFA	%tumor	60.0
TARGET-30-PASHFA	MKI	high
TARGET-30-PASJRT	age	741
TARGET-30-PASJRT	age group	2-6
TARGET-30-PASJRT	stage	stage 4
TARGET-30-PASJRT	ATRX	unknown
TARGET-30-PASJRT	ALK	
TARGET-30-PASJRT	MYCN	amplified
TARGET-30-PASJRT	Histology	unfavorable
TARGET-30-PASJRT	Grade	undifferentiated or poorly differentiated
TARGET-30-PASJRT	Ploidy	diploid (di=1)
TARGET-30-PASJRT	Protocol	ANBL00B1-ANBL0532-AEPI07N1-ANBL0032-ALTE05N1
TARGET-30-PASJRT	Category	neuroblastoma
TARGET-30-PASJRT	1p-	unknown
TARGET-30-PASJRT	1q+	unknown
TARGET-30-PASJRT	11q-	unknown
TARGET-30-PASJRT	17q+	unknown
TARGET-30-PASJRT	%tumor	80.0
TARGET-30-PASJRT	MKI	high
TARGET-30-PASJYB	age	522
TARGET-30-PASJYB	age group	1-2
TARGET-30-PASJYB	stage	stage 4
TARGET-30-PASJYB	ATRX	unknown
TARGET-30-PASJYB	ALK	
TARGET-30-PASJYB	MYCN	amplified
TARGET-30-PASJYB	Histology	unfavorable
TARGET-30-PASJYB	Grade	undifferentiated or poorly differentiated
TARGET-30-PASJYB	Ploidy	diploid (di=1)
TARGET-30-PASJYB	Protocol	ANBL00B1-ANBL0532-ADVL06B1-ALTE05N1
TARGET-30-PASJYB	Category	neuroblastoma
TARGET-30-PASJYB	1p-	unknown
TARGET-30-PASJYB	1q+	unknown
TARGET-30-PASJYB	11q-	unknown
TARGET-30-PASJYB	17q+	unknown
TARGET-30-PASJYB	%tumor	
TARGET-30-PASJYB	MKI	high
TARGET-30-PASJZC	age	74
TARGET-30-PASJZC	age group	0-1
TARGET-30-PASJZC	stage	stage 4s
TARGET-30-PASJZC	ATRX	normal
TARGET-30-PASJZC	ALK	
TARGET-30-PASJZC	MYCN	amplified
TARGET-30-PASJZC	Histology	favorable
TARGET-30-PASJZC	Grade	undifferentiated or poorly differentiated
TARGET-30-PASJZC	Ploidy	hyperdiploid (di>1)
TARGET-30-PASJZC	Protocol	ANBL00B1
TARGET-30-PASJZC	Category	neuroblastoma
TARGET-30-PASJZC	1p-	unknown
TARGET-30-PASJZC	1q+	unknown
TARGET-30-PASJZC	11q-	unknown
TARGET-30-PASJZC	17q+	unknown
TARGET-30-PASJZC	%tumor	55.0
TARGET-30-PASJZC	MKI	low
TARGET-30-PASKFV	age	992
TARGET-30-PASKFV	age group	2-6
TARGET-30-PASKFV	stage	stage 4
TARGET-30-PASKFV	ATRX	unknown
TARGET-30-PASKFV	ALK	mutated
TARGET-30-PASKFV	MYCN	amplified
TARGET-30-PASKFV	Histology	unfavorable
TARGET-30-PASKFV	Grade	undifferentiated or poorly differentiated
TARGET-30-PASKFV	Ploidy	hyperdiploid (di>1)
TARGET-30-PASKFV	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PASKFV	Category	neuroblastoma
TARGET-30-PASKFV	1p-	normal
TARGET-30-PASKFV	1q+	normal
TARGET-30-PASKFV	11q-	normal
TARGET-30-PASKFV	17q+	gain
TARGET-30-PASKFV	%tumor	90.0
TARGET-30-PASKFV	MKI	low
TARGET-30-PASKJX	age	7446
TARGET-30-PASKJX	age group	9-
TARGET-30-PASKJX	stage	stage 4
TARGET-30-PASKJX	ATRX	unknown
TARGET-30-PASKJX	ALK	
TARGET-30-PASKJX	MYCN	not amplified
TARGET-30-PASKJX	Histology	unfavorable
TARGET-30-PASKJX	Grade	undifferentiated or poorly differentiated
TARGET-30-PASKJX	Ploidy	diploid (di=1)
TARGET-30-PASKJX	Protocol	ANBL00B1-ANBL0532-ANBL1021
TARGET-30-PASKJX	Category	neuroblastoma
TARGET-30-PASKJX	1p-	unknown
TARGET-30-PASKJX	1q+	unknown
TARGET-30-PASKJX	11q-	unknown
TARGET-30-PASKJX	17q+	unknown
TARGET-30-PASKJX	%tumor	90.0
TARGET-30-PASKJX	MKI	intermediate
TARGET-30-PASKTB	age	1425
TARGET-30-PASKTB	age group	2-6
TARGET-30-PASKTB	stage	stage 4
TARGET-30-PASKTB	ATRX	unknown
TARGET-30-PASKTB	ALK	normal
TARGET-30-PASKTB	MYCN	not amplified
TARGET-30-PASKTB	Histology	unfavorable
TARGET-30-PASKTB	Grade	undifferentiated or poorly differentiated
TARGET-30-PASKTB	Ploidy	diploid (di=1)
TARGET-30-PASKTB	Protocol	ANBL00B1-AEPI07N1-ANBL0032
TARGET-30-PASKTB	Category	ganglioneuroblastoma, nodular
TARGET-30-PASKTB	1p-	normal
TARGET-30-PASKTB	1q+	normal
TARGET-30-PASKTB	11q-	normal
TARGET-30-PASKTB	17q+	normal
TARGET-30-PASKTB	%tumor	90.0
TARGET-30-PASKTB	MKI	low
TARGET-30-PASLGS	age	1218
TARGET-30-PASLGS	age group	2-6
TARGET-30-PASLGS	stage	stage 4
TARGET-30-PASLGS	ATRX	unknown
TARGET-30-PASLGS	ALK	normal
TARGET-30-PASLGS	MYCN	not amplified
TARGET-30-PASLGS	Histology	unfavorable
TARGET-30-PASLGS	Grade	undifferentiated or poorly differentiated
TARGET-30-PASLGS	Ploidy	hyperdiploid (di>1)
TARGET-30-PASLGS	Protocol	ANBL00B1-ANBL0532-ANBL0931
TARGET-30-PASLGS	Category	neuroblastoma
TARGET-30-PASLGS	1p-	normal
TARGET-30-PASLGS	1q+	normal
TARGET-30-PASLGS	11q-	loss
TARGET-30-PASLGS	17q+	gain
TARGET-30-PASLGS	%tumor	80.0
TARGET-30-PASLGS	MKI	intermediate
TARGET-30-PASMDM	age	25
TARGET-30-PASMDM	age group	0-1
TARGET-30-PASMDM	stage	stage 4s
TARGET-30-PASMDM	ATRX	normal
TARGET-30-PASMDM	ALK	
TARGET-30-PASMDM	MYCN	not amplified
TARGET-30-PASMDM	Histology	favorable
TARGET-30-PASMDM	Grade	undifferentiated or poorly differentiated
TARGET-30-PASMDM	Ploidy	hyperdiploid (di>1)
TARGET-30-PASMDM	Protocol	ANBL00B1
TARGET-30-PASMDM	Category	neuroblastoma
TARGET-30-PASMDM	1p-	unknown
TARGET-30-PASMDM	1q+	unknown
TARGET-30-PASMDM	11q-	unknown
TARGET-30-PASMDM	17q+	unknown
TARGET-30-PASMDM	%tumor	40.0
TARGET-30-PASMDM	MKI	low
TARGET-30-PASMJG	age	1765
TARGET-30-PASMJG	age group	2-6
TARGET-30-PASMJG	stage	stage 4
TARGET-30-PASMJG	ATRX	normal
TARGET-30-PASMJG	ALK	normal
TARGET-30-PASMJG	MYCN	not amplified
TARGET-30-PASMJG	Histology	unfavorable
TARGET-30-PASMJG	Grade	undifferentiated or poorly differentiated
TARGET-30-PASMJG	Ploidy	diploid (di=1)
TARGET-30-PASMJG	Protocol	ANBL00B1-ANBL0032
TARGET-30-PASMJG	Category	ganglioneuroblastoma, nodular
TARGET-30-PASMJG	1p-	normal
TARGET-30-PASMJG	1q+	normal
TARGET-30-PASMJG	11q-	normal
TARGET-30-PASMJG	17q+	normal
TARGET-30-PASMJG	%tumor	90.0
TARGET-30-PASMJG	MKI	
TARGET-30-PASMNT	age	4802
TARGET-30-PASMNT	age group	9-
TARGET-30-PASMNT	stage	stage 4
TARGET-30-PASMNT	ATRX	normal
TARGET-30-PASMNT	ALK	normal
TARGET-30-PASMNT	MYCN	not amplified
TARGET-30-PASMNT	Histology	unfavorable
TARGET-30-PASMNT	Grade	undifferentiated or poorly differentiated
TARGET-30-PASMNT	Ploidy	hyperdiploid (di>1)
TARGET-30-PASMNT	Protocol	ANBL00B1-ANBL0532
TARGET-30-PASMNT	Category	neuroblastoma
TARGET-30-PASMNT	1p-	normal
TARGET-30-PASMNT	1q+	normal
TARGET-30-PASMNT	11q-	loss
TARGET-30-PASMNT	17q+	gain
TARGET-30-PASMNT	%tumor	85.0
TARGET-30-PASMNT	MKI	intermediate
TARGET-30-PASNEF	age	696
TARGET-30-PASNEF	age group	1-2
TARGET-30-PASNEF	stage	stage 4
TARGET-30-PASNEF	ATRX	normal
TARGET-30-PASNEF	ALK	normal
TARGET-30-PASNEF	MYCN	not amplified
TARGET-30-PASNEF	Histology	unfavorable
TARGET-30-PASNEF	Grade	undifferentiated or poorly differentiated
TARGET-30-PASNEF	Ploidy	hyperdiploid (di>1)
TARGET-30-PASNEF	Protocol	ANBL00B1
TARGET-30-PASNEF	Category	neuroblastoma
TARGET-30-PASNEF	1p-	normal
TARGET-30-PASNEF	1q+	normal
TARGET-30-PASNEF	11q-	loss
TARGET-30-PASNEF	17q+	gain
TARGET-30-PASNEF	%tumor	85.0
TARGET-30-PASNEF	MKI	intermediate
TARGET-30-PASNML	age	8
TARGET-30-PASNML	age group	0-1
TARGET-30-PASNML	stage	stage 4s
TARGET-30-PASNML	ATRX	normal
TARGET-30-PASNML	ALK	
TARGET-30-PASNML	MYCN	not amplified
TARGET-30-PASNML	Histology	favorable
TARGET-30-PASNML	Grade	undifferentiated or poorly differentiated
TARGET-30-PASNML	Ploidy	hyperdiploid (di>1)
TARGET-30-PASNML	Protocol	ANBL00B1
TARGET-30-PASNML	Category	neuroblastoma
TARGET-30-PASNML	1p-	unknown
TARGET-30-PASNML	1q+	unknown
TARGET-30-PASNML	11q-	unknown
TARGET-30-PASNML	17q+	unknown
TARGET-30-PASNML	%tumor	90.0
TARGET-30-PASNML	MKI	intermediate
TARGET-30-PASNPG	age	318
TARGET-30-PASNPG	age group	0-1
TARGET-30-PASNPG	stage	stage 3
TARGET-30-PASNPG	ATRX	unknown
TARGET-30-PASNPG	ALK	
TARGET-30-PASNPG	MYCN	not amplified
TARGET-30-PASNPG	Histology	favorable
TARGET-30-PASNPG	Grade	undifferentiated or poorly differentiated
TARGET-30-PASNPG	Ploidy	hyperdiploid (di>1)
TARGET-30-PASNPG	Protocol	ANBL00B1-ANBL0531
TARGET-30-PASNPG	Category	neuroblastoma
TARGET-30-PASNPG	1p-	unknown
TARGET-30-PASNPG	1q+	unknown
TARGET-30-PASNPG	11q-	unknown
TARGET-30-PASNPG	17q+	unknown
TARGET-30-PASNPG	%tumor	90.0
TARGET-30-PASNPG	MKI	intermediate
TARGET-30-PASNZU	age	1099
TARGET-30-PASNZU	age group	2-6
TARGET-30-PASNZU	stage	stage 4
TARGET-30-PASNZU	ATRX	normal
TARGET-30-PASNZU	ALK	normal
TARGET-30-PASNZU	MYCN	amplified
TARGET-30-PASNZU	Histology	unfavorable
TARGET-30-PASNZU	Grade	undifferentiated or poorly differentiated
TARGET-30-PASNZU	Ploidy	diploid (di=1)
TARGET-30-PASNZU	Protocol	ANBL00B1-ANBL0532-ANBL1021-ANBL0032-ACCL0934
TARGET-30-PASNZU	Category	neuroblastoma
TARGET-30-PASNZU	1p-	loss
TARGET-30-PASNZU	1q+	normal
TARGET-30-PASNZU	11q-	normal
TARGET-30-PASNZU	17q+	gain
TARGET-30-PASNZU	%tumor	90.0
TARGET-30-PASNZU	MKI	high
TARGET-30-PASPBZ	age	62
TARGET-30-PASPBZ	age group	0-1
TARGET-30-PASPBZ	stage	stage 4s
TARGET-30-PASPBZ	ATRX	normal
TARGET-30-PASPBZ	ALK	
TARGET-30-PASPBZ	MYCN	not amplified
TARGET-30-PASPBZ	Histology	unfavorable
TARGET-30-PASPBZ	Grade	undifferentiated or poorly differentiated
TARGET-30-PASPBZ	Ploidy	diploid (di=1)
TARGET-30-PASPBZ	Protocol	ANBL00B1-ANBL0531
TARGET-30-PASPBZ	Category	neuroblastoma
TARGET-30-PASPBZ	1p-	unknown
TARGET-30-PASPBZ	1q+	unknown
TARGET-30-PASPBZ	11q-	unknown
TARGET-30-PASPBZ	17q+	unknown
TARGET-30-PASPBZ	%tumor	80.0
TARGET-30-PASPBZ	MKI	high
TARGET-30-PASPER	age	753
TARGET-30-PASPER	age group	2-6
TARGET-30-PASPER	stage	stage 4
TARGET-30-PASPER	ATRX	normal
TARGET-30-PASPER	ALK	normal
TARGET-30-PASPER	MYCN	not amplified
TARGET-30-PASPER	Histology	unfavorable
TARGET-30-PASPER	Grade	undifferentiated or poorly differentiated
TARGET-30-PASPER	Ploidy	diploid (di=1)
TARGET-30-PASPER	Protocol	ANBL00B1-ANBL0032
TARGET-30-PASPER	Category	neuroblastoma
TARGET-30-PASPER	1p-	normal
TARGET-30-PASPER	1q+	normal
TARGET-30-PASPER	11q-	normal
TARGET-30-PASPER	17q+	gain
TARGET-30-PASPER	%tumor	90.0
TARGET-30-PASPER	MKI	low
TARGET-30-PASREY	age	78
TARGET-30-PASREY	age group	0-1
TARGET-30-PASREY	stage	stage 4s
TARGET-30-PASREY	ATRX	unknown
TARGET-30-PASREY	ALK	
TARGET-30-PASREY	MYCN	not amplified
TARGET-30-PASREY	Histology	favorable
TARGET-30-PASREY	Grade	undifferentiated or poorly differentiated
TARGET-30-PASREY	Ploidy	hyperdiploid (di>1)
TARGET-30-PASREY	Protocol	ANBL00B1-AEPI07N1
TARGET-30-PASREY	Category	neuroblastoma
TARGET-30-PASREY	1p-	unknown
TARGET-30-PASREY	1q+	unknown
TARGET-30-PASREY	11q-	unknown
TARGET-30-PASREY	17q+	unknown
TARGET-30-PASREY	%tumor	60.0
TARGET-30-PASREY	MKI	low
TARGET-30-PASRFS	age	1328
TARGET-30-PASRFS	age group	2-6
TARGET-30-PASRFS	stage	stage 4
TARGET-30-PASRFS	ATRX	deleted
TARGET-30-PASRFS	ALK	normal
TARGET-30-PASRFS	MYCN	not amplified
TARGET-30-PASRFS	Histology	unfavorable
TARGET-30-PASRFS	Grade	undifferentiated or poorly differentiated
TARGET-30-PASRFS	Ploidy	diploid (di=1)
TARGET-30-PASRFS	Protocol	ANBL00B1-ANBL0032
TARGET-30-PASRFS	Category	neuroblastoma
TARGET-30-PASRFS	1p-	normal
TARGET-30-PASRFS	1q+	gain
TARGET-30-PASRFS	11q-	loss
TARGET-30-PASRFS	17q+	gain
TARGET-30-PASRFS	%tumor	70.0
TARGET-30-PASRFS	MKI	intermediate
TARGET-30-PASSRN	age	5345
TARGET-30-PASSRN	age group	9-
TARGET-30-PASSRN	stage	stage 4
TARGET-30-PASSRN	ATRX	normal
TARGET-30-PASSRN	ALK	normal
TARGET-30-PASSRN	MYCN	amplified
TARGET-30-PASSRN	Histology	unfavorable
TARGET-30-PASSRN	Grade	undifferentiated or poorly differentiated
TARGET-30-PASSRN	Ploidy	hyperdiploid (di>1)
TARGET-30-PASSRN	Protocol	ANBL00B1-ANBL0532-ANBL0931
TARGET-30-PASSRN	Category	neuroblastoma
TARGET-30-PASSRN	1p-	loss
TARGET-30-PASSRN	1q+	normal
TARGET-30-PASSRN	11q-	normal
TARGET-30-PASSRN	17q+	normal
TARGET-30-PASSRN	%tumor	35.0
TARGET-30-PASSRN	MKI	low
TARGET-30-PASSRS	age	2492
TARGET-30-PASSRS	age group	6-9
TARGET-30-PASSRS	stage	stage 4
TARGET-30-PASSRS	ATRX	normal
TARGET-30-PASSRS	ALK	normal
TARGET-30-PASSRS	MYCN	not amplified
TARGET-30-PASSRS	Histology	unfavorable
TARGET-30-PASSRS	Grade	undifferentiated or poorly differentiated
TARGET-30-PASSRS	Ploidy	hyperdiploid (di>1)
TARGET-30-PASSRS	Protocol	ANBL00B1-ANBL0532-ANBL0032-ADVL0912-ANBL1021
TARGET-30-PASSRS	Category	neuroblastoma
TARGET-30-PASSRS	1p-	loss
TARGET-30-PASSRS	1q+	normal
TARGET-30-PASSRS	11q-	loss
TARGET-30-PASSRS	17q+	gain
TARGET-30-PASSRS	%tumor	65.0
TARGET-30-PASSRS	MKI	intermediate
TARGET-30-PASSWB	age	910
TARGET-30-PASSWB	age group	2-6
TARGET-30-PASSWB	stage	stage 4
TARGET-30-PASSWB	ATRX	unknown
TARGET-30-PASSWB	ALK	normal
TARGET-30-PASSWB	MYCN	amplified
TARGET-30-PASSWB	Histology	unfavorable
TARGET-30-PASSWB	Grade	undifferentiated or poorly differentiated
TARGET-30-PASSWB	Ploidy	diploid (di=1)
TARGET-30-PASSWB	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PASSWB	Category	neuroblastoma
TARGET-30-PASSWB	1p-	loss
TARGET-30-PASSWB	1q+	normal
TARGET-30-PASSWB	11q-	normal
TARGET-30-PASSWB	17q+	gain
TARGET-30-PASSWB	%tumor	70.0
TARGET-30-PASSWB	MKI	high
TARGET-30-PASSWW	age	7
TARGET-30-PASSWW	age group	0-1
TARGET-30-PASSWW	stage	stage 4s
TARGET-30-PASSWW	ATRX	normal
TARGET-30-PASSWW	ALK	
TARGET-30-PASSWW	MYCN	not amplified
TARGET-30-PASSWW	Histology	favorable
TARGET-30-PASSWW	Grade	undifferentiated or poorly differentiated
TARGET-30-PASSWW	Ploidy	diploid (di=1)
TARGET-30-PASSWW	Protocol	ANBL00B1-ANBL0531-AEPI07N1
TARGET-30-PASSWW	Category	neuroblastoma
TARGET-30-PASSWW	1p-	unknown
TARGET-30-PASSWW	1q+	unknown
TARGET-30-PASSWW	11q-	unknown
TARGET-30-PASSWW	17q+	unknown
TARGET-30-PASSWW	%tumor	90.0
TARGET-30-PASSWW	MKI	low
TARGET-30-PASTCN	age	1900
TARGET-30-PASTCN	age group	2-6
TARGET-30-PASTCN	stage	stage 4
TARGET-30-PASTCN	ATRX	deleted
TARGET-30-PASTCN	ALK	normal
TARGET-30-PASTCN	MYCN	not amplified
TARGET-30-PASTCN	Histology	unfavorable
TARGET-30-PASTCN	Grade	undifferentiated or poorly differentiated
TARGET-30-PASTCN	Ploidy	diploid (di=1)
TARGET-30-PASTCN	Protocol	ANBL00B1-ANBL0532
TARGET-30-PASTCN	Category	neuroblastoma
TARGET-30-PASTCN	1p-	normal
TARGET-30-PASTCN	1q+	normal
TARGET-30-PASTCN	11q-	loss
TARGET-30-PASTCN	17q+	gain
TARGET-30-PASTCN	%tumor	50.0
TARGET-30-PASTCN	MKI	intermediate
TARGET-30-PASTKC	age	3035
TARGET-30-PASTKC	age group	6-9
TARGET-30-PASTKC	stage	stage 4
TARGET-30-PASTKC	ATRX	normal
TARGET-30-PASTKC	ALK	normal
TARGET-30-PASTKC	MYCN	not amplified
TARGET-30-PASTKC	Histology	unfavorable
TARGET-30-PASTKC	Grade	undifferentiated or poorly differentiated
TARGET-30-PASTKC	Ploidy	hyperdiploid (di>1)
TARGET-30-PASTKC	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PASTKC	Category	neuroblastoma
TARGET-30-PASTKC	1p-	normal
TARGET-30-PASTKC	1q+	gain
TARGET-30-PASTKC	11q-	loss
TARGET-30-PASTKC	17q+	gain
TARGET-30-PASTKC	%tumor	
TARGET-30-PASTKC	MKI	low
TARGET-30-PASTKW	age	716
TARGET-30-PASTKW	age group	1-2
TARGET-30-PASTKW	stage	stage 4
TARGET-30-PASTKW	ATRX	nonsense
TARGET-30-PASTKW	ALK	normal
TARGET-30-PASTKW	MYCN	not amplified
TARGET-30-PASTKW	Histology	unfavorable
TARGET-30-PASTKW	Grade	undifferentiated or poorly differentiated
TARGET-30-PASTKW	Ploidy	diploid (di=1)
TARGET-30-PASTKW	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PASTKW	Category	neuroblastoma
TARGET-30-PASTKW	1p-	normal
TARGET-30-PASTKW	1q+	normal
TARGET-30-PASTKW	11q-	loss
TARGET-30-PASTKW	17q+	gain
TARGET-30-PASTKW	%tumor	40.0
TARGET-30-PASTKW	MKI	low
TARGET-30-PASTXR	age	1100
TARGET-30-PASTXR	age group	2-6
TARGET-30-PASTXR	stage	stage 4
TARGET-30-PASTXR	ATRX	unknown
TARGET-30-PASTXR	ALK	normal
TARGET-30-PASTXR	MYCN	not amplified
TARGET-30-PASTXR	Histology	unfavorable
TARGET-30-PASTXR	Grade	undifferentiated or poorly differentiated
TARGET-30-PASTXR	Ploidy	hyperdiploid (di>1)
TARGET-30-PASTXR	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PASTXR	Category	neuroblastoma
TARGET-30-PASTXR	1p-	normal
TARGET-30-PASTXR	1q+	normal
TARGET-30-PASTXR	11q-	loss
TARGET-30-PASTXR	17q+	gain
TARGET-30-PASTXR	%tumor	90.0
TARGET-30-PASTXR	MKI	high
TARGET-30-PASUCB	age	1008
TARGET-30-PASUCB	age group	2-6
TARGET-30-PASUCB	stage	stage 4
TARGET-30-PASUCB	ATRX	normal
TARGET-30-PASUCB	ALK	normal
TARGET-30-PASUCB	MYCN	not amplified
TARGET-30-PASUCB	Histology	unfavorable
TARGET-30-PASUCB	Grade	undifferentiated or poorly differentiated
TARGET-30-PASUCB	Ploidy	diploid (di=1)
TARGET-30-PASUCB	Protocol	ANBL00B1-ANBL0532-AEPI07N1-ANBL0032
TARGET-30-PASUCB	Category	neuroblastoma
TARGET-30-PASUCB	1p-	loss
TARGET-30-PASUCB	1q+	gain
TARGET-30-PASUCB	11q-	normal
TARGET-30-PASUCB	17q+	gain
TARGET-30-PASUCB	%tumor	90.0
TARGET-30-PASUCB	MKI	low
TARGET-30-PASUML	age	4
TARGET-30-PASUML	age group	0-1
TARGET-30-PASUML	stage	stage 4s
TARGET-30-PASUML	ATRX	normal
TARGET-30-PASUML	ALK	
TARGET-30-PASUML	MYCN	not amplified
TARGET-30-PASUML	Histology	favorable
TARGET-30-PASUML	Grade	undifferentiated or poorly differentiated
TARGET-30-PASUML	Ploidy	diploid (di=1)
TARGET-30-PASUML	Protocol	ANBL00B1-ANBL0531
TARGET-30-PASUML	Category	neuroblastoma
TARGET-30-PASUML	1p-	unknown
TARGET-30-PASUML	1q+	unknown
TARGET-30-PASUML	11q-	unknown
TARGET-30-PASUML	17q+	unknown
TARGET-30-PASUML	%tumor	90.0
TARGET-30-PASUML	MKI	low
TARGET-30-PASUYG	age	1418
TARGET-30-PASUYG	age group	2-6
TARGET-30-PASUYG	stage	stage 4
TARGET-30-PASUYG	ATRX	normal
TARGET-30-PASUYG	ALK	normal
TARGET-30-PASUYG	MYCN	not amplified
TARGET-30-PASUYG	Histology	unfavorable
TARGET-30-PASUYG	Grade	undifferentiated or poorly differentiated
TARGET-30-PASUYG	Ploidy	hyperdiploid (di>1)
TARGET-30-PASUYG	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PASUYG	Category	neuroblastoma
TARGET-30-PASUYG	1p-	loss
TARGET-30-PASUYG	1q+	gain
TARGET-30-PASUYG	11q-	loss
TARGET-30-PASUYG	17q+	gain
TARGET-30-PASUYG	%tumor	60.0
TARGET-30-PASUYG	MKI	intermediate
TARGET-30-PASVRU	age	631
TARGET-30-PASVRU	age group	1-2
TARGET-30-PASVRU	stage	stage 4
TARGET-30-PASVRU	ATRX	normal
TARGET-30-PASVRU	ALK	mutated
TARGET-30-PASVRU	MYCN	amplified
TARGET-30-PASVRU	Histology	unfavorable
TARGET-30-PASVRU	Grade	undifferentiated or poorly differentiated
TARGET-30-PASVRU	Ploidy	diploid (di=1)
TARGET-30-PASVRU	Protocol	ANBL00B1-ANBL0532
TARGET-30-PASVRU	Category	neuroblastoma
TARGET-30-PASVRU	1p-	loss
TARGET-30-PASVRU	1q+	normal
TARGET-30-PASVRU	11q-	normal
TARGET-30-PASVRU	17q+	gain
TARGET-30-PASVRU	%tumor	80.0
TARGET-30-PASVRU	MKI	high
TARGET-30-PASWAU	age	1261
TARGET-30-PASWAU	age group	2-6
TARGET-30-PASWAU	stage	stage 4
TARGET-30-PASWAU	ATRX	unknown
TARGET-30-PASWAU	ALK	normal
TARGET-30-PASWAU	MYCN	not amplified
TARGET-30-PASWAU	Histology	unfavorable
TARGET-30-PASWAU	Grade	undifferentiated or poorly differentiated
TARGET-30-PASWAU	Ploidy	diploid (di=1)
TARGET-30-PASWAU	Protocol	ANBL00B1-ANBL0032
TARGET-30-PASWAU	Category	ganglioneuroblastoma, nodular
TARGET-30-PASWAU	1p-	normal
TARGET-30-PASWAU	1q+	normal
TARGET-30-PASWAU	11q-	normal
TARGET-30-PASWAU	17q+	normal
TARGET-30-PASWAU	%tumor	90.0
TARGET-30-PASWAU	MKI	
TARGET-30-PASWFB	age	727
TARGET-30-PASWFB	age group	1-2
TARGET-30-PASWFB	stage	stage 4
TARGET-30-PASWFB	ATRX	normal
TARGET-30-PASWFB	ALK	normal
TARGET-30-PASWFB	MYCN	amplified
TARGET-30-PASWFB	Histology	unfavorable
TARGET-30-PASWFB	Grade	undifferentiated or poorly differentiated
TARGET-30-PASWFB	Ploidy	hyperdiploid (di>1)
TARGET-30-PASWFB	Protocol	ANBL00B1
TARGET-30-PASWFB	Category	neuroblastoma
TARGET-30-PASWFB	1p-	loss
TARGET-30-PASWFB	1q+	normal
TARGET-30-PASWFB	11q-	normal
TARGET-30-PASWFB	17q+	gain
TARGET-30-PASWFB	%tumor	90.0
TARGET-30-PASWFB	MKI	high
TARGET-30-PASWIJ	age	2537
TARGET-30-PASWIJ	age group	6-9
TARGET-30-PASWIJ	stage	stage 4
TARGET-30-PASWIJ	ATRX	normal
TARGET-30-PASWIJ	ALK	normal
TARGET-30-PASWIJ	MYCN	not amplified
TARGET-30-PASWIJ	Histology	unfavorable
TARGET-30-PASWIJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PASWIJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PASWIJ	Protocol	ANBL00B1-ANBL0532-ANBL0931
TARGET-30-PASWIJ	Category	neuroblastoma
TARGET-30-PASWIJ	1p-	normal
TARGET-30-PASWIJ	1q+	gain
TARGET-30-PASWIJ	11q-	loss
TARGET-30-PASWIJ	17q+	gain
TARGET-30-PASWIJ	%tumor	80.0
TARGET-30-PASWIJ	MKI	intermediate
TARGET-30-PASWLY	age	979
TARGET-30-PASWLY	age group	2-6
TARGET-30-PASWLY	stage	stage 4
TARGET-30-PASWLY	ATRX	unknown
TARGET-30-PASWLY	ALK	normal
TARGET-30-PASWLY	MYCN	not amplified
TARGET-30-PASWLY	Histology	unfavorable
TARGET-30-PASWLY	Grade	undifferentiated or poorly differentiated
TARGET-30-PASWLY	Ploidy	diploid (di=1)
TARGET-30-PASWLY	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PASWLY	Category	neuroblastoma
TARGET-30-PASWLY	1p-	normal
TARGET-30-PASWLY	1q+	normal
TARGET-30-PASWLY	11q-	loss
TARGET-30-PASWLY	17q+	gain
TARGET-30-PASWLY	%tumor	
TARGET-30-PASWLY	MKI	low
TARGET-30-PASWVY	age	2477
TARGET-30-PASWVY	age group	6-9
TARGET-30-PASWVY	stage	stage 4
TARGET-30-PASWVY	ATRX	normal
TARGET-30-PASWVY	ALK	normal
TARGET-30-PASWVY	MYCN	not amplified
TARGET-30-PASWVY	Histology	unfavorable
TARGET-30-PASWVY	Grade	undifferentiated or poorly differentiated
TARGET-30-PASWVY	Ploidy	hyperdiploid (di>1)
TARGET-30-PASWVY	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PASWVY	Category	ganglioneuroblastoma, nodular
TARGET-30-PASWVY	1p-	normal
TARGET-30-PASWVY	1q+	normal
TARGET-30-PASWVY	11q-	loss
TARGET-30-PASWVY	17q+	gain
TARGET-30-PASWVY	%tumor	60.0
TARGET-30-PASWVY	MKI	intermediate
TARGET-30-PASWYR	age	958
TARGET-30-PASWYR	age group	2-6
TARGET-30-PASWYR	stage	stage 4
TARGET-30-PASWYR	ATRX	normal
TARGET-30-PASWYR	ALK	normal
TARGET-30-PASWYR	MYCN	amplified
TARGET-30-PASWYR	Histology	unfavorable
TARGET-30-PASWYR	Grade	undifferentiated or poorly differentiated
TARGET-30-PASWYR	Ploidy	hyperdiploid (di>1)
TARGET-30-PASWYR	Protocol	ANBL00B1-AEPI07N1-ANBL0032
TARGET-30-PASWYR	Category	neuroblastoma
TARGET-30-PASWYR	1p-	loss
TARGET-30-PASWYR	1q+	normal
TARGET-30-PASWYR	11q-	normal
TARGET-30-PASWYR	17q+	gain
TARGET-30-PASWYR	%tumor	60.0
TARGET-30-PASWYR	MKI	high
TARGET-30-PASXGP	age	834
TARGET-30-PASXGP	age group	2-6
TARGET-30-PASXGP	stage	stage 4
TARGET-30-PASXGP	ATRX	normal
TARGET-30-PASXGP	ALK	normal
TARGET-30-PASXGP	MYCN	not amplified
TARGET-30-PASXGP	Histology	unfavorable
TARGET-30-PASXGP	Grade	undifferentiated or poorly differentiated
TARGET-30-PASXGP	Ploidy	hyperdiploid (di>1)
TARGET-30-PASXGP	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PASXGP	Category	ganglioneuroblastoma, nodular
TARGET-30-PASXGP	1p-	normal
TARGET-30-PASXGP	1q+	normal
TARGET-30-PASXGP	11q-	loss
TARGET-30-PASXGP	17q+	gain
TARGET-30-PASXGP	%tumor	20.0
TARGET-30-PASXGP	MKI	low
TARGET-30-PASXHE	age	1438
TARGET-30-PASXHE	age group	2-6
TARGET-30-PASXHE	stage	stage 4
TARGET-30-PASXHE	ATRX	normal
TARGET-30-PASXHE	ALK	normal
TARGET-30-PASXHE	MYCN	not amplified
TARGET-30-PASXHE	Histology	unfavorable
TARGET-30-PASXHE	Grade	undifferentiated or poorly differentiated
TARGET-30-PASXHE	Ploidy	diploid (di=1)
TARGET-30-PASXHE	Protocol	ANBL00B1-ANBL0532-AEPI07N1-ANBL0931
TARGET-30-PASXHE	Category	neuroblastoma
TARGET-30-PASXHE	1p-	normal
TARGET-30-PASXHE	1q+	normal
TARGET-30-PASXHE	11q-	loss
TARGET-30-PASXHE	17q+	gain
TARGET-30-PASXHE	%tumor	80.0
TARGET-30-PASXHE	MKI	intermediate
TARGET-30-PASXIE	age	837
TARGET-30-PASXIE	age group	2-6
TARGET-30-PASXIE	stage	stage 4
TARGET-30-PASXIE	ATRX	normal
TARGET-30-PASXIE	ALK	normal
TARGET-30-PASXIE	MYCN	amplified
TARGET-30-PASXIE	Histology	unfavorable
TARGET-30-PASXIE	Grade	undifferentiated or poorly differentiated
TARGET-30-PASXIE	Ploidy	diploid (di=1)
TARGET-30-PASXIE	Protocol	ANBL00B1-ANBL0532-AEPI07N1
TARGET-30-PASXIE	Category	neuroblastoma
TARGET-30-PASXIE	1p-	normal
TARGET-30-PASXIE	1q+	normal
TARGET-30-PASXIE	11q-	normal
TARGET-30-PASXIE	17q+	gain
TARGET-30-PASXIE	%tumor	
TARGET-30-PASXIE	MKI	intermediate
TARGET-30-PASXNN	age	3598
TARGET-30-PASXNN	age group	9-
TARGET-30-PASXNN	stage	stage 4
TARGET-30-PASXNN	ATRX	unknown
TARGET-30-PASXNN	ALK	normal
TARGET-30-PASXNN	MYCN	not amplified
TARGET-30-PASXNN	Histology	unfavorable
TARGET-30-PASXNN	Grade	undifferentiated or poorly differentiated
TARGET-30-PASXNN	Ploidy	hyperdiploid (di>1)
TARGET-30-PASXNN	Protocol	ANBL00B1-ANBL0532
TARGET-30-PASXNN	Category	neuroblastoma
TARGET-30-PASXNN	1p-	normal
TARGET-30-PASXNN	1q+	normal
TARGET-30-PASXNN	11q-	loss
TARGET-30-PASXNN	17q+	gain
TARGET-30-PASXNN	%tumor	80.0
TARGET-30-PASXNN	MKI	intermediate
TARGET-30-PASXRG	age	1278
TARGET-30-PASXRG	age group	2-6
TARGET-30-PASXRG	stage	stage 4
TARGET-30-PASXRG	ATRX	normal
TARGET-30-PASXRG	ALK	normal
TARGET-30-PASXRG	MYCN	amplified
TARGET-30-PASXRG	Histology	unfavorable
TARGET-30-PASXRG	Grade	undifferentiated or poorly differentiated
TARGET-30-PASXRG	Ploidy	hyperdiploid (di>1)
TARGET-30-PASXRG	Protocol	ANBL00B1-ANBL0532-AEPI07N1-ANBL0931
TARGET-30-PASXRG	Category	ganglioneuroblastoma, nodular
TARGET-30-PASXRG	1p-	loss
TARGET-30-PASXRG	1q+	gain
TARGET-30-PASXRG	11q-	loss
TARGET-30-PASXRG	17q+	gain
TARGET-30-PASXRG	%tumor	
TARGET-30-PASXRG	MKI	high
TARGET-30-PASXRJ	age	583
TARGET-30-PASXRJ	age group	1-2
TARGET-30-PASXRJ	stage	stage 4
TARGET-30-PASXRJ	ATRX	normal
TARGET-30-PASXRJ	ALK	normal
TARGET-30-PASXRJ	MYCN	not amplified
TARGET-30-PASXRJ	Histology	unfavorable
TARGET-30-PASXRJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PASXRJ	Ploidy	diploid (di=1)
TARGET-30-PASXRJ	Protocol	ANBL00B1-ANBL0532-AEPI07N1
TARGET-30-PASXRJ	Category	neuroblastoma
TARGET-30-PASXRJ	1p-	normal
TARGET-30-PASXRJ	1q+	normal
TARGET-30-PASXRJ	11q-	loss
TARGET-30-PASXRJ	17q+	gain
TARGET-30-PASXRJ	%tumor	60.0
TARGET-30-PASXRJ	MKI	low
TARGET-30-PASYLD	age	2015
TARGET-30-PASYLD	age group	2-6
TARGET-30-PASYLD	stage	stage 4
TARGET-30-PASYLD	ATRX	unknown
TARGET-30-PASYLD	ALK	normal
TARGET-30-PASYLD	MYCN	not amplified
TARGET-30-PASYLD	Histology	unknown
TARGET-30-PASYLD	Grade	unknown
TARGET-30-PASYLD	Ploidy	diploid (di=1)
TARGET-30-PASYLD	Protocol	ANBL00B1-ANBL0532
TARGET-30-PASYLD	Category	unknown
TARGET-30-PASYLD	1p-	normal
TARGET-30-PASYLD	1q+	normal
TARGET-30-PASYLD	11q-	loss
TARGET-30-PASYLD	17q+	normal
TARGET-30-PASYLD	%tumor	60.0
TARGET-30-PASYLD	MKI	
TARGET-30-PASYMX	age	2894
TARGET-30-PASYMX	age group	6-9
TARGET-30-PASYMX	stage	stage 4
TARGET-30-PASYMX	ATRX	normal
TARGET-30-PASYMX	ALK	normal
TARGET-30-PASYMX	MYCN	not amplified
TARGET-30-PASYMX	Histology	unfavorable
TARGET-30-PASYMX	Grade	undifferentiated or poorly differentiated
TARGET-30-PASYMX	Ploidy	hyperdiploid (di>1)
TARGET-30-PASYMX	Protocol	ANBL00B1-ANBL0532-ADVL0918
TARGET-30-PASYMX	Category	neuroblastoma
TARGET-30-PASYMX	1p-	normal
TARGET-30-PASYMX	1q+	normal
TARGET-30-PASYMX	11q-	loss
TARGET-30-PASYMX	17q+	gain
TARGET-30-PASYMX	%tumor	70.0
TARGET-30-PASYMX	MKI	high
TARGET-30-PASYPX	age	1514
TARGET-30-PASYPX	age group	2-6
TARGET-30-PASYPX	stage	stage 4
TARGET-30-PASYPX	ATRX	normal
TARGET-30-PASYPX	ALK	normal
TARGET-30-PASYPX	MYCN	not amplified
TARGET-30-PASYPX	Histology	unfavorable
TARGET-30-PASYPX	Grade	undifferentiated or poorly differentiated
TARGET-30-PASYPX	Ploidy	hyperdiploid (di>1)
TARGET-30-PASYPX	Protocol	ANBL00B1-ANBL0532
TARGET-30-PASYPX	Category	neuroblastoma
TARGET-30-PASYPX	1p-	normal
TARGET-30-PASYPX	1q+	normal
TARGET-30-PASYPX	11q-	normal
TARGET-30-PASYPX	17q+	gain
TARGET-30-PASYPX	%tumor	
TARGET-30-PASYPX	MKI	intermediate
TARGET-30-PASZKE	age	31
TARGET-30-PASZKE	age group	0-1
TARGET-30-PASZKE	stage	stage 4s
TARGET-30-PASZKE	ATRX	normal
TARGET-30-PASZKE	ALK	
TARGET-30-PASZKE	MYCN	not amplified
TARGET-30-PASZKE	Histology	unknown
TARGET-30-PASZKE	Grade	undifferentiated or poorly differentiated
TARGET-30-PASZKE	Ploidy	hyperdiploid (di>1)
TARGET-30-PASZKE	Protocol	ANBL00B1-AEPI07N1
TARGET-30-PASZKE	Category	neuroblastoma
TARGET-30-PASZKE	1p-	unknown
TARGET-30-PASZKE	1q+	unknown
TARGET-30-PASZKE	11q-	unknown
TARGET-30-PASZKE	17q+	unknown
TARGET-30-PASZKE	%tumor	85.0
TARGET-30-PASZKE	MKI	high
TARGET-30-PASZPI	age	645
TARGET-30-PASZPI	age group	1-2
TARGET-30-PASZPI	stage	stage 4
TARGET-30-PASZPI	ATRX	normal
TARGET-30-PASZPI	ALK	normal
TARGET-30-PASZPI	MYCN	amplified
TARGET-30-PASZPI	Histology	unfavorable
TARGET-30-PASZPI	Grade	undifferentiated or poorly differentiated
TARGET-30-PASZPI	Ploidy	hyperdiploid (di>1)
TARGET-30-PASZPI	Protocol	ANBL00B1-ANBL0532-ANBL0032
TARGET-30-PASZPI	Category	neuroblastoma
TARGET-30-PASZPI	1p-	normal
TARGET-30-PASZPI	1q+	normal
TARGET-30-PASZPI	11q-	normal
TARGET-30-PASZPI	17q+	gain
TARGET-30-PASZPI	%tumor	40.0
TARGET-30-PASZPI	MKI	high
TARGET-30-PATAYJ	age	52
TARGET-30-PATAYJ	age group	0-1
TARGET-30-PATAYJ	stage	stage 4s
TARGET-30-PATAYJ	ATRX	normal
TARGET-30-PATAYJ	ALK	
TARGET-30-PATAYJ	MYCN	not amplified
TARGET-30-PATAYJ	Histology	favorable
TARGET-30-PATAYJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PATAYJ	Ploidy	hyperdiploid (di>1)
TARGET-30-PATAYJ	Protocol	ANBL00B1
TARGET-30-PATAYJ	Category	neuroblastoma
TARGET-30-PATAYJ	1p-	unknown
TARGET-30-PATAYJ	1q+	unknown
TARGET-30-PATAYJ	11q-	unknown
TARGET-30-PATAYJ	17q+	unknown
TARGET-30-PATAYJ	%tumor	90.0
TARGET-30-PATAYJ	MKI	low
TARGET-30-PATBMM	age	1112
TARGET-30-PATBMM	age group	2-6
TARGET-30-PATBMM	stage	stage 4
TARGET-30-PATBMM	ATRX	normal
TARGET-30-PATBMM	ALK	normal
TARGET-30-PATBMM	MYCN	not amplified
TARGET-30-PATBMM	Histology	unfavorable
TARGET-30-PATBMM	Grade	undifferentiated or poorly differentiated
TARGET-30-PATBMM	Ploidy	hyperdiploid (di>1)
TARGET-30-PATBMM	Protocol	ANBL00B1-AEPI07N1-ANBL0032-ADVL0912
TARGET-30-PATBMM	Category	ganglioneuroblastoma, nodular
TARGET-30-PATBMM	1p-	loss
TARGET-30-PATBMM	1q+	gain
TARGET-30-PATBMM	11q-	loss
TARGET-30-PATBMM	17q+	gain
TARGET-30-PATBMM	%tumor	90.0
TARGET-30-PATBMM	MKI	low
TARGET-30-PATCFL	age	1041
TARGET-30-PATCFL	age group	2-6
TARGET-30-PATCFL	stage	stage 4
TARGET-30-PATCFL	ATRX	normal
TARGET-30-PATCFL	ALK	normal
TARGET-30-PATCFL	MYCN	not amplified
TARGET-30-PATCFL	Histology	unfavorable
TARGET-30-PATCFL	Grade	undifferentiated or poorly differentiated
TARGET-30-PATCFL	Ploidy	diploid (di=1)
TARGET-30-PATCFL	Protocol	ANBL00B1-AEPI07N1-ANBL0032
TARGET-30-PATCFL	Category	neuroblastoma
TARGET-30-PATCFL	1p-	normal
TARGET-30-PATCFL	1q+	normal
TARGET-30-PATCFL	11q-	normal
TARGET-30-PATCFL	17q+	normal
TARGET-30-PATCFL	%tumor	
TARGET-30-PATCFL	MKI	intermediate
TARGET-30-PATDWN	age	1435
TARGET-30-PATDWN	age group	2-6
TARGET-30-PATDWN	stage	stage 4
TARGET-30-PATDWN	ATRX	normal
TARGET-30-PATDWN	ALK	normal
TARGET-30-PATDWN	MYCN	amplified
TARGET-30-PATDWN	Histology	unfavorable
TARGET-30-PATDWN	Grade	undifferentiated or poorly differentiated
TARGET-30-PATDWN	Ploidy	diploid (di=1)
TARGET-30-PATDWN	Protocol	ANBL00B1-ANBL0032
TARGET-30-PATDWN	Category	neuroblastoma
TARGET-30-PATDWN	1p-	normal
TARGET-30-PATDWN	1q+	normal
TARGET-30-PATDWN	11q-	normal
TARGET-30-PATDWN	17q+	normal
TARGET-30-PATDWN	%tumor	70.0
TARGET-30-PATDWN	MKI	high
TARGET-30-PATDXC	age	1659
TARGET-30-PATDXC	age group	2-6
TARGET-30-PATDXC	stage	stage 4
TARGET-30-PATDXC	ATRX	normal
TARGET-30-PATDXC	ALK	normal
TARGET-30-PATDXC	MYCN	not amplified
TARGET-30-PATDXC	Histology	unfavorable
TARGET-30-PATDXC	Grade	undifferentiated or poorly differentiated
TARGET-30-PATDXC	Ploidy	hyperdiploid (di>1)
TARGET-30-PATDXC	Protocol	ANBL00B1-ANBL0931
TARGET-30-PATDXC	Category	neuroblastoma
TARGET-30-PATDXC	1p-	normal
TARGET-30-PATDXC	1q+	gain
TARGET-30-PATDXC	11q-	normal
TARGET-30-PATDXC	17q+	gain
TARGET-30-PATDXC	%tumor	80.0
TARGET-30-PATDXC	MKI	high
TARGET-30-PATDXG	age	688
TARGET-30-PATDXG	age group	1-2
TARGET-30-PATDXG	stage	stage 4
TARGET-30-PATDXG	ATRX	unknown
TARGET-30-PATDXG	ALK	normal
TARGET-30-PATDXG	MYCN	amplified
TARGET-30-PATDXG	Histology	unfavorable
TARGET-30-PATDXG	Grade	undifferentiated or poorly differentiated
TARGET-30-PATDXG	Ploidy	hyperdiploid (di>1)
TARGET-30-PATDXG	Protocol	ANBL00B1-ANBL0032
TARGET-30-PATDXG	Category	neuroblastoma
TARGET-30-PATDXG	1p-	normal
TARGET-30-PATDXG	1q+	gain
TARGET-30-PATDXG	11q-	normal
TARGET-30-PATDXG	17q+	gain
TARGET-30-PATDXG	%tumor	90.0
TARGET-30-PATDXG	MKI	high
TARGET-30-PATEKG	age	1275
TARGET-30-PATEKG	age group	2-6
TARGET-30-PATEKG	stage	stage 4
TARGET-30-PATEKG	ATRX	unknown
TARGET-30-PATEKG	ALK	normal
TARGET-30-PATEKG	MYCN	not amplified
TARGET-30-PATEKG	Histology	unfavorable
TARGET-30-PATEKG	Grade	undifferentiated or poorly differentiated
TARGET-30-PATEKG	Ploidy	diploid (di=1)
TARGET-30-PATEKG	Protocol	ANBL00B1-ANBL0032
TARGET-30-PATEKG	Category	ganglioneuroblastoma, nodular
TARGET-30-PATEKG	1p-	normal
TARGET-30-PATEKG	1q+	normal
TARGET-30-PATEKG	11q-	normal
TARGET-30-PATEKG	17q+	normal
TARGET-30-PATEKG	%tumor	90.0
TARGET-30-PATEKG	MKI	intermediate
TARGET-30-PATEPF	age	1434
TARGET-30-PATEPF	age group	2-6
TARGET-30-PATEPF	stage	stage 4
TARGET-30-PATEPF	ATRX	normal
TARGET-30-PATEPF	ALK	normal
TARGET-30-PATEPF	MYCN	not amplified
TARGET-30-PATEPF	Histology	unfavorable
TARGET-30-PATEPF	Grade	undifferentiated or poorly differentiated
TARGET-30-PATEPF	Ploidy	diploid (di=1)
TARGET-30-PATEPF	Protocol	ANBL00B1
TARGET-30-PATEPF	Category	ganglioneuroblastoma, nodular
TARGET-30-PATEPF	1p-	normal
TARGET-30-PATEPF	1q+	normal
TARGET-30-PATEPF	11q-	loss
TARGET-30-PATEPF	17q+	gain
TARGET-30-PATEPF	%tumor	90.0
TARGET-30-PATEPF	MKI	high
TARGET-30-PATESI	age	752
TARGET-30-PATESI	age group	2-6
TARGET-30-PATESI	stage	stage 4
TARGET-30-PATESI	ATRX	normal
TARGET-30-PATESI	ALK	normal
TARGET-30-PATESI	MYCN	amplified
TARGET-30-PATESI	Histology	unfavorable
TARGET-30-PATESI	Grade	undifferentiated or poorly differentiated
TARGET-30-PATESI	Ploidy	diploid (di=1)
TARGET-30-PATESI	Protocol	ANBL00B1
TARGET-30-PATESI	Category	neuroblastoma
TARGET-30-PATESI	1p-	loss
TARGET-30-PATESI	1q+	normal
TARGET-30-PATESI	11q-	normal
TARGET-30-PATESI	17q+	gain
TARGET-30-PATESI	%tumor	75.0
TARGET-30-PATESI	MKI	high
TARGET-30-PATFCY	age	1040
TARGET-30-PATFCY	age group	2-6
TARGET-30-PATFCY	stage	stage 4
TARGET-30-PATFCY	ATRX	normal
TARGET-30-PATFCY	ALK	mutated
TARGET-30-PATFCY	MYCN	not amplified
TARGET-30-PATFCY	Histology	unfavorable
TARGET-30-PATFCY	Grade	undifferentiated or poorly differentiated
TARGET-30-PATFCY	Ploidy	hyperdiploid (di>1)
TARGET-30-PATFCY	Protocol	ANBL00B1-AEPI07N1
TARGET-30-PATFCY	Category	neuroblastoma
TARGET-30-PATFCY	1p-	normal
TARGET-30-PATFCY	1q+	normal
TARGET-30-PATFCY	11q-	loss
TARGET-30-PATFCY	17q+	gain
TARGET-30-PATFCY	%tumor	90.0
TARGET-30-PATFCY	MKI	high
TARGET-30-PATFIN	age	631
TARGET-30-PATFIN	age group	1-2
TARGET-30-PATFIN	stage	stage 4
TARGET-30-PATFIN	ATRX	unknown
TARGET-30-PATFIN	ALK	normal
TARGET-30-PATFIN	MYCN	amplified
TARGET-30-PATFIN	Histology	unfavorable
TARGET-30-PATFIN	Grade	undifferentiated or poorly differentiated
TARGET-30-PATFIN	Ploidy	diploid (di=1)
TARGET-30-PATFIN	Protocol	ANBL00B1
TARGET-30-PATFIN	Category	neuroblastoma
TARGET-30-PATFIN	1p-	loss
TARGET-30-PATFIN	1q+	normal
TARGET-30-PATFIN	11q-	normal
TARGET-30-PATFIN	17q+	gain
TARGET-30-PATFIN	%tumor	90.0
TARGET-30-PATFIN	MKI	high
TARGET-30-PATFXV	age	648
TARGET-30-PATFXV	age group	1-2
TARGET-30-PATFXV	stage	stage 4
TARGET-30-PATFXV	ATRX	normal
TARGET-30-PATFXV	ALK	mutated
TARGET-30-PATFXV	MYCN	amplified
TARGET-30-PATFXV	Histology	unfavorable
TARGET-30-PATFXV	Grade	undifferentiated or poorly differentiated
TARGET-30-PATFXV	Ploidy	diploid (di=1)
TARGET-30-PATFXV	Protocol	ANBL00B1-AEPI07N1
TARGET-30-PATFXV	Category	neuroblastoma
TARGET-30-PATFXV	1p-	loss
TARGET-30-PATFXV	1q+	normal
TARGET-30-PATFXV	11q-	normal
TARGET-30-PATFXV	17q+	gain
TARGET-30-PATFXV	%tumor	70.0
TARGET-30-PATFXV	MKI	high
TARGET-30-PATGJU	age	59
TARGET-30-PATGJU	age group	0-1
TARGET-30-PATGJU	stage	stage 4s
TARGET-30-PATGJU	ATRX	normal
TARGET-30-PATGJU	ALK	
TARGET-30-PATGJU	MYCN	not amplified
TARGET-30-PATGJU	Histology	favorable
TARGET-30-PATGJU	Grade	undifferentiated or poorly differentiated
TARGET-30-PATGJU	Ploidy	hyperdiploid (di>1)
TARGET-30-PATGJU	Protocol	ANBL00B1
TARGET-30-PATGJU	Category	neuroblastoma
TARGET-30-PATGJU	1p-	unknown
TARGET-30-PATGJU	1q+	unknown
TARGET-30-PATGJU	11q-	unknown
TARGET-30-PATGJU	17q+	unknown
TARGET-30-PATGJU	%tumor	40.0
TARGET-30-PATGJU	MKI	low
TARGET-30-PATGLU	age	1037
TARGET-30-PATGLU	age group	2-6
TARGET-30-PATGLU	stage	stage 4
TARGET-30-PATGLU	ATRX	deleted
TARGET-30-PATGLU	ALK	normal
TARGET-30-PATGLU	MYCN	not amplified
TARGET-30-PATGLU	Histology	unfavorable
TARGET-30-PATGLU	Grade	undifferentiated or poorly differentiated
TARGET-30-PATGLU	Ploidy	diploid (di=1)
TARGET-30-PATGLU	Protocol	ANBL00B1-AEPI07N1-ANBL0931
TARGET-30-PATGLU	Category	neuroblastoma
TARGET-30-PATGLU	1p-	normal
TARGET-30-PATGLU	1q+	normal
TARGET-30-PATGLU	11q-	loss
TARGET-30-PATGLU	17q+	gain
TARGET-30-PATGLU	%tumor	80.0
TARGET-30-PATGLU	MKI	intermediate
TARGET-30-PATGWT	age	591
TARGET-30-PATGWT	age group	1-2
TARGET-30-PATGWT	stage	stage 4
TARGET-30-PATGWT	ATRX	unknown
TARGET-30-PATGWT	ALK	normal
TARGET-30-PATGWT	MYCN	amplified
TARGET-30-PATGWT	Histology	unfavorable
TARGET-30-PATGWT	Grade	undifferentiated or poorly differentiated
TARGET-30-PATGWT	Ploidy	diploid (di=1)
TARGET-30-PATGWT	Protocol	ANBL00B1-ANBL0032
TARGET-30-PATGWT	Category	neuroblastoma
TARGET-30-PATGWT	1p-	loss
TARGET-30-PATGWT	1q+	normal
TARGET-30-PATGWT	11q-	normal
TARGET-30-PATGWT	17q+	gain
TARGET-30-PATGWT	%tumor	50.0
TARGET-30-PATGWT	MKI	high
TARGET-30-PATHKB	age	7
TARGET-30-PATHKB	age group	0-1
TARGET-30-PATHKB	stage	stage 4s
TARGET-30-PATHKB	ATRX	normal
TARGET-30-PATHKB	ALK	
TARGET-30-PATHKB	MYCN	not amplified
TARGET-30-PATHKB	Histology	favorable
TARGET-30-PATHKB	Grade	undifferentiated or poorly differentiated
TARGET-30-PATHKB	Ploidy	hyperdiploid (di>1)
TARGET-30-PATHKB	Protocol	ANBL00B1-ANBL0531
TARGET-30-PATHKB	Category	neuroblastoma
TARGET-30-PATHKB	1p-	unknown
TARGET-30-PATHKB	1q+	unknown
TARGET-30-PATHKB	11q-	unknown
TARGET-30-PATHKB	17q+	unknown
TARGET-30-PATHKB	%tumor	80.0
TARGET-30-PATHKB	MKI	low
TARGET-30-PATHVK	age	2109
TARGET-30-PATHVK	age group	2-6
TARGET-30-PATHVK	stage	stage 4
TARGET-30-PATHVK	ATRX	normal
TARGET-30-PATHVK	ALK	normal
TARGET-30-PATHVK	MYCN	not amplified
TARGET-30-PATHVK	Histology	unfavorable
TARGET-30-PATHVK	Grade	undifferentiated or poorly differentiated
TARGET-30-PATHVK	Ploidy	hyperdiploid (di>1)
TARGET-30-PATHVK	Protocol	ANBL00B1
TARGET-30-PATHVK	Category	neuroblastoma
TARGET-30-PATHVK	1p-	normal
TARGET-30-PATHVK	1q+	normal
TARGET-30-PATHVK	11q-	loss
TARGET-30-PATHVK	17q+	gain
TARGET-30-PATHVK	%tumor	90.0
TARGET-30-PATHVK	MKI	high
TARGET-30-PATILE	age	824
TARGET-30-PATILE	age group	2-6
TARGET-30-PATILE	stage	stage 4
TARGET-30-PATILE	ATRX	unknown
TARGET-30-PATILE	ALK	normal
TARGET-30-PATILE	MYCN	not amplified
TARGET-30-PATILE	Histology	unfavorable
TARGET-30-PATILE	Grade	undifferentiated or poorly differentiated
TARGET-30-PATILE	Ploidy	diploid (di=1)
TARGET-30-PATILE	Protocol	ANBL00B1
TARGET-30-PATILE	Category	neuroblastoma
TARGET-30-PATILE	1p-	normal
TARGET-30-PATILE	1q+	normal
TARGET-30-PATILE	11q-	loss
TARGET-30-PATILE	17q+	gain
TARGET-30-PATILE	%tumor	75.0
TARGET-30-PATILE	MKI	intermediate
TARGET-30-PATINJ	age	1037
TARGET-30-PATINJ	age group	2-6
TARGET-30-PATINJ	stage	stage 4
TARGET-30-PATINJ	ATRX	normal
TARGET-30-PATINJ	ALK	normal
TARGET-30-PATINJ	MYCN	not amplified
TARGET-30-PATINJ	Histology	unfavorable
TARGET-30-PATINJ	Grade	undifferentiated or poorly differentiated
TARGET-30-PATINJ	Ploidy	diploid (di=1)
TARGET-30-PATINJ	Protocol	ANBL00B1-AEPI07N1-ANBL0032
TARGET-30-PATINJ	Category	neuroblastoma
TARGET-30-PATINJ	1p-	normal
TARGET-30-PATINJ	1q+	normal
TARGET-30-PATINJ	11q-	loss
TARGET-30-PATINJ	17q+	gain
TARGET-30-PATINJ	%tumor	75.0
TARGET-30-PATINJ	MKI	intermediate
TARGET-30-PATNKP	age	3446
TARGET-30-PATNKP	age group	9-
TARGET-30-PATNKP	stage	stage 4
TARGET-30-PATNKP	ATRX	unknown
TARGET-30-PATNKP	ALK	
TARGET-30-PATNKP	MYCN	not amplified
TARGET-30-PATNKP	Histology	unfavorable
TARGET-30-PATNKP	Grade	undifferentiated or poorly differentiated
TARGET-30-PATNKP	Ploidy	hyperdiploid (di>1)
TARGET-30-PATNKP	Protocol	ANBL00B1-ANBL0532-ADVL0912-ANBL0931
TARGET-30-PATNKP	Category	neuroblastoma
TARGET-30-PATNKP	1p-	unknown
TARGET-30-PATNKP	1q+	unknown
TARGET-30-PATNKP	11q-	unknown
TARGET-30-PATNKP	17q+	unknown
TARGET-30-PATNKP	%tumor	90.0
TARGET-30-PATNKP	MKI	intermediate
TARGET-30-PATYIL	age	328
TARGET-30-PATYIL	age group	0-1
TARGET-30-PATYIL	stage	stage 4
TARGET-30-PATYIL	ATRX	unknown
TARGET-30-PATYIL	ALK	
TARGET-30-PATYIL	MYCN	not amplified
TARGET-30-PATYIL	Histology	favorable
TARGET-30-PATYIL	Grade	undifferentiated or poorly differentiated
TARGET-30-PATYIL	Ploidy	diploid (di=1)
TARGET-30-PATYIL	Protocol	ANBL00B1-ANBL0531
TARGET-30-PATYIL	Category	neuroblastoma
TARGET-30-PATYIL	1p-	unknown
TARGET-30-PATYIL	1q+	unknown
TARGET-30-PATYIL	11q-	unknown
TARGET-30-PATYIL	17q+	unknown
TARGET-30-PATYIL	%tumor	70.0
TARGET-30-PATYIL	MKI	intermediate
TARGET-30-PAUDDK	age	361
TARGET-30-PAUDDK	age group	0-1
TARGET-30-PAUDDK	stage	stage 3
TARGET-30-PAUDDK	ATRX	unknown
TARGET-30-PAUDDK	ALK	
TARGET-30-PAUDDK	MYCN	not amplified
TARGET-30-PAUDDK	Histology	favorable
TARGET-30-PAUDDK	Grade	undifferentiated or poorly differentiated
TARGET-30-PAUDDK	Ploidy	hyperdiploid (di>1)
TARGET-30-PAUDDK	Protocol	ANBL00B1-ANBL0531
TARGET-30-PAUDDK	Category	neuroblastoma
TARGET-30-PAUDDK	1p-	unknown
TARGET-30-PAUDDK	1q+	unknown
TARGET-30-PAUDDK	11q-	unknown
TARGET-30-PAUDDK	17q+	unknown
TARGET-30-PAUDDK	%tumor	70.0
TARGET-30-PAUDDK	MKI	low
